Unnamed: 0
stringlengths 3
8
| Date
stringlengths 23
23
| Article_title
stringlengths 1
250
| Stock_symbol
stringlengths 1
5
| Url
stringlengths 44
135
| Publisher
stringclasses 1
value | Author
stringclasses 1
value | Article
stringlengths 1
343k
| Lsa_summary
stringlengths 3
53.9k
| Luhn_summary
stringlengths 1
53.9k
| Textrank_summary
stringlengths 1
53.9k
| Lexrank_summary
stringlengths 1
53.9k
| uuid
stringlengths 36
36
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
715900.0
|
2023-02-07 00:00:00 UTC
|
DuPont de Nemours (DD) Tops Q4 Earnings and Revenue Estimates
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-dd-tops-q4-earnings-and-revenue-estimates-0
|
nan
|
nan
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $1.08 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 12.66%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $0.81 per share when it actually produced earnings of $0.82, delivering a surprise of 1.23%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
DuPont de Nemours, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $3.1 billion for the quarter ended December 2022, surpassing the Zacks Consensus Estimate by 0.67%. This compares to year-ago revenues of $4.27 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
DuPont de Nemours shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 7.1%.
What's Next for DuPont de Nemours?
While DuPont de Nemours has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for DuPont de Nemours: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.97 on $3.07 billion in revenues for the coming quarter and $3.86 on $12.62 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Albemarle (ALB), is yet to report results for the quarter ended December 2022. The results are expected to be released on February 15.
This specialty chemicals company is expected to post quarterly earnings of $7.89 per share in its upcoming report, which represents a year-over-year change of +681.2%. The consensus EPS estimate for the quarter has been revised 16.6% higher over the last 30 days to the current level.
Albemarle's revenues are expected to be $2.63 billion, up 193.7% from the year-ago quarter.
Free Report: Must-See Hydrogen Stocks
Hydrogen fuel cells are already used to provide efficient, ultra-clean energy to buses, ships and even hospitals. This technology is on the verge of a massive breakthrough, one that could make hydrogen a major source of America's power. It could even totally revolutionize the EV industry.
Zacks has released a special report revealing the 4 stocks experts believe will deliver the biggest gains.
Download Cashing In on Cleaner Energy today, absolutely free.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Albemarle Corporation (ALB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.79 per share. DuPont de Nemours shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 7.1%. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont de Nemours (DD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.79 per share. DuPont de Nemours shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 7.1%.
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.79 per share. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont de Nemours shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 7.1%.
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.79 per share. DuPont de Nemours shares have added about 5.4% since the beginning of the year versus the S&P 500's gain of 7.1%. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook.
|
2ed5deac-d68f-497e-b531-82a35eae0d3f
|
715901.0
|
2023-02-07 00:00:00 UTC
|
EI DuPont De Nemours & Co. Q4 Income Falls
|
DD
|
https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q4-income-falls
|
nan
|
nan
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) revealed earnings for fourth quarter that decreased from the same period last year
The company's earnings totaled $105 million, or $0.20 per share. This compares with $167 million, or $0.29 per share, in last year's fourth quarter.
Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $425 million or $0.89 per share for the period.
The company's revenue for the quarter fell 4.6% to $3.10 billion from $3.25 billion last year.
EI DuPont De Nemours & Co. earnings at a glance (GAAP) :
-Earnings (Q4): $105 Mln. vs. $167 Mln. last year. -EPS (Q4): $0.20 vs. $0.29 last year. -Revenue (Q4): $3.10 Bln vs. $3.25 Bln last year.
-Guidance: Next quarter EPS guidance: $0.80 Next quarter revenue guidance: $2,900 Mln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) revealed earnings for fourth quarter that decreased from the same period last year The company's earnings totaled $105 million, or $0.20 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $425 million or $0.89 per share for the period. EI DuPont De Nemours & Co. earnings at a glance (GAAP) : -Earnings (Q4): $105 Mln.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) revealed earnings for fourth quarter that decreased from the same period last year The company's earnings totaled $105 million, or $0.20 per share. EI DuPont De Nemours & Co. earnings at a glance (GAAP) : -Earnings (Q4): $105 Mln. -Guidance: Next quarter EPS guidance: $0.80 Next quarter revenue guidance: $2,900 Mln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) revealed earnings for fourth quarter that decreased from the same period last year The company's earnings totaled $105 million, or $0.20 per share. This compares with $167 million, or $0.29 per share, in last year's fourth quarter. -Guidance: Next quarter EPS guidance: $0.80 Next quarter revenue guidance: $2,900 Mln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) revealed earnings for fourth quarter that decreased from the same period last year The company's earnings totaled $105 million, or $0.20 per share. This compares with $167 million, or $0.29 per share, in last year's fourth quarter. EI DuPont De Nemours & Co. earnings at a glance (GAAP) : -Earnings (Q4): $105 Mln.
|
3654b8f3-1f86-4627-9dd2-17839f491c58
|
715902.0
|
2023-02-07 00:00:00 UTC
|
EI DuPont De Nemours & Co. Q4 22 Earnings Conference Call At 8:00 AM ET
|
DD
|
https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q4-22-earnings-conference-call-at-8%3A00-am-et
|
nan
|
nan
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on Feb. 7, 2023, to discuss Q4 22 earnings results.
To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx
To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on Feb. 7, 2023, to discuss Q4 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on Feb. 7, 2023, to discuss Q4 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on Feb. 7, 2023, to discuss Q4 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on Feb. 7, 2023, to discuss Q4 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
a9758451-9e2e-4d3e-a8f2-3eb16d4e6322
|
715903.0
|
2023-02-07 00:00:00 UTC
|
EU considers ban on 'forever chemicals', urges search for alternatives
|
DD
|
https://www.nasdaq.com/articles/eu-considers-ban-on-forever-chemicals-urges-search-for-alternatives-0
|
nan
|
nan
|
Adds details, background
Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry.
The substances have been used in tens of thousands of products, including aircraft, cars, textiles, medical gear and wind mills due to their long-term resistance to extreme temperatures and corrosion, but PFAS have also been linked to health risks like cancer, hormonal dysfunction and a weakened immune system as well as environmental damage.
The five countries - Germany, the Netherlands, Denmark, Sweden and non-EU state Norway - which have been collaborating on the proposal said in a joint statement on Tuesday that, if passed, it would become "one of the largest bans on chemical substances ever in Europe".
"A ban on PFAS would reduce quantities of PFAS in the environment over the long term. It would also make products and processes safer for humans," they added.
Companies will be given between 18 months to 12 years to introduce alternatives substances, depending on the application and availability of alternatives, according to the draft proposal.
Makers and users of PFAS, which have formed a lobby subgroup under the European chemical makers' association CEFIC, include BASF BASFn.DE, 3M MMM.N, Bayer BAYGn.DE, Solvay SOLB.BR, Merck KGaA MRCG.DE and Synthomer SYNTS.L.
"In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
The moniker "forever chemicals" stems from their ability to accumulate in water and soils because they do not decompose as a result of an extremely strong bond between carbon and fluorine atoms that characterise them.
It will likely take years before the ban takes effect.
According to the draft, a certain number of pharmaceuticals, animal health products, crop protection chemicals and disinfectants would be exempt, or benefit from so-called derogations, because they already fall under existing regulatory regimes.
DIFFICULT PROCESS
The countries submitting the dossier said that it reviewed 14 industrial sectors that use PFAS and the "regulatory action" is warranted in all of them.
They added that once a ban is in place, emissions and accumulation in the environment will go on for many years because PFAS containing gear and vehicles will continue to operate for some time and waste products would continue to shed the molecules.
A type of PFAS goes into Bayer's liver and kidney cancer drug Nexvar, for instance, and finding a replacement would take up to 15 years, according to the lobby group.
Other uses include cooling agents for large commercial refrigerators. In the aerospace and defence industry as well as in the car industry they are used to make parts resist fire, weather, and aggressive chemicals.
Within the European Chemicals Agency (ECHA), two scientific committees for Risk Assessment (RAC) and for Socio-Economic Analysis (SEAC) will now review whether the proposal to ban PFAS conforms with wider EU regulation of chemicals known as REACH, followed by a scientific evaluation and consultation with the industry.
ECHA has said that the two committees may need longer than the usual 12 months to conclude their evaluation. Afterwards, the European Commission and EU member states will decide on potential restrictions.
In other regions, initiatives to restrict PFAS are also underway. U.S. industrial conglomerate 3M Co MMM.N in December set itself a 2025 deadline to stop producing them.
In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
Shareholders have also called for production of the chemicals to stop. Investors managing $8 trillion in assets earlier this year wrote to 54 companies urging them to phase out their use.
In August, the United States government said it will propose designating certain forever chemicals as hazardous substances under the U.S. Superfund programme.
DuPont has said it was limiting the use of PFAS to "essential industrial applications" and working with customers to pursue alternatives.
Between 140,000 and 310,000 tonnes of PFASs were sold in European markets in 2020, and the overall annual health costs from exposure to PFAS in Europe has been estimated to be 52 billion-84 billion euros ($55.72 billion-$90.01 billion), according to the draft.
($1 = 0.9332 euros)
Call to phase out 'forever chemicals' gains investor momentum
(Reporting by Ludwig Burger; Editing by Susan Fenton)
((ludwig.burger@thomsonreuters.com; +49 30 220133634;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds details, background Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry. It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
|
Adds details, background Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry. It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
|
Adds details, background Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry. It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
|
Adds details, background Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry. It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
|
f77f5207-4201-41e9-814f-50c4b2766dee
|
715904.0
|
2023-02-07 00:00:00 UTC
|
EU considers ban on 'forever chemicals', urges search for alternatives
|
DD
|
https://www.nasdaq.com/articles/eu-considers-ban-on-forever-chemicals-urges-search-for-alternatives
|
nan
|
nan
|
Feb 7 (Reuters) - The European Union on Tuesday started to consider a proposal to ban widely used substances known as PFAS or "forever chemicals" in what could become the bloc's most extensive piece of regulation of the chemical industry.
The substances have been used in tens of thousands of products, including aircraft, cars, textiles, medical gear and wind mills due to their long-term resistance to extreme temperatures and corrosion, but PFAS have also been linked to health risks like cancer, hormonal dysfunction and a weakened immune system as well as environmental damage.
The five countries - Germany, the Netherlands, Denmark, Sweden and non-EU state Norway - which have been collaborating on the proposal said in a joint statement that, if passed, it would become "one of the largest bans on chemical substances ever in Europe".
"A ban on PFAS would reduce quantities of PFAS in the environment over the long term. It would also make products and processes safer for humans," they added.
Companies will be given between 18 months to 12 years to introduce alternatives substances, depending on the application and availability of alternatives, according to the draft proposal.
Makers and users of PFAS, which have formed a lobby subgroup under the European chemical makers' association CEFIC, include BASF BASFn.DE, 3M MMM.N, Bayer BAYGn.DE, Solvay SOLB.BR, Merck KGaA MRCG.DE and Synthomer SYNTS.L.
"In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes.
The moniker "forever chemicals" stems from their ability to accumulate in water and soils because they do not decompose as a result of an extremely strong bond between carbon and fluorine atoms that characterise them.
It will likely take years before the ban takes effect.
Within the European Chemicals Agency (ECHA), two scientific committees for Risk Assessment (RAC) and for Socio-Economic Analysis (SEAC) will now review whether the proposal conforms with wider EU regulation of chemicals known as REACH, followed by a scientific evaluation and consultation with the industry.
ECHA has said that the two committees may need longer than the usual 12 months to conclude their evaluation. Afterwards, the European Commission and EU member states will decide on potential restrictions.
In other regions, initiatives to restrict PFAS are also underway. U.S. industrial conglomerate 3M Co MMM.N in December set itself a 2025 deadline to stop producing them.
In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
Shareholders have also called for production of the chemicals to stop. Investors managing $8 trillion in assets earlier this year wrote to 54 companies urging them to phase out their use.
In August, the United States government said it will propose designating certain forever chemicals as hazardous substances under the U.S. Superfund programme.
DuPont has said it was limiting the use of PFAS to "essential industrial applications" and working with customers to pursue alternatives.
Between 140,000 and 310,000 tonnes of PFASs were sold in European markets in 2020, and the overall annual health costs from exposure to PFAS in Europe has been estimated to be 52 billion-84 billion euros ($55.72 billion-$90.01 billion), according to the draft.
($1 = 0.9332 euros)
Call to phase out 'forever chemicals' gains investor momentum
(Reporting by Ludwig Burger; Editing by Susan Fenton)
((ludwig.burger@thomsonreuters.com; +49 30 220133634;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes. In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
|
It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes. In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
|
It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes. In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
|
It would also make products and processes safer for humans," they added. "In many cases, no such alternatives currently exist, and in some they possibly never will," the five countries said in their statement, adding that companies now need to start to find substitutes. In November, 3M and DuPont de Nemours Inc DD.N were among several companies sued by California's attorney general to recover clean-up costs.
|
68b989c6-cf4a-48f2-8ba7-df6b78c74779
|
715905.0
|
2023-02-06 00:00:00 UTC
|
Pre-Market Earnings Report for February 7, 2023 : LIN, FISV, KKR, CNC, CARR, TDG, DD, BP, IT, XYL, INCY, RCL
|
DD
|
https://www.nasdaq.com/articles/pre-market-earnings-report-for-february-7-2023-%3A-lin-fisv-kkr-cnc-carr-tdg-dd-bp-it-xyl-0
|
nan
|
nan
|
The following companies are expected to report earnings prior to market open on 02/07/2023. Visit our Earnings Calendar for a full list of expected earnings releases.
Linde plc (LIN)is reporting for the quarter ending December 31, 2022. The chemical company's consensus earnings per share forecast from the 7 analysts that follow the stock is $2.91. This value represents a 5.05% increase compared to the same quarter last year. In the past year LIN has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 5.44%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for LIN is 26.88 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
Fiserv, Inc. (FISV)is reporting for the quarter ending December 31, 2022. The financial transactions company's consensus earnings per share forecast from the 10 analysts that follow the stock is $1.91. This value represents a 21.66% increase compared to the same quarter last year. FISV missed the consensus earnings per share in the 3rd calendar quarter of 2022 by -4.12%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for FISV is 16.43 vs. an industry ratio of 15.60, implying that they will have a higher earnings growth than their competitors in the same industry.
KKR & Co. Inc. (KKR)is reporting for the quarter ending December 31, 2022. The finance/investment management company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.76. This value represents a 52.20% decrease compared to the same quarter last year. KKR missed the consensus earnings per share in the 2nd calendar quarter of 2022 by -23.81%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for KKR is 16.91 vs. an industry ratio of 12.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Centene Corporation (CNC)is reporting for the quarter ending December 31, 2022. The hmo company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.87. This value represents a 13.86% decrease compared to the same quarter last year. In the past year CNC has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 6.56%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CNC is 12.41 vs. an industry ratio of 36.70.
Carrier Global Corporation (CARR)is reporting for the quarter ending December 31, 2022. The electrical instrument company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.40. This value represents a 9.09% decrease compared to the same quarter last year. In the past year CARR has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 7.69%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CARR is 20.04 vs. an industry ratio of -9.20, implying that they will have a higher earnings growth than their competitors in the same industry.
Transdigm Group Incorporated (TDG)is reporting for the quarter ending December 31, 2022. The aerospace and defense company's consensus earnings per share forecast from the 3 analysts that follow the stock is $3.68. This value represents a 39.39% increase compared to the same quarter last year. Zacks Investment Research reports that the 2023 Price to Earnings ratio for TDG is 35.89 vs. an industry ratio of 27.90, implying that they will have a higher earnings growth than their competitors in the same industry.
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. The chemical company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.79. This value represents a 26.85% decrease compared to the same quarter last year. In the past year DD has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 1.23%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
BP p.l.c. (BP)is reporting for the quarter ending December 31, 2022. The oil company's consensus earnings per share forecast from the 4 analysts that follow the stock is $1.65. This value represents a 34.15% increase compared to the same quarter last year. In the past year BP has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 33.51%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for BP is 4.02 vs. an industry ratio of 7.20.
Gartner, Inc. (IT)is reporting for the quarter ending December 31, 2022. The consulting company's consensus earnings per share forecast from the 3 analysts that follow the stock is $2.57. This value represents a 14.05% decrease compared to the same quarter last year. In the past year IT has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 30.27%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for IT is 33.69 vs. an industry ratio of 25.10, implying that they will have a higher earnings growth than their competitors in the same industry.
Xylem Inc. (XYL)is reporting for the quarter ending December 31, 2022. The machinery company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.80. This value represents a 26.98% increase compared to the same quarter last year. In the past year XYL has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 19.7%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for XYL is 38.69 vs. an industry ratio of 26.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Incyte Corporation (INCY)is reporting for the quarter ending December 31, 2022. The biomedical (gene) company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.45. This value represents a 742.86% increase compared to the same quarter last year. Zacks Investment Research reports that the 2022 Price to Earnings ratio for INCY is 39.44 vs. an industry ratio of 4.00, implying that they will have a higher earnings growth than their competitors in the same industry.
Royal Caribbean Group (RCL)is reporting for the quarter ending December 31, 2022. The leisure (recreational) company's consensus earnings per share forecast from the 6 analysts that follow the stock is $-1.37. This value represents a 71.34% increase compared to the same quarter last year. RCL missed the consensus earnings per share in the 4th calendar quarter of 2021 by -29.19%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for RCL is -8.81 vs. an industry ratio of 11.70.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
6b231b6f-ac94-4f0f-b876-b2ac0bf3ecd8
|
715906.0
|
2023-02-06 00:00:00 UTC
|
Pre-Market Earnings Report for February 7, 2023 : LIN, FISV, KKR, CNC, CARR, TDG, DD, BP, IT, XYL, INCY, RCL
|
DD
|
https://www.nasdaq.com/articles/pre-market-earnings-report-for-february-7-2023-%3A-lin-fisv-kkr-cnc-carr-tdg-dd-bp-it-xyl
|
nan
|
nan
|
The following companies are expected to report earnings prior to market open on 02/07/2023. Visit our Earnings Calendar for a full list of expected earnings releases.
Linde plc (LIN)is reporting for the quarter ending December 31, 2022. The chemical company's consensus earnings per share forecast from the 7 analysts that follow the stock is $2.91. This value represents a 5.05% increase compared to the same quarter last year. In the past year LIN has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 5.44%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for LIN is 26.88 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
Fiserv, Inc. (FISV)is reporting for the quarter ending December 31, 2022. The financial transactions company's consensus earnings per share forecast from the 10 analysts that follow the stock is $1.91. This value represents a 21.66% increase compared to the same quarter last year. FISV missed the consensus earnings per share in the 3rd calendar quarter of 2022 by -4.12%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for FISV is 16.43 vs. an industry ratio of 15.60, implying that they will have a higher earnings growth than their competitors in the same industry.
KKR & Co. Inc. (KKR)is reporting for the quarter ending December 31, 2022. The finance/investment management company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.76. This value represents a 52.20% decrease compared to the same quarter last year. KKR missed the consensus earnings per share in the 2nd calendar quarter of 2022 by -23.81%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for KKR is 16.91 vs. an industry ratio of 12.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Centene Corporation (CNC)is reporting for the quarter ending December 31, 2022. The hmo company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.87. This value represents a 13.86% decrease compared to the same quarter last year. In the past year CNC has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 6.56%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CNC is 12.41 vs. an industry ratio of 36.70.
Carrier Global Corporation (CARR)is reporting for the quarter ending December 31, 2022. The electrical instrument company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.40. This value represents a 9.09% decrease compared to the same quarter last year. In the past year CARR has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 7.69%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CARR is 20.04 vs. an industry ratio of -9.20, implying that they will have a higher earnings growth than their competitors in the same industry.
Transdigm Group Incorporated (TDG)is reporting for the quarter ending December 31, 2022. The aerospace and defense company's consensus earnings per share forecast from the 3 analysts that follow the stock is $3.68. This value represents a 39.39% increase compared to the same quarter last year. Zacks Investment Research reports that the 2023 Price to Earnings ratio for TDG is 35.89 vs. an industry ratio of 27.90, implying that they will have a higher earnings growth than their competitors in the same industry.
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. The chemical company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.79. This value represents a 26.85% decrease compared to the same quarter last year. In the past year DD has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 1.23%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
BP p.l.c. (BP)is reporting for the quarter ending December 31, 2022. The oil company's consensus earnings per share forecast from the 4 analysts that follow the stock is $1.65. This value represents a 34.15% increase compared to the same quarter last year. In the past year BP has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 33.51%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for BP is 4.02 vs. an industry ratio of 7.20.
Gartner, Inc. (IT)is reporting for the quarter ending December 31, 2022. The consulting company's consensus earnings per share forecast from the 3 analysts that follow the stock is $2.57. This value represents a 14.05% decrease compared to the same quarter last year. In the past year IT has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 30.27%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for IT is 33.69 vs. an industry ratio of 25.10, implying that they will have a higher earnings growth than their competitors in the same industry.
Xylem Inc. (XYL)is reporting for the quarter ending December 31, 2022. The machinery company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.80. This value represents a 26.98% increase compared to the same quarter last year. In the past year XYL has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 19.7%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for XYL is 38.69 vs. an industry ratio of 26.50, implying that they will have a higher earnings growth than their competitors in the same industry.
Incyte Corporation (INCY)is reporting for the quarter ending December 31, 2022. The biomedical (gene) company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.45. This value represents a 742.86% increase compared to the same quarter last year. Zacks Investment Research reports that the 2022 Price to Earnings ratio for INCY is 39.44 vs. an industry ratio of 4.00, implying that they will have a higher earnings growth than their competitors in the same industry.
Royal Caribbean Group (RCL)is reporting for the quarter ending December 31, 2022. The leisure (recreational) company's consensus earnings per share forecast from the 6 analysts that follow the stock is $-1.37. This value represents a 71.34% increase compared to the same quarter last year. RCL missed the consensus earnings per share in the 4th calendar quarter of 2021 by -29.19%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for RCL is -8.81 vs. an industry ratio of 11.70.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending December 31, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 22.05 vs. an industry ratio of 14.10, implying that they will have a higher earnings growth than their competitors in the same industry.
|
c0eb1c33-aac3-4840-94fb-3b5401895211
|
715907.0
|
2023-02-03 00:00:00 UTC
|
EXCLUSIVE-Starboard to challenge engineering materials maker Rogers' board -sources
|
DD
|
https://www.nasdaq.com/articles/exclusive-starboard-to-challenge-engineering-materials-maker-rogers-board-sources
|
nan
|
nan
|
By Svea Herbst-Bayliss
NEW YORK, Feb 3 (Reuters) - Activist investment firm Starboard Value LP has amassed a sizable stake in Rogers Corp ROG.N and is seeking seats on the electronics materials company's board in its push for changes, people familiar with the matter said on Friday.
The board challenge comes after chemical company DuPont DD.N in November walked away from a $5.2 billion deal to acquire Rogers because it failed to secure regulatory approval for the transaction in China. The deal had originally been announced in late 2021.
Starboard, which is led by Jeffrey Smith, has been building a stake in Rogers that is nearing 5% and has notified the company that it will nominate at least three people to the company's 10-member board, the sources said, requesting anonymity because the matter is confidential.
Starboard's plans for the company could not immediately be learned. Starboard and Rogers did not respond to requests for comment.
Rogers, which was founded in 1832, makes materials that are used in electronics and wireless infrastructure.
Its stock price tumbled after the DuPont deal was scrapped and is down 47% over the last 52 weeks. Since the start of 2023, the stock has climbed 22% as the broader market moved higher, giving Rogers a market value of $2.8 billion.
The company has made changes since the DuPont deal fell apart. Colin Gouveia, who ran Rogers' elastomeric material solutions unit, became CEO this year. Former chief executive, Bruce Hoechner, who retired at the end of last year, will step down from the board at the end of March, according to the company's website.
Starboard has been active, including recent bets on cloud-based software company Salesforce CRM.N, software company Splunk SPLK.O and website maker Wix.com WIX.O.
(Reporting by Svea Herbst-Bayliss in New York; Editing by Leslie Adler)
((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The board challenge comes after chemical company DuPont DD.N in November walked away from a $5.2 billion deal to acquire Rogers because it failed to secure regulatory approval for the transaction in China. By Svea Herbst-Bayliss NEW YORK, Feb 3 (Reuters) - Activist investment firm Starboard Value LP has amassed a sizable stake in Rogers Corp ROG.N and is seeking seats on the electronics materials company's board in its push for changes, people familiar with the matter said on Friday. Colin Gouveia, who ran Rogers' elastomeric material solutions unit, became CEO this year.
|
The board challenge comes after chemical company DuPont DD.N in November walked away from a $5.2 billion deal to acquire Rogers because it failed to secure regulatory approval for the transaction in China. By Svea Herbst-Bayliss NEW YORK, Feb 3 (Reuters) - Activist investment firm Starboard Value LP has amassed a sizable stake in Rogers Corp ROG.N and is seeking seats on the electronics materials company's board in its push for changes, people familiar with the matter said on Friday. Starboard has been active, including recent bets on cloud-based software company Salesforce CRM.N, software company Splunk SPLK.O and website maker Wix.com WIX.O.
|
The board challenge comes after chemical company DuPont DD.N in November walked away from a $5.2 billion deal to acquire Rogers because it failed to secure regulatory approval for the transaction in China. By Svea Herbst-Bayliss NEW YORK, Feb 3 (Reuters) - Activist investment firm Starboard Value LP has amassed a sizable stake in Rogers Corp ROG.N and is seeking seats on the electronics materials company's board in its push for changes, people familiar with the matter said on Friday. Starboard, which is led by Jeffrey Smith, has been building a stake in Rogers that is nearing 5% and has notified the company that it will nominate at least three people to the company's 10-member board, the sources said, requesting anonymity because the matter is confidential.
|
The board challenge comes after chemical company DuPont DD.N in November walked away from a $5.2 billion deal to acquire Rogers because it failed to secure regulatory approval for the transaction in China. By Svea Herbst-Bayliss NEW YORK, Feb 3 (Reuters) - Activist investment firm Starboard Value LP has amassed a sizable stake in Rogers Corp ROG.N and is seeking seats on the electronics materials company's board in its push for changes, people familiar with the matter said on Friday. Starboard, which is led by Jeffrey Smith, has been building a stake in Rogers that is nearing 5% and has notified the company that it will nominate at least three people to the company's 10-member board, the sources said, requesting anonymity because the matter is confidential.
|
c2c8f18d-8c0c-48b4-8f09-9cd08ec2eef7
|
715908.0
|
2023-02-03 00:00:00 UTC
|
DuPont (DD) Warms Up for Q4 Earnings: What's in the Cards?
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-warms-up-for-q4-earnings%3A-whats-in-the-cards
|
nan
|
nan
|
DuPont de Nemours, Inc. DD is scheduled to come up with fourth-quarter 2022 results, before the opening bell on Feb 7.
The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters. In this timeframe, it delivered an earnings surprise of around 12.4%, on average. It posted an earnings surprise of 1.2% in the last reported quarter.
The company is likely to have benefited from strong end-market demand and its pricing and productivity actions in the fourth quarter. However, its results are likely to reflect the impacts of raw material and energy cost inflation as well as currency headwinds.
DuPont’s shares have lost 5.9% over a year compared with 5.2% decline recorded by the industry it belongs to.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What do the Estimates Say?
The Zacks Consensus Estimate for revenues for the fourth quarter for DuPont is currently pinned at $3,083 million, suggesting an expected year-over-year decline of 27.8%.
The consensus estimate for the company’s Electronics & Industrial segment is pegged at $1,368 million, indicating a 9% decline sequentially. The same for the Water & Protection unit is pegged at $1,455 million, suggesting a 5.1% sequential decline.
Some Factors to Watch For
DuPont is expected to have benefited from sustained strong global demand in semiconductors in the fourth quarter. Strong demand in water and general industrial end-markets is also likely to have supported its volumes.
The company is also likely to have benefited from its cost and productivity actions in the quarter to be reported. Its structural cost actions are likely to have contributed to its bottom line in the quarter.
The company is likely to have gained from its pricing actions. It continues to implement strategic price increases to offset the cost inflation. These actions are likely to have supported its results in the fourth quarter.
However, the company is likely to have faced challenges from higher raw material and logistics costs in the December quarter. Supply constraints for major raw materials are expected to have continued in the quarter. Higher energy costs driven by the Russia-Ukraine conflict are also expected to have impacted its results.
DuPont is also expected to have witnessed softness in the consumer electronics market in the fourth quarter. Weaker global demand in this market is likely to have affected its performance.
Currency headwinds due to strengthening of the U.S. dollar against key currencies are also likely to have affected the company’s top line in the quarter to be reported.
DuPont de Nemours, Inc. Price and EPS Surprise
DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote
Zacks Model
Our proven model does not conclusively predict an earnings beat for DuPont this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for DuPont is -0.73%. The Zacks Consensus Estimate for earnings for the fourth quarter is currently pegged at 79 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: DuPont currently carries a Zacks Rank #3 (Hold).
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
Albemarle Corporation ALB, slated to release earnings on Feb 15, has an Earnings ESP of +7.16% and carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Albemarle’s fourth-quarter earnings has been revised 2.6% upward in the past 60 days. The Zacks Consensus Estimate for ALB’s earnings for the quarter is pegged at $7.89.
Quaker Chemical Corporation KWR, expected to release earnings on Feb 23, has an Earnings ESP of +7.38%.
The Zacks Consensus Estimate for Quaker Chemical’s fourth-quarter earnings is currently pegged at $1.22. KWR currently carries a Zacks Rank #2.
Teck Resources Limited TECK, scheduled to release earnings on Feb 21, has an Earnings ESP of +2.40%.
The Zacks Consensus Estimate for Teck Resources’ fourth-quarter earnings is currently pegged at 93 cents. TECK currently carries a Zacks Rank #2.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Albemarle Corporation (ALB) : Free Stock Analysis Report
Quaker Houghton (KWR) : Free Stock Analysis Report
Teck Resources Ltd (TECK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD is scheduled to come up with fourth-quarter 2022 results, before the opening bell on Feb 7. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report Quaker Houghton (KWR) : Free Stock Analysis Report Teck Resources Ltd (TECK) : Free Stock Analysis Report To read this article on Zacks.com click here. The Zacks Consensus Estimate for revenues for the fourth quarter for DuPont is currently pinned at $3,083 million, suggesting an expected year-over-year decline of 27.8%.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report Quaker Houghton (KWR) : Free Stock Analysis Report Teck Resources Ltd (TECK) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont de Nemours, Inc. DD is scheduled to come up with fourth-quarter 2022 results, before the opening bell on Feb 7. DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report Quaker Houghton (KWR) : Free Stock Analysis Report Teck Resources Ltd (TECK) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont de Nemours, Inc. DD is scheduled to come up with fourth-quarter 2022 results, before the opening bell on Feb 7. DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
DuPont de Nemours, Inc. DD is scheduled to come up with fourth-quarter 2022 results, before the opening bell on Feb 7. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Albemarle Corporation (ALB) : Free Stock Analysis Report Quaker Houghton (KWR) : Free Stock Analysis Report Teck Resources Ltd (TECK) : Free Stock Analysis Report To read this article on Zacks.com click here. It posted an earnings surprise of 1.2% in the last reported quarter.
|
cd222fff-8cca-4cf1-b291-98b791adedbd
|
715909.0
|
2023-02-02 00:00:00 UTC
|
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
|
DD
|
https://www.nasdaq.com/articles/analysts-estimate-chemours-cc-to-report-a-decline-in-earnings%3A-what-to-look-out-for
|
nan
|
nan
|
Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on February 9, 2023, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on theearnings call it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus Estimate
This chemical company is expected to post quarterly earnings of $0.15 per share in its upcoming report, which represents a year-over-year change of -81.5%.
Revenues are expected to be $1.42 billion, down 9.7% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Chemours?
For Chemours, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -130.41%.
On the other hand, the stock currently carries a Zacks Rank of #5.
So, this combination makes it difficult to conclusively predict that Chemours will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Chemours would post earnings of $1.16 per share when it actually produced earnings of $1.24, delivering a surprise of +6.90%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Chemours doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected Results
DuPont de Nemours (DD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $0.79 for the quarter ended December 2022. This estimate points to a year-over-year change of -26.9%. Revenues for the quarter are expected to be $3.08 billion, down 27.8% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for DuPont de Nemours has been revised 10.2% down to the current level. Nevertheless, the company now has an Earnings ESP of -0.73%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), makes it difficult to conclusively predict that DuPont de Nemours will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Chemours Company (CC) : Free Stock Analysis Report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. An Industry Player's Expected Results DuPont de Nemours (DD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $0.79 for the quarter ended December 2022. Click to get this free report The Chemours Company (CC) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
An Industry Player's Expected Results DuPont de Nemours (DD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $0.79 for the quarter ended December 2022. Click to get this free report The Chemours Company (CC) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. An Industry Player's Expected Results DuPont de Nemours (DD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $0.79 for the quarter ended December 2022. Click to get this free report The Chemours Company (CC) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. An Industry Player's Expected Results DuPont de Nemours (DD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $0.79 for the quarter ended December 2022. Click to get this free report The Chemours Company (CC) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
ed22e790-404a-483a-8853-293effd6ae3f
|
715910.0
|
2023-01-31 00:00:00 UTC
|
Earnings Preview: DuPont de Nemours (DD) Q4 Earnings Expected to Decline
|
DD
|
https://www.nasdaq.com/articles/earnings-preview%3A-dupont-de-nemours-dd-q4-earnings-expected-to-decline
|
nan
|
nan
|
The market expects DuPont de Nemours (DD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on February 7, 2023, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on theearnings call it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus Estimate
This specialty chemicals maker is expected to post quarterly earnings of $0.79 per share in its upcoming report, which represents a year-over-year change of -26.9%.
Revenues are expected to be $3.08 billion, down 27.8% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has been revised 10.19% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for DuPont de Nemours?
For DuPont de Nemours, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.73%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that DuPont de Nemours will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that DuPont de Nemours would post earnings of $0.81 per share when it actually produced earnings of $0.82, delivering a surprise of +1.23%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
DuPont de Nemours doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry Player
Air Products and Chemicals (APD), another stock in the Zacks Chemical - Diversified industry, is expected to report earnings per share of $2.73 for the quarter ended December 2022. This estimate points to a year-over-year change of +8.3%. Revenues for the quarter are expected to be $3.29 billion, up 10% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Air Products and Chemicals has been revised 0.2% up to the current level. Nevertheless, the company now has an Earnings ESP of 2.67%, reflecting a higher Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #2 (Buy), suggests that Air Products and Chemicals will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Free Report Reveals How You Could Profit from the Growing Electric Vehicle Industry
Globally, electric car sales continue their remarkable growth even after breaking records in 2021. High gas prices have fueled his demand, but so has evolving EV comfort, features and technology. So, the fervor for EVs will be around long after gas prices normalize. Not only are manufacturers seeing record-high profits, but producers of EV-related technology are raking in the dough as well. Do you know how to cash in? If not, we have the perfect report for you – and it’s FREE! Today, don't miss your chance to download Zacks' top 5 stocks for the electric vehicle revolution at no cost and with no obligation.
>>Send me my free report on the top 5 EV stocks
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The market expects DuPont de Nemours (DD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The market expects DuPont de Nemours (DD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report To read this article on Zacks.com click here. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
The market expects DuPont de Nemours (DD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The market expects DuPont de Nemours (DD) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
9f4ee43d-1722-44e4-8a3d-a9c3bc0ba259
|
715911.0
|
2023-01-26 00:00:00 UTC
|
Corning Stock Likely To Trade Sideways Post Q4
|
DD
|
https://www.nasdaq.com/articles/corning-stock-likely-to-trade-sideways-post-q4
|
nan
|
nan
|
Corning (NYSE: GLW) is scheduled to report its Q4 2022 results on Tuesday, January 31. We expect the company to post revenue and earnings in line with the street expectations. Although the company has benefited from 5G expansion and cloud computing in recent quarters, it expects a sequential decline in optical communication segment sales in Q4, primarily due to the timing of specific projects. Furthermore, we believe GLW stock has little room for growth, as discussed below. Our interactive dashboard analysis of Corning Earnings Preview has additional details.
(1) Revenues expected to be in line with the consensus estimates
Trefis estimates Corning’s Q4 2022 revenues to be around $3.50 billion, reflecting a mid-single-digit y-o-y decline and broadly aligning with the consensus estimate of $3.55 billion.
Corning should continue to benefit from a pickup in optical fiber demand as carriers expand their 5G coverage. However, due to the timing of specific projects in North America, it may see a sequential decline in segment sales.
The company also expects a sequential decline in the Specialty Materials segment due to lower demand in the smartphone, notebook, and tablet markets.
On the positive side, the company will likely benefit from sustained higher price realization for its display glass.
Looking back at Q3 2022, Corning’s revenues declined 4% y-o-y to $3.5 billion, primarily due to a 22% fall in Display Technologies segment sales.
Our dashboard on Corning’s Revenues offers more details on the company’s segments.
2) EPS likely to align with the consensus estimates
Corning’s Q4 2022 earnings per share (EPS) is expected to be $0.45 per Trefis analysis, aligning with the $0.44 consensus estimate but lower than the $0.54 figure seen in the prior year quarter.
Corning’s adjusted net income of $438 million in Q3 2022 reflected a 10% fall from its $485 million figure in the prior-year quarter. This can be attributed to lower revenues and a 120 bps operating margin contraction.
For the full-year 2023, we expect the adjusted EPS to be higher at $2.28, compared to $2.07 in 2021 and an estimated $2.07 in 2022.
(3) GLW stock has little room for growth
We estimate Corning’s Valuation to be around $38 per share, which is 6% above the current market price of $36.
At its current levels, Corning stock is trading at a forward P/E multiple of 16x based on our EPS estimate of $2.28 for 2023, compared to the last three-year average of 18x, implying that GLW stock has little room for growth.
However, if the company reports upbeat Q4 results and provides a 2023 outlook better than the street estimates, the P/E multiple will likely be revised upward, resulting in higher levels for GLW stock.
Note: P/E Multiples are based on Share Price at the end of the year and reported (or expected) Earnings for the full year
While GLW stock looks like it has little room for growth, it is helpful to see how Corning’s Peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.
Furthermore, the Covid-19 crisis has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised at how counter-intuitive the stock valuation is for 3M vs. AGCO.
Despite higher inflation and the Fed raising interest rates, GLW stock has risen 1% in the last twelve months. But can it drop from here? See how low Corning stock can go by comparing its decline in previous market crashes. Here is a performance summary of all stocks in previous market crashes.
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
Returns Jan 2023
MTD [1] 2023
YTD [1] 2017-23
Total [2]
GLW Return 12% 12% 48%
S&P 500 Return 5% 5% 79%
Trefis Multi-Strategy Portfolio 9% 9% 242%
[1] Month-to-date and year-to-date as of 1/25/2023
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Although the company has benefited from 5G expansion and cloud computing in recent quarters, it expects a sequential decline in optical communication segment sales in Q4, primarily due to the timing of specific projects. The company also expects a sequential decline in the Specialty Materials segment due to lower demand in the smartphone, notebook, and tablet markets.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Although the company has benefited from 5G expansion and cloud computing in recent quarters, it expects a sequential decline in optical communication segment sales in Q4, primarily due to the timing of specific projects. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q4 2022 revenues to be around $3.50 billion, reflecting a mid-single-digit y-o-y decline and broadly aligning with the consensus estimate of $3.55 billion.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q4 2022 revenues to be around $3.50 billion, reflecting a mid-single-digit y-o-y decline and broadly aligning with the consensus estimate of $3.55 billion. 2) EPS likely to align with the consensus estimates Corning’s Q4 2022 earnings per share (EPS) is expected to be $0.45 per Trefis analysis, aligning with the $0.44 consensus estimate but lower than the $0.54 figure seen in the prior year quarter.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Our dashboard on Corning’s Revenues offers more details on the company’s segments. 2) EPS likely to align with the consensus estimates Corning’s Q4 2022 earnings per share (EPS) is expected to be $0.45 per Trefis analysis, aligning with the $0.44 consensus estimate but lower than the $0.54 figure seen in the prior year quarter.
|
6150810a-0bed-407c-a56b-782cbefbdad7
|
715912.0
|
2023-01-25 00:00:00 UTC
|
PREVIEW-Chemical makers to feel pinch of weak demand, cost inflation
|
DD
|
https://www.nasdaq.com/articles/preview-chemical-makers-to-feel-pinch-of-weak-demand-cost-inflation
|
nan
|
nan
|
By Ankit Kumar
Jan 24 (Reuters) - U.S. chemical makers are likely to see their margins pressured by higher energy costs and supply chain snags in the fourth quarter, although China lifting its COVID curbs could offer some relief in the second half of 2023.
Prices of U.S. natural gas, a key material for making chemicals, hit a 14-year peak last year after sanctions on Russian supply caused a scramble for U.S. exports of gas chilled to liquid form.
Chemical maker Dow Inc's DOW.N margins were hit by the rising energy costs in the prior quarter and the lingering effects will be felt in the current quarter as well, according to analysts.
"It's going to be probably one of the weakest quarters for this economic cycle, if not the trough," said Aleksey Yefremov, analyst at KeyBanc Capital Markets.
Natural gas NGc1 averaged $6.10 per million metric British thermal units (mmBtu) during the quarter, nearly 26% higher than the previous year.
THE CONTEXT
Concerns of an economic slowdown have hit demand for the sector's chemicals and products that are used in industries ranging from automobiles and cosmetics to food packaging and electronics.
"Supply chain disruptions in other areas of the market can create bottlenecks for Dow's customer base that in turn reduce demand. Supply chain constraints in the automotive industry in recent quarters are a good example of this," said Katherine Olexa, analyst at Morningstar Research Services LLC.
Dow Chief Executive Jim Fitterling in October said high energy and feedstock costs were driving record inflation and impacting demand in the eurozone.
Lockdowns in China, meanwhile, had pressured both consumer spending and infrastructure investments.
In the second half of the year, however, analysts expect China's reopening from COVID-led lockdowns to boost the sector, especially commodities chemical firms such as Dow.
Demand and margins are seen improving from current levels towards the second half of the year, but will remain below last year's levels.
Dow is scheduled to report its quarterly results on Jan. 26, while DuPont de Nemours Inc DD.Nis expected to report results on Feb. 7.
FUNDAMENTALS
Company
Refinitiv Q4 revenue estimate
Refinitiv Q4 EPS estimate
Dow Inc
$12 billion (down 16% YoY)
58 cents (down 73% YoY)
DuPont de Nemours Inc
$3.1 billion (down 28% YoY)
78 cents (down 28% YoY)
WALL STREET SENTIMENT
Company
Recommendation
Median Price Target
Dow Inc
Three of 26 analysts rate the stock "buy" or higher, 21 "hold" and two "sell"
$54
DuPont de Nemours Inc
Fourteen of 21 analysts rate the stock "buy" or higher and seven "hold"
$80
Chemical makers revenues dwindle in 2022 as economic conditions worsenhttps://tmsnrt.rs/3wurB2c
Higher natural gas prices expected to hurt chemical makers' Q4 resultshttps://tmsnrt.rs/3XE74E3
(Reporting by Ankit Kumar, additional reporting by Arunima Kumar in Bengaluru; Editing by Devika Syamnath)
((Ankit.Kumar2@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Company Recommendation Median Price Target Dow Inc Three of 26 analysts rate the stock "buy" or higher, 21 "hold" and two "sell" $54 DuPont de Nemours Inc Fourteen of 21 analysts rate the stock "buy" or higher and seven "hold" $80 Chemical makers revenues dwindle in 2022 as economic conditions worsenhttps://tmsnrt.rs/3wurB2c Higher natural gas prices expected to hurt chemical makers' Q4 resultshttps://tmsnrt.rs/3XE74E3 (Reporting by Ankit Kumar, additional reporting by Arunima Kumar in Bengaluru; Editing by Devika Syamnath) ((Ankit.Kumar2@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Dow is scheduled to report its quarterly results on Jan. 26, while DuPont de Nemours Inc DD.Nis expected to report results on Feb. 7. By Ankit Kumar Jan 24 (Reuters) - U.S. chemical makers are likely to see their margins pressured by higher energy costs and supply chain snags in the fourth quarter, although China lifting its COVID curbs could offer some relief in the second half of 2023.
|
Dow is scheduled to report its quarterly results on Jan. 26, while DuPont de Nemours Inc DD.Nis expected to report results on Feb. 7. Company Recommendation Median Price Target Dow Inc Three of 26 analysts rate the stock "buy" or higher, 21 "hold" and two "sell" $54 DuPont de Nemours Inc Fourteen of 21 analysts rate the stock "buy" or higher and seven "hold" $80 Chemical makers revenues dwindle in 2022 as economic conditions worsenhttps://tmsnrt.rs/3wurB2c Higher natural gas prices expected to hurt chemical makers' Q4 resultshttps://tmsnrt.rs/3XE74E3 (Reporting by Ankit Kumar, additional reporting by Arunima Kumar in Bengaluru; Editing by Devika Syamnath) ((Ankit.Kumar2@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Company Refinitiv Q4 revenue estimate Refinitiv Q4 EPS estimate Dow Inc $12 billion (down 16% YoY) 58 cents (down 73% YoY) DuPont de Nemours Inc $3.1 billion (down 28% YoY) 78 cents (down 28% YoY)
|
Company Recommendation Median Price Target Dow Inc Three of 26 analysts rate the stock "buy" or higher, 21 "hold" and two "sell" $54 DuPont de Nemours Inc Fourteen of 21 analysts rate the stock "buy" or higher and seven "hold" $80 Chemical makers revenues dwindle in 2022 as economic conditions worsenhttps://tmsnrt.rs/3wurB2c Higher natural gas prices expected to hurt chemical makers' Q4 resultshttps://tmsnrt.rs/3XE74E3 (Reporting by Ankit Kumar, additional reporting by Arunima Kumar in Bengaluru; Editing by Devika Syamnath) ((Ankit.Kumar2@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Dow is scheduled to report its quarterly results on Jan. 26, while DuPont de Nemours Inc DD.Nis expected to report results on Feb. 7. By Ankit Kumar Jan 24 (Reuters) - U.S. chemical makers are likely to see their margins pressured by higher energy costs and supply chain snags in the fourth quarter, although China lifting its COVID curbs could offer some relief in the second half of 2023.
|
Company Recommendation Median Price Target Dow Inc Three of 26 analysts rate the stock "buy" or higher, 21 "hold" and two "sell" $54 DuPont de Nemours Inc Fourteen of 21 analysts rate the stock "buy" or higher and seven "hold" $80 Chemical makers revenues dwindle in 2022 as economic conditions worsenhttps://tmsnrt.rs/3wurB2c Higher natural gas prices expected to hurt chemical makers' Q4 resultshttps://tmsnrt.rs/3XE74E3 (Reporting by Ankit Kumar, additional reporting by Arunima Kumar in Bengaluru; Editing by Devika Syamnath) ((Ankit.Kumar2@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Dow is scheduled to report its quarterly results on Jan. 26, while DuPont de Nemours Inc DD.Nis expected to report results on Feb. 7. By Ankit Kumar Jan 24 (Reuters) - U.S. chemical makers are likely to see their margins pressured by higher energy costs and supply chain snags in the fourth quarter, although China lifting its COVID curbs could offer some relief in the second half of 2023.
|
3e854c05-f12b-496a-80ff-92698ac987aa
|
715913.0
|
2023-01-15 00:00:00 UTC
|
Validea's Top Ten Healthcare Stocks Based On Peter Lynch - 1/15/2023
|
DD
|
https://www.nasdaq.com/articles/valideas-top-ten-healthcare-stocks-based-on-peter-lynch-1-15-2023
|
nan
|
nan
|
The following are the top rated Healthcare stocks according to Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
EMERGENT BIOSOLUTIONS INC (EBS) is a small-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: chemical, biological, radiological, nuclear and explosives (CBRNE); emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); acute, emergency, and community care. Its business lines include Medical Countermeasures (MCM), Commercial and CDMO. MCM focuses primarily on procurement of MCM products and procured product candidates by domestic and international government customers. It provides solutions for PHTs through a portfolio of vaccines and therapeutics that it develops and manufactures for governments and consumers. It offers TEMBEXA (brincidofovir) an antiviral for the treatment of smallpox in all age groups, including adults, and for patients who have difficulty swallowing.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of EMERGENT BIOSOLUTIONS INC
EBS Guru Analysis
EBS Fundamental Analysis
LABORATORY CORP. OF AMERICA HOLDINGS (LH) is a large-cap value stock in the Healthcare Facilities industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Laboratory Corporation of America Holdings is a global life sciences company. The Company provides information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make decisions. Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). The Dx segment is an independent clinical laboratory business. It offers a menu of frequently requested and specialty diagnostic tests through an integrated network of primary and specialty laboratories across the United States. In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services. The DD segment is a contract research organizations (CRO) business that provides end-to-end drug development services. The DD segment provides these services predominantly to pharmaceutical, biotechnology and medical device companies across the world. It serves clients in more than 100 countries.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of LABORATORY CORP. OF AMERICA HOLDINGS
LH Guru Analysis
LH Fundamental Analysis
NOVARTIS AG (ADR) (NVS) is a large-cap value stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of NOVARTIS AG (ADR)
NVS Guru Analysis
NVS Fundamental Analysis
REGENERON PHARMACEUTICALS INC (REGN) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of REGENERON PHARMACEUTICALS INC
REGN Guru Analysis
REGN Fundamental Analysis
ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women's health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of ABBOTT LABORATORIES
ABT Guru Analysis
ABT Fundamental Analysis
CORCEPT THERAPEUTICS INCORPORATED (CORT) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Corcept Therapeutics Incorporated is a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. It has marketed Korlym (mifepristone) for the treatment of patients suffering from Cushing's syndrome. The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Its cortisol activity can be modulated by a drug that competes with cortisol as it attempts to bind to the glucocorticoid receptor (GR). The Company's ingredient, mifepristone, reduces the binding of excess cortisol to GR. Its compounds bind to GR but not the progesterone, estrogen, or androgen receptors.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: NEUTRAL
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of CORCEPT THERAPEUTICS INCORPORATED
CORT Guru Analysis
CORT Fundamental Analysis
DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: DuPont de Nemours, Inc. provides technology-based materials and solutions. The Company's segments include Electronics & Industrial and Water & Protection. Its Electronics & Industrial segment is a global supplier of differentiated materials and systems for a range of consumer electronics, including mobile devices, television monitors, personal computers, and electronics used in a variety of industries. The segment is a provider of materials and solutions for the fabrication and packaging of semiconductors and integrated circuits. It also provides solutions for thermal management and electromagnetic shielding as well as metallization processes for metal finishing, decorative, and industrial applications. The Company's Water & Protection segment is a provider of engineered products and integrated systems for a range of industries, including, worker safety, water purification and separation, transportation, energy, medical packaging, and building materials.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of DUPONT DE NEMOURS INC
DD Guru Analysis
DD Fundamental Analysis
QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provide insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services primarily are provided under the Quest Diagnostics brand. The Company is also engaged in providing outreach laboratory services business.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of QUEST DIAGNOSTICS INC
DGX Guru Analysis
DGX Fundamental Analysis
FUJIFILM HOLDINGS CORP. (ADR) (FUJIY) is a large-cap value stock in the Medical Equipment & Supplies industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: FUJIFILM Holdings Corporation is a Japan-based holding company engaged in the business related to photography, medical care & printing & liquid crystal display materials and copying machines. The Company operates in three business segments. Imaging Solutions segment develops, manufactures and sells color films, digital cameras, color paper services for photographic prints, instant printing equipment and optical devices mainly for general consumers. Healthcare & Materials Solutions segment provides medical system equipment, cosmetics and supplements, pharmaceutical products, biopharmaceutical manufacturing development contract, regenerative medicine products, chemical products, graphic system equipment, inkjet equipment, display materials, recording media and electronic materials for commercial use. Document Solutions segment provides digital multi-functional peripherals, publishing systems, document management software and related solution services mainly for commercial use.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
INVENTORY TO SALES: PASS
YIELD ADJUSTED P/E TO GROWTH (PEG) RATIO: PASS
EARNINGS PER SHARE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of FUJIFILM HOLDINGS CORP. (ADR)
FUJIY Guru Analysis
FUJIY Fundamental Analysis
MERCK & CO INC (MRK) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 91% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of MERCK & CO INC
MRK Guru Analysis
MRK Fundamental Analysis
Peter Lynch Portfolio
Top Peter Lynch Stocks
About Peter Lynch: Perhaps the greatest mutual fund manager of all-time, Lynch guided Fidelity Investment's Magellan Fund to a 29.2 percent average annual return from 1977 until his retirement in 1990, almost doubling the S&P 500's 15.8 percent yearly return over that time. Lynch's common sense approach and quick wit made him one of the most quoted investors on Wall Street. ("Go for a business that any idiot can run -- because sooner or later, any idiot probably is going to run it," is one of his many pearls of wisdom.) Lynch's bestseller One Up on Wall Street is something of a "stocks for the everyman/everywoman", breaking his approach down into easy-to-understand concepts.
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services.
|
Detailed Analysis of CORCEPT THERAPEUTICS INCORPORATED CORT Guru Analysis CORT Fundamental Analysis DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD).
|
Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services.
|
Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). Its segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). In addition to diagnostic testing along with occupational and wellness testing for employers and forensic DNA analysis, Dx segment also offers a range of other testing services.
|
a659c281-c53e-4637-9d5a-95a0265caaeb
|
715914.0
|
2023-01-13 00:00:00 UTC
|
DuPont (DD) Rides on Strong End-Market Demand and Innovation
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-rides-on-strong-end-market-demand-and-innovation
|
nan
|
nan
|
DuPont de Nemours, Inc. DD is benefiting from strong end-market demand, productivity actions and innovation-driven investment.
The company’s shares have popped around 36.2% over the past six months, outperforming its industry’s rise of 22.2% over the same time frame.
Image Source: Zacks Investment Research
DuPont, a Zacks Rank #1 (Strong Buy) stock, is gaining from strong underlying demand in its major end-markets, especially semiconductor, water and general industrial, which is driving its top line. Its volumes rose in the third quarter of 2022 on strong demand in semiconductor, water and industrial end-markets. DuPont envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter, offset by continued weakness in consumer electronics globally
The company also continues to implement strategic price increases in the wake of raw material and energy cost inflation. These actions are likely to support its results in the fourth quarter.
DuPont also remains focused on driving growth though innovation and new product development. Its innovation-driven investment is focused on several high-growth areas. It remains committed to drive returns from its R&D investment. It is also benefiting from cost synergy savings and productivity improvement actions. Its structural cost actions are contributing to its bottom line.
The company is also managing its portfolio with an aim for value creation. It is divesting non-core assets to focus more on high-growth, high-margin businesses. DuPont completed the divestment of the majority of its Mobility & Materials unit to Celanese on Nov 1, 2022 as part of its ongoing transformation. The company received $11 billion in gross cash from the transaction. The move is expected to boost its underlying performance, strengthen its balance sheet, maximize shareholders’ return and provide opportunities to grow business through targeted mergers and acquisitions.
DuPont de Nemours, Inc. Price and Consensus
DuPont de Nemours, Inc. price-consensus-chart | DuPont de Nemours, Inc. Quote
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Olympic Steel, Inc. ZEUS, Commercial Metals Company CMC and Nucor Corporation NUE.
Olympic Steel currently sports a Zacks Rank #1. The Zacks Consensus Estimate for ZEUS's current-year earnings has been revised 4.8% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Olympic Steel’s earnings beat the Zacks Consensus Estimate in three of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 25.4%, on average. ZEUS has rallied around 50% in a year.
Commercial Metals currently carries a Zacks Rank #1. The consensus estimate for CMC's current-year earnings has been revised 10.2% upward in the past 60 days.
Commercial Metals’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 16.7%, on average. CMC has gained around 61% in a year.
Nucor currently carries a Zacks Rank #1. The company has a projected earnings growth rate of 21.5% for the current year.
Nucor’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 3.9%, on average. NUE has rallied roughly 42% in a year.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Nucor Corporation (NUE) : Free Stock Analysis Report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Commercial Metals Company (CMC) : Free Stock Analysis Report
Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD is benefiting from strong end-market demand, productivity actions and innovation-driven investment. Click to get this free report Nucor Corporation (NUE) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter, offset by continued weakness in consumer electronics globally
|
DuPont de Nemours, Inc. DD is benefiting from strong end-market demand, productivity actions and innovation-driven investment. Click to get this free report Nucor Corporation (NUE) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont, a Zacks Rank #1 (Strong Buy) stock, is gaining from strong underlying demand in its major end-markets, especially semiconductor, water and general industrial, which is driving its top line.
|
Click to get this free report Nucor Corporation (NUE) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. DuPont de Nemours, Inc. DD is benefiting from strong end-market demand, productivity actions and innovation-driven investment. DuPont, a Zacks Rank #1 (Strong Buy) stock, is gaining from strong underlying demand in its major end-markets, especially semiconductor, water and general industrial, which is driving its top line.
|
DuPont de Nemours, Inc. DD is benefiting from strong end-market demand, productivity actions and innovation-driven investment. Click to get this free report Nucor Corporation (NUE) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. Image Source: Zacks Investment Research
|
5406e0c9-d9fb-45ac-91d9-52c47c3ffce7
|
715915.0
|
2023-01-13 00:00:00 UTC
|
NEWSMAKER-Investor Peltz, corporate doctor, pushes Disney to take bitter pill
|
DD
|
https://www.nasdaq.com/articles/newsmaker-investor-peltz-corporate-doctor-pushes-disney-to-take-bitter-pill
|
nan
|
nan
|
By Svea Herbst-Bayliss and Dawn Chmielewski
NEW YORK, Jan 13 (Reuters) - Billionaire activist investor Nelson Peltz often presents himself as a partner with constructive advice for corporations and in 2019 Walt Disney Co Chief Executive DIS.N Bob Iger was eager to hear his ideas.
But in 2023, Iger, who came out of retirement in November to again lead the media giant after a 66% decline in quarterly profit, does not want Peltz as a Disney director. Still, the fund manager has a compelling case to push for change, with Disney's stock price down 36% over the last 52 weeks.
Weeks of discussion last year ended with Disney denying Peltz's request for a board seat leaving the parties embroiled in what bankers and lawyers say may become one the most expensive and explosive proxy contests in recent history.
Longtime Disney CEO Iger returned late last year to help stanch losses from the fledgeling streaming service Disney+. Three years ago, Iger had invited Peltz to speak to Disney's board about his philosophy, Peltz's firm Trian Fund Management said and a source close to Disney confirmed. At that time Trian did not own Disney stock.
Then Trian amassed a 0.5% stake in Disney last year and Peltz wanted a bigger voice and vote after criticizing capital spending, past acquisitions and a bungled succession plan.
When he requested a board seat, Disney balked and instead offered an "information sharing agreement." This would let Peltz speak with the management team and the board but not have a vote as a director.
Iger and other directors agree Disney needs to cut costs, and many cuts have already been announced. They say they want to continue the dialogue with Peltz but expressed concern that had not made concrete suggestions to address the problems he identified, people familiar with the company's thinking said.
Media analyst Michael Nathanson agreed with Peltz and wrote in a note that "many of Disney's wounds are self-inflicted," but expressed confidence in Iger's ability to "make the difficult decisions" required to improve Disney's long-term profitability.
Peltz and his colleagues mostly negotiate for changes out of the limelight and have been invited by 15 companies, including Unilever Plc ULVR.L and Invesco Ltd, to join the board. Peltz himself has served on 11 boards. At three -- Procter & Gamble, H.J. Heinz and DuPont de Nemours -- Trian waged boardroom battles that went to a vote where all investors got a say on whether Trian should have a seat.
While those three companies worked hard to keep Trian out, their CEOs later lauded the firm's collaborative efforts and insights. Mostly Peltz's medicine worked as Trian said companies where he was on the board outperformed the broader S&P 500 stock index by 9% during his tenure.
For Disney, however, Peltz may be an especially aggravating activist, arriving shortly after Third Point's billionaire founder Daniel Loeb showed up again last year. Disney and Loeb engaged in conversations and the two sides quickly agreed to add media executive Carolyn Everson to the Disney board.
FASTER FASTER
Many times activist investors push corporations for changes the company may already be considering. But they want management to act faster and more broadly.
Indeed Peltz may be betting the playbook he used at P&G will work at Disney too. This includes updating aging brands, simplifying bureaucracy and bringing along binders of information and data to find new ways of doing things.
With Disney's stock swooning, investors are unhappy and may be ready to back Peltz in a vote, investors and advisers who are not permitted to speak publicly said on Thursday.
Firms including T.Rowe Price, Legal & General Investment Management, Nuveen and Dimensional Fund Advisors are invested in Disney and are invested in P&G as well where they saw shares climb with Peltz on the board.
In his current battle, Peltz may be helped by new U.S. regulations that allow investors to see all director candidates on a so-called universal proxy card. Bankers and lawyers say this process may make it easier for activists like Peltz to win at least one board seat at an election. This is because investors can now pick and choose instead of selecting either all of the activist's choices or the company choices.
"Even though Disney has publicly rebuffed Peltz's agenda, this proxy battle is likely to cause more ripples," said Paul Verna, principal analyst at Insider Intelligence. "In the current climate, with Disney's stock underperforming the market and a slew of unfavorable economic conditions and business dynamics, Peltz may have more leverage to force Disney's hand."
(Reporting by Svea Herbst-Bayliss with additional reporting by Dawn Chmielewski in Los Angeles and Chavi Mehta in Bengaluru; Editing by David Gregorio)
((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
They say they want to continue the dialogue with Peltz but expressed concern that had not made concrete suggestions to address the problems he identified, people familiar with the company's thinking said. Disney and Loeb engaged in conversations and the two sides quickly agreed to add media executive Carolyn Everson to the Disney board. (Reporting by Svea Herbst-Bayliss with additional reporting by Dawn Chmielewski in Los Angeles and Chavi Mehta in Bengaluru; Editing by David Gregorio) ((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
They say they want to continue the dialogue with Peltz but expressed concern that had not made concrete suggestions to address the problems he identified, people familiar with the company's thinking said. Disney and Loeb engaged in conversations and the two sides quickly agreed to add media executive Carolyn Everson to the Disney board. (Reporting by Svea Herbst-Bayliss with additional reporting by Dawn Chmielewski in Los Angeles and Chavi Mehta in Bengaluru; Editing by David Gregorio) ((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
They say they want to continue the dialogue with Peltz but expressed concern that had not made concrete suggestions to address the problems he identified, people familiar with the company's thinking said. Disney and Loeb engaged in conversations and the two sides quickly agreed to add media executive Carolyn Everson to the Disney board. (Reporting by Svea Herbst-Bayliss with additional reporting by Dawn Chmielewski in Los Angeles and Chavi Mehta in Bengaluru; Editing by David Gregorio) ((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
They say they want to continue the dialogue with Peltz but expressed concern that had not made concrete suggestions to address the problems he identified, people familiar with the company's thinking said. Disney and Loeb engaged in conversations and the two sides quickly agreed to add media executive Carolyn Everson to the Disney board. (Reporting by Svea Herbst-Bayliss with additional reporting by Dawn Chmielewski in Los Angeles and Chavi Mehta in Bengaluru; Editing by David Gregorio) ((svea.herbst@thomsonreuters.com; +617 856 4331; Reuters Messaging: svea.herbst.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
31980cf9-c595-4a19-a674-ca135094f9fa
|
715916.0
|
2023-01-12 00:00:00 UTC
|
Disney Has a New Chairman -- and a Proxy Fight on Its Hands
|
DD
|
https://www.nasdaq.com/articles/disney-has-a-new-chairman-and-a-proxy-fight-on-its-hands
|
nan
|
nan
|
"The only constant in life is change," as the old saying goes. That seems to be particularly appropriate when applied to Walt Disney (NYSE: DIS) in recent months.
In late November, Disney shareholders sent up a collective cheer at the return of iconic CEO Bob Iger, who returned to run the House of Mouse after a nearly two-year hiatus. Iger immediately set to work, unwinding a sweeping reorganization initiated by former CEO Bob Chapek before his very public ouster. Several other recent developments bear Iger's fingerprints, including some fan-friendly changes to theme park policies and a requirement that employees return to the office at least four days per week.
Today, two new developments greeted Disney investors. The company has elected a chairman of the board, and an activist investor is picking a fight with the house that Mickey built.
Mark Parker will run the show
Disney's board of directors announced late Wednesday that it named Mark Parker as its new board chair, succeeding the departing Susan Arnold -- who has reached Disney's term limits.
Parker is the executive chairman at Nike and was CEO at the shoemaker for 13 years. He has been an independent director at Disney for the past seven years. Parker will also helm the board's Succession Planning Committee, tasked with finding an eventual replacement for Iger, whose current term as CEO will be up in two years.
In a statement accepting the role, Parker addressed the elephant in the room, saying (emphasis mine), "I am honored to have the opportunity to serve as Disney's Chairman, and I look forward to working closely with Bob and his management team on a strategy of growth that balances investment with profitability." Parker also said one of his top priorities would be to identify a successor for Iger once his current two-year stint ends. It's worth noting that Parker has experience in handling a chief executive transition, having done so at Nike.
Agitating for change
In another development, Disney announced that activist investor Nelson Peltz of Trian Fund Management is looking to pick a proxy fight. Trian accumulated a stake in Disney worth more than $100 million, according to The Wall Street Journal. The fund is angling to get Peltz a seat on Disney's board, but the company declined. Disney said its board of directors had "engaged with Mr. Peltz numerous times over the last few months," but after several overtures was unable to come to an agreement.
Soon after Disney's announcement, Trian Fund publicly nominated Peltz for election to Disney's board. The matter will ultimately be decided by Disney shareholders at the company's annual meeting in the coming months. The company has urged investors to vote with Disney's slate of director nominations.
Peltz is a well-known activist investor who hasn't shied away from going after big targets. He has previously taken on Procter & Gamble, General Electric, and DuPont, with mixed success.
Trian and Peltz launched a public campaign and a presentation titled "Restore the Magic." He cited the recent stock price decline and financial performance as evidence of mismanagement, calling Disney "a company in crisis." Peltz accused the company of inadequate succession planning, excessive compensation, and a lack of cost discipline, among other alleged shortfalls. Peltz also called Disney's streaming strategy "flawed" and is pushing for the reinstatement of Disney's dividend by 2025.
The only constant is change
These developments come at a time of great transition for Disney. The company's theme park business has largely recovered from its pandemic-induced slump, though investors have largely focused on Disney's direct-to-consumer (DTC) business.
The segment has been adding subscribers at a healthy clip, with more than 12 million joining the ranks of the company's flagship service, Disney+, in its fiscal 2022 fourth quarter (which ended Oct. 1). In all, the total number of subscribers for Disney+, Hulu, and ESPN+ was 236 million, surpassing streaming pioneer Netflix, which has a total of 223 million.
Unfortunately, investors were concerned about the high cost to acquire these subscribers, sending Disney's stock lower in the wake of results. The DTC segment generated revenue of $19.5 billion last year but delivered losses of more than $4 billion, primarily the result of its significant investment in content for Disney+. The company noted that Disney+ was still on track to reach profitability by 2024.
The company faces other challenges. The ongoing phenomenon of cord-cutting has reached epic proportions, while the costs of programming at ESPN continue to skyrocket.
On the other hand, investors should take heart in the fact that Disney has a 100-year history of success dealing with an ever-shifting-audience, changes in technology, and overcoming economic headwinds. Furthermore, the company warned investors that it would spend heavily to make Disney+ a streaming contender, something it achieved much more quickly than many imagined.
The bear market hasn't distinguished between quality companies and their inferior peers, with most stocks well off their peak. Given its track record of success and position as an industry-leading media company, Disney will no doubt recover its magic. And with a price-to-sales ratio of less than 2, Disney stock is a bargain.
Find out why Walt Disney is one of the 10 best stocks to buy now
Our award-winning analyst team has spent more than a decade beating the market. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed their ten top stock picks for investors to buy right now. Walt Disney is on the list -- but there are nine others you may be overlooking.
Click here to get access to the full list!
*Stock Advisor returns as of January 9, 2023
Danny Vena has positions in Netflix and Walt Disney. The Motley Fool has positions in and recommends Netflix, Nike, and Walt Disney. The Motley Fool recommends the following options: long January 2024 $145 calls on Walt Disney, long January 2025 $47.50 calls on Nike, and short January 2024 $155 calls on Walt Disney. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In a statement accepting the role, Parker addressed the elephant in the room, saying (emphasis mine), "I am honored to have the opportunity to serve as Disney's Chairman, and I look forward to working closely with Bob and his management team on a strategy of growth that balances investment with profitability." The segment has been adding subscribers at a healthy clip, with more than 12 million joining the ranks of the company's flagship service, Disney+, in its fiscal 2022 fourth quarter (which ended Oct. 1). Several other recent developments bear Iger's fingerprints, including some fan-friendly changes to theme park policies and a requirement that employees return to the office at least four days per week.
|
In a statement accepting the role, Parker addressed the elephant in the room, saying (emphasis mine), "I am honored to have the opportunity to serve as Disney's Chairman, and I look forward to working closely with Bob and his management team on a strategy of growth that balances investment with profitability." The segment has been adding subscribers at a healthy clip, with more than 12 million joining the ranks of the company's flagship service, Disney+, in its fiscal 2022 fourth quarter (which ended Oct. 1). Agitating for change In another development, Disney announced that activist investor Nelson Peltz of Trian Fund Management is looking to pick a proxy fight.
|
In a statement accepting the role, Parker addressed the elephant in the room, saying (emphasis mine), "I am honored to have the opportunity to serve as Disney's Chairman, and I look forward to working closely with Bob and his management team on a strategy of growth that balances investment with profitability." The segment has been adding subscribers at a healthy clip, with more than 12 million joining the ranks of the company's flagship service, Disney+, in its fiscal 2022 fourth quarter (which ended Oct. 1). Mark Parker will run the show Disney's board of directors announced late Wednesday that it named Mark Parker as its new board chair, succeeding the departing Susan Arnold -- who has reached Disney's term limits.
|
In a statement accepting the role, Parker addressed the elephant in the room, saying (emphasis mine), "I am honored to have the opportunity to serve as Disney's Chairman, and I look forward to working closely with Bob and his management team on a strategy of growth that balances investment with profitability." The segment has been adding subscribers at a healthy clip, with more than 12 million joining the ranks of the company's flagship service, Disney+, in its fiscal 2022 fourth quarter (which ended Oct. 1). Agitating for change In another development, Disney announced that activist investor Nelson Peltz of Trian Fund Management is looking to pick a proxy fight.
|
a800d2e2-1466-4370-b5cb-b90b7100dd44
|
715917.0
|
2023-01-09 00:00:00 UTC
|
DuPont (DD) Up 32% in 6 Months: What's Behind the Rally?
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-up-32-in-6-months%3A-whats-behind-the-rally
|
nan
|
nan
|
Shares of DuPont de Nemours, Inc. DD have shot up 32% over the past six months. The company has also outperformed its industry’s rise of 13.2% over the same time frame. It has also topped the S&P 500’s roughly 2% decline over the same period.
Let’s take a look into the factors that are driving this Zacks Rank #2 (Buy) stock.
Image Source: Zacks Investment Research
What’s Aiding DD?
DuPont is benefiting from strong underlying demand in its major end-markets, especially semiconductor, water and general industrial, which is driving its top line. Its volumes rose in the third quarter of 2022 on strong demand in semiconductor, water and industrial end-markets. DuPont envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter, offset by continued weakness in consumer electronics globally
DuPont also continues to implement strategic price increases in the wake of raw material and energy cost inflation. These actions are likely to support its results in the fourth quarter.
The company is also managing its portfolio with an aim for value creation. It is divesting non-core assets to focus more on high-growth, high-margin businesses. DuPont completed the divestment of the majority of its Mobility & Materials unit to Celanese on Nov 1, 2022 as part of its ongoing transformation. The company received $11 billion in gross cash from the transaction. The move is expected to boost its underlying performance, strengthen its balance sheet, maximize shareholders’ return and provide opportunities to grow business through targeted mergers and acquisitions.
DuPont also remains focused on driving growth though innovation and new product development. Its innovation-driven investment is focused on several high-growth areas. It remains committed to drive returns from its R&D investment. It is also benefiting from cost synergy savings and productivity improvement actions. Its structural cost actions are contributing to its bottom line.
DuPont de Nemours, Inc. Price and Consensus
DuPont de Nemours, Inc. price-consensus-chart | DuPont de Nemours, Inc. Quote
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Olympic Steel, Inc. ZEUS, Sociedad Quimica y Minera de Chile S.A. SQM and Commercial Metals Company CMC.
Olympic Steel currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for ZEUS's current-year earnings has been revised 4.8% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Olympic Steel’s earnings beat the Zacks Consensus Estimate in three of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 25.4%, on average. ZEUS has rallied around 35% in a year.
Sociedad has a projected earnings growth rate of 553.7% for the current year. The Zacks Consensus Estimate for SQM’s current-year earnings has been revised 3.6% upward in the past 60 days.
Sociedad has a trailing four-quarter earnings surprise of roughly 37.4%. SQM has rallied roughly 57% in a year. The company currently carries a Zacks Rank #1.
Commercial Metals currently carries a Zacks Rank #1. The consensus estimate for CMC's current-year earnings has been revised 10.2% upward in the past 60 days.
Commercial Metals’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 19.7%, on average. CMC has gained around 41% in a year.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report
Commercial Metals Company (CMC) : Free Stock Analysis Report
Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Shares of DuPont de Nemours, Inc. DD have shot up 32% over the past six months. Image Source: Zacks Investment Research What’s Aiding DD? Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. Shares of DuPont de Nemours, Inc. DD have shot up 32% over the past six months. Image Source: Zacks Investment Research What’s Aiding DD?
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. Shares of DuPont de Nemours, Inc. DD have shot up 32% over the past six months. Image Source: Zacks Investment Research What’s Aiding DD?
|
Shares of DuPont de Nemours, Inc. DD have shot up 32% over the past six months. Image Source: Zacks Investment Research What’s Aiding DD? Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
b0317cfc-be90-4777-9872-87c3fd452c30
|
715918.0
|
2023-01-09 00:00:00 UTC
|
Noteworthy Monday Option Activity: DD, MCD, WMT
|
DD
|
https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-dd-mcd-wmt
|
nan
|
nan
|
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 15,620 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 66.2% of DD's average daily trading volume over the past month of 2.4 million shares. Especially high volume was seen for the $75 strike put option expiring July 21, 2023, with 2,655 contracts trading so far today, representing approximately 265,500 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $75 strike highlighted in orange:
McDonald's Corp (Symbol: MCD) options are showing a volume of 15,159 contracts thus far today. That number of contracts represents approximately 1.5 million underlying shares, working out to a sizeable 61.9% of MCD's average daily trading volume over the past month, of 2.4 million shares. Especially high volume was seen for the $267.50 strike put option expiring January 20, 2023, with 2,639 contracts trading so far today, representing approximately 263,900 underlying shares of MCD. Below is a chart showing MCD's trailing twelve month trading history, with the $267.50 strike highlighted in orange:
And Walmart Inc (Symbol: WMT) options are showing a volume of 34,344 contracts thus far today. That number of contracts represents approximately 3.4 million underlying shares, working out to a sizeable 60.3% of WMT's average daily trading volume over the past month, of 5.7 million shares. Particularly high volume was seen for the $155 strike call option expiring March 17, 2023, with 5,430 contracts trading so far today, representing approximately 543,000 underlying shares of WMT. Below is a chart showing WMT's trailing twelve month trading history, with the $155 strike highlighted in orange:
For the various different available expirations for DD options, MCD options, or WMT options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Institutional Holders of MHG
Institutional Holders of SMLL
Institutional Holders of Microsoft
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $75 strike put option expiring July 21, 2023, with 2,655 contracts trading so far today, representing approximately 265,500 underlying shares of DD. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 15,620 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 66.2% of DD's average daily trading volume over the past month of 2.4 million shares.
|
Below is a chart showing DD's trailing twelve month trading history, with the $75 strike highlighted in orange: McDonald's Corp (Symbol: MCD) options are showing a volume of 15,159 contracts thus far today. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 15,620 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 66.2% of DD's average daily trading volume over the past month of 2.4 million shares.
|
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 15,620 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 66.2% of DD's average daily trading volume over the past month of 2.4 million shares. Especially high volume was seen for the $75 strike put option expiring July 21, 2023, with 2,655 contracts trading so far today, representing approximately 265,500 underlying shares of DD.
|
Below is a chart showing WMT's trailing twelve month trading history, with the $155 strike highlighted in orange: For the various different available expirations for DD options, MCD options, or WMT options, visit StockOptionsChannel.com. Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in DuPont (Symbol: DD), where a total of 15,620 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to about 66.2% of DD's average daily trading volume over the past month of 2.4 million shares.
|
cef95a00-70d4-4f69-96ba-e89b7ba76f79
|
715919.0
|
2023-01-05 00:00:00 UTC
|
Is CalMaine Foods (CALM) Outperforming Other Basic Materials Stocks This Year?
|
DD
|
https://www.nasdaq.com/articles/is-calmaine-foods-calm-outperforming-other-basic-materials-stocks-this-year-1
|
nan
|
nan
|
Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Has Cal-Maine Foods (CALM) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.
Cal-Maine Foods is a member of the Basic Materials sector. This group includes 239 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Cal-Maine Foods is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for CALM's full-year earnings has moved 51.7% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, CALM has returned 5.1% so far this year. At the same time, Basic Materials stocks have lost an average of 3.1%. As we can see, Cal-Maine Foods is performing better than its sector in the calendar year.
Another Basic Materials stock, which has outperformed the sector so far this year, is DuPont de Nemours (DD). The stock has returned 2.8% year-to-date.
For DuPont de Nemours, the consensus EPS estimate for the current year has increased 1.8% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Cal-Maine Foods belongs to the Agriculture - Products industry, a group that includes 7 individual companies and currently sits at #70 in the Zacks Industry Rank. On average, this group has lost an average of 9.8% so far this year, meaning that CALM is performing better in terms of year-to-date returns.
DuPont de Nemours, however, belongs to the Chemical - Diversified industry. Currently, this 34-stock industry is ranked #216. The industry has moved -4.9% so far this year.
Investors interested in the Basic Materials sector may want to keep a close eye on Cal-Maine Foods and DuPont de Nemours as they attempt to continue their solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CalMaine Foods, Inc. (CALM) : Free Stock Analysis Report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Another Basic Materials stock, which has outperformed the sector so far this year, is DuPont de Nemours (DD). Click to get this free report CalMaine Foods, Inc. (CALM) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here. A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question.
|
Another Basic Materials stock, which has outperformed the sector so far this year, is DuPont de Nemours (DD). Click to get this free report CalMaine Foods, Inc. (CALM) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here. Over the past three months, the Zacks Consensus Estimate for CALM's full-year earnings has moved 51.7% higher.
|
Another Basic Materials stock, which has outperformed the sector so far this year, is DuPont de Nemours (DD). Click to get this free report CalMaine Foods, Inc. (CALM) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here. To break things down more, Cal-Maine Foods belongs to the Agriculture - Products industry, a group that includes 7 individual companies and currently sits at #70 in the Zacks Industry Rank.
|
Another Basic Materials stock, which has outperformed the sector so far this year, is DuPont de Nemours (DD). Click to get this free report CalMaine Foods, Inc. (CALM) : Free Stock Analysis Report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report To read this article on Zacks.com click here. Has Cal-Maine Foods (CALM) been one of those stocks this year?
|
0e232dcb-18f6-4280-ac4a-fbe7893685e2
|
715920.0
|
2023-01-05 00:00:00 UTC
|
Here's Why You Should Add DuPont (DD) to Your Portfolio Now
|
DD
|
https://www.nasdaq.com/articles/heres-why-you-should-add-dupont-dd-to-your-portfolio-now-0
|
nan
|
nan
|
Shares of DuPont de Nemours, Inc. DD have popped around 33% over the past three months. It is benefiting from strong end-market demand, productivity actions and innovation-driven investment.
We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
Let’s take a look into the factors that make this Zacks Rank #2 (Buy) stock an attractive choice for investors right now.
Healthy Growth Prospects
The Zacks Consensus Estimate for earnings for 2023 for DuPont is currently pegged at $3.80, implying an expected year-over-year growth of around 14.7%. The company also has an expected long-term earnings per share growth rate of 8%.
Impressive Earnings Surprise History
DuPont has outpaced the Zacks Consensus Estimate in each of the trailing four quarters. In this time frame, it has delivered an earnings surprise of 12.4%, on average.
Capital Allocation
The company remains focused on driving cash flow and shareholder value. It looks to boost cash flow through working capital productivity and earnings growth. DuPont returned $1,625 million to shareholders through share repurchases and dividends during the first nine months of 2022, including $415 million in the third quarter. It expects to return roughly $670 million in dividends for full-year 2022. DuPont's board, on Nov 7, 2022, also approved a new share buyback program authorizing the repurchase of up to $5 billion of common stock.
Growth Drivers in Place
DuPont is gaining from strong underlying demand in its major end-markets, especially semiconductor, water and general industrial, which is driving its top line as witnessed in the third quarter of 2022. Its volumes rose in the third quarter on strong demand in semiconductor, water and industrial end-markets. DuPont envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter, offset by continued weakness in consumer electronics globally
The company also remains focused on driving growth though innovation and new product development. Its innovation-driven investment is focused on several high-growth areas. It remains committed to drive returns from its R&D investment. It is also benefiting from cost synergy savings and productivity improvement actions. Its structural cost actions are contributing to its bottom line.
DuPont also continues to implement strategic price increases in the wake of raw material and energy cost inflation. These actions are likely to support its results in the fourth quarter.
The company is also managing its portfolio with an aim for value creation. It is divesting non-core assets to focus more on high-growth, high-margin businesses. DuPont completed the divestment of the majority of its Mobility & Materials unit to Celanese on Nov 1, 2022 as part of its ongoing transformation. The company received $11 billion in gross cash from the transaction. The move is expected to boost its underlying performance, strengthen its balance sheet, maximize shareholders’ return and provide opportunities to grow business through targeted mergers and acquisitions.
DuPont de Nemours, Inc. Price and Consensus
DuPont de Nemours, Inc. price-consensus-chart | DuPont de Nemours, Inc. Quote
Other Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Olympic Steel, Inc. ZEUS, Sociedad Quimica y Minera de Chile S.A. SQM and Commercial Metals Company CMC.
Olympic Steel currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for ZEUS's current-year earnings has been revised 4.8% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Olympic Steel’s earnings beat the Zacks Consensus Estimate in three of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 25.4%, on average. ZEUS has rallied around 30% in a year.
Sociedad has a projected earnings growth rate of 553.7% for the current year. The Zacks Consensus Estimate for SQM’s current-year earnings has been revised 3.6% upward in the past 60 days.
Sociedad has a trailing four-quarter earnings surprise of roughly 37.4%. SQM has rallied roughly 59% in a year. The company currently carries a Zacks Rank #1.
Commercial Metals currently carries a Zacks Rank #1. The consensus estimate for CMC's current-year earnings has been revised 8.7% upward in the past 60 days.
Commercial Metals’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 19.7%, on average. CMC has gained around 37% in a year.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report
Commercial Metals Company (CMC) : Free Stock Analysis Report
Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Shares of DuPont de Nemours, Inc. DD have popped around 33% over the past three months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. Shares of DuPont de Nemours, Inc. DD have popped around 33% over the past three months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here. Shares of DuPont de Nemours, Inc. DD have popped around 33% over the past three months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
|
Shares of DuPont de Nemours, Inc. DD have popped around 33% over the past three months. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report Sociedad Quimica y Minera S.A. (SQM) : Free Stock Analysis Report Commercial Metals Company (CMC) : Free Stock Analysis Report Olympic Steel, Inc. (ZEUS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
b83e03f7-fef6-40f4-a9a7-679b3f487213
|
715921.0
|
2022-12-20 00:00:00 UTC
|
Noteworthy Tuesday Option Activity: DD, MRNA, HD
|
DD
|
https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-dd-mrna-hd
|
nan
|
nan
|
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 58,130 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 220.6% of DD's average daily trading volume over the past month, of 2.6 million shares. Particularly high volume was seen for the $67 strike call option expiring January 06, 2023, with 25,008 contracts trading so far today, representing approximately 2.5 million underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $67 strike highlighted in orange:
Moderna Inc (Symbol: MRNA) options are showing a volume of 66,675 contracts thus far today. That number of contracts represents approximately 6.7 million underlying shares, working out to a sizeable 105.4% of MRNA's average daily trading volume over the past month, of 6.3 million shares. Particularly high volume was seen for the $210 strike call option expiring December 23, 2022, with 5,340 contracts trading so far today, representing approximately 534,000 underlying shares of MRNA. Below is a chart showing MRNA's trailing twelve month trading history, with the $210 strike highlighted in orange:
And Home Depot Inc (Symbol: HD) options are showing a volume of 22,765 contracts thus far today. That number of contracts represents approximately 2.3 million underlying shares, working out to a sizeable 45% of HD's average daily trading volume over the past month, of 5.1 million shares. Especially high volume was seen for the $350 strike call option expiring January 20, 2023, with 4,993 contracts trading so far today, representing approximately 499,300 underlying shares of HD. Below is a chart showing HD's trailing twelve month trading history, with the $350 strike highlighted in orange:
For the various different available expirations for DD options, MRNA options, or HD options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
NGHT Insider Buying
Institutional Holders of RRAC
VOX YTD Return
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Particularly high volume was seen for the $67 strike call option expiring January 06, 2023, with 25,008 contracts trading so far today, representing approximately 2.5 million underlying shares of DD. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 58,130 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 220.6% of DD's average daily trading volume over the past month, of 2.6 million shares.
|
Below is a chart showing DD's trailing twelve month trading history, with the $67 strike highlighted in orange: Moderna Inc (Symbol: MRNA) options are showing a volume of 66,675 contracts thus far today. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 58,130 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 220.6% of DD's average daily trading volume over the past month, of 2.6 million shares.
|
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 58,130 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 220.6% of DD's average daily trading volume over the past month, of 2.6 million shares. Particularly high volume was seen for the $67 strike call option expiring January 06, 2023, with 25,008 contracts trading so far today, representing approximately 2.5 million underlying shares of DD.
|
Particularly high volume was seen for the $67 strike call option expiring January 06, 2023, with 25,008 contracts trading so far today, representing approximately 2.5 million underlying shares of DD. Below is a chart showing HD's trailing twelve month trading history, with the $350 strike highlighted in orange: For the various different available expirations for DD options, MRNA options, or HD options, visit StockOptionsChannel.com. Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 58,130 contracts has been traded thus far today, a contract volume which is representative of approximately 5.8 million underlying shares (given that every 1 contract represents 100 underlying shares).
|
4e14868e-a47f-4e62-b088-b5f6b7e5c43b
|
715922.0
|
2022-12-08 00:00:00 UTC
|
Why Is DuPont de Nemours (DD) Up 4% Since Last Earnings Report?
|
DD
|
https://www.nasdaq.com/articles/why-is-dupont-de-nemours-dd-up-4-since-last-earnings-report
|
nan
|
nan
|
It has been about a month since the last earnings report for DuPont de Nemours (DD). Shares have added about 4% in that time frame, underperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is DuPont de Nemours due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
DuPont's Earnings and Revenues Surpass Estimates in Q3
DuPont logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter.
Barring one-time items, earnings came in at 82 cents per share for the reported quarter, beating the Zacks Consensus Estimate of 81 cents.
DuPont raked in net sales of $3,317 million, up 4% from the year-ago quarter. It also surpassed the Zacks Consensus Estimate by 1.53%. The company saw an 11% rise in organic sales in the quarter, supported by 3% higher volumes and 8% pricing gains. It benefited from strong underlying demand in its major end-markets during the quarter, especially semiconductor, water and general industrial.
Pricing actions and operational execution helped the company offset the cost inflation in the quarter. Volume rose on strong demand in semiconductor, water and industrial end-markets, partly masked by reduced volumes from protective garments within Safety Solutions and weakness in smartphones and personal computing within Interconnect Solutions.
Segment Highlights
The company’s Electronics & Industrial segment recorded net sales of $1,511 million in the reported quarter, up 3% on a year-over-year comparison basis. Organic sales rose 7% on higher volumes and prices. Semiconductor Technologies organic sales rose on strong demand. Industrial Solutions also registered higher sales while organic sales declined in Interconnect Solutions on lower volumes.
Net sales in the Water & Protection unit were $1,534 million, up 10% year over year. Organic sales rose 15% on 13% pricing gains and 2% higher volumes.
Financials
DuPont had cash and cash equivalents of $1,785 million at the end of the quarter, up around 7% year over year. Long-term debt was $10,564 million, down around 0.6% year over year.
The company also generated operating cash flow of $419 million during the quarter. It returned $415 million to shareholders through share repurchases and dividends during the quarter.
DuPont's board, on Nov 7, 2022, approved a new share buyback program authorizing the repurchase of up to $5 billion of common stock.
Outlook
The company sees net sales for 2022 to be roughly $13 billion. Adjusted earnings per share for 2022 is now expected to be roughly $3.30.
DuPont also envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter. However, it sees continued weakness in consumer electronics globally and some slowdown in customer semiconductor fab production rates. It also intends to cut production rates to realign working capital in expectation of a more normal supply chain environment. The company also sees incremental currency headwinds to further impact both top and bottom lines.
DuPont also completed the Mobility & Materials divestment to Celanese on Nov 1, 2022. Moreover, it terminated the earlier announced agreement to buy the outstanding shares of Rogers Corporation on Nov 1 due to lack of receipt of regulatory clearance.
How Have Estimates Been Moving Since Then?
It turns out, estimates review flatlined during the past month.
VGM Scores
At this time, DuPont de Nemours has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
DuPont de Nemours has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
Performance of an Industry Player
DuPont de Nemours is part of the Zacks Chemical - Diversified industry. Over the past month, LyondellBasell (LYB), a stock from the same industry, has gained 2%. The company reported its results for the quarter ended September 2022 more than a month ago.
LyondellBasell reported revenues of $12.25 billion in the last reported quarter, representing a year-over-year change of -3.5%. EPS of $1.96 for the same period compares with $5.25 a year ago.
LyondellBasell is expected to post earnings of $1.09 per share for the current quarter, representing a year-over-year change of -70%. Over the last 30 days, the Zacks Consensus Estimate has changed -16%.
The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for LyondellBasell. Also, the stock has a VGM Score of B.
Just Released: Zacks Unveils the Top 5 EV Stocks for 2022
For several months now, electric vehicles have been disrupting the $82 billion automotive industry. And that disruption is only getting bigger thanks to sky-high gas prices. Even titans in the financial industry including George Soros, Jeff Bezos, and Ray Dalio have invested in this unstoppable wave. You don't want to be sitting on your hands while EV stocks break out and climb to new highs. In a new free report, Zacks is revealing the top 5 EV stocks for investors. Next year, don't look back on today wishing you had taken advantage of this opportunity.
>>Send me my free report revealing the top 5 EV stocks
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
LyondellBasell Industries N.V. (LYB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It has been about a month since the last earnings report for DuPont de Nemours (DD). Shares have added about 4% in that time frame, underperforming the S&P 500. VGM Scores At this time, DuPont de Nemours has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report LyondellBasell Industries N.V. (LYB) : Free Stock Analysis Report To read this article on Zacks.com click here. It has been about a month since the last earnings report for DuPont de Nemours (DD). Shares have added about 4% in that time frame, underperforming the S&P 500.
|
Click to get this free report DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report LyondellBasell Industries N.V. (LYB) : Free Stock Analysis Report To read this article on Zacks.com click here. It has been about a month since the last earnings report for DuPont de Nemours (DD). Shares have added about 4% in that time frame, underperforming the S&P 500.
|
It has been about a month since the last earnings report for DuPont de Nemours (DD). Shares have added about 4% in that time frame, underperforming the S&P 500. VGM Scores At this time, DuPont de Nemours has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
|
39a493cb-a3f2-4514-9c2d-7110220a382c
|
715923.0
|
2022-12-02 00:00:00 UTC
|
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
|
DD
|
https://www.nasdaq.com/articles/this-industrial-stock-looks-dirt-cheap.-is-it-a-buy
|
nan
|
nan
|
Sometimes, when someone is looking for investment ideas and scanning stock screeners, a few companies stand out among their peers in peculiar ways. The Chemours Company (NYSE: CC) is one of those peculiar oddities. Its stock trades at a deep discount to its chemical manufacturing peers, and it's one of the few companies in this industry with a dividend yield above 3%. Moreover, it has a portfolio of specialty chemicals aligned with many long-term global growth trends.
Sounds too good to be true, right? Perhaps, but there is something that the market doesn't like about this stock. So let's take a closer look at Chemours to see why Wall Street is shunning this industrial stock and whether that makes it a contrarian stock to buy.
A compelling portfolio and stellar performance
Chemours is a rather young company, but its roots go much further back as a part of DuPont de Nemours (NYSE: DD). The company was spun off in 2015 and has three primary manufacturing divisions: titanium dioxide, refrigerants and propellants, and fluoropolymers, which are better known by their brand names, such as Teflon. These chemicals are used in a wide range of products and end markets. For example, titanium dioxide is a white pigment and UV-ray blocker commonly found in paints, dyes, sunscreen, and plastics.
Titanium dioxide is a rather mature industry that is pretty sensitive to economic cycles, but it is a highly consolidated industry with decent margins and doesn't require much capital investment. It has been a cash engine for Chemours to invest in its other divisions and reward shareholders. Chemours' refrigerant business is compelling because it has created a lower potential greenhouse-warming gas for air conditioners and other refrigeration needs that hit a lot of growth trends: growing residential air conditioning, commercial cooling demand for data centers, and global chemical regulations pushing toward lower potential greenhouse-warming chemicals for refrigeration.
Furthermore, its fluoropolymers division has the number one or number two market position for 12 different industries, including high-growth sectors such as electronic components, industrial coatings, and fuel cell membranes.
Since going public, the company has produced some rather impressive financial results. Since 2015, it has more than doubled its earnings per share and currently has a return on invested capital of 18%. It carries quite a bit of debt on its balance sheet (debt to capital is 73%), but it also has about $1.1 billion in cash and has been chipping away at that debt balance. In addition, it pays a decent dividend and has retired about 15% of shares outstanding since going public.
Together, these points would suggest Chemours is a company worth an investment; its current valuation of five times earnings suggests you could get it on the cheap.
The big risk
Based on its financial performance, it seems silly for DuPont to have spun off Chemours into its own entity. I'm sure management talked at the time about "unlocking value" or "freeing up these businesses to make better capital decisions." But alongside those businesses were some potentially massive environmental liabilities.
The most notable of these liabilities relates to contamination from what are commonly referred to as PFAS. These chemicals break down incredibly slowly in the environment and typically require active cleanup to remove them. According to Bloomberg Law, total PFAS liabilities for just one company, 3M, could reach $30 billion. Chemours had significant liabilities as the original spin-off agreement left Chemours covering much of DuPont's legacy liabilities.
Chemours and DuPont have subsequently agreed to share PFAS-related costs up to $4 billion over the next 20 years and have set up a $1 billion escrow account to cover expenses for these cases.
You don't have to do a lot of math to conclude that $2 billion in litigation and cleanup expenses is an overwhelming chunk of cash for a $4 billion company. There is even the possibility that PFAS litigation costs could increase from there. Over the past two years, there has been a significant uptick in lawsuits filed related to PFAS.
Is it worth it?
Any investment today is betting that the company is either not going to get hit too hard by PFAS liabilities or is in a good enough financial position to handle whatever liabilities are awarded.
Chemours has, so far, been able to generate solid financial results. It has also done this while contributing to the escrow fund for future liabilities. So if the spending rate for PFAS liabilities remains steady, then Chemours could be okay. That's a big if, though, with more and more cases being filed recently.
If Chemours can drastically improve its balance sheet and prepare the business for a big financial hit, it is a company worth revisiting. For now, though, Chemours stock remains risky enough that it is probably worth staying away from for some time.
10 stocks we like better than Chemours
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Chemours wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of November 7, 2022
Tyler Crowe has no position in any of the stocks mentioned. The Motley Fool recommends 3M. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A compelling portfolio and stellar performance Chemours is a rather young company, but its roots go much further back as a part of DuPont de Nemours (NYSE: DD). The Chemours Company (NYSE: CC) is one of those peculiar oddities. In addition, it pays a decent dividend and has retired about 15% of shares outstanding since going public.
|
The Chemours Company (NYSE: CC) is one of those peculiar oddities. A compelling portfolio and stellar performance Chemours is a rather young company, but its roots go much further back as a part of DuPont de Nemours (NYSE: DD). In addition, it pays a decent dividend and has retired about 15% of shares outstanding since going public.
|
The Chemours Company (NYSE: CC) is one of those peculiar oddities. A compelling portfolio and stellar performance Chemours is a rather young company, but its roots go much further back as a part of DuPont de Nemours (NYSE: DD). In addition, it pays a decent dividend and has retired about 15% of shares outstanding since going public.
|
The Chemours Company (NYSE: CC) is one of those peculiar oddities. A compelling portfolio and stellar performance Chemours is a rather young company, but its roots go much further back as a part of DuPont de Nemours (NYSE: DD). In addition, it pays a decent dividend and has retired about 15% of shares outstanding since going public.
|
06ed5eb4-47f8-499d-8f91-b97bc9cbf36f
|
715924.0
|
2022-12-01 00:00:00 UTC
|
DuPont De Nemours & Co. To Present At Credit Suisse Conference; Webcast At 8:45 AM ET
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-co.-to-present-at-credit-suisse-conference-webcast-at-8%3A45-am-et
|
nan
|
nan
|
(RTTNews) - DuPont De Nemours & Co. (DD) will participate in a fireside chat at the Credit Suisse Global Industrials Conference.
The event is scheduled to begin at 8:45 AM ET on December 1, 2022.
To access the live webcast, log on to http://www.dupont.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont De Nemours & Co. (DD) will participate in a fireside chat at the Credit Suisse Global Industrials Conference. The event is scheduled to begin at 8:45 AM ET on December 1, 2022. To access the live webcast, log on to http://www.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont De Nemours & Co. (DD) will participate in a fireside chat at the Credit Suisse Global Industrials Conference. The event is scheduled to begin at 8:45 AM ET on December 1, 2022. To access the live webcast, log on to http://www.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont De Nemours & Co. (DD) will participate in a fireside chat at the Credit Suisse Global Industrials Conference. The event is scheduled to begin at 8:45 AM ET on December 1, 2022. To access the live webcast, log on to http://www.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont De Nemours & Co. (DD) will participate in a fireside chat at the Credit Suisse Global Industrials Conference. The event is scheduled to begin at 8:45 AM ET on December 1, 2022. To access the live webcast, log on to http://www.dupont.com The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
23ffeeb9-028c-41c2-ad9b-db3b97e35467
|
715925.0
|
2022-11-30 00:00:00 UTC
|
Warren Buffett's Buying This Passive Income Stock
|
DD
|
https://www.nasdaq.com/articles/warren-buffetts-buying-this-passive-income-stock-1
|
nan
|
nan
|
Warren Buffett is considered a stock market legend because he has steered Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) to mind-blowing returns in the six decades he has been at the helm.
Since 1965, the investment vehicle has generated roughly a 3,600,000% return for investors, or an average of more than 20% annually. In contrast, the S&P 500 has generated about a 30,000% return, or an average of 10% a year. There's a reason Buffett is called the Oracle of Omaha.
Image source: The Motley Fool.
Buffett has tried to share with the public his investment philosophy in broad terms over the years, such as buying good companies at a discount and holding on to them for years. In general it serves investors well, but there is much left unsaid in the details. He enjoys special privileges as a billionaire investor that are unavailable to the average investor, and Buffett doesn't always follow his own advice.
Still, following his general principles can help your own returns. Recently, Buffett bought more shares in Celanese (NYSE: CE), a global chemicals company that he first began acquiring earlier this year. So let's see if following his lead in this stock is a worthwhile purchase for your own portfolio.
Finding the right chemistry
Buffett purchased his first tranche of Celanese stock in the first quarter, spending $1.1 billion to acquire some 7.9 million shares, back when it was trading north of $140 a share. He added more shares in the second quarter, and again in the third, so that Berkshire Hathaway now holds 9.71 million shares, or 9% of Celanese's outstanding shares, which are worth just over $1 billion.
Needless to say, with Celanese trading at around $104 per share today, you would be able to buy the stock for prices lower than what Buffett paid himself. Would you want to, though?
Celanese primarily makes polymers, acetyls, and acetates, or plastic and plastic-like materials. For example, polyoxymethylene, or POM, is one of its key products and is a thermoplastic used in precision parts often in the automotive industry for fuel systems and window lift parts. It's also used for conveyor belts, sprinkler systems, and drug delivery systems, as well as for gears like those you would find in large and small appliances in the home.
The chemical company also makes acesulfame potassium, or Ace-K, an artificial sweetener, and the preservatives potassium sorbate and sorbic acid, which are found in food, beverages, and personal products.
Image source: Getty Images.
A good value
What Buffett probably likes about this stock is that aside from being an industry leader in the space, it's attractively valued. While chemical companies aren't typically known for nosebleed valuations, compared to most of its peers, Celanese is trading at a discount.
STOCK
PRICE/EQUITY RATIO
FORWARD P/E RATIO
PRICE/SALES RATIO
PRICE/FREE CASH FLOW RATIO
BASF
8.9
10.8
0.5
N/A
Celanese
6.9
7.9
1.2
11.0
Dow
6.7
11.7
0.6
5.0
DuPont
31.4
18.8
2.5
62.7
Eastman Chemical
9.6
10.5
0.9
572.4
ExxonMobil
9.3
10.0
1.2
10.6
Data source: Finviz.com. Yahoo! Finance.
Celanese doesn't have a lot of large competitors because of the high barriers to entry in the market, and its products are essential to key industries. It also just completed its acquisition of DuPont's mobility and materials segment that services the automotive industry. This is likely in order to make a play for a bigger part of the electric vehicle market in which it has already invested heavily.
Buffett continues to dump shares in China's EV maker BYD and may think it's better to invest in a pick-and-shovel materials business that plays to the whole field rather than trying to find the one horse that will win. Celanese is an overall stable business with a long runway of future growth before it that possesses relatively low risk.
A healthy stream of income
Buffett doesn't buy stocks because they pay a dividend, but certainly enjoys the income they provide when they do. Celanese has paid a dividend for the past 17 years and has hiked the payout every year since 2010, most recently last month when it raised the quarterly rate 3% to $0.70 per share. The dividend yields a healthy 2.7% annually and with a payout ratio of just 18.5%, the dividend is both safe and has plenty of room for future increases.
Blindly following an investor's stock purchases is not a wise strategy, even if it's someone like Warren Buffett. But Celanese looks like a chemicals stock worth owning. Getting a lifetime of passive income at a price cheaper than what Buffett paid makes the stock opportunity all that much sweeter.
10 stocks we like better than Celanese
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Celanese wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of November 7, 2022
Rich Duprey has positions in ExxonMobil. The Motley Fool has positions in and recommends BYD and Berkshire Hathaway (B shares). The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
He added more shares in the second quarter, and again in the third, so that Berkshire Hathaway now holds 9.71 million shares, or 9% of Celanese's outstanding shares, which are worth just over $1 billion. Recently, Buffett bought more shares in Celanese (NYSE: CE), a global chemicals company that he first began acquiring earlier this year. Celanese doesn't have a lot of large competitors because of the high barriers to entry in the market, and its products are essential to key industries.
|
He added more shares in the second quarter, and again in the third, so that Berkshire Hathaway now holds 9.71 million shares, or 9% of Celanese's outstanding shares, which are worth just over $1 billion. A healthy stream of income Buffett doesn't buy stocks because they pay a dividend, but certainly enjoys the income they provide when they do. The Motley Fool has positions in and recommends BYD and Berkshire Hathaway (B shares).
|
He added more shares in the second quarter, and again in the third, so that Berkshire Hathaway now holds 9.71 million shares, or 9% of Celanese's outstanding shares, which are worth just over $1 billion. Finding the right chemistry Buffett purchased his first tranche of Celanese stock in the first quarter, spending $1.1 billion to acquire some 7.9 million shares, back when it was trading north of $140 a share. Needless to say, with Celanese trading at around $104 per share today, you would be able to buy the stock for prices lower than what Buffett paid himself.
|
He added more shares in the second quarter, and again in the third, so that Berkshire Hathaway now holds 9.71 million shares, or 9% of Celanese's outstanding shares, which are worth just over $1 billion. Buffett has tried to share with the public his investment philosophy in broad terms over the years, such as buying good companies at a discount and holding on to them for years. For example, polyoxymethylene, or POM, is one of its key products and is a thermoplastic used in precision parts often in the automotive industry for fuel systems and window lift parts.
|
cc18719b-b255-4d10-a3d4-d86fd43a9d71
|
715926.0
|
2022-11-29 00:00:00 UTC
|
Noteworthy Tuesday Option Activity: DD, YETI, IIPR
|
DD
|
https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-dd-yeti-iipr
|
nan
|
nan
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 21,961 contracts has been traded thus far today, a contract volume which is representative of approximately 2.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 55% of DD's average daily trading volume over the past month, of 4.0 million shares. Especially high volume was seen for the $80 strike call option expiring January 20, 2023, with 9,500 contracts trading so far today, representing approximately 950,000 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $80 strike highlighted in orange:
Yeti Holdings Inc (Symbol: YETI) saw options trading volume of 8,418 contracts, representing approximately 841,800 underlying shares or approximately 54.3% of YETI's average daily trading volume over the past month, of 1.5 million shares. Especially high volume was seen for the $34 strike put option expiring December 16, 2022, with 5,204 contracts trading so far today, representing approximately 520,400 underlying shares of YETI. Below is a chart showing YETI's trailing twelve month trading history, with the $34 strike highlighted in orange:
And Innovative Industrial Properties Inc (Symbol: IIPR) options are showing a volume of 1,357 contracts thus far today. That number of contracts represents approximately 135,700 underlying shares, working out to a sizeable 52.7% of IIPR's average daily trading volume over the past month, of 257,695 shares. Especially high volume was seen for the $115 strike put option expiring January 20, 2023, with 775 contracts trading so far today, representing approximately 77,500 underlying shares of IIPR. Below is a chart showing IIPR's trailing twelve month trading history, with the $115 strike highlighted in orange:
For the various different available expirations for DD options, YETI options, or IIPR options, visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
Also see:
Top Ranked Dividend Stocks With Insider Buying
Institutional Holders of HIHO
Top Ten Hedge Funds Holding ARAY
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Especially high volume was seen for the $80 strike call option expiring January 20, 2023, with 9,500 contracts trading so far today, representing approximately 950,000 underlying shares of DD. Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 21,961 contracts has been traded thus far today, a contract volume which is representative of approximately 2.2 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 55% of DD's average daily trading volume over the past month, of 4.0 million shares.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 21,961 contracts has been traded thus far today, a contract volume which is representative of approximately 2.2 million underlying shares (given that every 1 contract represents 100 underlying shares). Especially high volume was seen for the $80 strike call option expiring January 20, 2023, with 9,500 contracts trading so far today, representing approximately 950,000 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $80 strike highlighted in orange: Yeti Holdings Inc (Symbol: YETI) saw options trading volume of 8,418 contracts, representing approximately 841,800 underlying shares or approximately 54.3% of YETI's average daily trading volume over the past month, of 1.5 million shares.
|
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in DuPont (Symbol: DD), where a total volume of 21,961 contracts has been traded thus far today, a contract volume which is representative of approximately 2.2 million underlying shares (given that every 1 contract represents 100 underlying shares). Below is a chart showing DD's trailing twelve month trading history, with the $80 strike highlighted in orange: Yeti Holdings Inc (Symbol: YETI) saw options trading volume of 8,418 contracts, representing approximately 841,800 underlying shares or approximately 54.3% of YETI's average daily trading volume over the past month, of 1.5 million shares. That number works out to 55% of DD's average daily trading volume over the past month, of 4.0 million shares.
|
Especially high volume was seen for the $80 strike call option expiring January 20, 2023, with 9,500 contracts trading so far today, representing approximately 950,000 underlying shares of DD. Below is a chart showing DD's trailing twelve month trading history, with the $80 strike highlighted in orange: Yeti Holdings Inc (Symbol: YETI) saw options trading volume of 8,418 contracts, representing approximately 841,800 underlying shares or approximately 54.3% of YETI's average daily trading volume over the past month, of 1.5 million shares. Below is a chart showing IIPR's trailing twelve month trading history, with the $115 strike highlighted in orange: For the various different available expirations for DD options, YETI options, or IIPR options, visit StockOptionsChannel.com.
|
208efe41-1d48-4d23-8bcc-7c335b0e7e15
|
715927.0
|
2022-11-29 00:00:00 UTC
|
Implied SPYV Analyst Target Price: $44
|
DD
|
https://www.nasdaq.com/articles/implied-spyv-analyst-target-price%3A-%2444
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR Portfolio S&P 500 Value ETF (Symbol: SPYV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $43.66 per unit.
With SPYV trading at a recent price near $39.83 per unit, that means that analysts see 9.61% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SPYV's underlying holdings with notable upside to their analyst target prices are DuPont de Nemours Inc (Symbol: DD), AMETEK Inc (Symbol: AME), and American Express Co. (Symbol: AXP). Although DD has traded at a recent price of $69.35/share, the average analyst target is 10.82% higher at $76.86/share. Similarly, AME has 10.51% upside from the recent share price of $139.36 if the average analyst target price of $154.00/share is reached, and analysts on average are expecting AXP to reach a target price of $165.61/share, which is 9.77% above the recent price of $150.87. Below is a twelve month price history chart comparing the stock performance of DD, AME, and AXP:
Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
SPDR Portfolio S&P 500 Value ETF SPYV $39.83 $43.66 9.61%
DuPont de Nemours Inc DD $69.35 $76.86 10.82%
AMETEK Inc AME $139.36 $154.00 10.51%
American Express Co. AXP $150.87 $165.61 9.77%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
Auto Parts Dividend Stocks
DOM Historical Stock Prices
UBS Average Annual Return
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
SPDR Portfolio S&P 500 Value ETF SPYV $39.83 $43.66 9.61% DuPont de Nemours Inc DD $69.35 $76.86 10.82% AMETEK Inc AME $139.36 $154.00 10.51% American Express Co. AXP $150.87 $165.61 9.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPYV's underlying holdings with notable upside to their analyst target prices are DuPont de Nemours Inc (Symbol: DD), AMETEK Inc (Symbol: AME), and American Express Co. (Symbol: AXP). Although DD has traded at a recent price of $69.35/share, the average analyst target is 10.82% higher at $76.86/share.
|
Three of SPYV's underlying holdings with notable upside to their analyst target prices are DuPont de Nemours Inc (Symbol: DD), AMETEK Inc (Symbol: AME), and American Express Co. (Symbol: AXP). SPDR Portfolio S&P 500 Value ETF SPYV $39.83 $43.66 9.61% DuPont de Nemours Inc DD $69.35 $76.86 10.82% AMETEK Inc AME $139.36 $154.00 10.51% American Express Co. AXP $150.87 $165.61 9.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Although DD has traded at a recent price of $69.35/share, the average analyst target is 10.82% higher at $76.86/share.
|
Three of SPYV's underlying holdings with notable upside to their analyst target prices are DuPont de Nemours Inc (Symbol: DD), AMETEK Inc (Symbol: AME), and American Express Co. (Symbol: AXP). Although DD has traded at a recent price of $69.35/share, the average analyst target is 10.82% higher at $76.86/share. Below is a twelve month price history chart comparing the stock performance of DD, AME, and AXP: Below is a summary table of the current analyst target prices discussed above:
|
SPDR Portfolio S&P 500 Value ETF SPYV $39.83 $43.66 9.61% DuPont de Nemours Inc DD $69.35 $76.86 10.82% AMETEK Inc AME $139.36 $154.00 10.51% American Express Co. AXP $150.87 $165.61 9.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPYV's underlying holdings with notable upside to their analyst target prices are DuPont de Nemours Inc (Symbol: DD), AMETEK Inc (Symbol: AME), and American Express Co. (Symbol: AXP). Although DD has traded at a recent price of $69.35/share, the average analyst target is 10.82% higher at $76.86/share.
|
693a4a5a-82e3-402a-9c5e-eba7feba27be
|
715928.0
|
2022-11-28 00:00:00 UTC
|
Got $5,000? 3 Top Materials Stocks to Buy for the Long Term
|
DD
|
https://www.nasdaq.com/articles/got-%245000-3-top-materials-stocks-to-buy-for-the-long-term
|
nan
|
nan
|
If you are considering buying a few stocks with a spare $5,000 and forgetting about your investments for a while, it makes sense to look at companies with excellent long-term prospects, even if they face some near-term uncertainty.
That's the case with chemicals company Celanese (NYSE: CE), specialty chemicals distributor Univar Solutions (NYSE: UNVR), and copper miner Freeport-McMoRan (NYSE: FCX). Admittedly, they are not the best-known of businesses, but that shouldn't dissuade investors from considering three companies with exciting futures.
1. Celanese
As the name suggests, Celanese's polymers are supplied to manufacturers that use them to manufacture products across various industries -- from food & beverage to building products, consumer products, and industrial adhesives.
As such, demand for Celanese's products is highly exposed to the economy. Moreover, given that production and demand tend to be tight, any dropoff in demand can cause a slump in the price, and vice versa.
Data by YCharts
Indeed, chemical prices did slump over the summer as the market priced in slower growth, and they could fall further in 2023 -- the near-term risk I alluded to earlier. Therefore, the market isn't being irrational when it gives Celanese a price-to-earnings ratio of less than 7 times its estimated 2022 earnings.
While the company's revenue and earnings will fluctuate through the cycle, management is driving long-term margin expansion by investing in low-cost plants, rationalizing less productive facilities, and generating growth through the integration of DuPont's mobility and materials business.
These investments should pay off over time and long after investors have forgotten about cyclical weakness in chemicals prices through 2022. It's also good know that Warren Buffett's Berkshire Hathaway has been been buying the stock in 2022.
2. Univar Solutions
Sticking with the chemicals theme, Univar is a distributor of specialty chemicals that has been fundamentally restructured in recent years. The company divested non-core businesses and made strategic acquisitions, such as the 2019 purchase of Nexeo Solutions, which reduced its exposure to servicing the energy and agriculture industries from 26% of revenue in 2024 to just 7% today.
Univar is now focused on servicing industrial and consumer customers with specialty chemicals and ingredients. This transformation has resulted in a significant ramp-up of earnings before interest, taxation, depreciation, and amortization (EBITDA) margin over the last few years.
Data by YCharts
These various steps have been a success. Management is now aiming for adjusted EBITDA margins above 9% and adjusted EPS of more than $4.50 through 2025. Moreover, management believes it will generate $1.5 billion in free cash flow from 2023 to 2025, a figure that represents approximately 31% of its current market capitalization and should allow for debt reduction from its current net debt position of around $2 billion while making substantive share repurchases.
Univar is a company transformed and on track to generate significant value for investors.
3. Freeport-McMoRan
This copper miner's results fluctuate -- as you would expect -- with the price of copper, so don't go near the stock unless you are confident of price appreciation for the industrial metal. Still, it's a robust case driven by increased marginal demand for copper used in electric vehicles, renewable energy, industrial automation, and the general trend toward electrification. At the same time, supply may be constrained due to increasing environmental concerns, political instability, and the difficulty of acquiring mining permits.
Indeed, the latter is believed to be behind the flurry of takeover activity in the sector in 2022. If the copper bulls are correct, Freeport stands well-placed to deliver significant returns for investors, not in the least because it has key expansion projects in more politically stable countries like the U.S. and Indonesia.
However, just as with Celanese and Univar Solutions, there is the risk that a slowdown in the economy in 2023 will hit the company -- in this case, with a decline in the price of copper. While that uncertainty is evident, the long-term case for copper remains in place.
All told, all three of these stocks could appreciate substantially over the next decade, and $5,000 invested now and forgotten about for a while could result in excellent returns if the global economy returns to its historical growth rate trends.
10 stocks we like better than Freeport-McMoRan Inc
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Freeport-McMoRan Inc wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of November 7, 2022
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Berkshire Hathaway (B shares). The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While the company's revenue and earnings will fluctuate through the cycle, management is driving long-term margin expansion by investing in low-cost plants, rationalizing less productive facilities, and generating growth through the integration of DuPont's mobility and materials business. The company divested non-core businesses and made strategic acquisitions, such as the 2019 purchase of Nexeo Solutions, which reduced its exposure to servicing the energy and agriculture industries from 26% of revenue in 2024 to just 7% today. If the copper bulls are correct, Freeport stands well-placed to deliver significant returns for investors, not in the least because it has key expansion projects in more politically stable countries like the U.S. and Indonesia.
|
That's the case with chemicals company Celanese (NYSE: CE), specialty chemicals distributor Univar Solutions (NYSE: UNVR), and copper miner Freeport-McMoRan (NYSE: FCX). While the company's revenue and earnings will fluctuate through the cycle, management is driving long-term margin expansion by investing in low-cost plants, rationalizing less productive facilities, and generating growth through the integration of DuPont's mobility and materials business. The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares).
|
That's the case with chemicals company Celanese (NYSE: CE), specialty chemicals distributor Univar Solutions (NYSE: UNVR), and copper miner Freeport-McMoRan (NYSE: FCX). Freeport-McMoRan This copper miner's results fluctuate -- as you would expect -- with the price of copper, so don't go near the stock unless you are confident of price appreciation for the industrial metal. The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares).
|
Univar is a company transformed and on track to generate significant value for investors. However, just as with Celanese and Univar Solutions, there is the risk that a slowdown in the economy in 2023 will hit the company -- in this case, with a decline in the price of copper. The Motley Fool has positions in and recommends Berkshire Hathaway (B shares).
|
9dbadd3c-41b6-47ea-97de-ab83f768748e
|
715929.0
|
2022-11-15 00:00:00 UTC
|
3 Top Industrial Stocks to Buy in November
|
DD
|
https://www.nasdaq.com/articles/3-top-industrial-stocks-to-buy-in-november
|
nan
|
nan
|
These three stocks crushed the market in 2022. All are in positive territory compared to the S&P 500's 21% decline, and I think they have room to run. Here's why agricultural science company Corteva (NYSE: CTVA), advanced materials specialist Hexcel (NYSE: HXL), and electrical products producer nVent Electric (NYSE: NVT) are suitable investments today.
1. The best stock in the agriculture sector
Seed and crop protection company Corteva is finally realizing its potential. Created out of the DowDuPont merger in 2017 and then separated as a stand-alone company in 2019, the company combined DuPont's (NYSE: DD) expertise in seeds with Dow's (NYSE: DOW) crop science business in one entity. Unfortunately, it's taken a few years and the involvement of an activist hedge fund, Starboard Value, for the benefits of the merger to come to fruition.
But Corteva is now firmly on the path of expanding its sales and profit margin. It's using a combination of cost synergies, focusing on its core end-market geographies, cutting royalty payments by selling relatively more products using its technology (led by plans to gain 60% market share of U.S. soybean acres with its Enlist soybeans), and its new higher-margin products.
As such, management believes it will expand the margin on earnings before interest, taxation, depreciation, and amortization (EBITDA) from 17.4% in 2022 to a 21% to 23% range by 2025. The recent third-quarter results showed the company making good progress with year-to-date organic sales up 16% and operating EBITDA up 23%. Management believes its EBITDA margin will hit 20.9% in 2022, and Corteva looks well on its way to substantial margin expansion in the coming years.
2. An aerospace stock to buy
Hexcel makes advanced composites used in commercial aerospace, defense & space, and the industrial sector in general. Commercial aerospace is its most important end market, including such customers as Boeing and Airbus.
Advanced composites offer weight and strength advantages over traditional metals. They are increasingly being used on newer airplanes to reduce costs; lighter planes use less fuel, and stronger and tougher planes require less maintenance.
As such, the case for buying the stock relies on a combination of Boeing and Airbus ramping up production, Hexcel increasing its content on newer airplanes, and increased production of wide-body planes with significantly more advanced-composite content.
With Boeing and Airbus desperately trying to ramp up production and reduce their mult-year backlogs, Hexcel has excellent prospects. Furthermore, increasing content per plane on newer airplanes means the company can grow revenue even if unit airplane production is flat. Lastly, as the commercial aerospace recovery expands from domestic markets to international, demand for wide-body aircraft will likely pick up.
3. A stock to play the electrification theme
The connection and protection electrical-products manufacturer nVent Electric is a play on a very powerful megatrend in the economy, namely electrification. Electric vehicles and charging networks, data centers, smart buildings and smart infrastructure, industrial automation, renewable energy, and good old-fashioned spending on upgrading electrical transmission and distribution networks are all economic growth areas.
In addition, the drive toward electrification will continue even if the economy slows, not least because many of the above trends involve increasing productivity or sustainability.
The power of these trends can be seen in nVent's earnings in 2022. In a challenging year for the markets and the economy, it has raised sales and earnings guidance on all three quarterly reports in its financial 2022. Having started the year forecasting organic sales growth of 6% to 9% and adjusted earnings per share (EPS) of $2.10 to $2.20, management is now forecasting organic sales growth of 15% to 17% and adjusted EPS of $2.17 to $2.23.
Earnings would have been even more substantial had it not been for soaring supply chain costs and foreign exchange headwinds in 2022. Still, both those factors can turn into tailwinds in 2023 as the supply chain pressures ease and comparisons with 2022 get easier. So all told, nVent's near- and long-term prospects look excellent.
10 stocks we like better than nVent Electric plc
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and nVent Electric plc wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of November 7, 2022
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool recommends Hexcel. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Created out of the DowDuPont merger in 2017 and then separated as a stand-alone company in 2019, the company combined DuPont's (NYSE: DD) expertise in seeds with Dow's (NYSE: DOW) crop science business in one entity. In addition, the drive toward electrification will continue even if the economy slows, not least because many of the above trends involve increasing productivity or sustainability. The best stock in the agriculture sector Seed and crop protection company Corteva is finally realizing its potential.
|
Created out of the DowDuPont merger in 2017 and then separated as a stand-alone company in 2019, the company combined DuPont's (NYSE: DD) expertise in seeds with Dow's (NYSE: DOW) crop science business in one entity. In addition, the drive toward electrification will continue even if the economy slows, not least because many of the above trends involve increasing productivity or sustainability. Here's why agricultural science company Corteva (NYSE: CTVA), advanced materials specialist Hexcel (NYSE: HXL), and electrical products producer nVent Electric (NYSE: NVT) are suitable investments today.
|
Created out of the DowDuPont merger in 2017 and then separated as a stand-alone company in 2019, the company combined DuPont's (NYSE: DD) expertise in seeds with Dow's (NYSE: DOW) crop science business in one entity. In addition, the drive toward electrification will continue even if the economy slows, not least because many of the above trends involve increasing productivity or sustainability. Here's why agricultural science company Corteva (NYSE: CTVA), advanced materials specialist Hexcel (NYSE: HXL), and electrical products producer nVent Electric (NYSE: NVT) are suitable investments today.
|
Created out of the DowDuPont merger in 2017 and then separated as a stand-alone company in 2019, the company combined DuPont's (NYSE: DD) expertise in seeds with Dow's (NYSE: DOW) crop science business in one entity. In addition, the drive toward electrification will continue even if the economy slows, not least because many of the above trends involve increasing productivity or sustainability. An aerospace stock to buy Hexcel makes advanced composites used in commercial aerospace, defense & space, and the industrial sector in general.
|
331fcbe4-e02b-4965-aa52-883eefa8953d
|
715930.0
|
2022-11-10 00:00:00 UTC
|
California sues 3M, Dupont over toxic 'forever chemicals'
|
DD
|
https://www.nasdaq.com/articles/california-sues-3m-dupont-over-toxic-forever-chemicals-0
|
nan
|
nan
|
Adds company comment and context
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals."
Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances (PFAS) for decades despite knowing they cause cancer, developmental defects and other health problems.
Dupont did not immediately return requests for comment. 3M spokesperson Carolyn LaViolette said in a statement the company "acted responsibly in connection with products containing PFAS and will defend its record of environmental stewardship."
The substances are known as forever chemicals because of how long they stay in the human body and environment.
They have been mass produced since the 1950s, and used in products such as firefighting foams, nonstick pans and personal care items.
Bonta said the defendants created a public nuisance and demanded they pay to clean up PFAS, which he said has been found in drinking water, rivers, lakes, wildlife and the bloodstreams of about 98% of California's approximately 39 million people.
"The damage caused by 3M, DuPont, and other manufacturers of PFAS is nothing short of staggering, and without drastic action, California will be dealing with the harms of these toxic chemicals for generations," Bonta said.
Thousands of lawsuits have been filed against chemical companies in the last two decades for health and environmental damage from PFAS, potentially leading to billions of dollars in liabilities.
Thursday's lawsuit was filed in Alameda County, which includes Oakland, and is the first statewide legal action over PFAS contamination.
It alleges violations of state consumer protection and environmental law violations and invokes the federal Superfund law, which establishes a path to recoup the costs of cleaning up hazardous substances.
In June, the U.S. Environmental Protection Agency warned that forever chemicals could be dangerous even at undetectable levels.
The Biden administration is expected to issue the first enforceable drinking water regulations for PFAS in public water systems this year.
Biden administration to declare 'forever chemicals' hazardous substances
U.S. issues new warnings on 'forever chemicals' in drinking water
(Reporting by Clark Mindock; Editing by Deepa Babington and Lisa Shumaker)
((Clark.Mindock@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds company comment and context Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances (PFAS) for decades despite knowing they cause cancer, developmental defects and other health problems. Bonta said the defendants created a public nuisance and demanded they pay to clean up PFAS, which he said has been found in drinking water, rivers, lakes, wildlife and the bloodstreams of about 98% of California's approximately 39 million people.
|
Adds company comment and context Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." In June, the U.S. Environmental Protection Agency warned that forever chemicals could be dangerous even at undetectable levels. The Biden administration is expected to issue the first enforceable drinking water regulations for PFAS in public water systems this year.
|
Adds company comment and context Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances (PFAS) for decades despite knowing they cause cancer, developmental defects and other health problems. Biden administration to declare 'forever chemicals' hazardous substances U.S. issues new warnings on 'forever chemicals' in drinking water (Reporting by Clark Mindock; Editing by Deepa Babington and Lisa Shumaker) ((Clark.Mindock@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds company comment and context Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Thousands of lawsuits have been filed against chemical companies in the last two decades for health and environmental damage from PFAS, potentially leading to billions of dollars in liabilities. The Biden administration is expected to issue the first enforceable drinking water regulations for PFAS in public water systems this year.
|
6d472c0e-56e0-4e4d-9b35-af423d15d7ad
|
715931.0
|
2022-11-10 00:00:00 UTC
|
California sues 3M, Dupont over toxic 'forever chemicals'
|
DD
|
https://www.nasdaq.com/articles/california-sues-3m-dupont-over-toxic-forever-chemicals
|
nan
|
nan
|
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals."
Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances ("PFAS") for decades despite knowing they cause cancer, developmental defects and other health problems.
The substances are known as forever chemicals because of how long they stay in the human body and environment.
They have been mass produced since the 1950s, and used in products such as firefighting foams, nonstick pans and personal care items.
Bonta said the defendants created a public nuisance and demanded they pay to clean up PFAS, which he said has been found in drinking water, rivers, lakes, wildlife and the bloodstreams of about 98% of California's approximately 39 million people.
"The damage caused by 3M, DuPont, and other manufacturers of PFAS is nothing short of staggering, and without drastic action, California will be dealing with the harms of these toxic chemicals for generations," Bonta said.
(Reporting by Clark Mindock, Editing by Alessandra Rafferty and Deepa Babington)
((Clark.Mindock@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances ("PFAS") for decades despite knowing they cause cancer, developmental defects and other health problems. Bonta said the defendants created a public nuisance and demanded they pay to clean up PFAS, which he said has been found in drinking water, rivers, lakes, wildlife and the bloodstreams of about 98% of California's approximately 39 million people.
|
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances ("PFAS") for decades despite knowing they cause cancer, developmental defects and other health problems. "The damage caused by 3M, DuPont, and other manufacturers of PFAS is nothing short of staggering, and without drastic action, California will be dealing with the harms of these toxic chemicals for generations," Bonta said.
|
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances ("PFAS") for decades despite knowing they cause cancer, developmental defects and other health problems. "The damage caused by 3M, DuPont, and other manufacturers of PFAS is nothing short of staggering, and without drastic action, California will be dealing with the harms of these toxic chemicals for generations," Bonta said.
|
Nov 10 (Reuters) - California's attorney general on Thursday sued 3M Co MMM.N, DuPont de Nemours Inc DD.N and several other companies to recoup the "staggering" clean-up costs from toxic pollutants known as "forever chemicals." Attorney General Rob Bonta said the lawsuit followed a multiyear probe that found the companies marketed products containing polyfluoroalkyl and perfluoroalkyl substances ("PFAS") for decades despite knowing they cause cancer, developmental defects and other health problems. The substances are known as forever chemicals because of how long they stay in the human body and environment.
|
efe22ff1-fe55-4ba7-a381-6e16e4246bb4
|
715932.0
|
2022-11-10 00:00:00 UTC
|
Zacks Earnings Trends Highlights: Disney, Take-Two, DuPont and Viatris
|
DD
|
https://www.nasdaq.com/articles/zacks-earnings-trends-highlights%3A-disney-take-two-dupont-and-viatris
|
nan
|
nan
|
For Immediate Release
Chicago, IL – November 10, 2022 – Zacks Director of Research Sheraz Mian says, "For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates."
Making Sense of the Earnings Picture and Estimate Revisions
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>
Here are the key points:
We continue to see the picture that emerged from the 2022 Q3 earnings season running counter to pre-season fears of an impending earnings cliff. Overall corporate profitability isn’t great, but it isn’t bad either. That said, estimates for the coming periods are steadily coming down, with the revisions trend accelerating in recent days.
For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates.
Looking at 2022 Q3 as a whole, total S&P 500 earnings are currently expected to be up +1.5% from the same period last year on +11.4% higher revenues. Excluding contributions from the Energy sector, Q3 earnings for the rest of the index would be -6.0% below the year-earlier level.
Looking at the calendar-year picture, total S&P 500 earnings are expected to be up +5.0% in 2022 and +3.5% in 2023. On an ex-Energy basis, total 2022 index earnings would be down -1.8% (instead of +5.0%, with Energy).
The overall earnings picture has proved to be a lot more stable and resilient than many were willing to give it credit for before the start of the Q3 earnings season that’s now entering its final phase.
As we have consistently been stating, corporate earnings aren’t great, but they aren’t bad either. Many in the market feared an earnings cliff that would force management teams to provide downbeat guidance.
We got some of those downbeat reports, with Disney DIS and Take-Two Interactive TTWO as notable such examples from this week’s docket. But we also had DuPont DD, Viatris VTRS and many others that left the market impressed.
Not much growth was expected given where we are in the economic cycle. But the actual growth coming through the results is ever so slightly better than expected. It is this performance relative to expectations rather than the absolute level of earnings or the growth pace that is of relevance to the market.
Looking at those expectations for 2022 Q4 and beyond, they are getting reset lower, as we have been pointing out for a while now.
Analysts have been steadily cutting their estimates for some time. We saw this in the run up to the start of the Q3 earnings season and the trend continues with respect to estimates for the current period (2022 Q4) and full-year 2023.
As we have consistently been pointing out, aggregate S&P 500 earnings outside of the Energy sector peaked in mid-April and have been steadily trending down ever since.
In fact, S&P 500 earnings estimates in the aggregate outside of the Energy sector have declined -10.8% since mid-April, with double-digit percentage declines in Retail, Construction, Consumer Discretionary, Tech, Industrial Products and the Aerospace sectors. On the whole, estimates are down for 13 of the 16 Zacks sectors.
The Overall Earnings Picture
Earnings next year are expected to be up only +3.5%. This magnitude of growth can hardly be called out-of-sync with a flat or even modestly down economic growth outlook. Don’t forget that headline GDP growth numbers are in real or inflation-adjusted terms while S&P 500 earnings discussed here are not.
As mentioned earlier, 2023 aggregate earnings estimates on an ex-Energy basis are already down by more than tenth since mid-April. Perhaps we see a bit more downward adjustments to estimates over the coming weeks, after we have seen Q3 results. But we have nevertheless already covered some ground in taking estimates to a fair or appropriate level.
This is particularly so if whatever economic downturn lies ahead proves to be more of the garden variety rather than the last two such events. Recency bias forces us to use the last two economic downturns, which were also among the nastiest in recent history, as our reference points. But we need to be cautious against that natural tendency as the economy’s foundations at present remain unusually strong.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%,and +95.3%. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
TakeTwo Interactive Software, Inc. (TTWO): Free Stock Analysis Report
The Walt Disney Company (DIS): Free Stock Analysis Report
Viatris Inc. (VTRS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report We saw this in the run up to the start of the Q3 earnings season and the trend continues with respect to estimates for the current period (2022 Q4) and full-year 2023.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report For Immediate Release Chicago, IL – November 10, 2022 – Zacks Director of Research Sheraz Mian says, "For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates."
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report For Immediate Release Chicago, IL – November 10, 2022 – Zacks Director of Research Sheraz Mian says, "For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates."
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Not much growth was expected given where we are in the economic cycle.
|
c07e40a9-4f7f-491e-a6a3-3baa76a7cc23
|
715933.0
|
2022-11-09 00:00:00 UTC
|
Making Sense of the Earnings Picture and Estimate Revisions
|
DD
|
https://www.nasdaq.com/articles/making-sense-of-the-earnings-picture-and-estimate-revisions
|
nan
|
nan
|
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>
Here are the key points:
We continue to see the picture that emerged from the 2022 Q3 earnings season running counter to pre-season fears of an impending earnings cliff. Overall corporate profitability isn’t great, but it isn’t bad either. That said, estimates for the coming periods are steadily coming down, with the revisions trend accelerating in recent days.
For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates.
Looking at 2022 Q3 as a whole, total S&P 500 earnings are currently expected to be up +1.5% from the same period last year on +11.4% higher revenues. Excluding contributions from the Energy sector, Q3 earnings for the rest of the index would be -6.0% below the year-earlier level.
Looking at the calendar-year picture, total S&P 500 earnings are expected to be up +5.0% in 2022 and +3.5% in 2023. On an ex-Energy basis, total 2022 index earnings would be down -1.8% (instead of +5.0%, with Energy).
The overall earnings picture has proved to be a lot more stable and resilient than many were willing to give it credit for before the start of the Q3 earnings season that’s now entering its final phase.
As we have consistently been stating, corporate earnings aren’t great, but they aren’t bad either. Many in the market feared an earnings cliff that would force management teams to provide downbeat guidance.
We got some of those downbeat reports, with Disney DIS and Take-Two Interactive TTWO as notable such examples from this week’s docket. But we also had DuPont DD, Viatris VTRS and many others that left the market impressed.
Not much growth was expected given where we are in the economic cycle. But the actual growth coming through the results is ever so slightly better than expected. It is this performance relative to expectations rather than the absolute level of earnings or the growth pace that is of relevance to the market.
Looking at those expectations for 2022 Q4 and beyond, they are getting reset lower, as we have been pointing out for a while now.
Analysts have been steadily cutting their estimates for some time. We saw this in the run up to the start of the Q3 earnings season and the trend continues with respect to estimates for the current period (2022 Q4) and full-year 2023.
The charts below show how earnings growth expectations for the 2022 Q4, as a whole and on an ex-Energy basis, have evolved in recent weeks.
Image Source: Zacks Investment Research
The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
Image Source: Zacks Investment Research
As we have consistently been pointing out, aggregate S&P 500 earnings outside of the Energy sector peaked in mid-April and have been steadily trending down ever since.
In fact, S&P 500 earnings estimates in the aggregate outside of the Energy sector have declined -10.8% since mid-April, with double-digit percentage declines in Retail, Construction, Consumer Discretionary, Tech, Industrial Products and the Aerospace sectors. On the whole, estimates are down for 13 of the 16 Zacks sectors.
The Overall Earnings Picture
The chart below that provides a big-picture view of earnings on a quarterly basis. The growth rate for Q3 is on a blended basis, where the actual reports that have come out are combined with estimates for the still-to-come companies.
Image Source: Zacks Investment Research
The chart below shows the overall earnings picture on an annual basis, with the growth momentum expected to continue.
Image Source: Zacks Investment Research
As you can see above, earnings next year are expected to be up only +3.5%. This magnitude of growth can hardly be called out-of-sync with a flat or even modestly down economic growth outlook. Don’t forget that headline GDP growth numbers are in real or inflation-adjusted terms while S&P 500 earnings discussed here are not.
As mentioned earlier, 2023 aggregate earnings estimates on an ex-Energy basis are already down by more than tenth since mid-April. Perhaps we see a bit more downward adjustments to estimates over the coming weeks, after we have seen Q3 results. But we have nevertheless already covered some ground in taking estimates to a fair or appropriate level.
This is particularly so if whatever economic downturn lies ahead proves to be more of the garden variety rather than the last two such events. Recency bias forces us to use the last two economic downturns, which were also among the nastiest in recent history, as our reference points. But we need to be cautious against that natural tendency as the economy’s foundations at present remain unusually strong.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
TakeTwo Interactive Software, Inc. (TTWO): Free Stock Analysis Report
The Walt Disney Company (DIS): Free Stock Analysis Report
Viatris Inc. (VTRS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Image Source: Zacks Investment Research The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Image Source: Zacks Investment Research The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>> Here are the key points: We continue to see the picture that emerged from the 2022 Q3 earnings season running counter to pre-season fears of an impending earnings cliff.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report The charts below show how earnings growth expectations for the 2022 Q4, as a whole and on an ex-Energy basis, have evolved in recent weeks.
|
cae674e3-ea2f-4d13-8e25-6a1140b203a1
|
715934.0
|
2022-11-09 00:00:00 UTC
|
Making Sense of the Earnings Picture and Estimate Revisions
|
DD
|
https://www.nasdaq.com/articles/making-sense-of-the-earnings-picture-and-estimate-revisions-0
|
nan
|
nan
|
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>>
Here are the key points:
We continue to see the picture that emerged from the 2022 Q3 earnings season running counter to pre-season fears of an impending earnings cliff. Overall corporate profitability isn’t great, but it isn’t bad either. That said, estimates for the coming periods are steadily coming down, with the revisions trend accelerating in recent days.
For the 453 S&P 500 members that have reported Q3 results already, total earnings are up +2.6% from the same period last year on +12.4% higher revenues, with 69.3% beating EPS estimates and 68.0% beating revenue estimates.
Looking at 2022 Q3 as a whole, total S&P 500 earnings are currently expected to be up +1.5% from the same period last year on +11.4% higher revenues. Excluding contributions from the Energy sector, Q3 earnings for the rest of the index would be -6.0% below the year-earlier level.
Looking at the calendar-year picture, total S&P 500 earnings are expected to be up +5.0% in 2022 and +3.5% in 2023. On an ex-Energy basis, total 2022 index earnings would be down -1.8% (instead of +5.0%, with Energy).
The overall earnings picture has proved to be a lot more stable and resilient than many were willing to give it credit for before the start of the Q3 earnings season that’s now entering its final phase.
As we have consistently been stating, corporate earnings aren’t great, but they aren’t bad either. Many in the market feared an earnings cliff that would force management teams to provide downbeat guidance.
We got some of those downbeat reports, with Disney DIS and Take-Two Interactive TTWO as notable such examples from this week’s docket. But we also had DuPont DD, Viatris VTRS and many others that left the market impressed.
Not much growth was expected given where we are in the economic cycle. But the actual growth coming through the results is ever so slightly better than expected. It is this performance relative to expectations rather than the absolute level of earnings or the growth pace that is of relevance to the market.
Looking at those expectations for 2022 Q4 and beyond, they are getting reset lower, as we have been pointing out for a while now.
Analysts have been steadily cutting their estimates for some time. We saw this in the run up to the start of the Q3 earnings season and the trend continues with respect to estimates for the current period (2022 Q4) and full-year 2023.
The charts below show how earnings growth expectations for the 2022 Q4, as a whole and on an ex-Energy basis, have evolved in recent weeks.
Image Source: Zacks Investment Research
The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
Image Source: Zacks Investment Research
As we have consistently been pointing out, aggregate S&P 500 earnings outside of the Energy sector peaked in mid-April and have been steadily trending down ever since.
In fact, S&P 500 earnings estimates in the aggregate outside of the Energy sector have declined -10.8% since mid-April, with double-digit percentage declines in Retail, Construction, Consumer Discretionary, Tech, Industrial Products and the Aerospace sectors. On the whole, estimates are down for 13 of the 16 Zacks sectors.
The Overall Earnings Picture
The chart below that provides a big-picture view of earnings on a quarterly basis. The growth rate for Q3 is on a blended basis, where the actual reports that have come out are combined with estimates for the still-to-come companies.
Image Source: Zacks Investment Research
The chart below shows the overall earnings picture on an annual basis, with the growth momentum expected to continue.
Image Source: Zacks Investment Research
As you can see above, earnings next year are expected to be up only +3.5%. This magnitude of growth can hardly be called out-of-sync with a flat or even modestly down economic growth outlook. Don’t forget that headline GDP growth numbers are in real or inflation-adjusted terms while S&P 500 earnings discussed here are not.
As mentioned earlier, 2023 aggregate earnings estimates on an ex-Energy basis are already down by more than tenth since mid-April. Perhaps we see a bit more downward adjustments to estimates over the coming weeks, after we have seen Q3 results. But we have nevertheless already covered some ground in taking estimates to a fair or appropriate level.
This is particularly so if whatever economic downturn lies ahead proves to be more of the garden variety rather than the last two such events. Recency bias forces us to use the last two economic downturns, which were also among the nastiest in recent history, as our reference points. But we need to be cautious against that natural tendency as the economy’s foundations at present remain unusually strong.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
TakeTwo Interactive Software, Inc. (TTWO): Free Stock Analysis Report
The Walt Disney Company (DIS): Free Stock Analysis Report
Viatris Inc. (VTRS): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Image Source: Zacks Investment Research The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Image Source: Zacks Investment Research The chart below shows how the expected aggregate total earnings for full-year 2023 have evolved on an ex-Energy basis.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report You can access the full report that contains detailed historical actual and estimates for the current and following periods, please click here>>> Here are the key points: We continue to see the picture that emerged from the 2022 Q3 earnings season running counter to pre-season fears of an impending earnings cliff.
|
But we also had DuPont DD, Viatris VTRS and many others that left the market impressed. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report The charts below show how earnings growth expectations for the 2022 Q4, as a whole and on an ex-Energy basis, have evolved in recent weeks.
|
264fdd86-1beb-4987-a78b-49ce065f5e2f
|
715935.0
|
2022-11-09 00:00:00 UTC
|
DD Dividend Yield Pushes Past 2%
|
DD
|
https://www.nasdaq.com/articles/dd-dividend-yield-pushes-past-2
|
nan
|
nan
|
Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of DuPont (Symbol: DD) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.32), with the stock changing hands as low as $65.85 on the day. Dividends are particularly important for investors to consider, because historically speaking dividends have provided a considerable share of the stock market's total return. To illustrate, suppose for example you purchased shares of the S&P 500 ETF (SPY) back on 12/31/1999 — you would have paid $146.88 per share. Fast forward to 12/31/2012 and each share was worth $142.41 on that date, a decrease of $4.67/share over all those years. But now consider that you collected a whopping $25.98 per share in dividends over the same period, for a positive total return of 23.36%. Even with dividends reinvested, that only amounts to an average annual total return of about 1.6%; so by comparison collecting a yield above 2% would appear considerably attractive if that yield is sustainable. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index.
In general, dividend amounts are not always predictable and tend to follow the ups and downs of profitability at each company. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield.
Click here to find out which 9 other dividend stocks just recently went on sale »
Also see:
STV Options Chain
SURE YTD Return
BDGE Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of DuPont (Symbol: DD) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.32), with the stock changing hands as low as $65.85 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield.
|
Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of DuPont (Symbol: DD) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.32), with the stock changing hands as low as $65.85 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield.
|
Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of DuPont (Symbol: DD) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.32), with the stock changing hands as low as $65.85 on the day. DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield.
|
DuPont (Symbol: DD) is an S&P 500 company, giving it special status as one of the large-cap companies making up the S&P 500 Index. Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of DuPont (Symbol: DD) were yielding above the 2% mark based on its quarterly dividend (annualized to $1.32), with the stock changing hands as low as $65.85 on the day. In the case of DuPont, looking at the history chart for DD below can help in judging whether the most recent dividend is likely to continue, and in turn whether it is a reasonable expectation to expect a 2% annual yield.
|
23b5872c-bb2e-4906-8d70-f0d0f2f78b49
|
715936.0
|
2022-11-08 00:00:00 UTC
|
DuPont (DD) Shares Cross Above 200 DMA
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-shares-cross-above-200-dma
|
nan
|
nan
|
In trading on Tuesday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $63.97, changing hands as high as $68.45 per share. DuPont shares are currently trading up about 8.5% on the day. The chart below shows the one year performance of DD shares, versus its 200 day moving average:
Looking at the chart above, DD's low point in its 52 week range is $49.52 per share, with $85.16 as the 52 week high point — that compares with a last trade of $67.37. The DD DMA information above was sourced from TechnicalAnalysisChannel.com
Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average »
Also see:
XNCR Options Chain
MINT Options Chain
Top Ten Hedge Funds Holding HLI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Tuesday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $63.97, changing hands as high as $68.45 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $49.52 per share, with $85.16 as the 52 week high point — that compares with a last trade of $67.37. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: XNCR Options Chain MINT Options Chain Top Ten Hedge Funds Holding HLI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Tuesday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $63.97, changing hands as high as $68.45 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $49.52 per share, with $85.16 as the 52 week high point — that compares with a last trade of $67.37. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: XNCR Options Chain MINT Options Chain Top Ten Hedge Funds Holding HLI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Tuesday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $63.97, changing hands as high as $68.45 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $49.52 per share, with $85.16 as the 52 week high point — that compares with a last trade of $67.37. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: XNCR Options Chain MINT Options Chain Top Ten Hedge Funds Holding HLI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In trading on Tuesday, shares of DuPont (Symbol: DD) crossed above their 200 day moving average of $63.97, changing hands as high as $68.45 per share. The chart below shows the one year performance of DD shares, versus its 200 day moving average: Looking at the chart above, DD's low point in its 52 week range is $49.52 per share, with $85.16 as the 52 week high point — that compares with a last trade of $67.37. The DD DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other dividend stocks recently crossed above their 200 day moving average » Also see: XNCR Options Chain MINT Options Chain Top Ten Hedge Funds Holding HLI The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
4170d460-cf01-4d73-9387-607ff01f34cd
|
715937.0
|
2022-11-08 00:00:00 UTC
|
DuPont's (DD) Earnings and Revenues Surpass Estimates in Q3
|
DD
|
https://www.nasdaq.com/articles/duponts-dd-earnings-and-revenues-surpass-estimates-in-q3
|
nan
|
nan
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter.
Barring one-time items, earnings came in at 82 cents per share for the reported quarter, beating the Zacks Consensus Estimate of 81 cents.
DuPont raked in net sales of $3,317 million, up 4% from the year-ago quarter. It also surpassed the Zacks Consensus Estimate by 1.53%. The company saw an 11% rise in organic sales in the quarter, supported by 3% higher volumes and 8% pricing gains. It benefited from strong underlying demand in its major end-markets during the quarter, especially semiconductor, water and general industrial.
Pricing actions and operational execution helped the company offset the cost inflation in the quarter. Volume rose on strong demand in semiconductor, water and industrial end-markets, partly masked by reduced volumes from protective garments within Safety Solutions and weakness in smartphones and personal computing within Interconnect Solutions.
DuPont de Nemours, Inc. Price, Consensus and EPS Surprise
DuPont de Nemours, Inc. price-consensus-eps-surprise-chart | DuPont de Nemours, Inc. Quote
Segment Highlights
The company’s Electronics & Industrial segment recorded net sales of $1,511 million in the reported quarter, up 3% on a year-over-year comparison basis. Organic sales rose 7% on higher volumes and prices. Semiconductor Technologies organic sales rose on strong demand. Industrial Solutions also registered higher sales while organic sales declined in Interconnect Solutions on lower volumes.
Net sales in the Water & Protection unit were $1,534 million, up 10% year over year. Organic sales rose 15% on 13% pricing gains and 2% higher volumes.
Financials
DuPont had cash and cash equivalents of $1,785 million at the end of the quarter, up around 7% year over year. Long-term debt was $10,564 million, down around 0.6% year over year.
The company also generated operating cash flow of $419 million during the quarter. It returned $415 million to shareholders through share repurchases and dividends during the quarter.
DuPont's board, on Nov 7, 2022, approved a new share buyback program authorizing the repurchase of up to $5 billion of common stock. The new authorization is in addition to the $250 million remaining under its current share repurchase program, which was approved in February 2022. It plans to enter accelerated share repurchase agreements imminently for the buyback of an aggregate of around $3.25 billion of common stock.
The company also intends to retire $2.5 billion of senior notes due in November 2023 during the fourth quarter of 2022.
Outlook
The company sees net sales for 2022 to be roughly $13 billion. Adjusted earnings per share for 2022 is now expected to be roughly $3.30.
DuPont also envisions demand to remain strong in most end-markets, notably water, industrial and auto adhesives in the fourth quarter. However, it sees continued weakness in consumer electronics globally and some slowdown in customer semiconductor fab production rates. It also intends to cut production rates to realign working capital in expectation of a more normal supply chain environment. The company also sees incremental currency headwinds to further impact both top and bottom lines.
DuPont also completed the Mobility & Materials (M&M) divestment to Celanese on Nov 1, 2022. Moreover, it terminated the earlier announced agreement to buy the outstanding shares of Rogers Corporation on Nov 1 due to lack of receipt of regulatory clearance.
Price Performance
DuPont’s shares are down 23.8% over a year compared with 12.2% decline recorded by the industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
DuPont currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks worth considering in the basic materials space include Sociedad Quimica y Minera de Chile S.A. SQM, Albemarle Corporation ALB and Commercial Metals Company CMC.
Sociedad has a projected earnings growth rate of 530.7% for the current year. The Zacks Consensus Estimate for SQM’s current-year earnings has been revised 2.1% upward in the past 60 days.
Sociedad has a trailing four-quarter earnings surprise of roughly 27.2%. SQM has rallied roughly 49% in a year. The company currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Albemarle, currently carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 430.9% for the current year. The Zacks Consensus Estimate for ALB's current-year earnings has been revised 5.8% upward in the past 60 days.
Albemarle’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 24.2%, on average. ALB has gained around 4% in a year.
Commercial Metals currently carries a Zacks Rank #2. The Zacks Consensus Estimate for CMC's current-year earnings has been revised 3.8% upward in the past 60 days.
Commercial Metals’ earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 19.7%, on average. CMC has gained around 33% in a year.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Albemarle Corporation (ALB): Free Stock Analysis Report
Sociedad Quimica y Minera S.A. (SQM): Free Stock Analysis Report
Commercial Metals Company (CMC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter. The new authorization is in addition to the $250 million remaining under its current share repurchase program, which was approved in February 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter. The new authorization is in addition to the $250 million remaining under its current share repurchase program, which was approved in February 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter. The new authorization is in addition to the $250 million remaining under its current share repurchase program, which was approved in February 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 69 cents per share for third-quarter 2022, up from 48 cents per share in the year-ago quarter. The new authorization is in addition to the $250 million remaining under its current share repurchase program, which was approved in February 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
62ee65b2-5189-4353-83c9-382634a6c6e0
|
715938.0
|
2022-11-08 00:00:00 UTC
|
S&P 500 Movers: TTWO, SEDG
|
DD
|
https://www.nasdaq.com/articles/sp-500-movers%3A-ttwo-sedg
|
nan
|
nan
|
In early trading on Tuesday, shares of SolarEdge Technologies topped the list of the day's best performing components of the S&P 500 index, trading up 19.7%. Year to date, SolarEdge Technologies has lost about 9.9% of its value.
And the worst performing S&P 500 component thus far on the day is Take-Two Interactive Software, trading down 10.2%. Take-Two Interactive Software is lower by about 45.2% looking at the year to date performance.
Two other components making moves today are Signature Bank, trading down 7.0%, and DuPont, trading up 7.8% on the day.
VIDEO: S&P 500 Movers: TTWO, SEDG
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
And the worst performing S&P 500 component thus far on the day is Take-Two Interactive Software, trading down 10.2%. Take-Two Interactive Software is lower by about 45.2% looking at the year to date performance. VIDEO: S&P 500 Movers: TTWO, SEDG The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Year to date, SolarEdge Technologies has lost about 9.9% of its value. And the worst performing S&P 500 component thus far on the day is Take-Two Interactive Software, trading down 10.2%. Take-Two Interactive Software is lower by about 45.2% looking at the year to date performance.
|
In early trading on Tuesday, shares of SolarEdge Technologies topped the list of the day's best performing components of the S&P 500 index, trading up 19.7%. And the worst performing S&P 500 component thus far on the day is Take-Two Interactive Software, trading down 10.2%. Two other components making moves today are Signature Bank, trading down 7.0%, and DuPont, trading up 7.8% on the day.
|
In early trading on Tuesday, shares of SolarEdge Technologies topped the list of the day's best performing components of the S&P 500 index, trading up 19.7%. And the worst performing S&P 500 component thus far on the day is Take-Two Interactive Software, trading down 10.2%. VIDEO: S&P 500 Movers: TTWO, SEDG The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
d0e012e6-f8a9-4486-9986-c05d0d1c56f8
|
715939.0
|
2022-11-08 00:00:00 UTC
|
Tuesday Sector Leaders: Materials, Utilities
|
DD
|
https://www.nasdaq.com/articles/tuesday-sector-leaders%3A-materials-utilities
|
nan
|
nan
|
In afternoon trading on Tuesday, Materials stocks are the best performing sector, higher by 1.1%. Within that group, DuPont (Symbol: DD) and Albemarle Corp. (Symbol: ALB) are two large stocks leading the way, showing a gain of 7.0% and 6.5%, respectively. Among the high volume ETFs, one ETF closely following materials stocks is the Materials Select Sector SPDR ETF (Symbol: XLB), which is up 1.6% on the day, and down 13.42% year-to-date. DuPont, meanwhile, is down 16.96% year-to-date, and Albemarle Corp. is up 31.08% year-to-date. Combined, DD and ALB make up approximately 8.1% of the underlying holdings of XLB.
The next best performing sector is the Utilities sector, up 0.6%. Among large Utilities stocks, NiSource Inc. (Symbol: NI) and Alliant Energy Corp (Symbol: LNT) are the most notable, showing a gain of 2.6% and 2.2%, respectively. One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is up 0.4% in midday trading, and down 5.65% on a year-to-date basis. NiSource Inc., meanwhile, is down 6.01% year-to-date, and Alliant Energy Corp, is down 11.47% year-to-date. Combined, NI and LNT make up approximately 2.8% of the underlying holdings of XLU.
Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom:
Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Tuesday. As you can see, six sectors are up on the day, while one sector is down.
SECTOR % CHANGE
Materials +1.1%
Utilities +0.6%
Technology & Communications +0.6%
Industrial +0.5%
Financial +0.4%
Services +0.1%
Consumer Products -0.0%
Healthcare -0.0%
Energy -0.7%
25 Dividend Giants Widely Held By ETFs »
Also see:
Funds Holding PLAB
GRPN Historical Stock Prices
Institutional Holders of SCM
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Within that group, DuPont (Symbol: DD) and Albemarle Corp. (Symbol: ALB) are two large stocks leading the way, showing a gain of 7.0% and 6.5%, respectively. Combined, DD and ALB make up approximately 8.1% of the underlying holdings of XLB. One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is up 0.4% in midday trading, and down 5.65% on a year-to-date basis.
|
One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is up 0.4% in midday trading, and down 5.65% on a year-to-date basis. Within that group, DuPont (Symbol: DD) and Albemarle Corp. (Symbol: ALB) are two large stocks leading the way, showing a gain of 7.0% and 6.5%, respectively. Combined, DD and ALB make up approximately 8.1% of the underlying holdings of XLB.
|
One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is up 0.4% in midday trading, and down 5.65% on a year-to-date basis. Within that group, DuPont (Symbol: DD) and Albemarle Corp. (Symbol: ALB) are two large stocks leading the way, showing a gain of 7.0% and 6.5%, respectively. Combined, DD and ALB make up approximately 8.1% of the underlying holdings of XLB.
|
Within that group, DuPont (Symbol: DD) and Albemarle Corp. (Symbol: ALB) are two large stocks leading the way, showing a gain of 7.0% and 6.5%, respectively. One ETF closely tracking Utilities stocks is the Utilities Select Sector SPDR ETF (XLU), which is up 0.4% in midday trading, and down 5.65% on a year-to-date basis. Combined, DD and ALB make up approximately 8.1% of the underlying holdings of XLB.
|
4f6db7e9-0176-401a-b09b-374357468672
|
715940.0
|
2022-11-08 00:00:00 UTC
|
DuPont quarterly profit slides nearly 7% on higher costs
|
DD
|
https://www.nasdaq.com/articles/dupont-quarterly-profit-slides-nearly-7-on-higher-costs
|
nan
|
nan
|
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds.
The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
((mrinalika.roy@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli) ((mrinalika.roy@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli) ((mrinalika.roy@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli) ((mrinalika.roy@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier. (Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli) ((mrinalika.roy@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
e8b2f418-5c0b-469a-bbdc-45a1116d9424
|
715941.0
|
2022-11-08 00:00:00 UTC
|
DuPont Board Approves $5.0 Bln Share Repurchase - Quick Facts
|
DD
|
https://www.nasdaq.com/articles/dupont-board-approves-%245.0-bln-share-repurchase-quick-facts
|
nan
|
nan
|
(RTTNews) - DuPont (DD) said its Board approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock. This new repurchase authorization is in addition to the $250 million remaining under the existing share repurchase program which was approved in February 2022.
The company plans to enter accelerated share repurchase agreements imminently, for the repurchase of an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the existing program and the remaining $3 billion under the new program. The new repurchase program terminates on June 30, 2024.
The company also announced its intent to retire $2.5 billion of Senior Notes due in November 2023 during the fourth quarter of 2022. This will enable approximately $100 million of annual interest savings.
In the fourth quarter, the company plans to reduce commercial paper balance to zero. As of September 30, 2022, the company had $1.3 billion of commercial paper outstanding.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont (DD) said its Board approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock. This new repurchase authorization is in addition to the $250 million remaining under the existing share repurchase program which was approved in February 2022. The company also announced its intent to retire $2.5 billion of Senior Notes due in November 2023 during the fourth quarter of 2022.
|
(RTTNews) - DuPont (DD) said its Board approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock. This new repurchase authorization is in addition to the $250 million remaining under the existing share repurchase program which was approved in February 2022. The company plans to enter accelerated share repurchase agreements imminently, for the repurchase of an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the existing program and the remaining $3 billion under the new program.
|
(RTTNews) - DuPont (DD) said its Board approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock. This new repurchase authorization is in addition to the $250 million remaining under the existing share repurchase program which was approved in February 2022. The company plans to enter accelerated share repurchase agreements imminently, for the repurchase of an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the existing program and the remaining $3 billion under the new program.
|
(RTTNews) - DuPont (DD) said its Board approved a new share repurchase program authorizing the repurchase and retirement of up to $5 billion of common stock. This new repurchase authorization is in addition to the $250 million remaining under the existing share repurchase program which was approved in February 2022. The company plans to enter accelerated share repurchase agreements imminently, for the repurchase of an aggregate of approximately $3.25 billion of common stock with $250 million of such repurchases under the existing program and the remaining $3 billion under the new program.
|
cbdc7513-696e-47c6-a1fc-d2b5e3ecdf68
|
715942.0
|
2022-11-08 00:00:00 UTC
|
DuPont de Nemours (DD) Beats Q3 Earnings and Revenue Estimates
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-dd-beats-q3-earnings-and-revenue-estimates
|
nan
|
nan
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $1.15 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 1.23%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $0.74 per share when it actually produced earnings of $0.88, delivering a surprise of 18.92%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
DuPont de Nemours, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $3.32 billion for the quarter ended September 2022, surpassing the Zacks Consensus Estimate by 1.53%. This compares to year-ago revenues of $4.27 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
DuPont de Nemours shares have lost about 23.6% since the beginning of the year versus the S&P 500's decline of -20.1%.
What's Next for DuPont de Nemours?
While DuPont de Nemours has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for DuPont de Nemours: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.79 on $3.36 billion in revenues for the coming quarter and $3.30 on $13.24 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 11% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Northern Technologies (NTIC), another stock in the same industry, has yet to report results for the quarter ended August 2022. The results are expected to be released on November 14.
This rust and corrosion prevention company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of -23.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Northern Technologies' revenues are expected to be $19.5 million, up 25.7% from the year-ago quarter.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Northern Technologies International Corporation (NTIC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.81 per share. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours (DD) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.81 per share. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook.
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.81 per share. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours (DD) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.81 per share. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
ba865167-7b6a-4c12-b408-fcfc4ba9572d
|
715943.0
|
2022-11-08 00:00:00 UTC
|
DuPont quarterly profit slides nearly 7% on higher costs
|
DD
|
https://www.nasdaq.com/articles/dupont-quarterly-profit-slides-nearly-7-on-higher-costs-0
|
nan
|
nan
|
Adds segment details
Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds.
Inflation has surged to levels not seen in several decades, prompted by the pandemic and now intensified by Russia's invasion of Ukraine, sending costs for raw materials and energy soaring.
Chief Executive Officer Ed Breen said DuPont faced a "continued challenging macro environment marked by substantial cost inflation."
Despite the cost headwinds, the company did see sustained demand in certain markets notably semiconductor, water and general industrial, which helped it shore up third-quarter revenue of $3.3 billion, up nearly 4% from last year.
The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
((mrinalika.roy@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds segment details Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. Inflation has surged to levels not seen in several decades, prompted by the pandemic and now intensified by Russia's invasion of Ukraine, sending costs for raw materials and energy soaring. Chief Executive Officer Ed Breen said DuPont faced a "continued challenging macro environment marked by substantial cost inflation."
|
Adds segment details Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. Inflation has surged to levels not seen in several decades, prompted by the pandemic and now intensified by Russia's invasion of Ukraine, sending costs for raw materials and energy soaring. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier.
|
Adds segment details Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. Despite the cost headwinds, the company did see sustained demand in certain markets notably semiconductor, water and general industrial, which helped it shore up third-quarter revenue of $3.3 billion, up nearly 4% from last year. The company's net income fell to $376 million, or 73 cents per share, in the three months ended Sept. 30, from $404 million, or 75 cents per share, a year earlier.
|
Adds segment details Nov 8 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 6.9% fall in third-quarter profit on Tuesday, hurt by higher raw material, energy and logistics costs as well as currency headwinds. Inflation has surged to levels not seen in several decades, prompted by the pandemic and now intensified by Russia's invasion of Ukraine, sending costs for raw materials and energy soaring. Chief Executive Officer Ed Breen said DuPont faced a "continued challenging macro environment marked by substantial cost inflation."
|
00b992dd-6a99-444f-947a-12b8f4e68db0
|
715944.0
|
2022-11-07 00:00:00 UTC
|
Pre-Market Earnings Report for November 8, 2022 : DD, GFS, RPRX, CNHI, PKI, EXPD, NFE, CG, BSY, BLDR, NCLH, CLVT
|
DD
|
https://www.nasdaq.com/articles/pre-market-earnings-report-for-november-8-2022-%3A-dd-gfs-rprx-cnhi-pki-expd-nfe-cg-bsy-bldr
|
nan
|
nan
|
The following companies are expected to report earnings prior to market open on 11/08/2022. Visit our Earnings Calendar for a full list of expected earnings releases.
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending September 30, 2022. The chemical company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.81. This value represents a 29.57% decrease compared to the same quarter last year. In the past year DD has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 18.92%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 18.65 vs. an industry ratio of 14.40, implying that they will have a higher earnings growth than their competitors in the same industry.
GlobalFoundries Inc. (GFS)is reporting for the quarter ending September 30, 2022. The electric company company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.54. This value represents a 5300.00% increase compared to the same quarter last year. In the past year GFS has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 41.18%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for GFS is 23.05 vs. an industry ratio of 3.80, implying that they will have a higher earnings growth than their competitors in the same industry.
Royalty Pharma plc (RPRX)is reporting for the quarter ending September 30, 2022. The financial services company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.71. This value represents a 2.74% decrease compared to the same quarter last year. RPRX missed the consensus earnings per share in the 1st calendar quarter of 2022 by -15.28%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for RPRX is 14.12 vs. an industry ratio of 13.00, implying that they will have a higher earnings growth than their competitors in the same industry.
CNH Industrial N.V. (CNHI)is reporting for the quarter ending September 30, 2022. The auto (foreign) company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.32. This value represents a 11.11% decrease compared to the same quarter last year. In the past year CNHI has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 16.22%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CNHI is 9.64 vs. an industry ratio of 5.20, implying that they will have a higher earnings growth than their competitors in the same industry.
PerkinElmer, Inc. (PKI)is reporting for the quarter ending September 30, 2022. The scientific instrument company's consensus earnings per share forecast from the 1 analyst that follows the stock is $1.48. This value represents a 35.93% decrease compared to the same quarter last year. In the past year PKI has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 14.29%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for PKI is 16.73 vs. an industry ratio of 25.10.
Expeditors International of Washington, Inc. (EXPD)is reporting for the quarter ending September 30, 2022. The transportation services company's consensus earnings per share forecast from the 4 analysts that follow the stock is $1.92. This value represents a 8.13% decrease compared to the same quarter last year. In the past year EXPD has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 8.61%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for EXPD is 12.05 vs. an industry ratio of 5.20, implying that they will have a higher earnings growth than their competitors in the same industry.
New Fortress Energy Inc. (NFE)is reporting for the quarter ending September 30, 2022. The oil company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.99. This value represents a 2080.00% increase compared to the same quarter last year. NFE missed the consensus earnings per share in the 3rd calendar quarter of 2021 by -111.11%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for NFE is 16.07 vs. an industry ratio of 5.70, implying that they will have a higher earnings growth than their competitors in the same industry.
The Carlyle Group Inc. (CG)is reporting for the quarter ending September 30, 2022. The investment fund company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.04. This value represents a 32.47% decrease compared to the same quarter last year. CG missed the consensus earnings per share in the 1st calendar quarter of 2022 by -24.49%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CG is 7.16 vs. an industry ratio of 4.40, implying that they will have a higher earnings growth than their competitors in the same industry.
Bentley Systems, Incorporated (BSY)is reporting for the quarter ending September 30, 2022. The internet software company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.13. This value represents a 13.33% decrease compared to the same quarter last year. In the past year BSY has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 38.46%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for BSY is 50.08 vs. an industry ratio of -78.00, implying that they will have a higher earnings growth than their competitors in the same industry.
Builders FirstSource, Inc. (BLDR)is reporting for the quarter ending September 30, 2022. The building company's consensus earnings per share forecast from the 7 analysts that follow the stock is $3.53. This value represents a 4.13% increase compared to the same quarter last year. In the past year BLDR has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 108.67%. Zacks Investment Research reports that the 2022 Price to Earnings ratio for BLDR is 3.60 vs. an industry ratio of 12.00.
Norwegian Cruise Line Holdings Ltd. (NCLH)is reporting for the quarter ending September 30, 2022. The leisure (recreational) company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.75. This value represents a 65.44% increase compared to the same quarter last year. Zacks Investment Research reports that the 2022 Price to Earnings ratio for NCLH is -3.71 vs. an industry ratio of -21.40, implying that they will have a higher earnings growth than their competitors in the same industry.
Clarivate Plc (CLVT)is reporting for the quarter ending September 30, 2022. The internet software company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.15. This value represents a no change for the same quarter last year. In the past year CLVT has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2022 Price to Earnings ratio for CLVT is 14.62 vs. an industry ratio of -78.00, implying that they will have a higher earnings growth than their competitors in the same industry.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending September 30, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 18.65 vs. an industry ratio of 14.40, implying that they will have a higher earnings growth than their competitors in the same industry.
|
Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 18.65 vs. an industry ratio of 14.40, implying that they will have a higher earnings growth than their competitors in the same industry. DuPont de Nemours, Inc. (DD)is reporting for the quarter ending September 30, 2022. In the past year DD has beat the expectations every quarter.
|
Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 18.65 vs. an industry ratio of 14.40, implying that they will have a higher earnings growth than their competitors in the same industry. DuPont de Nemours, Inc. (DD)is reporting for the quarter ending September 30, 2022. In the past year DD has beat the expectations every quarter.
|
DuPont de Nemours, Inc. (DD)is reporting for the quarter ending September 30, 2022. In the past year DD has beat the expectations every quarter. Zacks Investment Research reports that the 2022 Price to Earnings ratio for DD is 18.65 vs. an industry ratio of 14.40, implying that they will have a higher earnings growth than their competitors in the same industry.
|
67210bd1-e68c-4ef8-adc2-819c03f23c89
|
715945.0
|
2022-11-07 00:00:00 UTC
|
DuPont (DD) Gears Up for Q3 Earnings: What's in the Offing?
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-gears-up-for-q3-earnings%3A-whats-in-the-offing
|
nan
|
nan
|
DuPont de Nemours, Inc. DD is scheduled to come up with third-quarter 2022 results, before the opening bell on Nov 8.
The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters. In this timeframe, it delivered an earnings surprise of around 12.7%, on average. It posted an earnings surprise of 18.9% in the last reported quarter.
The company is likely to have benefited from strong end-market demand and its pricing and productivity actions in the third quarter. However, its results are likely to reflect the impacts of raw material and energy cost inflation as well as currency headwinds.
DuPont’s shares have lost 22.2% over a year compared with 12.1% decline recorded by the industry it belongs to.
Image Source: Zacks Investment Research
What do the Estimates Say?
The Zacks Consensus Estimate for revenues for the third quarter for DuPont is currently pinned at $3,267 million, suggesting an expected year-over-year decline of 23.5%.
The consensus estimate for the company’s Electronics & Industrial segment is pinned at $1,514 million, indicating a 0.9% decline sequentially. The same for the Water & Protection unit is pegged at $1,449 million, suggesting a 3.2% sequential decline.
Some Factors to Watch For
The company is expected to have benefited from sustained strong global demand in semiconductors in the third quarter. Strong demand in general industrial, water and construction end-markets is also likely to have supported its volumes.
DuPont is also likely to have benefited from its cost and productivity actions in the quarter to be reported. Its structural cost actions are likely to have contributed to its bottom line in the quarter.
The company is likely to have gained from its pricing actions. It continues to implement strategic price increases to offset the cost inflation. These actions are likely to have supported its results in the September quarter.
However, the company is likely to have faced challenges from higher raw material and logistics costs in the third quarter. Supply constraints for major raw materials are expected to have continued in the September quarter. Higher energy costs driven by the Russia-Ukraine conflict are also expected to have impacted its results.
DuPont is also expected to have witnessed lower volumes in the Safety Solutions business in the third quarter due to a plant downtime associated with a third-partly utility disruption.
Currency headwinds due to the strengthening of the U.S. dollar against key currencies are also likely to have affected the company’s top line in the quarter to be reported.
DuPont de Nemours, Inc. Price and EPS Surprise
DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote
Zacks Model
Our proven model does not conclusively predict an earnings beat for DuPont this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for DuPont is -0.62%. The Zacks Consensus Estimate for earnings for the third quarter is currently pegged at 81 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: DuPont currently carries a Zacks Rank #4 (Sell).
Stocks That Warrant a Look
Here are some companies you may want to consider, as our model shows these have the right combination of elements to post an earnings beat this quarter:
Plug Power Inc. PLUG, slated to release earnings on Nov 8, has an Earnings ESP of +1.08%.
The Zacks Consensus Estimate for Plug Power’s third-quarter earnings is currently pegged at a loss of 25 cents. PLUG currently carries a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
MAG Silver Corp. MAG, expected to release earnings on Nov 21, has an Earnings ESP of +18.18%.
The consensus estimate for MAG Silver's third-quarter earnings is currently pegged at 11 cents. MAG currently carries a Zacks Rank #3.
Perpetua Resources Corp. PPTA, expected to release earnings on Nov 11, has an Earnings ESP of +50.00%.
The Zacks Consensus Estimate for PPTA's earnings for the third quarter is currently pegged at a loss of 8 cents. PPTA currently carries a Zacks Rank #1.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?”
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How To Profit From Trillions On Spending For Infrastructure >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Plug Power, Inc. (PLUG): Free Stock Analysis Report
MAG Silver Corporation (MAG): Free Stock Analysis Report
Perpetua Resources Corp. (PPTA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD is scheduled to come up with third-quarter 2022 results, before the opening bell on Nov 8. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont is also expected to have witnessed lower volumes in the Safety Solutions business in the third quarter due to a plant downtime associated with a third-partly utility disruption.
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours, Inc. DD is scheduled to come up with third-quarter 2022 results, before the opening bell on Nov 8. DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
DuPont de Nemours, Inc. DD is scheduled to come up with third-quarter 2022 results, before the opening bell on Nov 8. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
DuPont de Nemours, Inc. DD is scheduled to come up with third-quarter 2022 results, before the opening bell on Nov 8. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report These actions are likely to have supported its results in the September quarter.
|
bf48c652-8022-427d-b078-34a3ad52f49a
|
715946.0
|
2022-11-03 00:00:00 UTC
|
Why Rogers Stock Tanked Again on Thursday
|
DD
|
https://www.nasdaq.com/articles/why-rogers-stock-tanked-again-on-thursday
|
nan
|
nan
|
What happened
Materials technology specialist Rogers Corporation (NYSE: ROG) was a dog of a stock for the second straight day on Thursday. A day after its share price plunged following the cancellation of a big-ticket merger, it again obeyed gravity by declining an additional 14%-plus.
So what
Investors really get their hopes up when their company is courted by a larger, more deep-pocketed peer. That was the case with Rogers, which was set to be absorbed by chemical industry bellwether DuPont (NYSE: DD) in a $5.2 billion deal that would have valued Rogers at $277 per share -- nearly 50% above its share price at that point.
Those hopes were dashed on Tuesday after market hours when DuPont announced it was pulling out of the arrangement due to the inability "to obtain timely clearance from all the required regulators" (China, specifically).
The company is paying Rogers a $162.5 million termination fee because of this. That's a decent sum, to be sure, but to investors, it surely feels more like a cheap consolation prize.
Now what
Outside of the Chinese regulatory hiccups, the DuPont/Rogers deal actually seemed to be going more or less smoothly. So that might be one factor in the shell shock investors are feeling just now.
While those folks are overreacting at this point, it's hard to escape playing that old, cancelled merger game of What Might Have Been. In the most likely scenario, Rogers will do fine on its own; it's just too bad it won't be part of the muscular, ever-influential and very well-capitalized DuPont. At least not for now.
10 stocks we like better than Rogers
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Rogers wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of September 30, 2022
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A day after its share price plunged following the cancellation of a big-ticket merger, it again obeyed gravity by declining an additional 14%-plus. That was the case with Rogers, which was set to be absorbed by chemical industry bellwether DuPont (NYSE: DD) in a $5.2 billion deal that would have valued Rogers at $277 per share -- nearly 50% above its share price at that point. What happened Materials technology specialist Rogers Corporation (NYSE: ROG) was a dog of a stock for the second straight day on Thursday.
|
A day after its share price plunged following the cancellation of a big-ticket merger, it again obeyed gravity by declining an additional 14%-plus. That was the case with Rogers, which was set to be absorbed by chemical industry bellwether DuPont (NYSE: DD) in a $5.2 billion deal that would have valued Rogers at $277 per share -- nearly 50% above its share price at that point. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.
|
That was the case with Rogers, which was set to be absorbed by chemical industry bellwether DuPont (NYSE: DD) in a $5.2 billion deal that would have valued Rogers at $277 per share -- nearly 50% above its share price at that point. A day after its share price plunged following the cancellation of a big-ticket merger, it again obeyed gravity by declining an additional 14%-plus. 10 stocks we like better than Rogers When our award-winning analyst team has a stock tip, it can pay to listen.
|
A day after its share price plunged following the cancellation of a big-ticket merger, it again obeyed gravity by declining an additional 14%-plus. That was the case with Rogers, which was set to be absorbed by chemical industry bellwether DuPont (NYSE: DD) in a $5.2 billion deal that would have valued Rogers at $277 per share -- nearly 50% above its share price at that point. 10 stocks we like better than Rogers When our award-winning analyst team has a stock tip, it can pay to listen.
|
463cd29f-0da4-4c79-ad15-ce588c1a5e17
|
715947.0
|
2022-11-02 00:00:00 UTC
|
DuPont's canceled acquisition fuels fears of China scuttling mergers
|
DD
|
https://www.nasdaq.com/articles/duponts-canceled-acquisition-fuels-fears-of-china-scuttling-mergers
|
nan
|
nan
|
By Anirban Sen
NEW YORK, Nov 2 (Reuters) - DuPont De Nemours Inc's DD.N decision to scrap its deal to buy Rogers Corp ROG.N has raised concerns that more Western buyers will follow the lead of the U.S. chemicals company in abandoning acquisitions because Chinese regulators will not clear them.
DuPont said on Tuesday it terminated its $5.2 billion acquisition of Rogers, a U.S. electronic materials maker, because of protracted delays in securing regulatory approval, marking the first major U.S. deal in four years to collapse because Chinese officials dragged their feet on providing clearance. Qualcomm QCOM.Oended its $44 billion purchase of Dutch peer NXP Semiconductors NV in 2018 after failing to secure regulatory approval.
China's regulators have declined to comment on the DuPont deal and have not provided a reason for the delay in reviewing it. But the deal's demise comes amid renewed trade and geopolitical tensions between Washington and Beijing that has fueled investor concerns that mergers could become a casualty.
One merger arbitrage fund investor, who declined to be named, said deals involving Chinese approval will be closely watched in the aftermath of the scrapped DuPont-Rogers deal.
Shares of some U.S. companies with a significant footprint in China that are waiting to complete deals dropped on Wednesday as a result.
Shares of Tower Semiconductor TSEM.O, which agreed in February to sell itself to Intel Corp for $5.4 billion, were down 4% on Wednesday afternoon at $41.31, a significant discount to the $53 per share deal price, reflecting doubt among investors over whether the transaction will be completed.
Shares of Altra Industrial Motion Corp AIMC.O, a U.S. automation equipment maker which agreed last week to sell itself to Regal Rexnord Corp RRX.N for $5 billion, traded down almost 1% to $59.19, their biggest discount to the $62-per-share deal price since the transaction was announced.
Shares of U.S. chip maker Silicon Motion Technology Corp SIMOy.F, which will require Chinese regulatory approval to complete its $3.8 billion sale to peer MaxLinear Inc, have dropped 40% since their transaction was announced in May.
Some investors cautioned, however, that the collapse of these deals hinges not just on whether Chinese regulators will withhold clearance but also on whether the acquirers are committed to the transactions.
In the case of Rogers, DuPont was happy to walk away rather than give the Chinese regulators more time because this year's market downturn had made the acquisition seem pricey compared to when it inked the deal 12 months ago, experts said.
"Investors felt that DuPont was paying too much for Rogers and there were expectations of a price cut," said Chris Pultz, portfolio manager for merger arbitrage at Kellner Capital.
(Editing by Deepa Babington)
((Anirban.Sen@thomsonreuters.com; Twitter: @asenjourno; Reuters Messaging: Signal/Telegram/Whatsapp - +1-646-705-9409))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Anirban Sen NEW YORK, Nov 2 (Reuters) - DuPont De Nemours Inc's DD.N decision to scrap its deal to buy Rogers Corp ROG.N has raised concerns that more Western buyers will follow the lead of the U.S. chemicals company in abandoning acquisitions because Chinese regulators will not clear them. DuPont said on Tuesday it terminated its $5.2 billion acquisition of Rogers, a U.S. electronic materials maker, because of protracted delays in securing regulatory approval, marking the first major U.S. deal in four years to collapse because Chinese officials dragged their feet on providing clearance. In the case of Rogers, DuPont was happy to walk away rather than give the Chinese regulators more time because this year's market downturn had made the acquisition seem pricey compared to when it inked the deal 12 months ago, experts said.
|
By Anirban Sen NEW YORK, Nov 2 (Reuters) - DuPont De Nemours Inc's DD.N decision to scrap its deal to buy Rogers Corp ROG.N has raised concerns that more Western buyers will follow the lead of the U.S. chemicals company in abandoning acquisitions because Chinese regulators will not clear them. DuPont said on Tuesday it terminated its $5.2 billion acquisition of Rogers, a U.S. electronic materials maker, because of protracted delays in securing regulatory approval, marking the first major U.S. deal in four years to collapse because Chinese officials dragged their feet on providing clearance. Shares of Tower Semiconductor TSEM.O, which agreed in February to sell itself to Intel Corp for $5.4 billion, were down 4% on Wednesday afternoon at $41.31, a significant discount to the $53 per share deal price, reflecting doubt among investors over whether the transaction will be completed.
|
By Anirban Sen NEW YORK, Nov 2 (Reuters) - DuPont De Nemours Inc's DD.N decision to scrap its deal to buy Rogers Corp ROG.N has raised concerns that more Western buyers will follow the lead of the U.S. chemicals company in abandoning acquisitions because Chinese regulators will not clear them. DuPont said on Tuesday it terminated its $5.2 billion acquisition of Rogers, a U.S. electronic materials maker, because of protracted delays in securing regulatory approval, marking the first major U.S. deal in four years to collapse because Chinese officials dragged their feet on providing clearance. Shares of Tower Semiconductor TSEM.O, which agreed in February to sell itself to Intel Corp for $5.4 billion, were down 4% on Wednesday afternoon at $41.31, a significant discount to the $53 per share deal price, reflecting doubt among investors over whether the transaction will be completed.
|
By Anirban Sen NEW YORK, Nov 2 (Reuters) - DuPont De Nemours Inc's DD.N decision to scrap its deal to buy Rogers Corp ROG.N has raised concerns that more Western buyers will follow the lead of the U.S. chemicals company in abandoning acquisitions because Chinese regulators will not clear them. DuPont said on Tuesday it terminated its $5.2 billion acquisition of Rogers, a U.S. electronic materials maker, because of protracted delays in securing regulatory approval, marking the first major U.S. deal in four years to collapse because Chinese officials dragged their feet on providing clearance. Shares of U.S. chip maker Silicon Motion Technology Corp SIMOy.F, which will require Chinese regulatory approval to complete its $3.8 billion sale to peer MaxLinear Inc, have dropped 40% since their transaction was announced in May.
|
f00eb72c-9d14-4aea-9ca5-6c4d73118dae
|
715948.0
|
2022-11-02 00:00:00 UTC
|
Why Rogers Stock Crashed Hard Today
|
DD
|
https://www.nasdaq.com/articles/why-rogers-stock-crashed-hard-today
|
nan
|
nan
|
What happened
Shares of engineered materials maker Rogers (NYSE: ROG) took a massive hit on Wednesday. The stock opened the morning session 43.7% lower and stayed within a few percentage points of that sharp drop all day. On Tuesday evening, materials and chemicals giant DuPont de Nemours (NYSE: DD) canceled its nearly completed buyout of Rogers, citing regulatory clearance issues.
So what
The acquisition originally offered Rogers shareholders a cash payment of $277 per stub. That was a 46% premium to the volume-weighted 30-day average price of Rogers' stock at the time. The deal cleared most of its hurdles in short order, but Chinese regulators never gave it the final thumbs-up. That approval mattered because Rogers has offices and manufacturing facilities in four Chinese cities. Thirty-four percent of the company's 2021 revenue was collected in the Chinese market.
So exactly one year after the original announcement, DuPont officially rescinded this $5.2 billion buyout bid, sending Rogers a termination fee of $162.5 million instead.
Rogers' stock now trades at roughly $130 per share. That's 32% below the weighted average price just before the buyout was announced.
Now what
Rogers investors started to lose confidence in the DuPont deal in August, when the Chinese government refused to rubber-stamp the contract. Last night, on the eve of cancellation, Rogers' stubs changed hands at $229 per share.
In sharp contrast to Rogers' steep price drop, DuPont stock traded 6.2% higher at 1:50 p.m. ET. The merger was supposed to give DuPont a leg up in Rogers' main markets, including electric vehicle battery materials and advanced antennas for high-speed wireless networks. In the end, DuPont's shareholders don't seem to mind losing that edge and sending over that juicy termination fee. Nobody likes the uncertainty of an unfinished merger. That dark cloud has been removed.
Rogers will soldier on, reviewing its options now that DuPont's offer is off the table. The termination fee will boost the company's cash reserves by 72%, perhaps opening the door to strategies or acquisitions that were too expensive last week.
The stock isn't a slam-dunk buy today, since there are many question marks around how Rogers moves forward from this stalemate. However, Rogers remains an indirect but robust bet on electric vehicles and 5G networking. Today's far lower share price could make it an interesting double play on those explosive markets.
10 stocks we like better than Rogers
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Rogers wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of September 30, 2022
Anders Bylund has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
On Tuesday evening, materials and chemicals giant DuPont de Nemours (NYSE: DD) canceled its nearly completed buyout of Rogers, citing regulatory clearance issues. So exactly one year after the original announcement, DuPont officially rescinded this $5.2 billion buyout bid, sending Rogers a termination fee of $162.5 million instead. The merger was supposed to give DuPont a leg up in Rogers' main markets, including electric vehicle battery materials and advanced antennas for high-speed wireless networks.
|
On Tuesday evening, materials and chemicals giant DuPont de Nemours (NYSE: DD) canceled its nearly completed buyout of Rogers, citing regulatory clearance issues. So what The acquisition originally offered Rogers shareholders a cash payment of $277 per stub. So exactly one year after the original announcement, DuPont officially rescinded this $5.2 billion buyout bid, sending Rogers a termination fee of $162.5 million instead.
|
On Tuesday evening, materials and chemicals giant DuPont de Nemours (NYSE: DD) canceled its nearly completed buyout of Rogers, citing regulatory clearance issues. In sharp contrast to Rogers' steep price drop, DuPont stock traded 6.2% higher at 1:50 p.m. 10 stocks we like better than Rogers When our award-winning analyst team has a stock tip, it can pay to listen.
|
On Tuesday evening, materials and chemicals giant DuPont de Nemours (NYSE: DD) canceled its nearly completed buyout of Rogers, citing regulatory clearance issues. So what The acquisition originally offered Rogers shareholders a cash payment of $277 per stub. Rogers' stock now trades at roughly $130 per share.
|
6ead47b1-5462-423b-a100-213e6fd68138
|
715949.0
|
2022-11-02 00:00:00 UTC
|
Rogers Exploring Options Following DuPont's Merger Termination Notice; Stock Plunges In Pre-market
|
DD
|
https://www.nasdaq.com/articles/rogers-exploring-options-following-duponts-merger-termination-notice-stock-plunges-in-pre
|
nan
|
nan
|
(RTTNews) - Rogers Corporation (ROG), an electronic components business, on Wednesday said it is currently evaluating all options to determine the best path forward, in response to DuPont de Nemours, Inc.'s (DD) notice of termination of the definitive merger agreement entered into by Rogers and DuPont on November 1, 2021.
Following the news, the stock nosedived more than 40% in pre-market activity.
Rogers Corporation had announced entering into a definitive merger agreement to be acquired by DuPont in an all-cash transaction that valued Rogers at approximately $5.2 billion. The transaction was expected to be closed in the second quarter of 2022.
Shares of Rogers Corporation sank more than 40 percent in pre-market to trade at $136.32.
Shares of DuPont de Nemours are currently trading in pre-market at $61.70, up $3.00 or 5.11 percent from the previous close.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Rogers Corporation (ROG), an electronic components business, on Wednesday said it is currently evaluating all options to determine the best path forward, in response to DuPont de Nemours, Inc.'s (DD) notice of termination of the definitive merger agreement entered into by Rogers and DuPont on November 1, 2021. Shares of Rogers Corporation sank more than 40 percent in pre-market to trade at $136.32. Shares of DuPont de Nemours are currently trading in pre-market at $61.70, up $3.00 or 5.11 percent from the previous close.
|
(RTTNews) - Rogers Corporation (ROG), an electronic components business, on Wednesday said it is currently evaluating all options to determine the best path forward, in response to DuPont de Nemours, Inc.'s (DD) notice of termination of the definitive merger agreement entered into by Rogers and DuPont on November 1, 2021. Rogers Corporation had announced entering into a definitive merger agreement to be acquired by DuPont in an all-cash transaction that valued Rogers at approximately $5.2 billion. Shares of DuPont de Nemours are currently trading in pre-market at $61.70, up $3.00 or 5.11 percent from the previous close.
|
(RTTNews) - Rogers Corporation (ROG), an electronic components business, on Wednesday said it is currently evaluating all options to determine the best path forward, in response to DuPont de Nemours, Inc.'s (DD) notice of termination of the definitive merger agreement entered into by Rogers and DuPont on November 1, 2021. Rogers Corporation had announced entering into a definitive merger agreement to be acquired by DuPont in an all-cash transaction that valued Rogers at approximately $5.2 billion. Shares of DuPont de Nemours are currently trading in pre-market at $61.70, up $3.00 or 5.11 percent from the previous close.
|
(RTTNews) - Rogers Corporation (ROG), an electronic components business, on Wednesday said it is currently evaluating all options to determine the best path forward, in response to DuPont de Nemours, Inc.'s (DD) notice of termination of the definitive merger agreement entered into by Rogers and DuPont on November 1, 2021. Following the news, the stock nosedived more than 40% in pre-market activity. Rogers Corporation had announced entering into a definitive merger agreement to be acquired by DuPont in an all-cash transaction that valued Rogers at approximately $5.2 billion.
|
d297c81f-750c-4747-bf33-786e103640c5
|
715950.0
|
2022-11-01 00:00:00 UTC
|
DuPont to end $5.2 bln acquisition of Rogers on clearance hurdles
|
DD
|
https://www.nasdaq.com/articles/dupont-to-end-%245.2-bln-acquisition-of-rogers-on-clearance-hurdles
|
nan
|
nan
|
Nov 1 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N said on Tuesday it was terminating its $5.2 billion buyout of Rogers Corp ROG.N as the companies have been unable to obtain timely clearances from regulators.
DuPont said it would pay Rogers a termination fee of $162.5 million.
(Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva)
((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 1 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N said on Tuesday it was terminating its $5.2 billion buyout of Rogers Corp ROG.N as the companies have been unable to obtain timely clearances from regulators. DuPont said it would pay Rogers a termination fee of $162.5 million. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 1 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N said on Tuesday it was terminating its $5.2 billion buyout of Rogers Corp ROG.N as the companies have been unable to obtain timely clearances from regulators. DuPont said it would pay Rogers a termination fee of $162.5 million. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 1 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N said on Tuesday it was terminating its $5.2 billion buyout of Rogers Corp ROG.N as the companies have been unable to obtain timely clearances from regulators. DuPont said it would pay Rogers a termination fee of $162.5 million. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Nov 1 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N said on Tuesday it was terminating its $5.2 billion buyout of Rogers Corp ROG.N as the companies have been unable to obtain timely clearances from regulators. DuPont said it would pay Rogers a termination fee of $162.5 million. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
8fb73843-37a7-43ac-8183-fd5a187502e1
|
715951.0
|
2022-11-01 00:00:00 UTC
|
Analysts Estimate DuPont de Nemours (DD) to Report a Decline in Earnings: What to Look Out for
|
DD
|
https://www.nasdaq.com/articles/analysts-estimate-dupont-de-nemours-dd-to-report-a-decline-in-earnings%3A-what-to-look-out-0
|
nan
|
nan
|
DuPont de Nemours (DD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2022. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on November 8, 2022, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus Estimate
This specialty chemicals maker is expected to post quarterly earnings of $0.81 per share in its upcoming report, which represents a year-over-year change of -29.6%.
Revenues are expected to be $3.27 billion, down 23.5% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has been revised 2.4% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for DuPont de Nemours?
For DuPont de Nemours, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that DuPont de Nemours will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that DuPont de Nemours would post earnings of $0.74 per share when it actually produced earnings of $0.88, delivering a surprise of +18.92%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
DuPont de Nemours doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected Results
Another stock from the Zacks Chemical - Diversified industry, Koppers (KOP), is soon expected to post earnings of $1.17 per share for the quarter ended September 2022. This estimate indicates a year-over-year change of +15.8%. Revenues for the quarter are expected to be $555 million, up 30.7% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Koppers has remained unchanged. Nevertheless, the company now has an Earnings ESP of 2.28%, reflecting a higher Most Accurate Estimate.
When combined with a Zacks Rank of #2 (Buy), this Earnings ESP indicates that Koppers will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Koppers Holdings Inc. (KOP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. DuPont de Nemours (DD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
DuPont de Nemours (DD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2022. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
DuPont de Nemours (DD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2022. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
DuPont de Nemours (DD) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2022. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success.
|
67cefaa6-b8d3-42cf-a189-ad2dc72dcf57
|
715952.0
|
2022-10-27 00:00:00 UTC
|
Interesting DD Put And Call Options For December 9th
|
DD
|
https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-december-9th
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options become available today, for the December 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new December 9th contracts and identified one put and one call contract of particular interest.
The put contract at the $57.00 strike price has a current bid of $2.30. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $57.00, but will also collect the premium, putting the cost basis of the shares at $54.70 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $57.32/share today.
Because the $57.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 4.04% return on the cash commitment, or 34.22% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $57.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $58.00 strike price has a current bid of $2.20. If an investor was to purchase shares of DD stock at the current price level of $57.32/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $58.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 5.02% if the stock gets called away at the December 9th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red:
Considering the fact that the $58.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 3.84% boost of extra return to the investor, or 32.55% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $57.32) to be 33%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the December 9th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new December 9th contracts and identified one put and one call contract of particular interest. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
fca4d077-2bf7-4dc9-9ec5-612cca3c3031
|
715953.0
|
2022-10-26 00:00:00 UTC
|
Olin (OLN) Q3 Earnings Beat Estimates
|
DD
|
https://www.nasdaq.com/articles/olin-oln-q3-earnings-beat-estimates
|
nan
|
nan
|
Olin (OLN) came out with quarterly earnings of $2.18 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $2.38 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 17.20%. A quarter ago, it was expected that this chlor-alkali and ammunition producer'would post earnings of $2.57 per share when it actually produced earnings of $2.76, delivering a surprise of 7.39%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Olin, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $2.32 billion for the quarter ended September 2022, missing the Zacks Consensus Estimate by 2.64%. This compares to year-ago revenues of $2.34 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Olin shares have lost about 14% since the beginning of the year versus the S&P 500's decline of -19%.
What's Next for Olin?
While Olin has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Olin: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.57 on $2.18 billion in revenues for the coming quarter and $8.71 on $9.64 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 6% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, DuPont de Nemours (DD), is yet to report results for the quarter ended September 2022. The results are expected to be released on November 8.
This specialty chemicals maker is expected to post quarterly earnings of $0.81 per share in its upcoming report, which represents a year-over-year change of -29.6%. The consensus EPS estimate for the quarter has been revised 2.4% lower over the last 30 days to the current level.
DuPont de Nemours' revenues are expected to be $3.27 billion, down 23.5% from the year-ago quarter.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Olin Corporation (OLN): Free Stock Analysis Report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. One other stock from the same industry, DuPont de Nemours (DD), is yet to report results for the quarter ended September 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. One other stock from the same industry, DuPont de Nemours (DD), is yet to report results for the quarter ended September 2022.
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. One other stock from the same industry, DuPont de Nemours (DD), is yet to report results for the quarter ended September 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. One other stock from the same industry, DuPont de Nemours (DD), is yet to report results for the quarter ended September 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
b0cee593-ec18-428b-98d7-853786e9965c
|
715954.0
|
2022-10-24 00:00:00 UTC
|
Analysts Expect 22% Gains Ahead For SPHQ
|
DD
|
https://www.nasdaq.com/articles/analysts-expect-22-gains-ahead-for-sphq
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P 500— Quality ETF (Symbol: SPHQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $51.28 per unit.
With SPHQ trading at a recent price near $41.99 per unit, that means that analysts see 22.12% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SPHQ's underlying holdings with notable upside to their analyst target prices are Qualcomm Inc (Symbol: QCOM), Teradyne, Inc. (Symbol: TER), and DuPont de Nemours Inc (Symbol: DD). Although QCOM has traded at a recent price of $115.74/share, the average analyst target is 51.98% higher at $175.90/share. Similarly, TER has 39.87% upside from the recent share price of $77.27 if the average analyst target price of $108.08/share is reached, and analysts on average are expecting DD to reach a target price of $73.00/share, which is 31.34% above the recent price of $55.58. Below is a twelve month price history chart comparing the stock performance of QCOM, TER, and DD:
Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
Invesco S&P 500— Quality ETF SPHQ $41.99 $51.28 22.12%
Qualcomm Inc QCOM $115.74 $175.90 51.98%
Teradyne, Inc. TER $77.27 $108.08 39.87%
DuPont de Nemours Inc DD $55.58 $73.00 31.34%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Invesco S&P 500— Quality ETF SPHQ $41.99 $51.28 22.12% Qualcomm Inc QCOM $115.74 $175.90 51.98% Teradyne, Inc. TER $77.27 $108.08 39.87% DuPont de Nemours Inc DD $55.58 $73.00 31.34% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPHQ's underlying holdings with notable upside to their analyst target prices are Qualcomm Inc (Symbol: QCOM), Teradyne, Inc. (Symbol: TER), and DuPont de Nemours Inc (Symbol: DD). Similarly, TER has 39.87% upside from the recent share price of $77.27 if the average analyst target price of $108.08/share is reached, and analysts on average are expecting DD to reach a target price of $73.00/share, which is 31.34% above the recent price of $55.58.
|
Three of SPHQ's underlying holdings with notable upside to their analyst target prices are Qualcomm Inc (Symbol: QCOM), Teradyne, Inc. (Symbol: TER), and DuPont de Nemours Inc (Symbol: DD). Similarly, TER has 39.87% upside from the recent share price of $77.27 if the average analyst target price of $108.08/share is reached, and analysts on average are expecting DD to reach a target price of $73.00/share, which is 31.34% above the recent price of $55.58. Invesco S&P 500— Quality ETF SPHQ $41.99 $51.28 22.12% Qualcomm Inc QCOM $115.74 $175.90 51.98% Teradyne, Inc. TER $77.27 $108.08 39.87% DuPont de Nemours Inc DD $55.58 $73.00 31.34% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
Similarly, TER has 39.87% upside from the recent share price of $77.27 if the average analyst target price of $108.08/share is reached, and analysts on average are expecting DD to reach a target price of $73.00/share, which is 31.34% above the recent price of $55.58. Three of SPHQ's underlying holdings with notable upside to their analyst target prices are Qualcomm Inc (Symbol: QCOM), Teradyne, Inc. (Symbol: TER), and DuPont de Nemours Inc (Symbol: DD). Below is a twelve month price history chart comparing the stock performance of QCOM, TER, and DD: Below is a summary table of the current analyst target prices discussed above:
|
Invesco S&P 500— Quality ETF SPHQ $41.99 $51.28 22.12% Qualcomm Inc QCOM $115.74 $175.90 51.98% Teradyne, Inc. TER $77.27 $108.08 39.87% DuPont de Nemours Inc DD $55.58 $73.00 31.34% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPHQ's underlying holdings with notable upside to their analyst target prices are Qualcomm Inc (Symbol: QCOM), Teradyne, Inc. (Symbol: TER), and DuPont de Nemours Inc (Symbol: DD). Similarly, TER has 39.87% upside from the recent share price of $77.27 if the average analyst target price of $108.08/share is reached, and analysts on average are expecting DD to reach a target price of $73.00/share, which is 31.34% above the recent price of $55.58.
|
6a1dcd6d-1ede-4f82-9f3d-d8424175c7a1
|
715955.0
|
2022-10-21 00:00:00 UTC
|
More Growth From Corning After Q3?
|
DD
|
https://www.nasdaq.com/articles/more-growth-from-corning-after-q3
|
nan
|
nan
|
Corning (NYSE: GLW) is scheduled to report its Q3 2022 results on Tuesday, October 25. We expect the company to post revenue and earnings slightly above the street expectations. The company should continue to benefit from 5G expansion and cloud computing. Better price realization should aid the overall performance. We expect the company to navigate well in Q3 and its stock to rise in the near term. Furthermore, we believe that GLW stock has ample room for growth, as discussed below. Our interactive dashboard analysis of Corning Earnings Preview has additional details.
(1) Revenues expected to be in line with the consensus estimates
Trefis estimates Corning’s Q3 2022 revenues to be around $3.7 billion, reflecting a low single-digit y-o-y rise and aligning with the consensus estimate.
Corning will likely see a pickup in demand for optical fiber as carriers continue to expand their 5G coverage.
The company will likely benefit from higher price realization for its display glass.
Looking back at Q2 2022, Corning’s revenues declined 2% y-o-y to $3.6 billion, as a 10% growth in optical communication was more than offset by a 13% decline in environmental technologies and an 8% cut in display technologies sales.
Our dashboard on Corning’s Revenues offers more details on the company’s segments.
2) EPS likely to be slightly above the consensus estimates
Corning’s Q3 2022 earnings per share (EPS) is expected to be $0.55 per Trefis analysis, slightly above the consensus estimate of $0.52 but lower than the $0.56 figure seen in the prior year quarter.
Corning’s adjusted net income of $489 million in Q2 2022 reflected a 5% rise from its $465 million figure in the prior-year quarter. This can be attributed to higher revenues and an 88 bps improvement in net margins.
We expect the margins to improve in Q3 as well, led by pricing actions taken by the company.
For the full-year 2022, we expect the adjusted EPS to be higher at $2.21, compared to $2.07 in 2021.
(3) GLW stock has room for growth
We estimate Corning’s Valuation to be around $42 per share, which is 34% above the current market price of $31.
At its current levels, Corning stock is trading at a forward P/E multiple of just 14x based on our EPS estimate of $2.21 for 2022, compared to the last three-year average of 18x, implying that GLW stock has ample room for growth.
Furthermore, if the company reports upbeat Q3 results and provides an outlook better than the street estimates, the P/E multiple will likely be revised upward, resulting in higher levels for GLW stock.
Note: P/E Multiples are based on Share Price at the end of the year and reported (or expected) Earnings for the full year
While GLW stock looks like it has some more room for growth, it is helpful to see how Corning’s Peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.
Furthermore, the Covid-19 crisis has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised at how counter-intuitive the stock valuation is for 3M vs. AGCO.
With inflation rising and the Fed raising interest rates, among other factors, GLW stock has fallen 16% this year. Can it drop more? See how low Corning stock can go by comparing its decline in previous market crashes. Here is a performance summary of all stocks in previous market crashes.
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
Returns Oct 2022
MTD [1] 2022
YTD [1] 2017-22
Total [2]
GLW Return 8% -16% 29%
S&P 500 Return 3% -23% 64%
Trefis Multi-Strategy Portfolio 2% -25% 196%
[1] Month-to-date and year-to-date as of 10/18/2022
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Corning will likely see a pickup in demand for optical fiber as carriers continue to expand their 5G coverage. (3) GLW stock has room for growth We estimate Corning’s Valuation to be around $42 per share, which is 34% above the current market price of $31.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q3 2022 revenues to be around $3.7 billion, reflecting a low single-digit y-o-y rise and aligning with the consensus estimate. 2) EPS likely to be slightly above the consensus estimates Corning’s Q3 2022 earnings per share (EPS) is expected to be $0.55 per Trefis analysis, slightly above the consensus estimate of $0.52 but lower than the $0.56 figure seen in the prior year quarter.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q3 2022 revenues to be around $3.7 billion, reflecting a low single-digit y-o-y rise and aligning with the consensus estimate. Note: P/E Multiples are based on Share Price at the end of the year and reported (or expected) Earnings for the full year While GLW stock looks like it has some more room for growth, it is helpful to see how Corning’s Peers fare on metrics that matter.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q3 2022 revenues to be around $3.7 billion, reflecting a low single-digit y-o-y rise and aligning with the consensus estimate. (3) GLW stock has room for growth We estimate Corning’s Valuation to be around $42 per share, which is 34% above the current market price of $31.
|
3658e0ab-0c60-4c5e-b264-0960bec2676c
|
715956.0
|
2022-10-20 00:00:00 UTC
|
Daily Dividend Report: BAC, SHW, KMI, ODFL, DD
|
DD
|
https://www.nasdaq.com/articles/daily-dividend-report%3A-bac-shw-kmi-odfl-dd
|
nan
|
nan
|
Bank of America announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.22 per share, payable on December 30, 2022 to shareholders of record as of December 2, 2022.
The Sherwin-Williams Company (SHW) announced a regular quarterly dividend of $0.60 per common share payable on December 2, 2022, to shareholders of record on November 18, 2022.
Kinder Morgan (KMI) approved a cash dividend of $0.2775 per share for the third quarter, payable on November 15, 2022, to stockholders of record as of the close of business on October 31, 2022. This dividend is a 3% increase over the third quarter of 2021.
Old Dominion Freight Line (ODFL) has declared a quarterly cash dividend of $0.30 per share of common stock, payable on December 21, 2022, to shareholders of record at the close of business on December 7, 2022. This dividend represents a 50.0% increase over the dividend paid in December 2021.
DuPont (DD) has declared a fourth quarter dividend of thirty-three cents per share on the outstanding Common Stock of the Company payable on December 15, 2022, to holders of record of said stock at the close of business on November 30, 2022.
VIDEO: Daily Dividend Report: BAC, SHW, KMI, ODFL, DD
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont (DD) has declared a fourth quarter dividend of thirty-three cents per share on the outstanding Common Stock of the Company payable on December 15, 2022, to holders of record of said stock at the close of business on November 30, 2022. VIDEO: Daily Dividend Report: BAC, SHW, KMI, ODFL, DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Bank of America announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.22 per share, payable on December 30, 2022 to shareholders of record as of December 2, 2022.
|
DuPont (DD) has declared a fourth quarter dividend of thirty-three cents per share on the outstanding Common Stock of the Company payable on December 15, 2022, to holders of record of said stock at the close of business on November 30, 2022. VIDEO: Daily Dividend Report: BAC, SHW, KMI, ODFL, DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Bank of America announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.22 per share, payable on December 30, 2022 to shareholders of record as of December 2, 2022.
|
DuPont (DD) has declared a fourth quarter dividend of thirty-three cents per share on the outstanding Common Stock of the Company payable on December 15, 2022, to holders of record of said stock at the close of business on November 30, 2022. VIDEO: Daily Dividend Report: BAC, SHW, KMI, ODFL, DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Bank of America announced the Board of Directors declared a regular quarterly cash dividend on Bank of America common stock of $0.22 per share, payable on December 30, 2022 to shareholders of record as of December 2, 2022.
|
DuPont (DD) has declared a fourth quarter dividend of thirty-three cents per share on the outstanding Common Stock of the Company payable on December 15, 2022, to holders of record of said stock at the close of business on November 30, 2022. VIDEO: Daily Dividend Report: BAC, SHW, KMI, ODFL, DD The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. This dividend is a 3% increase over the third quarter of 2021.
|
f2c9f9bc-c23c-42a5-aea3-7dd6957bad91
|
715957.0
|
2022-10-08 00:00:00 UTC
|
2 High-Yield Dividend Stocks That Are Passive Income Powerhouses
|
DD
|
https://www.nasdaq.com/articles/2-high-yield-dividend-stocks-that-are-passive-income-powerhouses
|
nan
|
nan
|
The energy sector is the best performing sector in 2022 and for good reason. Geopolitical events paired with years of underinvestment have resulted in a supply demand imbalance. When the economy is growing and the oil and gas supply is reliable, it's easy to take the energy sector for granted. But without reliable fuel sources, modern economies grind to a halt.
A heightened focus on energy security sets the stage for a strong oil and gas sector that can grow alongside renewable energy. However, higher oil prices paired with a potential recession are bad news for chemical companies that depend on oil inputs to make plastics and other products. Two high-yield stocks that stand out now are Chevron (NYSE: CVX) and Dow (NYSE: DOW). Chevron is thriving and producing record profits, while Dow stock has sold off and trades at a dirt cheap valuation. Here's what makes each dividend stock a great buy now.
Image source: Getty Images.
1. The best oil and gas major
Chevron stock has tumbled alongside the rest of the oil and gas industry in the last few months as oil and gas prices have fallen due to fears that demand will slow. The sell-off has pushed Chevron's dividend yield back up to 3.9%. Even if oil and gas prices continue to slip, Chevron can still make a killing because it has lowered its cost of production and bolstered its balance sheet for years.
It is no exaggeration that Chevron is firing on all cylinders. One of the most jaw-dropping Chevron charts is its trailing-12-month (TTM) net income.
CVX Net Income (TTM) data by YCharts.
Notice that Chevron went from a record loss of almost $12 billion in 2020 an all-time high TTM net income in just two years.
The company's profits and free cash flows (FCF) have outpaced the surge in its stock price -- even though Chevron stock is up 29% year to date. The result is that Chevron stock is the cheapest it has been in five years even though the stock price is near a five-year high.
CVX Price to Free Cash Flow data by YCharts.
Earnings could decline from here given the price movement of oil and gas prices. But what the above chart shows is that even if earnings and FCF are cut by a third, Chevron stock would still be a reasonable value at around a 15 P/E ratio and a 15 price to FCF ratio.
The dividend yield can also be used as a proxy for valuation.
CVX Dividend Yield data by YCharts
Chevron's dividend yield peaked during the worst of the 2020 oil and gas crash. However, even now, the yield of 3.9% is above the 25-year average yield thanks to years of Chevron stock underperforming the broader market paired with consistent dividend raises.
The company's diversified business in upstream, midstream, downstream, and global exposure gives it more stability than a pure-play producer. Despite relatively high oil and gas prices, Chevron and many of its peers have made only minor increases to production -- choosing instead to benefit from high margins and use excess profits to invest in alternative energy, buy back stock, and raise the dividend. The move looks wise, especially if oil and gas demand continues to fall.
All told, Chevron is arguably the best all-around oil and gas stock to buy now. And even if its earnings and FCF come down a little, the stock is still likely to be heavily discounted compared to its long-term average valuation.
2. A diversified chemicals company with a very attractive dividend
Economic growth and strong consumer spending tend to benefit materials companies that make more money when their end markets are strong. Dow, which is one of the largest chemical companies in the world, makes adhesives, sealants, polyethylene, polyurethanes, silicones, elastomers, plastomers, amines, chelates, and other products and technologies for major industries such as building, construction, infrastructure, chemical manufacturing, industrial applications, automotive, films, tapes, release liners for shipping, and even chemicals for beauty and personal care.
Dow is facing two headwinds right now. The first is that the economy could be contracting, which could lead to lower consumer spending and declining earnings across many of its core markets. The second is higher oil and gas prices increase input costs for Dow, which uses oil as a feedstock in its chemical plants. However, these headwinds seem to be priced in, as Dow stock is now down 39% from its 52-week high.
The company hasn't raised its dividend since spinning off from DuPont de Nemours and Corteva in 2019. But with a dividend yield of 6.3%, Dow already produces a sizable passive income stream. In 2021, the company earned $8.38 in diluted earnings per share, $6.26 in free cash flow (FCF) per share, and paid dividends of $2.80 per share. Put another way, the company could see earnings fall by two-thirds and FCF fall by half, and it would still be able to afford its dividend. Add it all up, and you have a high-yield dividend stock that looks like a great buy now.
A dynamic duo for an income-oriented investor
Chevron blends a high yield and a track record of payouts, while Dow stock provides an enviable amount of passive income from the dividend alone. Over the long term, both companies will likely face volatility in their earnings based on fluctuations in commodity prices and the broader economy.
Dividends help alleviate volatility by allowing investors to hold the underlying stock and collect passive income without selling shares. For patient investors looking for two industry-leading companies, Chevron and Dow look like a great all-around value now.
10 stocks we like better than Chevron
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Chevron wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of September 30, 2022
Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Add it all up, and you have a high-yield dividend stock that looks like a great buy now. Even if oil and gas prices continue to slip, Chevron can still make a killing because it has lowered its cost of production and bolstered its balance sheet for years. A dynamic duo for an income-oriented investor Chevron blends a high yield and a track record of payouts, while Dow stock provides an enviable amount of passive income from the dividend alone.
|
Add it all up, and you have a high-yield dividend stock that looks like a great buy now. CVX Dividend Yield data by YCharts Chevron's dividend yield peaked during the worst of the 2020 oil and gas crash. The second is higher oil and gas prices increase input costs for Dow, which uses oil as a feedstock in its chemical plants.
|
Add it all up, and you have a high-yield dividend stock that looks like a great buy now. The best oil and gas major Chevron stock has tumbled alongside the rest of the oil and gas industry in the last few months as oil and gas prices have fallen due to fears that demand will slow. The company's profits and free cash flows (FCF) have outpaced the surge in its stock price -- even though Chevron stock is up 29% year to date.
|
Add it all up, and you have a high-yield dividend stock that looks like a great buy now. Earnings could decline from here given the price movement of oil and gas prices. A diversified chemicals company with a very attractive dividend Economic growth and strong consumer spending tend to benefit materials companies that make more money when their end markets are strong.
|
f7bc522b-5fe3-4200-badc-f0c232dd6d7e
|
715958.0
|
2022-10-07 00:00:00 UTC
|
ANALYSIS-Dollar's gains spell earnings pain for U.S. companies
|
DD
|
https://www.nasdaq.com/articles/analysis-dollars-gains-spell-earnings-pain-for-u.s.-companies
|
nan
|
nan
|
By Saqib Iqbal Ahmed
NEW YORK, Oct 7 (Reuters) - A towering rally in the U.S. dollar is expected to hit third-quarter corporate earnings, potentially presenting another obstacle to stocks in a year that has experienced an already-painful market decline.
The dollar index .DXY, which measures the greenback's performance against a basket of peers, traded an average of 16.7% higher in the quarter that ended Sept. 30 than in the same period a year ago, helped by a hawkish Federal Reserve and turmoil in global financial markets that boosted the dollar's safe-haven appeal.
That means a wide range of companies will likely cite the dollar's rise as a headwind to their bottom lines as corporate earnings season kicks into gear this month. A stronger buck makes U.S. exporters' products less competitive abroad while hurting U.S. multinationals that need to exchange their earnings into dollars.
The stronger dollar is "one of the contributors to the notion that earnings expectations for the S&P 500 need to come down more," said Erik Knutzen, chief investment officer of Neuberger Berman's multi-asset class portfolios. "It is one of the factors that leads us to be more cautious on equities."
Ohsung Kwon, U.S. equity strategist at Bank of America Securities, expects the dollar's strength to cut between 5% and 6% of earnings for S&P 500 companies, compared to a 2% hit last quarter. The S&P 500's foreign exposure stands at about 30%, with the technology and materials sectors most vulnerable, BofA estimates.
Earnings estimates have already fallen this year, as analysts account for a darkening U.S. economic outlook amid rising inflation and tightening financial conditions.
Analysts expect third quarter S&P 500 earnings - which will start rolling in as the season kicks off next week - to have increased by 4.5% from a year ago. That is down from the 11.1% rise they were expecting at the start of July, according to IBES data from Refinitiv as of Sept. 30.
A bigger than expected earnings decline could further complicate the picture for U.S. stocks. The S&P 500 is down about 21% this year, with few investors expecting the volatility to end until there are clear signs the Fed is getting the upper hand in its battle against inflation.
"Dollar strength continues to serve as a headwind for equities ... and our FX strategists do not see the strong dollar going away any time soon," analysts at Morgan Stanley wrote.
The stronger dollar has already claimed its share of victims this year. Nike NKE.N, which receives more than half its revenue from outside North America, last month doubled its estimates for the currency's headwind on earnings to $4 billion, sending its shares down 13% on Sept. 30.
Other companies that have recently warned of the dollar’s impact include IBM Corp IBM.N, DuPont de Nemours DD.N and Procter & Gamble Co PG.N.
While companies take steps to guard their profits from big exchange rate moves by using various hedging strategies, including those that employ forwards and options, they typically hedge only about 50% to 75% of their foreign exchange exposure, said John Doyle, vice president of dealing and trading at Monex USA.
To be sure, there is an upside to the greenback's strength for U.S. stocks, as companies that rely on importing goods will find their buying power increased.
At the same time, expectations of a rising buck make dollar-denominated assets more attractive to foreign investors by assuaging fears of a possible foreign exchange hit when they convert assets back into their home currency.
"It allows (foreign) investors to invest in what they think is a high growth area without worrying too much about the currency," said Colin Graham, head of multi-asset strategies at Robeco Institutional Asset Management.
Signs of a dollar peak, however, could push investors into currencies they expect to rebound as the dollar falls, analysts said.
That peak is unlikely to come in the near future, according to analysts polled Reuters.
Though the dollar index is down about 2% from its recent high, 85% of analysts polled by Reuters said the dollar's broad strength against a basket of currencies has not yet reached an inflection point.
Similarly, analysts at UBS Global Wealth Management believe a hawkish Fed, a comparatively strong U.S. economy and weak growth in Europe will keep the dollar elevated for the time being.
"We think it's too early to call a peak in Fed hawkishness or a top in the greenback," they wrote in a recent report.
Dollar on a rollhttps://tmsnrt.rs/3SEjYj7
Petering profitshttps://tmsnrt.rs/3yhYro9
(Reporting by Saqib Iqbal Ahmed; Editing by Ira Iosebashvili and Josie Kao)
((saqib.ahmed@thomsonreuters.com; @SaqibReports; +1 332 219 1971; Reuters Messaging: saqib.ahmed.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Other companies that have recently warned of the dollar’s impact include IBM Corp IBM.N, DuPont de Nemours DD.N and Procter & Gamble Co PG.N. By Saqib Iqbal Ahmed NEW YORK, Oct 7 (Reuters) - A towering rally in the U.S. dollar is expected to hit third-quarter corporate earnings, potentially presenting another obstacle to stocks in a year that has experienced an already-painful market decline. "It allows (foreign) investors to invest in what they think is a high growth area without worrying too much about the currency," said Colin Graham, head of multi-asset strategies at Robeco Institutional Asset Management.
|
Other companies that have recently warned of the dollar’s impact include IBM Corp IBM.N, DuPont de Nemours DD.N and Procter & Gamble Co PG.N. At the same time, expectations of a rising buck make dollar-denominated assets more attractive to foreign investors by assuaging fears of a possible foreign exchange hit when they convert assets back into their home currency. Though the dollar index is down about 2% from its recent high, 85% of analysts polled by Reuters said the dollar's broad strength against a basket of currencies has not yet reached an inflection point.
|
Other companies that have recently warned of the dollar’s impact include IBM Corp IBM.N, DuPont de Nemours DD.N and Procter & Gamble Co PG.N. The dollar index .DXY, which measures the greenback's performance against a basket of peers, traded an average of 16.7% higher in the quarter that ended Sept. 30 than in the same period a year ago, helped by a hawkish Federal Reserve and turmoil in global financial markets that boosted the dollar's safe-haven appeal. Signs of a dollar peak, however, could push investors into currencies they expect to rebound as the dollar falls, analysts said.
|
Other companies that have recently warned of the dollar’s impact include IBM Corp IBM.N, DuPont de Nemours DD.N and Procter & Gamble Co PG.N. By Saqib Iqbal Ahmed NEW YORK, Oct 7 (Reuters) - A towering rally in the U.S. dollar is expected to hit third-quarter corporate earnings, potentially presenting another obstacle to stocks in a year that has experienced an already-painful market decline. Analysts expect third quarter S&P 500 earnings - which will start rolling in as the season kicks off next week - to have increased by 4.5% from a year ago.
|
9a2398e8-6059-417b-96d0-12f44c8d1715
|
715959.0
|
2022-10-06 00:00:00 UTC
|
DD November 25th Options Begin Trading
|
DD
|
https://www.nasdaq.com/articles/dd-november-25th-options-begin-trading
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options begin trading today, for the November 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new November 25th contracts and identified one put and one call contract of particular interest.
The put contract at the $51.00 strike price has a current bid of 95 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $51.00, but will also collect the premium, putting the cost basis of the shares at $50.05 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $53.49/share today.
Because the $51.00 strike represents an approximate 5% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.86% return on the cash commitment, or 13.59% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $51.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $54.00 strike price has a current bid of 80 cents. If an investor was to purchase shares of DD stock at the current price level of $53.49/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $54.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 2.45% if the stock gets called away at the November 25th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $54.00 strike highlighted in red:
Considering the fact that the $54.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.50% boost of extra return to the investor, or 10.91% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $53.49) to be 33%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $54.00 strike highlighted in red: Considering the fact that the $54.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $54.00 strike highlighted in red: Considering the fact that the $54.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the November 25th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $54.00 strike highlighted in red: Considering the fact that the $54.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $54.00 strike highlighted in red: Considering the fact that the $54.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the November 25th expiration.
|
83712d5b-94a6-4533-8b91-2d008174657d
|
715960.0
|
2022-10-06 00:00:00 UTC
|
This Dirt-Cheap High-Yield Dow Jones Stock Is a Screaming Buy
|
DD
|
https://www.nasdaq.com/articles/this-dirt-cheap-high-yield-dow-jones-stock-is-a-screaming-buy
|
nan
|
nan
|
The Dow Jones Industrial Average (DJIA) is home to 30 industry-leading companies, many of which pay dividends. Yet even the DJIA hasn't been immune to the market sell-off. In fact, it has joined the S&P 500 and the Nasdaq Composite as the latest major index to fall into a bear market.
Dow Inc. (NYSE: DOW), formerly known as Dow Chemical, is one of the largest chemical companies in the world. The "Dow" in Dow chemical has nothing to do with the "Dow" in the DJIA. But to make matters more confusing, Dow is one of the 30 components in the DJIA.
Dow currently has the lowest price-to-earnings ratio of any component at just 4.9. And it has the second-highest dividend yield (behind Verizon) at 6.3%. Here's why Dow is a dirt cheap high-yield dividend stock worth considering now.
Image source: Getty Images.
A brief background on Dow
In 2019, a chemicals conglomerate called DowDuPont split into three companies -- DuPont de Nemours (NYSE: DD), Corteva (NYSE: CTVA), and Dow. In general, the difference between the three companies is that DuPont makes specialty chemicals (lower volume, higher margin), Corteva makes agriculture chemicals, seeds, and related specialty chemical products, and Dow makes commodity chemicals (high volume, lower margin). In this vein, Dow can be more cyclical than the other chemical companies since it is more dependent on the price of feedstocks like oil and natural gas, as well as the price it can fetch for its end products.
Dow benefits when oil and natural gas prices are low, and prices for its end products are high. However, oil and natural gas prices are relatively high right now. And there are fears that feedstock prices could stay high while commodity chemical prices fall due to an economic slowdown.
The relationship between rising costs and revenue
A good way to view the impact of higher costs on Dow's business is to look at its cost of goods sold (COGS), revenue, and COGS as a percentage of revenue. COGS includes key items like labor costs, raw material costs, and power consumption for making products. For a manufacturing company like DOW, COGS will be the highest expense. By comparison, a software company with low raw material and labor costs may spend more on research and development, sales, marketing, and advertising than COGS.
DOW Cost of Goods Sold (Quarterly) data by YCharts
In the chart above, we can see that COGS and revenue are both at their highest levels since Dow spun off from the conglomerate, suggesting that it hasn't experienced a slowdown in its business -- yet. Also, notice that COGS as a percentage of revenue is much lower now than it was when revenue was falling and oil and gas prices were low during the peak of the COVID-19 pandemic in 2020. In sum, Dow has offset higher input costs with higher prices for its commodity chemicals.
The chart suggests that higher oil and gas prices aren't necessarily the end of the world for Dow. To bring home the point even further, take a look at Dow's gross profit margin and trailing twelve-month gross profit.
DOW Gross Profit Margin data by YCharts
Both are near their highest levels since the spinoff, suggesting that revenue is outpacing COGS and driving profits.
Setting expectations for Dow
As good as Dow's results have been, the concern is that margins will compress, and overall revenue could fall faster than COGS. Even if that happens, Dow is well positioned to remain a cheap stock and support its dividend. The company has a payout ratio of 30.8%, which is healthy and suggests that earnings could be cut in half or even by two-thirds and the company would still able to afford its dividend.
Investors should keep a close eye on Dow's COGS as a percentage of revenue to see how commodity chemical prices hold up if demand falls faster than feedstock prices. However, given the margin of safety for Dow's dividend, not to mention the stock's dirt-cheap valuation, Dow is a reliable blue chip dividend stock to buy now.
10 stocks we like better than DOW
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and DOW wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of September 30, 2022
Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A brief background on Dow In 2019, a chemicals conglomerate called DowDuPont split into three companies -- DuPont de Nemours (NYSE: DD), Corteva (NYSE: CTVA), and Dow. The Dow Jones Industrial Average (DJIA) is home to 30 industry-leading companies, many of which pay dividends. By comparison, a software company with low raw material and labor costs may spend more on research and development, sales, marketing, and advertising than COGS.
|
A brief background on Dow In 2019, a chemicals conglomerate called DowDuPont split into three companies -- DuPont de Nemours (NYSE: DD), Corteva (NYSE: CTVA), and Dow. In general, the difference between the three companies is that DuPont makes specialty chemicals (lower volume, higher margin), Corteva makes agriculture chemicals, seeds, and related specialty chemical products, and Dow makes commodity chemicals (high volume, lower margin). Dow benefits when oil and natural gas prices are low, and prices for its end products are high.
|
A brief background on Dow In 2019, a chemicals conglomerate called DowDuPont split into three companies -- DuPont de Nemours (NYSE: DD), Corteva (NYSE: CTVA), and Dow. Dow Inc. (NYSE: DOW), formerly known as Dow Chemical, is one of the largest chemical companies in the world. The "Dow" in Dow chemical has nothing to do with the "Dow" in the DJIA.
|
A brief background on Dow In 2019, a chemicals conglomerate called DowDuPont split into three companies -- DuPont de Nemours (NYSE: DD), Corteva (NYSE: CTVA), and Dow. The relationship between rising costs and revenue A good way to view the impact of higher costs on Dow's business is to look at its cost of goods sold (COGS), revenue, and COGS as a percentage of revenue. DOW Gross Profit Margin data by YCharts Both are near their highest levels since the spinoff, suggesting that revenue is outpacing COGS and driving profits.
|
37db65fc-bfdc-4541-ab41-8d1565060e9c
|
715961.0
|
2022-09-30 00:00:00 UTC
|
DuPont, Rogers Provide Update On Pending Merger
|
DD
|
https://www.nasdaq.com/articles/dupont-rogers-provide-update-on-pending-merger
|
nan
|
nan
|
(RTTNews) - DuPont de Nemours, Inc. (DD) and Rogers Corp. (ROG) on Friday provided an update on regulatory approval of the pending merger of Rogers and Cardinalis Merger Sub, Inc., a wholly owned subsidiary of DuPont, which was previously expected to close in the third quarter of 2022.
The companies said they have received all regulatory approvals required to consummate the merger except for approval, which remains pending, of the State Administration for Market Regulation of China.
At the request of SAMR, DuPont recently withdrew and refiled with SAMR the notice of the parties' planned merger. The parties continue to hold cooperative discussions with SAMR with the aim of securing regulatory approval of the planned merger.
The parties continue to seek to close the merger as soon as possible, subject to regulatory approval by SAMR and the satisfaction of other customary closing conditions set forth in the merger agreement.
On November 2, 2021, Rogers entered into a definitive merger agreement to be acquired by DuPont for $277.00 per share in cash. Rogers' shareholders approved the merger agreement at a special shareholder meeting held on January 25, 2022.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont de Nemours, Inc. (DD) and Rogers Corp. (ROG) on Friday provided an update on regulatory approval of the pending merger of Rogers and Cardinalis Merger Sub, Inc., a wholly owned subsidiary of DuPont, which was previously expected to close in the third quarter of 2022. The parties continue to hold cooperative discussions with SAMR with the aim of securing regulatory approval of the planned merger. On November 2, 2021, Rogers entered into a definitive merger agreement to be acquired by DuPont for $277.00 per share in cash.
|
(RTTNews) - DuPont de Nemours, Inc. (DD) and Rogers Corp. (ROG) on Friday provided an update on regulatory approval of the pending merger of Rogers and Cardinalis Merger Sub, Inc., a wholly owned subsidiary of DuPont, which was previously expected to close in the third quarter of 2022. At the request of SAMR, DuPont recently withdrew and refiled with SAMR the notice of the parties' planned merger. Rogers' shareholders approved the merger agreement at a special shareholder meeting held on January 25, 2022.
|
(RTTNews) - DuPont de Nemours, Inc. (DD) and Rogers Corp. (ROG) on Friday provided an update on regulatory approval of the pending merger of Rogers and Cardinalis Merger Sub, Inc., a wholly owned subsidiary of DuPont, which was previously expected to close in the third quarter of 2022. The parties continue to seek to close the merger as soon as possible, subject to regulatory approval by SAMR and the satisfaction of other customary closing conditions set forth in the merger agreement. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - DuPont de Nemours, Inc. (DD) and Rogers Corp. (ROG) on Friday provided an update on regulatory approval of the pending merger of Rogers and Cardinalis Merger Sub, Inc., a wholly owned subsidiary of DuPont, which was previously expected to close in the third quarter of 2022. The companies said they have received all regulatory approvals required to consummate the merger except for approval, which remains pending, of the State Administration for Market Regulation of China. The parties continue to hold cooperative discussions with SAMR with the aim of securing regulatory approval of the planned merger.
|
1906e881-4ad2-493b-b371-30c8d43d8aba
|
715962.0
|
2022-09-30 00:00:00 UTC
|
DuPont's $5.2 bln Rogers buyout deal held up by Chinese regulator
|
DD
|
https://www.nasdaq.com/articles/duponts-%245.2-bln-rogers-buyout-deal-held-up-by-chinese-regulator
|
nan
|
nan
|
Adds deal background
Sept 30 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N has received all regulatory approvals for its $5.2 billion buyout of Rogers Corp ROG.N except from China, the companies said on Friday.
DuPont's all-cash takeover of the engineering materials maker would be its biggest deal since splitting from DowDuPont in 2019.
DuPont and Rogers said they were continuing discussions with the State Administration for Market Regulation of China (SAMR) to close the deal as soon as possible.
DuPont in November last year said it had agreed to buy Chandler, Arizona-based Rogers for $277 per share, in its bid to supply to fast-growing industries such as electric vehicles, 5G and clean energy.
(Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva and Shinjini Ganguli)
((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds deal background Sept 30 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N has received all regulatory approvals for its $5.2 billion buyout of Rogers Corp ROG.N except from China, the companies said on Friday. DuPont and Rogers said they were continuing discussions with the State Administration for Market Regulation of China (SAMR) to close the deal as soon as possible. DuPont in November last year said it had agreed to buy Chandler, Arizona-based Rogers for $277 per share, in its bid to supply to fast-growing industries such as electric vehicles, 5G and clean energy.
|
Adds deal background Sept 30 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N has received all regulatory approvals for its $5.2 billion buyout of Rogers Corp ROG.N except from China, the companies said on Friday. DuPont and Rogers said they were continuing discussions with the State Administration for Market Regulation of China (SAMR) to close the deal as soon as possible. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva and Shinjini Ganguli) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds deal background Sept 30 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N has received all regulatory approvals for its $5.2 billion buyout of Rogers Corp ROG.N except from China, the companies said on Friday. DuPont in November last year said it had agreed to buy Chandler, Arizona-based Rogers for $277 per share, in its bid to supply to fast-growing industries such as electric vehicles, 5G and clean energy. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva and Shinjini Ganguli) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds deal background Sept 30 (Reuters) - Chemicals maker DuPont De Nemours Inc DD.N has received all regulatory approvals for its $5.2 billion buyout of Rogers Corp ROG.N except from China, the companies said on Friday. DuPont's all-cash takeover of the engineering materials maker would be its biggest deal since splitting from DowDuPont in 2019. DuPont and Rogers said they were continuing discussions with the State Administration for Market Regulation of China (SAMR) to close the deal as soon as possible.
|
ddd3a7a2-ff26-4dd5-bfc3-956970ba0464
|
715963.0
|
2022-09-30 00:00:00 UTC
|
DuPont's $5.2 bln Rogers buyout held up by Chinese regulator
|
DD
|
https://www.nasdaq.com/articles/duponts-%245.2-bln-rogers-buyout-held-up-by-chinese-regulator
|
nan
|
nan
|
Sept 30 (Reuters) - DuPont De Nemours Inc DD.N has not received Chinese regulatory approval for its $5.2 billion buyout of Rogers Corp ROG.N, the companies said on Friday.
(Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva)
((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Sept 30 (Reuters) - DuPont De Nemours Inc DD.N has not received Chinese regulatory approval for its $5.2 billion buyout of Rogers Corp ROG.N, the companies said on Friday. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Sept 30 (Reuters) - DuPont De Nemours Inc DD.N has not received Chinese regulatory approval for its $5.2 billion buyout of Rogers Corp ROG.N, the companies said on Friday. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Sept 30 (Reuters) - DuPont De Nemours Inc DD.N has not received Chinese regulatory approval for its $5.2 billion buyout of Rogers Corp ROG.N, the companies said on Friday. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Sept 30 (Reuters) - DuPont De Nemours Inc DD.N has not received Chinese regulatory approval for its $5.2 billion buyout of Rogers Corp ROG.N, the companies said on Friday. (Reporting by Ruhi Soni in Bengaluru; Editing by Anil D'Silva) ((Ruhi.Soni@thomsonreuters.com Twitter: https://twitter.com/ruhithere)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
d0ea7daa-dcb5-427f-ae16-9d02326bd31a
|
715964.0
|
2022-09-22 00:00:00 UTC
|
Interesting DD Put And Call Options For November 4th
|
DD
|
https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-november-4th
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options begin trading today, for the November 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new November 4th contracts and identified one put and one call contract of particular interest.
The put contract at the $46.00 strike price has a current bid of 60 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $46.00, but will also collect the premium, putting the cost basis of the shares at $45.40 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $52.55/share today.
Because the $46.00 strike represents an approximate 12% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 1.30% return on the cash commitment, or 11.07% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $46.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $53.00 strike price has a current bid of $2.35. If an investor was to purchase shares of DD stock at the current price level of $52.55/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $53.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 5.33% if the stock gets called away at the November 4th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $53.00 strike highlighted in red:
Considering the fact that the $53.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 4.47% boost of extra return to the investor, or 37.96% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $52.55) to be 32%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $53.00 strike highlighted in red: Considering the fact that the $53.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $53.00 strike highlighted in red: Considering the fact that the $53.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the November 4th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $53.00 strike highlighted in red: Considering the fact that the $53.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new November 4th contracts and identified one put and one call contract of particular interest. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $53.00 strike highlighted in red: Considering the fact that the $53.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
f69c730b-0cfd-4372-8090-adfcc689d644
|
715965.0
|
2022-09-21 00:00:00 UTC
|
Celanese offers remedies in bid to allay EU antitrust concerns on DuPont deal
|
DD
|
https://www.nasdaq.com/articles/celanese-offers-remedies-in-bid-to-allay-eu-antitrust-concerns-on-dupont-deal
|
nan
|
nan
|
BRUSSELS, Sept 21 (Reuters) - U.S. chemicals company Celanese Corp CE.N has offered remedies in a bid to address EU antitrust concerns about its proposed $11 billion acquisition of DuPont's mobility and materials business, a European Commission filing showed on Wednesday.
Celanese, which announced the deal in February, submitted its proposal on Tuesday, according to the filing which did not set out details.
The EU competition enforcer will seek feedback from rivals and customers before deciding by Oct. 11 whether to accept the remedies or demand more. It can also open a four-month long investigation if it has serious concerns.
DuPont is remoulding its portfolio to focus on high-margin electronics and water solutions businesses.
(Reporting by Foo Yun Chee;Editing by Elaine Hardcastle)
((foo.yunchee@thomsonreuters.com; +32 2 287 6844; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
BRUSSELS, Sept 21 (Reuters) - U.S. chemicals company Celanese Corp CE.N has offered remedies in a bid to address EU antitrust concerns about its proposed $11 billion acquisition of DuPont's mobility and materials business, a European Commission filing showed on Wednesday. Celanese, which announced the deal in February, submitted its proposal on Tuesday, according to the filing which did not set out details. The EU competition enforcer will seek feedback from rivals and customers before deciding by Oct. 11 whether to accept the remedies or demand more.
|
BRUSSELS, Sept 21 (Reuters) - U.S. chemicals company Celanese Corp CE.N has offered remedies in a bid to address EU antitrust concerns about its proposed $11 billion acquisition of DuPont's mobility and materials business, a European Commission filing showed on Wednesday. Celanese, which announced the deal in February, submitted its proposal on Tuesday, according to the filing which did not set out details. (Reporting by Foo Yun Chee;Editing by Elaine Hardcastle) ((foo.yunchee@thomsonreuters.com; +32 2 287 6844; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
BRUSSELS, Sept 21 (Reuters) - U.S. chemicals company Celanese Corp CE.N has offered remedies in a bid to address EU antitrust concerns about its proposed $11 billion acquisition of DuPont's mobility and materials business, a European Commission filing showed on Wednesday. The EU competition enforcer will seek feedback from rivals and customers before deciding by Oct. 11 whether to accept the remedies or demand more. (Reporting by Foo Yun Chee;Editing by Elaine Hardcastle) ((foo.yunchee@thomsonreuters.com; +32 2 287 6844; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
BRUSSELS, Sept 21 (Reuters) - U.S. chemicals company Celanese Corp CE.N has offered remedies in a bid to address EU antitrust concerns about its proposed $11 billion acquisition of DuPont's mobility and materials business, a European Commission filing showed on Wednesday. Celanese, which announced the deal in February, submitted its proposal on Tuesday, according to the filing which did not set out details. The EU competition enforcer will seek feedback from rivals and customers before deciding by Oct. 11 whether to accept the remedies or demand more.
|
cefe4565-b01c-4fce-8269-91129bec0831
|
715966.0
|
2022-09-18 00:00:00 UTC
|
Validea's Top Five Healthcare Stocks Based On Peter Lynch - 9/18/2022
|
DD
|
https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-9-18-2022
|
nan
|
nan
|
The following are the top rated Healthcare stocks according to Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong balance sheets.
ABBOTT LABORATORIES (ABT) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women's health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of ABBOTT LABORATORIES
Full Guru Analysis for ABT>
Full Factor Report for ABT>
DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: DuPont de Nemours, Inc. provides technology-based materials and solutions. The Company's segments include Electronics & Industrial, Water & Protection and Mobility & Materials. Electronics & Industrial is a global supplier of various materials and systems for a range of consumer electronics, including mobile devices, television monitors, personal computers and electronics used in a variety of industries. Mobility & Materials segment provides engineering thermoplastics, elastomers, adhesives, silicone encapsulants, pastes, filaments and advanced films to engineers and designers in the transportation, electronics, renewable energy, industrial and consumer end-markets to enable systems solutions for demanding applications and environments. Water & Protection segment is focused on providing engineered products and integrated systems for a range of industries, including, worker safety, water purification and separation, transportation, energy, medical packaging and building materials.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of DUPONT DE NEMOURS INC
Full Guru Analysis for DD>
Full Factor Report for DD>
QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). It is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of QUEST DIAGNOSTICS INC
Full Guru Analysis for DGX>
Full Factor Report for DGX>
EMERGENT BIOSOLUTIONS INC (EBS) is a small-cap value stock in the Biotechnology & Drugs industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: chemical, biological, radiological, nuclear and explosives (CBRNE); emerging infectious diseases; travel health; public health crises (such as the opioid crisis and the COVID-19 pandemic); acute, emergency, and community care. Its business lines include Medical Countermeasures (MCM), Commercial and CDMO. MCM focuses primarily on procurement of MCM products and procured product candidates by domestic and international government customers. It provides solutions for public health threats through a portfolio of vaccines and therapeutics that it develops and manufactures for governments and consumers. The Company also offers a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of EMERGENT BIOSOLUTIONS INC
Full Guru Analysis for EBS>
Full Factor Report for EBS>
HOLOGIC, INC. (HOLX) is a large-cap value stock in the Medical Equipment & Supplies industry. The rating according to our strategy based on Peter Lynch is 93% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
Company Description: Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a portfolio of solutions for breast cancer care for radiology, pathology and surgery. The GYN Surgical segment offers a range of products, including its NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System as well as its Fluent Fluid Management system. The Skeletal Health segment offers products such as the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
P/E/GROWTH RATIO: PASS
SALES AND P/E RATIO: PASS
INVENTORY TO SALES: PASS
EPS GROWTH RATE: PASS
TOTAL DEBT/EQUITY RATIO: PASS
FREE CASH FLOW: NEUTRAL
NET CASH POSITION: NEUTRAL
Detailed Analysis of HOLOGIC, INC.
Full Guru Analysis for HOLX>
Full Factor Report for HOLX>
More details on Validea's Peter Lynch strategy
Peter Lynch Stock Ideas
About Peter Lynch: Perhaps the greatest mutual fund manager of all-time, Lynch guided Fidelity Investment's Magellan Fund to a 29.2 percent average annual return from 1977 until his retirement in 1990, almost doubling the S&P 500's 15.8 percent yearly return over that time. Lynch's common sense approach and quick wit made him one of the most quoted investors on Wall Street. ("Go for a business that any idiot can run -- because sooner or later, any idiot probably is going to run it," is one of his many pearls of wisdom.) Lynch's bestseller One Up on Wall Street is something of a "stocks for the everyman/everywoman", breaking his approach down into easy-to-understand concepts.
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Detailed Analysis of ABBOTT LABORATORIES Full Guru Analysis for ABT> Full Factor Report for ABT> DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of DUPONT DE NEMOURS INC Full Guru Analysis for DD> Full Factor Report for DD> QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs).
|
Detailed Analysis of ABBOTT LABORATORIES Full Guru Analysis for ABT> Full Factor Report for ABT> DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of DUPONT DE NEMOURS INC Full Guru Analysis for DD> Full Factor Report for DD> QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs).
|
Detailed Analysis of ABBOTT LABORATORIES Full Guru Analysis for ABT> Full Factor Report for ABT> DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of DUPONT DE NEMOURS INC Full Guru Analysis for DD> Full Factor Report for DD> QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs).
|
Detailed Analysis of ABBOTT LABORATORIES Full Guru Analysis for ABT> Full Factor Report for ABT> DUPONT DE NEMOURS INC (DD) is a large-cap growth stock in the Biotechnology & Drugs industry. Detailed Analysis of DUPONT DE NEMOURS INC Full Guru Analysis for DD> Full Factor Report for DD> QUEST DIAGNOSTICS INC (DGX) is a large-cap value stock in the Healthcare Facilities industry. Company Description: Emergent BioSolutions, Inc. is a life sciences company focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats (PHTs).
|
a2995e39-125d-4a6a-a38c-aaad342e0eb9
|
715967.0
|
2022-09-12 00:00:00 UTC
|
DD January 2025 Options Begin Trading
|
DD
|
https://www.nasdaq.com/articles/dd-january-2025-options-begin-trading
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2025 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new January 2025 contracts and identified one put and one call contract of particular interest.
The put contract at the $57.50 strike price has a current bid of $6.50. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $57.50, but will also collect the premium, putting the cost basis of the shares at $51.00 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $59.62/share today.
Because the $57.50 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 11.30% return on the cash commitment, or 4.81% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $57.50 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $60.00 strike price has a current bid of $9.00. If an investor was to purchase shares of DD stock at the current price level of $59.62/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $60.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 15.73% if the stock gets called away at the January 2025 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $60.00 strike highlighted in red:
Considering the fact that the $60.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 15.10% boost of extra return to the investor, or 6.42% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 251 trading day closing values as well as today's price of $59.62) to be 32%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $60.00 strike highlighted in red: Considering the fact that the $60.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $60.00 strike highlighted in red: Considering the fact that the $60.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the January 2025 expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $60.00 strike highlighted in red: Considering the fact that the $60.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new January 2025 contracts and identified one put and one call contract of particular interest. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $60.00 strike highlighted in red: Considering the fact that the $60.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
74842cb3-b4b8-4090-95fc-f02d052eb439
|
715968.0
|
2022-09-08 00:00:00 UTC
|
Interesting DD Put And Call Options For October 28th
|
DD
|
https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-october-28th
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new October 28th contracts and identified one put and one call contract of particular interest.
The put contract at the $55.00 strike price has a current bid of $1.65. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $55.00, but will also collect the premium, putting the cost basis of the shares at $53.35 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $56.35/share today.
Because the $55.00 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 3.00% return on the cash commitment, or 21.90% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $55.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $58.00 strike price has a current bid of $1.10. If an investor was to purchase shares of DD stock at the current price level of $56.35/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $58.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 4.88% if the stock gets called away at the October 28th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red:
Considering the fact that the $58.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 1.95% boost of extra return to the investor, or 14.25% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $56.35) to be 32%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 28th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $58.00 strike highlighted in red: Considering the fact that the $58.00 strike represents an approximate 3% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 28th expiration.
|
d4e0ec24-8fee-4b7d-8b4d-4b1bd332cfcb
|
715969.0
|
2022-09-02 00:00:00 UTC
|
AMD To Replace DuPont In S&P 100
|
DD
|
https://www.nasdaq.com/articles/amd-to-replace-dupont-in-sp-100
|
nan
|
nan
|
(RTTNews) - S&P Dow Jones Indices said that Advanced Micro Devices Inc. (AMD) will replace DuPont de Nemours Inc. (DD) in the S&P 100. Dupont de Neumors is no longer representative of the mega-capitalization market space. It will remain in the S&P 500.
CoStar Group Inc. (CSGP) and Invitation Homes Inc. (INVH) will replace PVH Corp. (PVH) and PENN Entertainment Inc. (PENN) respectively in the S&P 500.
PVH and PENN Entertainment will replace Hudson Pacific Properties Inc. (HPP) and Mercury General Corp. (MCY) respectively in the S&P MidCap 400.
Hudson Pacific Properties and Mercury General will replace American Public Education Inc (APEI) and eHealth Inc. (EHTH) respectively in the S&P SmallCap 600.
Dynatrace Inc. (DT) and Annaly Capital Management Inc. (NLY) will replace American Eagle Outfitters Inc. (AEO) and Minerals Technologies Inc. (MTX) respectively in the S&P MidCap 400.
American Eagle Outfitters and Minerals Technologies will replace CalAmp Corp. (CAMP) and Glatfelter Corp. (GLT) respectively in the S&P SmallCap 600. Outfront Media Inc. (OUT) will replace Fossil Group Inc. (FOSL) in the S&P SmallCap 600.
The changes will be effective prior to the open of trading on Monday, September 19.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - S&P Dow Jones Indices said that Advanced Micro Devices Inc. (AMD) will replace DuPont de Nemours Inc. (DD) in the S&P 100. Hudson Pacific Properties and Mercury General will replace American Public Education Inc (APEI) and eHealth Inc. (EHTH) respectively in the S&P SmallCap 600. Dynatrace Inc. (DT) and Annaly Capital Management Inc. (NLY) will replace American Eagle Outfitters Inc. (AEO) and Minerals Technologies Inc. (MTX) respectively in the S&P MidCap 400.
|
(RTTNews) - S&P Dow Jones Indices said that Advanced Micro Devices Inc. (AMD) will replace DuPont de Nemours Inc. (DD) in the S&P 100. CoStar Group Inc. (CSGP) and Invitation Homes Inc. (INVH) will replace PVH Corp. (PVH) and PENN Entertainment Inc. (PENN) respectively in the S&P 500. PVH and PENN Entertainment will replace Hudson Pacific Properties Inc. (HPP) and Mercury General Corp. (MCY) respectively in the S&P MidCap 400.
|
(RTTNews) - S&P Dow Jones Indices said that Advanced Micro Devices Inc. (AMD) will replace DuPont de Nemours Inc. (DD) in the S&P 100. CoStar Group Inc. (CSGP) and Invitation Homes Inc. (INVH) will replace PVH Corp. (PVH) and PENN Entertainment Inc. (PENN) respectively in the S&P 500. PVH and PENN Entertainment will replace Hudson Pacific Properties Inc. (HPP) and Mercury General Corp. (MCY) respectively in the S&P MidCap 400.
|
(RTTNews) - S&P Dow Jones Indices said that Advanced Micro Devices Inc. (AMD) will replace DuPont de Nemours Inc. (DD) in the S&P 100. Dupont de Neumors is no longer representative of the mega-capitalization market space. PVH and PENN Entertainment will replace Hudson Pacific Properties Inc. (HPP) and Mercury General Corp. (MCY) respectively in the S&P MidCap 400.
|
630cc379-ad24-487a-90ac-0e6c370b050e
|
715970.0
|
2022-09-01 00:00:00 UTC
|
After Hours Most Active for Sep 1, 2022 : EUFN, LNW, AAPL, MDLZ, TQQQ, TLT, BHP, EPD, DD, PFE, F, ELAN
|
DD
|
https://www.nasdaq.com/articles/after-hours-most-active-for-sep-1-2022-%3A-eufn-lnw-aapl-mdlz-tqqq-tlt-bhp-epd-dd-pfe-f-elan
|
nan
|
nan
|
The NASDAQ 100 After Hours Indicator is up 12.33 to 12,286.96. The total After hours volume is currently 59,660,638 shares traded.
The following are the most active stocks for the after hours session:
iShares MSCI Europe Financials Sector Index Fund (EUFN) is +0.0337 at $15.00, with 3,700,000 shares traded. This represents a 4.48% increase from its 52 Week Low.
Light & Wonder, Inc. (LNW) is unchanged at $47.22, with 2,009,793 shares traded. As reported in the last short interest update the days to cover for LNW is 7.206346; this calculation is based on the average trading volume of the stock.
Apple Inc. (AAPL) is +0.47 at $158.43, with 1,609,407 shares traded. As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".
Mondelez International, Inc. (MDLZ) is unchanged at $61.97, with 1,468,953 shares traded. MDLZ's current last sale is 83.74% of the target price of $74.
ProShares UltraPro QQQ (TQQQ) is +0.05 at $27.89, with 1,305,046 shares traded. This represents a 30.82% increase from its 52 Week Low.
iShares 20+ Year Treasury Bond ETF (TLT) is +0.16 at $109.76, with 1,198,224 shares traded. This represents a 1.52% increase from its 52 Week Low.
BHP Group Limited (BHP) is unchanged at $49.88, with 1,002,365 shares traded. BHP's current last sale is 71.26% of the target price of $70.
Enterprise Products Partners L.P. (EPD) is unchanged at $26.17, with 992,206 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Sep 2022. The consensus EPS forecast is $0.63. As reported by Zacks, the current mean recommendation for EPD is in the "buy range".
DuPont de Nemours, Inc. (DD) is unchanged at $55.23, with 873,762 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range".
Pfizer, Inc. (PFE) is +0.04 at $46.67, with 672,747 shares traded. As reported by Zacks, the current mean recommendation for PFE is in the "buy range".
Ford Motor Company (F) is -0.01 at $15.18, with 578,962 shares traded. F's current last sale is 89.29% of the target price of $17.
Elanco Animal Health Incorporated (ELAN) is +0.025 at $15.38, with 566,809 shares traded. ELAN's current last sale is 69.91% of the target price of $22.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. (DD) is unchanged at $55.23, with 873,762 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". iShares MSCI Europe Financials Sector Index Fund (EUFN) is +0.0337 at $15.00, with 3,700,000 shares traded.
|
DuPont de Nemours, Inc. (DD) is unchanged at $55.23, with 873,762 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The total After hours volume is currently 59,660,638 shares traded.
|
DuPont de Nemours, Inc. (DD) is unchanged at $55.23, with 873,762 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". The total After hours volume is currently 59,660,638 shares traded.
|
DuPont de Nemours, Inc. (DD) is unchanged at $55.23, with 873,762 shares traded. As reported by Zacks, the current mean recommendation for DD is in the "buy range". As reported by Zacks, the current mean recommendation for AAPL is in the "buy range".
|
e5df943a-6d2a-46ed-a904-1c55b2c41130
|
715971.0
|
2022-09-01 00:00:00 UTC
|
Interesting DD Put And Call Options For October 14th
|
DD
|
https://www.nasdaq.com/articles/interesting-dd-put-and-call-options-for-october-14th
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options become available today, for the October 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new October 14th contracts and identified one put and one call contract of particular interest.
The put contract at the $54.00 strike price has a current bid of 35 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $54.00, but will also collect the premium, putting the cost basis of the shares at $53.65 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $54.62/share today.
Because the $54.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.65% return on the cash commitment, or 5.50% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $54.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $55.00 strike price has a current bid of 40 cents. If an investor was to purchase shares of DD stock at the current price level of $54.62/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $55.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 1.43% if the stock gets called away at the October 14th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $55.00 strike highlighted in red:
Considering the fact that the $55.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.73% boost of extra return to the investor, or 6.22% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $54.62) to be 32%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $55.00 strike highlighted in red: Considering the fact that the $55.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $55.00 strike highlighted in red: Considering the fact that the $55.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the October 14th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $55.00 strike highlighted in red: Considering the fact that the $55.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new October 14th contracts and identified one put and one call contract of particular interest. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $55.00 strike highlighted in red: Considering the fact that the $55.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
1f5f0086-d1ba-4aab-8713-93c7fa86d8b9
|
715972.0
|
2022-08-30 00:00:00 UTC
|
Pricing, Demand Up International Flavors (IFF) Despite Cost Woes
|
DD
|
https://www.nasdaq.com/articles/pricing-demand-up-international-flavors-iff-despite-cost-woes
|
nan
|
nan
|
International Flavors & Fragrances IFF will benefit from pricing actions, productivity initiatives and acquisition-related synergies that will help it negate the inflationary cost pressures and drive its margins. IFF continues to invest in organic investments and strategic acquisitions, while returning significant capital to its shareholders.
Pricing & Acquisitions to Offset Cost Impact in 2022
International Flavors estimates sales of $12.6-$13 billion for 2022. The guidance factors in additional pricing actions to counter inflationary pressure, impact of the divestiture of the microbial control business and the acquisition of Health Wright Products. Also, higher pricing will help offset the impacts of lower volumes for the year amid a more challenging environment, including the loss of revenues as a result of the Russia-Ukraine war and the ongoing global supply-chain issues.
Adjusted EBITDA is expected between $2.5 billion and $2.6 billion, suggesting a rise from the adjusted EBITDA of $2.4 billion reported in 2021. The adjusted EBITDA margin is projected to grow 4-8% on a currency-neutral basis.
International Flavors also continues to incur high raw material costs and additional costs related to labor, shipping and cleaning due to COVID-led supply-chain disruptions. Energy costs are expected to be higher in 2022. Nevertheless, focus on driving greater efficiencies in business through costs and productivity initiatives, margin improvement and acquisition-related synergies will support margins.
Solid End-Market Demand Bodes Well
International Flavors’ largest segment Nourish continues to deliver strong results, primarily aided by the Flavors, Ingredients and Food Design businesses. The Scent segment has been performing well for a while, courtesy of continued strengths in Cosmetic Actives and Consumer Fragrances. The segment is consistently witnessing a significant rebound in Fine Fragrance, driven by volume recovery and business wins.
The Health & Biosciences segment’s performance was supported by growth in Health, Cultures & Food Enzymes, Microbial Control and Animal Nutrition. In the Pharma Solutions segment, growth was witnessed in Industrials and demand recovery in Pharma.
Backed by its global presence, diversified business platform, broad product portfolio, and global and regional customer base, IFF will be able to capitalize on higher demand in the flavors and fragrances markets and deliver long-term growth.
Acquisitions Remain a Key Catalyst
Over time, International Flavors has made meaningful acquisitions, which helped expand its offerings and in turn, boosted profitability. The acquisition of Frutarom in 2018 was the biggest in its history, which made it a global leader in natural taste, scent and nutrition, with a broader customer base, more diversified product offerings and exposure to end markets, including those with a focus on naturals, and health and wellness.
IFF recently acquired Health Wright Products, a leader in formulation and capsule manufacturing for the dietary supplement industry. The buyout will bring formulation and finished format capabilities to IFF’s Health & Biosciences probiotics, natural extracts and botanicals businesses, allowing innovation in custom formulation and combination products through joint capabilities.
International Flavors merged with DuPont de Nemours, Inc.’s DD Nutrition & Biosciences (N&B) business. IFF now holds leading positions in the core categories of nutrition, cultures, enzymes, probiotics, soy proteins, flavors and fragrances.
Additionally, a diverse and broad customer base, and about 48% of annual sales from small, medium and private-label customers, position International Flavors well for growth. Revenue synergies already began to contribute to IFF’s top-line performance. It realized $60 million of merger-related cost synergies in fiscal 2021, ahead of its $45-million target. IFF has a three-year run-rate cost synergy target of around $300 million.
Price Performance
Image Source: Zacks Investment Research
In the past year, International Flavors’ shares have fallen 25.4% compared with the industry’s decline of 35.5%.
Zacks Rank & Key Picks
International Flavors currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the Consumer Staples sector are The Chef's Warehouse CHEF and General Mills, Inc. GIS.
Chef’s Warehouse, a distributor of specialty food products in the United States, currently flaunts a Zacks Rank #1 (Strong Buy). CHEF has a trailing four-quarter earnings surprise of 355.9%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Chef Warehouse’s current financial-year sales suggests growth of 40.7%from the year-ago reported number. The estimate for earnings is currently pegged at $1.36. A loss of 5 cents per share was reported in fiscal 2021.
General Mills, which manufactures and markets branded consumer foods worldwide, currently carries a Zacks Rank #2 (Buy). GIS has a trailing four-quarter earnings surprise of 6.5%, on average.
The Zacks Consensus Estimate for General Mills’ current financial-year sales and EPS suggests growth of almost 2% and 1.5%, respectively, from the corresponding year-ago reported figures.
How to Profit from the Hot Electric Vehicle Industry
Global electric car sales in 2021 more than doubled their 2020 numbers. And today, the electric vehicle (EV) technology and very nature of the business is changing quickly. The next push for future technologies is happening now and investors who get in early could see exceptional profits.
See Zacks' Top Stocks to Profit from the EV Revolution >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
General Mills, Inc. (GIS): Free Stock Analysis Report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
International Flavors & Fragrances Inc. (IFF): Free Stock Analysis Report
The Chefs' Warehouse, Inc. (CHEF): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The guidance factors in additional pricing actions to counter inflationary pressure, impact of the divestiture of the microbial control business and the acquisition of Health Wright Products. International Flavors also continues to incur high raw material costs and additional costs related to labor, shipping and cleaning due to COVID-led supply-chain disruptions. International Flavors merged with DuPont de Nemours, Inc.’s DD Nutrition & Biosciences (N&B) business.
|
The guidance factors in additional pricing actions to counter inflationary pressure, impact of the divestiture of the microbial control business and the acquisition of Health Wright Products. International Flavors also continues to incur high raw material costs and additional costs related to labor, shipping and cleaning due to COVID-led supply-chain disruptions. International Flavors merged with DuPont de Nemours, Inc.’s DD Nutrition & Biosciences (N&B) business.
|
The guidance factors in additional pricing actions to counter inflationary pressure, impact of the divestiture of the microbial control business and the acquisition of Health Wright Products. International Flavors also continues to incur high raw material costs and additional costs related to labor, shipping and cleaning due to COVID-led supply-chain disruptions. International Flavors merged with DuPont de Nemours, Inc.’s DD Nutrition & Biosciences (N&B) business.
|
The guidance factors in additional pricing actions to counter inflationary pressure, impact of the divestiture of the microbial control business and the acquisition of Health Wright Products. International Flavors also continues to incur high raw material costs and additional costs related to labor, shipping and cleaning due to COVID-led supply-chain disruptions. International Flavors merged with DuPont de Nemours, Inc.’s DD Nutrition & Biosciences (N&B) business.
|
dabd8389-db39-4f1f-b61a-22ba6255f43e
|
715973.0
|
2022-08-30 00:00:00 UTC
|
An Intrinsic Calculation For DuPont de Nemours, Inc. (NYSE:DD) Suggests It's 23% Undervalued
|
DD
|
https://www.nasdaq.com/articles/an-intrinsic-calculation-for-dupont-de-nemours-inc.-nyse%3Add-suggests-its-23-undervalued
|
nan
|
nan
|
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DuPont de Nemours, Inc. (NYSE:DD) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. We will use the Discounted Cash Flow (DCF) model on this occasion. There's really not all that much to it, even though it might appear quite complex.
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
The Model
We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars:
10-year free cash flow (FCF) forecast
2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Levered FCF ($, Millions) US$1.51b US$1.65b US$1.75b US$1.84b US$1.92b US$1.98b US$2.04b US$2.10b US$2.15b US$2.20b
Growth Rate Estimate Source Analyst x7 Analyst x3 Est @ 6.34% Est @ 5.02% Est @ 4.1% Est @ 3.45% Est @ 3% Est @ 2.68% Est @ 2.46% Est @ 2.3%
Present Value ($, Millions) Discounted @ 6.7% US$1.4k US$1.4k US$1.4k US$1.4k US$1.4k US$1.3k US$1.3k US$1.2k US$1.2k US$1.1k
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$13b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.9%. We discount the terminal cash flows to today's value at a cost of equity of 6.7%.
Terminal Value (TV)= FCF2032 × (1 + g) ÷ (r – g) = US$2.2b× (1 + 1.9%) ÷ (6.7%– 1.9%) = US$47b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$47b÷ ( 1 + 6.7%)10= US$24b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$38b. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Compared to the current share price of US$57.9, the company appears a touch undervalued at a 23% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.
NYSE:DD Discounted Cash Flow August 30th 2022
Important Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at DuPont de Nemours as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.7%, which is based on a levered beta of 1.131. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
Looking Ahead:
Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For DuPont de Nemours, we've put together three essential elements you should look at:
Risks: For example, we've discovered 1 warning sign for DuPont de Nemours that you should be aware of before investing here.
Future Earnings: How does DD's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NYSE every day. If you want to find the calculation for other stocks just search here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DuPont de Nemours, Inc. (NYSE:DD) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. NYSE:DD Discounted Cash Flow August 30th 2022 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Future Earnings: How does DD's growth rate compare to its peers and the wider market?
|
NYSE:DD Discounted Cash Flow August 30th 2022 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DuPont de Nemours, Inc. (NYSE:DD) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. Future Earnings: How does DD's growth rate compare to its peers and the wider market?
|
NYSE:DD Discounted Cash Flow August 30th 2022 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DuPont de Nemours, Inc. (NYSE:DD) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. Future Earnings: How does DD's growth rate compare to its peers and the wider market?
|
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of DuPont de Nemours, Inc. (NYSE:DD) as an investment opportunity by taking the forecast future cash flows of the company and discounting them back to today's value. NYSE:DD Discounted Cash Flow August 30th 2022 Important Assumptions Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. Future Earnings: How does DD's growth rate compare to its peers and the wider market?
|
91c912e4-2d47-4468-99a7-07b2db63cd90
|
715974.0
|
2022-08-25 00:00:00 UTC
|
DD October 7th Options Begin Trading
|
DD
|
https://www.nasdaq.com/articles/dd-october-7th-options-begin-trading
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new October 7th contracts and identified one put and one call contract of particular interest.
The put contract at the $60.00 strike price has a current bid of 25 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $60.00, but will also collect the premium, putting the cost basis of the shares at $59.75 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $60.50/share today.
Because the $60.00 strike represents an approximate 1% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 0.42% return on the cash commitment, or 3.54% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $60.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $61.00 strike price has a current bid of 30 cents. If an investor was to purchase shares of DD stock at the current price level of $60.50/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $61.00. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 1.32% if the stock gets called away at the October 7th expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $61.00 strike highlighted in red:
Considering the fact that the $61.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 0.50% boost of extra return to the investor, or 4.21% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $60.50) to be 31%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $61.00 strike highlighted in red: Considering the fact that the $61.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $61.00 strike highlighted in red: Considering the fact that the $61.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 7th expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $61.00 strike highlighted in red: Considering the fact that the $61.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $61.00 strike highlighted in red: Considering the fact that the $61.00 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options begin trading today, for the October 7th expiration.
|
a0236dbe-2fdd-41b1-ae33-281081b667ff
|
715975.0
|
2022-08-22 00:00:00 UTC
|
Analysts See 14% Upside For The Holdings of SPYX
|
DD
|
https://www.nasdaq.com/articles/analysts-see-14-upside-for-the-holdings-of-spyx
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P 500 Fossil Fuel Reserves Free ETF (Symbol: SPYX), we found that the implied analyst target price for the ETF based upon its underlying holdings is $117.71 per unit.
With SPYX trading at a recent price near $103.22 per unit, that means that analysts see 14.04% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SPYX's underlying holdings with notable upside to their analyst target prices are Carnival Corp (Symbol: CCL), ABIOMED, Inc. (Symbol: ABMD), and DuPont de Nemours Inc (Symbol: DD). Although CCL has traded at a recent price of $9.87/share, the average analyst target is 50.30% higher at $14.84/share. Similarly, ABMD has 28.20% upside from the recent share price of $270.68 if the average analyst target price of $347.00/share is reached, and analysts on average are expecting DD to reach a target price of $77.23/share, which is 27.70% above the recent price of $60.48. Below is a twelve month price history chart comparing the stock performance of CCL, ABMD, and DD:
Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
SPDR S&P 500 Fossil Fuel Reserves Free ETF SPYX $103.22 $117.71 14.04%
Carnival Corp CCL $9.87 $14.84 50.30%
ABIOMED, Inc. ABMD $270.68 $347.00 28.20%
DuPont de Nemours Inc DD $60.48 $77.23 27.70%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
SPDR S&P 500 Fossil Fuel Reserves Free ETF SPYX $103.22 $117.71 14.04% Carnival Corp CCL $9.87 $14.84 50.30% ABIOMED, Inc. ABMD $270.68 $347.00 28.20% DuPont de Nemours Inc DD $60.48 $77.23 27.70% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPYX's underlying holdings with notable upside to their analyst target prices are Carnival Corp (Symbol: CCL), ABIOMED, Inc. (Symbol: ABMD), and DuPont de Nemours Inc (Symbol: DD). Similarly, ABMD has 28.20% upside from the recent share price of $270.68 if the average analyst target price of $347.00/share is reached, and analysts on average are expecting DD to reach a target price of $77.23/share, which is 27.70% above the recent price of $60.48.
|
Three of SPYX's underlying holdings with notable upside to their analyst target prices are Carnival Corp (Symbol: CCL), ABIOMED, Inc. (Symbol: ABMD), and DuPont de Nemours Inc (Symbol: DD). Similarly, ABMD has 28.20% upside from the recent share price of $270.68 if the average analyst target price of $347.00/share is reached, and analysts on average are expecting DD to reach a target price of $77.23/share, which is 27.70% above the recent price of $60.48. SPDR S&P 500 Fossil Fuel Reserves Free ETF SPYX $103.22 $117.71 14.04% Carnival Corp CCL $9.87 $14.84 50.30% ABIOMED, Inc. ABMD $270.68 $347.00 28.20% DuPont de Nemours Inc DD $60.48 $77.23 27.70% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
Similarly, ABMD has 28.20% upside from the recent share price of $270.68 if the average analyst target price of $347.00/share is reached, and analysts on average are expecting DD to reach a target price of $77.23/share, which is 27.70% above the recent price of $60.48. Three of SPYX's underlying holdings with notable upside to their analyst target prices are Carnival Corp (Symbol: CCL), ABIOMED, Inc. (Symbol: ABMD), and DuPont de Nemours Inc (Symbol: DD). Below is a twelve month price history chart comparing the stock performance of CCL, ABMD, and DD: Below is a summary table of the current analyst target prices discussed above:
|
SPDR S&P 500 Fossil Fuel Reserves Free ETF SPYX $103.22 $117.71 14.04% Carnival Corp CCL $9.87 $14.84 50.30% ABIOMED, Inc. ABMD $270.68 $347.00 28.20% DuPont de Nemours Inc DD $60.48 $77.23 27.70% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Three of SPYX's underlying holdings with notable upside to their analyst target prices are Carnival Corp (Symbol: CCL), ABIOMED, Inc. (Symbol: ABMD), and DuPont de Nemours Inc (Symbol: DD). Similarly, ABMD has 28.20% upside from the recent share price of $270.68 if the average analyst target price of $347.00/share is reached, and analysts on average are expecting DD to reach a target price of $77.23/share, which is 27.70% above the recent price of $60.48.
|
de4118fe-7dfc-4a8e-bbb8-c53c2f538cb3
|
715976.0
|
2022-08-18 00:00:00 UTC
|
How the U.S. Is Building Its Semiconductor Ecosystem
|
DD
|
https://www.nasdaq.com/articles/how-the-u.s.-is-building-its-semiconductor-ecosystem
|
nan
|
nan
|
M
icrochips, often dubbed as the brain of any computing device, are core to devices all around us be it a smartphone, game console, MRI scanner or a defense system. The dynamics in the chip market are complex, and the damage that can be caused by a breakdown in the supply chain can extend much beyond economics. The chip shortage caused by the pandemic and geopolitical tensions between the U.S. and China have awakened governments across the globe to the fact that localization of chip manufacturing is critical to national and economic security.
Here’s an overview of how the U.S. is working to reduce dependency for chip manufacturing from East Asia by strengthening its own ecosystem.
The chip market and its supply chain have many elements with different companies and nations dominating each one. The U.S. semiconductor industry has consistently accounted for 45% to 50% of global revenues. In 2021, the global semiconductor sales reached $556 billion, out of which the U.S. semiconductor companies accounted $258 billion or 46% of the global market.
The first segment is the electronic design automation (EDA) which “consists of software, hardware, and services with the collective goal of assisting in the definition, planning, design, implementation, verification, and subsequent manufacturing of semiconductor devices, or chips.” The U.S. remains the unchallenged leader in the electronic design automation (EDA) tools, controlling about 85% of the world market. Synopsys (SNPS) and Cadence (CDNS) together account for 62% of the total market share. The global EDA market is expected to reach $22.21 billion by 2030, growing at a CAGR of 9.1% from 2022 to 2030.
Another layer of critical inputs in the semiconductor supply chain is the specialized equipment. In semiconductor manufacturing inputs, the U.S. retains a strong position with more than 50% of the market share as against 2% for China. Applied Materials (AMAT), Lam Research (LRCX), KLA (KLAC) and Teradyne (TER) are some of the key U.S. players in this market. The global semiconductor manufacturing equipment market, valued at $95.3 billion in 2021, is projected to reach $175.0 billion by 2027.
The third important segment is specialized chemicals and materials. The global electronic chemicals and materials market valued at $62.51 billion in 2021 is expected to reach a value of $ 91.21 billion by 2027. Some of the prominent American companies operating in this sphere are Air Products (APD), Dow Chemical, DuPont (DD), CMC Materials (formally Cabot Microelectronics).
While the U.S. has held its dominance in these segments, there is a huge gap in the fourth part created by an erosion in its manufacturing capacity.
“America invented the semiconductor, but today produces about 10% of the world’s supply—and none of the most advanced chips. Instead, we rely on East Asia for 75% of global production,” as per a White House report.
The huge dependence of the U.S. on Taiwan is reflective in the region wise sales revenue of Taiwan Semiconductor Manufacturing Company (TMC). The company’s revenue from the U.S. during 2021 stood at 64% vis-à-vis 61.07% in 2020 while China’s share declined from 17.46% in 2020 to 10.37% in 2021.
Back in 2020, a BCG report highlighted that, “only 6% of the new global capacity in development will be in the U.S. In contrast, it is projected that during the next decade China will add about 40% of the new capacity and become the largest semiconductor manufacturing location in the world.”
Efforts are being made to change such predications. Here’s an overview of the announcements and investments in 2022.
In January 2022, Intel (INTC) announced plans for an initial investment of more than $20 billion in the construction of two new leading-edge chip factories in Ohio. The construction is expected to begin late in 2022 while production will go online in 2025. “Ohio will be home to Intel’s first new manufacturing site location in 40 years,” as per the company’s statement.
In February, Intel’s decision to acquire Tower Semiconductor (TSEM) to strengthen its global, end-to-end foundry business for approximately $5.4 billion was announced. TSEM, a leading foundry for analog semiconductor solutions, owns two manufacturing facilities in Israel, the U.S., Japan and Italy (some are via percentage stake and partnerships).
In addition to investing in the U.S., companies are extending support to manufacturing units in Europe. Intel plans to invest €80 billion in the European Union over the next decade along the entire semiconductor value chain right from research and development (R&D) to manufacturing to state-of-the art packaging technologies. In March, Intel announced the initial investment €17 billion into a fab mega-site in Germany, R&D, and design hub in France, and to invest in R&D, manufacturing, and foundry services in Ireland, Italy, Poland and Spain.
Texas Instruments (TXN) plans to spend around an average of $3.5 billion annually on Capex in the next four years from 2022 to 2025. During the earnings call in April, the company clarified that $3.5 billion is an average and they are likely to run below this in 2022 and would run higher in the next three years.
The Chip and Science Act of 2022 was passed by the Congress in July and Signed by President Biden this month. The Act provides $52.7 billion for American semiconductor R&D, manufacturing and workforce development. It also offers a 25% investment tax credit for capital expenses for manufacturing of semiconductors and related equipment.
The passage of the Act has spurred companies to announce additional investments in American semiconductor manufacturing.
Micron (MU), the only U.S.-based manufacturer of memory, announced its plans to invest $40 billion through the end of the decade to build leading-edge memory manufacturing in multiple phases. The investment will create up to 40,000 American jobs. This investment aligns with the Micron’s plan of $150+ billion global investment in manufacturing and R&D over the next decade. Sanjay Mehrotra, CEO and President of Micron said that the CHIPS and Science Act “will enable Micron to grow domestic production of memory from less than 2% to up to 10% of the global market in the next decade, making the U.S. home to the most advanced memory manufacturing and R&D in the world.”
To secure long-term supply, Qualcomm (QCOM) will be buying an additional $4.2 billion in semiconductor chips from GlobalFoundries’ (GFS) upstate New York facility. This builds on a prior $3.2 billion purchasing agreement between the two companies taking the total commitment to $7.4 billion through 2028. Qualcomm plans to “increase semiconductor production in the U.S. by up to 50% over the next five years.” GlobalFoundries is the only American company to rank among the top five semiconductor foundries globally. In July, GlobalFoundries and STMicroelectronics (STM) signed a Memorandum of Understanding to create a new, jointly operated 300-mm semiconductor manufacturing facility in France.
In addition, TSMC recently celebrated placing the last beam which is the construction industry is known as a “topping” milestone in FAB 21’s fab building. Two years ago, TSMC announced its intention to invest $12 billions to build a 5-nanometer semiconductor fab in Arizona.
Disclaimer: The author has no position in any stocks mentioned. Investors should consider the above information not as a de facto recommendation, but as an idea for further consideration. The report has been carefully prepared, and any exclusions or errors in it are totally unintentional. Details based on linked reports, company earnings reports and press releases.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Some of the prominent American companies operating in this sphere are Air Products (APD), Dow Chemical, DuPont (DD), CMC Materials (formally Cabot Microelectronics). Sanjay Mehrotra, CEO and President of Micron said that the CHIPS and Science Act “will enable Micron to grow domestic production of memory from less than 2% to up to 10% of the global market in the next decade, making the U.S. home to the most advanced memory manufacturing and R&D in the world.” To secure long-term supply, Qualcomm (QCOM) will be buying an additional $4.2 billion in semiconductor chips from GlobalFoundries’ (GFS) upstate New York facility. In contrast, it is projected that during the next decade China will add about 40% of the new capacity and become the largest semiconductor manufacturing location in the world.” Efforts are being made to change such predications.
|
The passage of the Act has spurred companies to announce additional investments in American semiconductor manufacturing. Some of the prominent American companies operating in this sphere are Air Products (APD), Dow Chemical, DuPont (DD), CMC Materials (formally Cabot Microelectronics). In contrast, it is projected that during the next decade China will add about 40% of the new capacity and become the largest semiconductor manufacturing location in the world.” Efforts are being made to change such predications.
|
Sanjay Mehrotra, CEO and President of Micron said that the CHIPS and Science Act “will enable Micron to grow domestic production of memory from less than 2% to up to 10% of the global market in the next decade, making the U.S. home to the most advanced memory manufacturing and R&D in the world.” To secure long-term supply, Qualcomm (QCOM) will be buying an additional $4.2 billion in semiconductor chips from GlobalFoundries’ (GFS) upstate New York facility. Some of the prominent American companies operating in this sphere are Air Products (APD), Dow Chemical, DuPont (DD), CMC Materials (formally Cabot Microelectronics). In contrast, it is projected that during the next decade China will add about 40% of the new capacity and become the largest semiconductor manufacturing location in the world.” Efforts are being made to change such predications.
|
Sanjay Mehrotra, CEO and President of Micron said that the CHIPS and Science Act “will enable Micron to grow domestic production of memory from less than 2% to up to 10% of the global market in the next decade, making the U.S. home to the most advanced memory manufacturing and R&D in the world.” To secure long-term supply, Qualcomm (QCOM) will be buying an additional $4.2 billion in semiconductor chips from GlobalFoundries’ (GFS) upstate New York facility. Some of the prominent American companies operating in this sphere are Air Products (APD), Dow Chemical, DuPont (DD), CMC Materials (formally Cabot Microelectronics). In contrast, it is projected that during the next decade China will add about 40% of the new capacity and become the largest semiconductor manufacturing location in the world.” Efforts are being made to change such predications.
|
13e7d98f-bc40-465e-98e5-396c223e780e
|
715977.0
|
2022-08-18 00:00:00 UTC
|
April 2023 Options Now Available For DuPont (DD)
|
DD
|
https://www.nasdaq.com/articles/april-2023-options-now-available-for-dupont-dd
|
nan
|
nan
|
Investors in DuPont (Symbol: DD) saw new options become available today, for the April 2023 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 246 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new April 2023 contracts and identified one put and one call contract of particular interest.
The put contract at the $60.00 strike price has a current bid of $3.90. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $60.00, but will also collect the premium, putting the cost basis of the shares at $56.10 (before broker commissions). To an investor already interested in purchasing shares of DD, that could represent an attractive alternative to paying $61.61/share today.
Because the $60.00 strike represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 6.50% return on the cash commitment, or 9.64% annualized — at Stock Options Channel we call this the YieldBoost.
Below is a chart showing the trailing twelve month trading history for DuPont, and highlighting in green where the $60.00 strike is located relative to that history:
Turning to the calls side of the option chain, the call contract at the $62.50 strike price has a current bid of $5.00. If an investor was to purchase shares of DD stock at the current price level of $61.61/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $62.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 9.56% if the stock gets called away at the April 2023 expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $62.50 strike highlighted in red:
Considering the fact that the $62.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted). Should the covered call contract expire worthless, the premium would represent a 8.12% boost of extra return to the investor, or 12.04% annualized, which we refer to as the YieldBoost.
Meanwhile, we calculate the actual trailing twelve month volatility (considering the last 252 trading day closing values as well as today's price of $61.61) to be 31%. For more put and call options contract ideas worth looking at, visit StockOptionsChannel.com.
Top YieldBoost Calls of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if DD shares really soar, which is why looking at the trailing twelve month trading history for DuPont, as well as studying the business fundamentals becomes important. Below is a chart showing DD's trailing twelve month trading history, with the $62.50 strike highlighted in red: Considering the fact that the $62.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $62.50 strike highlighted in red: Considering the fact that the $62.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. Investors in DuPont (Symbol: DD) saw new options become available today, for the April 2023 expiration.
|
The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $62.50 strike highlighted in red: Considering the fact that the $62.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. On our website under the contract detail page for this contract, Stock Options Channel will track those odds over time to see how they change and publish a chart of those numbers (the trading history of the option contract will also be charted).
|
At Stock Options Channel, our YieldBoost formula has looked up and down the DD options chain for the new April 2023 contracts and identified one put and one call contract of particular interest. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Below is a chart showing DD's trailing twelve month trading history, with the $62.50 strike highlighted in red: Considering the fact that the $62.50 strike represents an approximate 1% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected.
|
8bb00249-f944-4922-8d25-d08effccacad
|
715978.0
|
2022-08-09 00:00:00 UTC
|
7 Blue-Chip Stocks That Will Survive 2022
|
DD
|
https://www.nasdaq.com/articles/7-blue-chip-stocks-that-will-survive-2022
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Buying high-quality blue-chip stocks in a bear market could be a solid path to generating lucrative long-term returns. Blue-chip stocks are typically large-cap businesses in the mature stage of their business cycle. They boast solid business models, strong balance sheets, and positive free cash flow, which allow them to make significant dividend payments.
Therefore, blue-chip stocks offer stability to investor portfolios during economic uncertainty and market volatility. While they are particularly popular among conservative investors, more risk-tolerant investors could also consider buying blue chip stocks these days to add stability to their portfolios.
For instance, exchange-traded funds (ETFs) such as the ProShares S&P 500 Dividend Aristocrats ETF (BATS:NOBL) and the Fidelity Blue Chip Value ETF (NYSEARCA:FBCV) have lost about 7% and 4% so far in 2022. On the other hand, the S&P 500 index is currently down 13% year-to-date (YTD), compared with the 19% decline in the Nasdaq 100 index so far in 2022.
Meanwhile, the recent market downturn has created attractive blue-chip stock bargain opportunities even among the world’s most prominent companies. These businesses have survived past downturns and are well-equipped to cope with future volatility as well.
With that information, here are the seven blue-chip stocks that could help investors ride through the bear market this year.
ABBV AbbVie $140.34
BDX Becton Dickinson $255.97
CI Cigna $281.77
DD Dupont De Nemours $59.33
MMM 3M $148.48
JPM JPMorgan Chase $114.35
PFE Pfizer $49.57
AbbVie (ABBV)
Source: Piotr Swat / Shutterstock.com
52-week range: $105.56 – $175.91
AbbVie (NYSE:ABBV), the first blue-chip stock on our list, is an important biopharma company. Aside from its popular aesthetic therapies like Botox and Juvederm, the medical giant focuses on key therapeutic areas such as immunology, neuroscience, oncology, eye care and virology.
Management released second-quarter results on July 29. Revenue increased by 4.5% year-over-year (YOY) to $14.58 billion. Adjusted diluted earnings per share, EPS, stood at $3.37, up 11.2% YOY.
AbbVie’s biggest cash cow, the rheumatoid arthritis drug Humira, is losing patent protection in 2023. Q2 revenue from Humira increased by 5.8% to surpass $5.3 billion despite rising competition from generics in international markets.
Meanwhile, revenues from the immunology and neuroscience portfolios have jumped 17.8% and 13.7%, respectively. Analysts expect Skyrizi and Rinvoq to replace Humira’s contribution to top-line growth. By 2025, these two drugs are forecast to generate more than $15 billion annually, outperforming Humira at its peak.
ABBV stock is up nearly 2% YTD and 20% over a 12-month period. The Dividend King currently generates a 4.1% dividend yield.
Shares are trading at a moderate valuation of 10.1 times forward earnings and 4.4 times sales. Meanwhile, the 12-month median price forecast for ABBV stands at $158.
Becton Dickinson (BDX)
Source: JHVEPhoto / Shutterstock.com
52-week range: $229.24 – $277.29
Becton Dickinson (NYSE:BDX) develops and manufactures medical devices, supplies, and instruments. The company’s portfolio includes around 20,000 products.
Becton Dickinson announced third-quarter earnings on Aug. 4. Revenue increased 3.8% YOY on a currency-neutral basis to $4.64 billion. Adjusted diluted EPS came in at $2.66, up 16.7% YOY from $2.28. Cash and equivalents ended the quarter at $2.56 billion.
Wall Street has noted the company continued with its growth strategy that relies significantly on strategic acquisitions. For instance, in early June, it acquired Parata Systems for more than $1.5 billion, entering the high-growth pharmacy automation market segment by offering a unique set of technologies across the healthcare spectrum.
One of the most recent acquisitions was MedKeeper, a cloud-based pharmacy management applications provider. This acquisition highlights the company’s recent focus on high-technology pharmacy solutions.
BDX stock is up 1% YTD. Shares are trading at 19 times forward earnings and 3.5 times sales. The dividend yield currently stands at 1.4%. Analysts’ 12-month median forecast stands at $278.
Cigna (CI)
Source: Piotr Swat / Shutterstock
52-week range: $191.74 – $284.46
Next on our list of blue-chip stocks is the global health services group Cigna (NYSE:CI). The insurance juggernaut offers medical and dental insurance. Its customer base of 20 million members makes the company the fourth largest health insurer stateside.
The insurance play announced Q2 results on Aug. 4. It generated $45.5 billion in revenue, up from $43.1 billion in the prior-year quarter. Adjusted EPS came in at $6.22, up 19% from $5.24 in the year-ago quarter.
Cigna is expected to benefit from increasing global demand for health insurance benefits. Such growth will in part be driven by an aging global population as well as soaring healthcare costs. Management raised its EPS outlook for 2022 by 30 cents to come in at least $22.90.
According to Global Market Insights, the global health insurance industry is expected to deliver compounded annual growth rate (CAGR) of over 4.5%, well exceeding $3.9 trillion by 2027.
So far in 2022, CI stock is up 23%. Yet, shares are still trading at an attractive valuation of 12.4 times forward earnings and just 0.5 times sales. Meanwhile, Cigna offers a dividend yield of 1.6%. The 12-month median price forecast for CI stock is $311.
Dupont De Nemours (DD)
Source: ricochet64 / Shutterstock.com
52-week range: $52.56 – $85.16
Specialty chemicals giant Dupont De Nemours (NYSE:DD) focuses on various key markets such as electronics, transportation, construction, and healthcare. Its most profitable segment and region are Electronics & Industrial and Asia-Pacific, respectively.
Dupont reported Q2 results on Aug. 2. Net revenue came in at $3.32 billion, representing 7% YOY growth. Adjusted EPS was 88 cents, up 11% compared with the year-ago quarter. Cash and equivalents ended the quarter at $1.44 billion.
The chemicals play saw a 9% increase in organic sales. Electronics & Industrial segment generated net sales of $1.53 billion, up 16% YOY. Pricing actions fully compensated for rising inflation costs in raw materials, logistics, and energy.
Meanwhile, in late July, Dupont opened a new Liveo Healthcare Solutions manufacturing site at the Cooper River Site in South Carolina. Wall Street will be paying close attention to how DD’s new facility will add to top-line growth.
DD stock is down 27% YTD. The price level currently supports a 2.2% dividend yield. Shares are changing hands at 18.1 times forward earnings and two times sales. Wall Street’s 12-month median price forecast for DD stock stands at $76.
3M (MMM)
Source: JPstock / Shutterstock.com
52-week range: $125.60 – $202.77
Industrial giant 3M (NYSE:MMM) develops products for consumers, industry, health care, and worker safety. It manufactures roughly 60,000 products under well-known brands such as Post-It, ACE, Command, and Scotch.
In late July, 3M reported Q2 financials. Sales totaled $8.7 billion, down 3% year-on-year (YOY). Adjusted earnings were $2.48, compared to $2.75 the year before. Adjusted free cash flow was $1.0 billion, down 41% YOY.
Organic sales increased just 1% YOY due to the lockdowns in China and falling global demand for its face masks. Yet, 3M’s earnings and guidance came in better than market forecasts. Management anticipates full-year organic sales growth to come in at 1.5% to 3.5%.
Meanwhile, 3M is spinning off its healthcare division as a stand-alone public company. The transaction is expected to be finalized by the end of 2023. The transaction aims to reduce leverage and free up liquidity by transferring debt onto the spinoff.
The Dividend King has hiked its payout for 64 consecutive years and currently supports a 4% dividend yield. So far in 2022, MMM stock is down 17%.
Shares offer a compelling buying opportunity at 13.9 times forward earnings and 2.4 times sales. Wall Street’s 12-month median price forecast for MMM stock stands at $145.
JPMorgan Chase (JPM)
Source: Daryl L / Shutterstock.com
52-week range: $106.06 – $172.96
Next on our list of blue-chip stocks is the global financial powerhouse JPMorgan Chase (NYSE:JPM). JPMorgan is the largest bank stateside. Its market capitalization (cap) stands well over $335 billion.
JPMorgan issued Q2 results on July 14. Revenue increased 1% YOY to $31.6 billion. Net income came in at $8.6 billion, down 28% YOY.
In the second quarter, net interest income (NII) came in at $15.2 billion, up $1.3 billion from the prior quarter. Management also raised its 2022 NII guidance.
However, investment-banking revenue plunged by almost $2.1 billion YOY as initial public offerings came to a halt in 2022. Moreover, the bank suspended share buybacks to quickly respond to capital growth needs outlined by the Federal Reserve’s recent stress test.
So far in 2022, JPM stock is down roughly 27%, generating a robust dividend yield of 3.5%. Shares offer value at 10.1 times forward earnings and 1.3 times book value. Meanwhile, the 12-month median price forecast for JPMorgan stock is $135.
Pfizer (PFE)
Source: photobyphm / Shutterstock.com
52-week range: $40.94 – $61.71
Last on our list of blue-chip stocks is the global pharma giant Pfizer (NYSE:PFE). The company has more than 350 drug offerings, with nine that boasted sales higher than $1 billion in 2021.
Pfizer reported Q2 results on July 28. Revenue jumped 47% YOY to $27.7 billion, the highest quarterly revenue in Pfizer’s history. Adjusted diluted earnings per share came in at $2.04, representing an impressive 92% YOY growth.
Comirnaty, the Covid-19 vaccine jointly developed with BioNTech (NASDAQ:BNTX), generated more than $8.8 billion in sales, up 20% YOY. In early July, the company received full U.S. Food and Drug Administration (FDA) approval for offering the vaccine to adolescents between 12-15 years of age. Wall Street will be paying attention to how vaccine sales will contribute to the firm’s bottom line in the fall when Covid cases could rise again.
Meanwhile, the antiviral Covid-19 therapy Paxlovid sales surpassed $8.1 billion in the second quarter. A recent decision by the FDA to allow authorized state-licensed pharmacists to prescribe the pill is forecast to boost sales through the second half of 2022.
PFE stock is down almost 17% so far in 2022 yet remains up 9% over the past year. Shares are trading at 7.7 times forward earnings and 2.8 times sales. The dividend yield currently stands at 3.25%. Analysts’ 12-month median forecast for Pfizer is at $55.
On the date of publication, Tezcan Gecgil, Ph.D., is both long and short BNTX stock. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post 7 Blue-Chip Stocks That Will Survive 2022 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While they are particularly popular among conservative investors, more risk-tolerant investors could also consider buying blue chip stocks these days to add stability to their portfolios. ABBV AbbVie $140.34 BDX Becton Dickinson $255.97 CI Cigna $281.77 DD Dupont De Nemours $59.33 Dupont De Nemours (DD) Source: ricochet64 / Shutterstock.com 52-week range: $52.56 – $85.16 Specialty chemicals giant Dupont De Nemours (NYSE:DD) focuses on various key markets such as electronics, transportation, construction, and healthcare.
|
ABBV AbbVie $140.34 BDX Becton Dickinson $255.97 CI Cigna $281.77 DD Dupont De Nemours $59.33 Dupont De Nemours (DD) Source: ricochet64 / Shutterstock.com 52-week range: $52.56 – $85.16 Specialty chemicals giant Dupont De Nemours (NYSE:DD) focuses on various key markets such as electronics, transportation, construction, and healthcare. While they are particularly popular among conservative investors, more risk-tolerant investors could also consider buying blue chip stocks these days to add stability to their portfolios.
|
While they are particularly popular among conservative investors, more risk-tolerant investors could also consider buying blue chip stocks these days to add stability to their portfolios. ABBV AbbVie $140.34 BDX Becton Dickinson $255.97 CI Cigna $281.77 DD Dupont De Nemours $59.33 Dupont De Nemours (DD) Source: ricochet64 / Shutterstock.com 52-week range: $52.56 – $85.16 Specialty chemicals giant Dupont De Nemours (NYSE:DD) focuses on various key markets such as electronics, transportation, construction, and healthcare.
|
While they are particularly popular among conservative investors, more risk-tolerant investors could also consider buying blue chip stocks these days to add stability to their portfolios. ABBV AbbVie $140.34 BDX Becton Dickinson $255.97 CI Cigna $281.77 DD Dupont De Nemours $59.33 Dupont De Nemours (DD) Source: ricochet64 / Shutterstock.com 52-week range: $52.56 – $85.16 Specialty chemicals giant Dupont De Nemours (NYSE:DD) focuses on various key markets such as electronics, transportation, construction, and healthcare.
|
45e18388-e19c-4d8e-bf53-97da9dda3797
|
715979.0
|
2022-08-04 00:00:00 UTC
|
Getting In Cheap On DuPont de Nemours, Inc. (NYSE:DD) Might Be Difficult
|
DD
|
https://www.nasdaq.com/articles/getting-in-cheap-on-dupont-de-nemours-inc.-nyse%3Add-might-be-difficult
|
nan
|
nan
|
With a price-to-earnings (or "P/E") ratio of 18.7x DuPont de Nemours, Inc. (NYSE:DD) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 15x and even P/E's lower than 8x are not unusual. However, the P/E might be high for a reason and it requires further investigation to determine if it's justified.
DuPont de Nemours certainly has been doing a good job lately as it's been growing earnings more than most other companies. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. If not, then existing shareholders might be a little nervous about the viability of the share price.
NYSE:DD Price Based on Past Earnings August 4th 2022
If you'd like to see what analysts are forecasting going forward, you should check out our free report on DuPont de Nemours.
What Are Growth Metrics Telling Us About The High P/E?
In order to justify its P/E ratio, DuPont de Nemours would need to produce impressive growth in excess of the market.
If we review the last year of earnings growth, the company posted a terrific increase of 36%. However, the latest three year period hasn't been as great in aggregate as it didn't manage to provide any growth at all. So it appears to us that the company has had a mixed result in terms of growing earnings over that time.
Turning to the outlook, the next three years should generate growth of 14% each year as estimated by the analysts watching the company. With the market only predicted to deliver 10% per annum, the company is positioned for a stronger earnings result.
In light of this, it's understandable that DuPont de Nemours' P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.
The Final Word
Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.
We've established that DuPont de Nemours maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. Unless these conditions change, they will continue to provide strong support to the share price.
It's always necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with DuPont de Nemours, and understanding should be part of your investment process.
If these risks are making you reconsider your opinion on DuPont de Nemours, explore our interactive list of high quality stocks to get an idea of what else is out there.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
NYSE:DD Price Based on Past Earnings August 4th 2022 If you'd like to see what analysts are forecasting going forward, you should check out our free report on DuPont de Nemours. With a price-to-earnings (or "P/E") ratio of 18.7x DuPont de Nemours, Inc. (NYSE:DD) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 15x and even P/E's lower than 8x are not unusual. We've established that DuPont de Nemours maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected.
|
With a price-to-earnings (or "P/E") ratio of 18.7x DuPont de Nemours, Inc. (NYSE:DD) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 15x and even P/E's lower than 8x are not unusual. NYSE:DD Price Based on Past Earnings August 4th 2022 If you'd like to see what analysts are forecasting going forward, you should check out our free report on DuPont de Nemours. In order to justify its P/E ratio, DuPont de Nemours would need to produce impressive growth in excess of the market.
|
With a price-to-earnings (or "P/E") ratio of 18.7x DuPont de Nemours, Inc. (NYSE:DD) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 15x and even P/E's lower than 8x are not unusual. NYSE:DD Price Based on Past Earnings August 4th 2022 If you'd like to see what analysts are forecasting going forward, you should check out our free report on DuPont de Nemours. We've established that DuPont de Nemours maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected.
|
With a price-to-earnings (or "P/E") ratio of 18.7x DuPont de Nemours, Inc. (NYSE:DD) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 15x and even P/E's lower than 8x are not unusual. NYSE:DD Price Based on Past Earnings August 4th 2022 If you'd like to see what analysts are forecasting going forward, you should check out our free report on DuPont de Nemours. DuPont de Nemours certainly has been doing a good job lately as it's been growing earnings more than most other companies.
|
a0f9fc1d-e780-4ad5-9a3e-56eb217fa14d
|
715980.0
|
2022-08-02 00:00:00 UTC
|
Wall Street set to open lower as U.S.-China tensions grow
|
DD
|
https://www.nasdaq.com/articles/wall-street-set-to-open-lower-as-u.s.-china-tensions-grow
|
nan
|
nan
|
By Aniruddha Ghosh and Devik Jain
Aug 2 (Reuters) - U.S. stock indexes were set to open lower on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China.
The latest geopolitical uncertainty comes at a time when financial markets are already dealing with the fallout from a war in Ukraine, energy crisis in Europe, soaring inflation and tightening of financial conditions.
Shares of chipmakers, which have a large exposure to China, fell in premarket trading. Advanced Micro Devices AMD.O, Qualcomm QCOM.O, Intel Corp INTC.O, Micron Technology Inc MU.O and Nvidia Corp NVDA.O were down between 0.9% and 1.3%.
The CBOE volatility index .VIX, also known as Wall Street's fear gauge, rose to 24.23 points, its highest level in nearly a week.
"Chip stocks are really exposed to Asia. Some of them have 70% of their sales, especially chip equipment companies, in that region so it's a big deal for them," said Jack DeGan, chief investment officer at Harbor Advisory.
Wall Street has kicked off August on a lackluster note following its best monthly performance since 2020 in July amid heightened fears of a global recession, after data showed factory activity weakened across the United States, Europe and Asia.
Against that backdrop, investors have turned increasingly jittery about the health of corporate America.
"Any kind of geopolitical concern can cause traders who gained quite a bit last week to take a little bit (profit) off the table," Degan said.
At 8:17 a.m. ET, Dow e-minis 1YMcv1 were down 178 points, or 0.54%, S&P 500 e-minis EScv1 were down 26.75 points, or 0.65%, and Nasdaq 100 e-minis NQcv1 were down 112.75 points, or 0.87%.
Caterpillar Inc CAT.N slipped 3.4% after its quarterly sales missed market expectations due to supply-chain issues and the suspension of its Russia operations.
DuPont de Nemours DD.N fell 2% after the industrial materials maker lowered its full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.5% on downbeat 2022 profit forecast.
Among others, Uber Technologies Inc UBER.N jumped 14% after the ride-hailing firm reported positive quarterly cash flow for the first time ever and forecast upbeat third-quarter operating profit.
Pinterest Inc PINS.N surged 17.8% as the activist investor Elliott Investment Management become the largest shareholder of the digital pin-board firm.
Arista Networks Inc ANET.N rose 5.4% after the cloud networking solutions company posted stronger second-quarter results.
On the data front, the Labor Department's Job Openings and Labor Turnover Survey (JOLTS) report for June is due at 10 a.m. ET. Economists polled by Reuters are forecasting 11 million vacancies.
(Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva)
((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - U.S. stock indexes were set to open lower on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2% after the industrial materials maker lowered its full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.5% on downbeat 2022 profit forecast. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - U.S. stock indexes were set to open lower on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. DuPont de Nemours DD.N fell 2% after the industrial materials maker lowered its full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.5% on downbeat 2022 profit forecast.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - U.S. stock indexes were set to open lower on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2% after the industrial materials maker lowered its full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.5% on downbeat 2022 profit forecast. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - U.S. stock indexes were set to open lower on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2% after the industrial materials maker lowered its full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.5% on downbeat 2022 profit forecast. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
8738e216-bf31-4af7-b5c9-0b0f52012239
|
715981.0
|
2022-08-02 00:00:00 UTC
|
DuPont de Nemours, Inc. (DD) Q2 2022 Earnings Call Transcript
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-inc.-dd-q2-2022-earnings-call-transcript
|
nan
|
nan
|
Image source: The Motley Fool.
DuPont de Nemours, Inc. (NYSE: DD)
Q2 2022 Earnings Call
Aug 02, 2022, 8:00 a.m. ET
Contents:
Prepared Remarks
Questions and Answers
Call Participants
Prepared Remarks:
Operator
Good morning, and welcome to DuPont 2Q 2022earnings conference call [Operator instructions] Thank you. Chris Mecray, you may begin your conference.
Chris Mecray -- Vice President, Investor Relations
Good morning, everyone. Thank you for joining us for review of DuPont's second quarter 2022 financial results. Joining me today are Ed Breen, chief executive officer; and Lori Koch, chief financial officer. We prepared slides to supplement our comments during this review, which are posted on the Investor Relations section of DuPont's website and through the webcast link.
Please read the forward-looking statement disclaimer contained in the slides. During this financial review, we'll make forward-looking statements regarding our expectations or predictions about the future. Because these statements are based on current assumptions and factors that involve risks and uncertainties, our actual performance and results may differ materially from our forward-looking statements. Our 2021 Form 10-K as updated by current and periodic reports, includes detailed discussion of principal risks and uncertainties which may cause such differences.
10 stocks we like better than DuPont de Nemours, Inc.
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and DuPont de Nemours, Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of July 27, 2022
Unless otherwise specified, all historical financial measures presented today exclude significant items. We'll also refer to other non-GAAP measures. A reconciliation to the most directly comparable GAAP measures are included in our press release and posted to the Investor page of our website. I'll now turn the call over to Ed.
Ed Breen -- Chief Executive Officer
Good morning. Thank you for joining our second quarter financial review. We posted strong quarterly results above expectations in a difficult environment. Our top-line revenue growth of 7% versus the year-ago period included solid organic growth of 9%.
Overall, customer demand remains strong across our key end markets as E&I delivered a 6% volume increase driven by ongoing strength in semiconductor technologies and industrial solutions. In terms of inflation, our pricing actions continue to fully offset higher costs associated with raw materials, logistics, and energy. Early in the quarter, our expectation for full year 2022 was about $600 million of increased costs and that number has now risen to over $700 million, mainly due to higher energy and logistics costs. We still expect to remain price cost neutral in the second half and for the full year based on pricing actions we have taken.
Overall, our second quarter results reflect year-over-year and sequential earnings growth. These results highlight the strength of our end markets and our team's efforts to successfully navigate a challenging macro environment, which was further complicated by China's COVID lockdowns during the quarter. We were very pleased with the lockdowns alleviated by mid-June and that our China-based colleagues who operated diligently under difficult circumstances have been able to return to some form of normalcy. More broadly, our focus on execution continues to drive results as we increase our use of digital tools and other plant site investments to drive additional productivity and capacity release.
Finally, with regards to sustainability, I am pleased to highlight that last month, we announced our commitment to setting targets to reduce greenhouse gas emissions in line with the Paris Accord science-based targets initiative, or SBTi. This is an important step toward reducing our overall climate impact. and it builds on our existing commitment to protect the planet by reducing the carbon footprint across our value chain in partnership with customers and suppliers. Turning to Slide 4.
I'd like to update you on key initiatives for 2022 stakeholder value creation, namely our portfolio transformation and our balanced approach to capital allocation. In addition, I will highlight our continued focus on growth execution on the following slide. First, as it relates to the Rogers acquisition, the progress is being made on the required regulatory reviews with China being the last jurisdiction outstanding. We expect the deal to close during the third quarter.
Regarding Rogers' first quarter 2022 performance, we were satisfied with top-line progress for the business with growth in the high single digits, and we're especially pleased to see new wins and ongoing growth in the electric vehicle space. Rogers' business in the period was impacted by a price cost gap and several operational challenges that held back full earnings potential, but we remain confident in the actions that the Rogers team is taking, and we expect improvement as we move forward. For the M&M transactions, we are on track regarding timing associated with the M&M divestiture to Celanese with a completion anticipated around year-end. We continue to make the necessary progress to separate the business and we were pleased to see Celanese secure permanent financing in the last few weeks.
We also continue to move forward with plans to divest the Delrin business and affirm our expectation for completion around midyear 2023. This past July 1st marked the one-year anniversary of our acquisition of Laird Performance Materials. I've commented previously on how successful this acquisition has been for us, including overall financial performance ahead of plan on both the top and bottom lines. We also continue to advance commercial synergy opportunities on top of cost synergies previously noted.
Finally, we completed the sale of the biomaterials business at the end of May, which was the last of our previously announced non-core business divestitures. Since 2019, we generated gross proceeds of over $2.2 billion by divesting eight non-core businesses, which collectively produced lower growth, lower margins, and overall higher volatility in earnings. We received solid value for these divestitures, selling them at a low double-digit EBITDA multiple. Shifting to capital allocation.
We continue to pursue a balanced strategy that includes prioritizing the return of excess capital to shareholders as well as bolt-on M&A. During the second quarter, we repurchased $500 million of shares bringing our year-to-date total to $875 million, which represents 2.5% of total shares outstanding. We anticipate completing the $500 million of authorization remaining on our existing share repurchase program during the remainder of this year. As I noted during our lastearnings call given the magnitude of anticipated proceeds from the M&M divestitures, we expect there will be room to execute substantial incremental share buybacks while disciplined M&A will also remain a key deployment priority over time as we continue to seek accretive and opportunistic transactions that can leverage our existing growth even further.
Finally, our balance sheet remains strong, and this remains a key priority, particularly in uncertain volatile macro environment. Turning to Slide 5. Another key value driver for us is innovation-led growth. Greater focus on secular high-growth end markets and electronics, water, protection industrial technologies and next-generation automotive will serve as a sound basis for our organic growth execution.
We continue to invest actively in both advancing the technology within our existing product portfolio and also introducing new products around the pillars highlighted here. with an overall R&D investment rate of around 4% of total sales, in line with best-in-class peers. This investment is coupled with substantial application engineering focus where our technical personnel have a seat at our customers' table in the design phases of their products. This past quarter, we had a number of highlights, which we note on the slide, but I'd emphasize that we are proud to have won four Edison Awards across different technology platforms and we continue to make progress in introducing new technologies, such as applications and EV batteries, which has strong growth potential.
With that, let me turn it to Lori to discuss the details of the quarter as well as our financial outlook.
Lori Koch -- Chief Financial Officer
Thanks, Ed, and good morning, everyone. As Ed mentioned, we saw continued strong demand during the quarter in key end markets with volumes higher than our expectations coming into the quarter. Cost inflation intensified further compared to previous estimates, but additional pricing actions are anticipated to fully offset these higher costs. These factors, along with our team's continued strong execution focus, contributed to both top and bottom line results well above expectations for the quarter.
We also delivered a consistent operating EBITDA margin on both a year-over-year and sequential basis. Focusing on financial highlights for the quarter on Slide 6. Net sales of $3.3 billion increased 7% as reported versus the second quarter of 2021 and increased 9% on an organic basis. The acquisition of Laird partially offset by non-core divestitures provided a 1% net tailwind in net sales, while currency was a 3% headwind during the quarter as the U.S.
dollar strengthened against key currencies, including the euro and the yen. Organic sales growth included 8% pricing gains and 1% higher volume. Volume growth reflects continued strong demand in key end markets, namely semiconductor, general industrial, water and construction, muted primarily by lower volumes for protective garments within safety solutions. These factors resulted in organic sales growth during the quarter, up 9% for W&P, 8% for E&I, and 15% for the retained businesses of the former M&M segment they report in corporate, which predominantly reflects our cases portfolio tied to next-generation auto.
On a regional basis, we delivered organic sales growth in all four regions globally, including volume increases in Asia Pacific, North America, and Latin America. In China, organic sales growth was up slightly versus the year-ago period and volumes in China were up low single digits sequentially from first quarter despite government-mandated lockdowns in parts of the country into early June. From an earnings perspective, operating EBITDA of $829 million was up 6% versus the year-ago period and adjusted EPS of $0.88 per share increased 11%. The increase in operating EBITDA was driven by pricing actions, stronger earnings contribution from the Laird acquisition, and volume gains, which more than offset higher inflationary cost pressures.
Operating EBITDA margin of 25% was slightly better than our expectations set earlier this quarter and flat on both a year-over-year and sequential basis. Our pricing actions have fully offset cost inflation on a dollar basis, but have impacted EBITDA margins. Our operating EBITDA margin adjusted to exclude price cost with 26.6% or 150 basis points higher than the year ago, driven by productivity and higher volume. Our incremental margin was 22% on an as-reported basis.
Excluding the impact of price cost, incremental margin for our core businesses was almost 60%, demonstrating strong cost discipline and operational productivity. From a cash perspective, cash flow from operations during the quarter of $86 million and capital expenditures of $135 million resulted in a free cash outflow of $49 million. Working capital was an additional headwind during the quarter as we continue to secure inventory given tight supply chains and incur higher inventory costs related to inflation. We expect improvement in free cash flow during the second half of the year, consistent with our typical pattern and factoring in a reduction of working capital level.
As we separate the M&M business, we continue to encourage transactions-related expenses with over $100 million of transaction costs incurred during the second quarter and about $700 million in costs related to the M&M separations expected in full year 2022. These costs, combined with higher working capital related to the M&M business that we are divesting, are significant headwinds to our 2022 cash flow. Turning to Slide 7. Adjusted EPS of $0.88 per share increased 11%, compared to $0.79 per share in the year-ago period.
Higher volumes and earnings from Laird provided a benefit to adjusted EPS in the quarter of $0.11 per share. These gains were partially offset by weaker mix in W&P related to lower garment production and Capstone plant start-up costs totaling $0.03 per share. A lower share count from ongoing share repurchase provided a $0.04 benefit to adjusted EPS while below-the-line items including a higher tax rate and exchange gains netted to a $0.03 headwind. Our base tax rate for the quarter was 22.6%, up slightly from 21.8% in the first quarter and up notably from the year-ago period given certain discrete tax benefits recorded in the prior year, resulting from tax law changes.
We are maintaining an expected base tax rate range for the full year 2022 of 21% to 23%. Turning to segment results, beginning with E&I on Slide E&I delivered net sales growth of 16%, including 8% organic growth, an 11% portfolio benefit from Laird, and a 3% headwind from currency. Organic growth for E&I included a 6% increase in volume and a 2% increase in pricing. The line of business view, organic sales growth was led by semiconductor technologies, which increased mid-teens as strong demand continued, led by the ongoing transition to more advanced node technologies and ongoing high semiconductor fab utilization, along with growth in 5G communications and data centers.
Within industrial solutions, organic sales growth was up high single digits, led by continued demand for OLED materials for displays, ongoing strength for Kalrez semi capex-related product offerings, Vespel products, serving recovering aerospace markets and for healthcare applications such as biopharmaceutic. Interconnect solutions sales decreased low single digits on an organic basis as expected due to a slight volume decline. Volume gains for films and laminates in certain industrial end markets,were more than offset by lower smartphone volumes due to the anticipated return to more normal seasonal order pattern compared to last year and including softness in China smartphones. The business was also impacted somewhat by lower global PC and tablet demand and continued constraints in automotive production.
Looking forward, we expect similar growth patterns for semiconductor technologies and industrial solutions to continue into the second half of 2022. Within interconnect, we expect to return to positive organic growth in the second half given seasonal strength and added capacity from our Kapton expansion. For the full year, we expect interconnect solutions to be up low to mid-single digits on an organic basis. This reflects a slight decline from our previous expectations as supply chain constraints and softer consumer demand are expected to meet volumes for smartphones, PCs, and tablets.
Operating EBITDA for E&I of $480 million increased 13% as strong earnings from Laird, volume gains, and pricing actions were partially offset by higher raw material and logistics costs. Operating EBITDA margin of 31.4% reflects sequential improvement of 40 basis points. On a year-over-year basis, operating EBITDA margin was down 70 basis points due primarily to a 100 basis point headwind from price cost. Turning to Slide 9.
W&P delivered net sales growth of 6% and as organic sales growth of 9% was partially offset by a 3% headwind from currency. Organic growth for W&P reflects a 12% increase in price and a 3% volume headwind. Pricing gains reflect broad-based actions across the segment, most notably in shelter and safety solutions. Volume declines were driven by safety solutions.
From a line of business view, organic sales growth was led by shelter solutions, which increased high teens driven by pricing actions and continued robust demand in North America residential construction as well as ongoing growth in commercial construction and strength in repair and remodel-related demand during the quarter. Within safety solutions, sales were up mid-single digits on an organic basis as pricing actions were partially offset by lower volumes, given the shift from garments to other end market applications and the resulting negative impact of increased manufacturing line changeovers on overall production. Sales for water solutions were up mid-single digits on an organic basis on pricing gains and continued steady demand for water filtration technologies, muted by supply chain constraints in Asia Pacific, due to COVID lockdowns in China and an earthquake in Japan impacting our production. Operating EBITDA for W&T of $348 million declined 1% versus last year as pricing actions taken to offset higher costs are more than offset by volume declines.
Operating EBITDA margin of 23.2% was 170 basis points below the year-ago period as the impact of price cost was an approximate 200 basis point headwind to margins. Excluding the price/cost impact, operating EBITDA margin was over 25%. I'll close with a few comments on our financial outlook on Slide 10. We are still seeing solid demand and our order book is sound in most of our end markets.
However, future uncertainties continue to exist in the macro environment driven by inflationary pressure, challenging supply chain, and U.S. dollar strength. Our teams remain focused keenly on execution, and we are concentrated on a leverage within our control in order to continue to drive value for our shareholders. For the full year 2022, we are narrowing our adjusted EPS range while maintaining the midpoint of our previous range.
We now expect full year adjusted EPS in the range of $3.27 to $3.43 per share versus our previous range of $3.20 to $3.50 per share. We are updating our full year '22 net sales guidance range to be between $13 billion and $13.4 billion reflecting a $200 million of incremental foreign currency headwinds, along with the removal of about $120 million in net sales related to the biomaterials business, given its divestiture at the end of May. We continue to expect organic sales growth for the year to be up high single digits. After adjusting the high end of our operating EBITDA guidance primarily for incremental currency headwinds in the renewal of the biomaterials business, we now expect full year 2022 operating EBITDA to be between $3.25 billion and $3.35 billion.
For third quarter 2022, we expect net sales to be between $3.17 billion and $3.37 billion and operating EBITDA to be about $810 million. We expect third quarter net sales and operating EBITDA to be slightly weaker than the second quarter as sequential volume increases are expected to be offset by further foreign currency headwinds and the absence of the biomaterials business. We are also expecting impact during the third quarter on operating EBITDA of approximately $15 million from unplanned downtime at our W&P screw-in site in Virginia associated with an unforeseen utility disruption from a third-party supplier. On a year-over-year basis, we expect third quarter net sales to be up 2% at the midpoint and up high single digits on an organic basis.
We expect third quarter 2022 adjusted EPS of approximately $0.81 per share. With that, we are pleased to take your questions, and let me turn it back to the operator to open the Q&A.
Questions & Answers:
Operator
Thank you. [Operator instructions] Your first question comes from Jeff Sprague from Vertical Research. Please go ahead.
Jeff Sprague -- Vertical Research Partners -- Analyst
Thank you. Good morning, everyone.
Ed Breen -- Chief Executive Officer
Good morning, Jeff.
Jeff Sprague -- Vertical Research Partners -- Analyst
Hey. Good morning. Ed or Lori, could you just comment on kind of the visibility on the top line in the back half kind of around some of the economic worry points, right, U.S. resi, some of the consumer electronic, cellphone, and the like.
Just what you're seeing from your customer and channel partners there and your comfort level that, that's all dialed now properly relative to the guidance.
Ed Breen -- Chief Executive Officer
Yeah, Jeff. So we looked over the weekend at our order rates as of the end of last week and across the board, our order rates are hanging right in there where we would expect them to be. The only softness that we've seen, which we've mentioned before, as smartphones in China, demand is down, and I don't know how much of that is because of the lockdowns versus just true demand down. And we're seeing some lightness on the PCB board side, which is really for PCs, tablets, things like that, not significant, but a little bit of a downdraft there.
And besides that, everything at least in our order rate, is holding in. And now remember, we have a really solid look, I would say, on our orders out about 30 days. And the bulk of the businesses, some of them longer than that, like the water business is actually some months. So we're a little bit shorter cycle on the order rate.
But as we sit today, it looks like things are hanging in there. We have seen no downdraft to your specific point on the construction side, both the resi order rates are good in the last week. The commercial was good and the do-it-yourself piece of that business was still good. By having said that, Jeff, we're not naive.
We see data points out there. And obviously, we're doing recession planning, just to be ready if things do soften up. But at this point in time, not seeing it.
Jeff Sprague -- Vertical Research Partners -- Analyst
Great. Thanks for that color. And then just wondering back to the ultimate deployment of cash, particularly as it comes to the M&M proceeds. Is it still your bias to wait until that cash is in the door? Or now that Celanese has secured funding and maybe we're a little bit further down the kind of regulatory path.
Perhaps there's some comfort to get a running start on some of that.
Ed Breen -- Chief Executive Officer
Yeah, Jeff. So we're talking to the board about it and just to reiterate the prepared comments we made, we're clearly thinking heavy on a share repurchase here with the amount of cash available. And I wouldn't say the cash has to be in the door. I just want to see kind of use the term green lights through town that the timing is what we think we're going to be ready to do this by November 1st with all the internal work, both we're doing and Celanese is doing.
But my gut is by the time you get through regulatory, our comment was kind of end of the year right at the first of the year 2023. But you never know with regulatory and there's COVID lockdowns, you just. You don't know for sure. So I just want to get closer and then we'll make a final decision.
Jeff Sprague -- Vertical Research Partners -- Analyst
Great. Thanks for the color.
Ed Breen -- Chief Executive Officer
Yep.
Operator
Your next question comes from Scott Davis from Melius Research. Please go ahead.
Scott Davis -- Melius Research -- Analyst
Hey, good morning, everybody.
Ed Breen -- Chief Executive Officer
Good morning, Scott.
Scott Davis -- Melius Research -- Analyst
Good morning. Ed, you mentioned in your remarks, Rogers is having kind of a challenging price cost, I think you said GAAP. Is it off the deal model then for '22? Is it materially off or it impacts kind of your '23 look at it?
Ed Breen -- Chief Executive Officer
Yeah. So the night -- there's a good and a bad. I guess I'll just put it that way. The good is the revenue line is right on what the planning assumptions were and the win rate is looking really, really nice.
The EBITDA is off the planning model and by the way, I'd say it's four -- putting price costs aside, which you can catch up on, which will happen. There were four or five operational issues that have been hitting them that are really impacting the EBITDA percent. By the way, all fixable, all within the control of the team to fix those. So we expect improvement to come.
By the way, I'll just give you, too, one of them is not really even something they can control. They're being shorted as the whole industry is on the silicon side and it's a very high-margin application for them. So obviously, we're trying to -- they're trying to secure more silicon supply. And at some point here, that will even out, but that's off.
And then just to give you one other example, they used more contract manufacturing because they're bringing up a facility that they had a fire in it that they're bringing that back up online. But in the meantime, to satisfy the customers, they're using contract manufacturing, which is really eating into the margin of that business. So that's two examples, but there's three other ones. So those things, that's being worked on and they're getting ready to launch that facility again and bring the production back in-house.
So it's items like that. We'll work through that. My hope and gut is we'll be in good shape going into 2023 as we get these operational issues fixed.
Lori Koch -- Chief Financial Officer
Yes, I think I'd point to on the top line, one of the areas that we're really impressed with is their penetration in EV. And so they've seen really nice growth there. and we'll continue to take advantage of the opportunity, especially the combined opportunity in DuPont when we put it together with our EV applications. I think we've mentioned in the past, the two portfolios generate about $400 million of revenue today.
So we're excited to get those two together and see what we can do.
Scott Davis -- Melius Research -- Analyst
Right. And then just on Laird, I assume based on what I see in the slides here that Laird is a little ahead of its steel model?
Ed Breen -- Chief Executive Officer
Yeah. Both revenue and earnings are ahead. And we got good synergies out of that. We're getting -- we're probably about 80% through that.
We've identified real solidly $63 million in synergies. But what I'm more excited about on Laird, and I think the same is going to play out with Rogers is of really the revenue opportunities between the two as Lori was sort of just alluding to, we just had another one in European auto. Customers who layered had a direct relationship with and we were able to use some of our existing DuPont technology and an application to resolve an issue for them. And it seems like a nice new revenue stream with that customer.
So that's really exciting with the kind of putting this toolkit together.
Scott Davis -- Melius Research -- Analyst
Sounds good. Best of luck. Thank you.
Ed Breen -- Chief Executive Officer
Thank you.
Operator
Your next question comes from Steve Tusa from J.P. Morgan. Please go ahead.
Steve Tusa -- J.P. Morgan -- Analyst
Hi. Good morning.
Ed Breen -- Chief Executive Officer
Hi, Steve.
Steve Tusa -- J.P. Morgan -- Analyst
On this the price cost side, what's your estimate for the year now? I think you had $350 million in raw material headwind prior. This quarter, obviously, inflation is tough, but this quarter seemed a little bit higher than I was expecting. And then also, are you including logistics in that? And if not, I think you had given like a $225 million headwind prior, maybe just an update on those two?
Lori Koch -- Chief Financial Officer
Yes. So we're now expecting between raw materials, logistics, and higher energy costs, about $700 million. So it's about a $100 million increase from where we were sitting when we did the priorearnings call But we still expect to fully cover that with price increases.
So we'll be net neutral on the bottom line. It just creates the headwinds on the margin profile as we have telegraphed. It was about 150 basis points in total this quarter. So underlying -- we held flat on margins year over year.
But if you take out that delta, we were actually up about 140, 150 basis points, a nice leverage through the P&L.
Ed Breen -- Chief Executive Officer
Steve, I'll break down for you because you were just using rolls. The breakdown of the inflation is about 60% as rolls, 20% is logistics, and 20% is energy. Just to give you kind of a feel for it. And by about 70% of our inflation is in the WP segment, where you can see we got phenomenal pricing.
Steve Tusa -- J.P. Morgan -- Analyst
Yes. That energy cost was that previously recorded through the raw materials line? I don't recall you guys kind of breaking that out explicitly. Had that been running through that raw materials number in prior quarters? Or is that new line item?
Lori Koch -- Chief Financial Officer
Yeah. It wouldn't have been in the raws, but it would have been in the total 600. So it's not new in total. But the increase from the prior 600 to the current 700 is really primarily the increase in energy costs and then the knock-on effect to logistics as we see higher fuel costs.
Steve Tusa -- J.P. Morgan -- Analyst
Yeah. OK. That makes a lot of sense. And then just one last one on the W&P business, I guess, how do you see that performing through, let's say, you have kind of a consumer recession where housing takes a bit of a hit.
I mean, can that business grow through that on a volume basis? Or is there kind of too much cyclical exposure in that business? How do you look at that business through that type of recession?
Ed Breen -- Chief Executive Officer
Well, remember, Steve, one of the -- first of all, it just depends how deep recession is it's a hard one to answer. But remember that the Tyvek product line, which is one of the biggest segments in there, that's a sold-out asset. So we can divert product to other end markets. For instance, we are shorting right now.
Unfortunately, the medical market, medical packaging market. We're trying to work through that backlog as we speak. So we have other applications for it in a sold-out asset. And by the way, I think the water business just to use W&P, I think the water business would hold in there pretty well in a recession.
So yes, we'll see some effect of it. Nomex probably go down a little bit. Kevlar might go down a little bit, but I think we can hang in there pretty well.
Lori Koch -- Chief Financial Officer
And I think you just to be sure. So the residential piece of construction is about 40%. The rest is 40% commercial and then about 20% repair and remodel. In the commercial, the largest end markets underneath there are more on the healthcare side and the restaurant side.
So those are -- they make up the bulk of the commercial opportunity for us.
Steve Tusa -- J.P. Morgan -- Analyst
Excellent. Thanks, guys. Appreciate the color.
Ed Breen -- Chief Executive Officer
Thank you.
Operator
Your next question comes from John Walsh from Credit Suisse. Please go ahead.
John Walsh -- Credit Suisse -- Analyst
Hi. Good morning.
Ed Breen -- Chief Executive Officer
Good morning, John.
John Walsh -- Credit Suisse -- Analyst
Just following up to Steve's question there, maybe we could talk a little bit on the pricing side. You highlighted strong pricing there in W&P, but as you look forward, where do you think you have the most structural pricing? And then where might you have to give back as potentially we see some material deflation in the future?
Ed Breen -- Chief Executive Officer
Yeah. Well, John, that is a great question. We talk about it all the time. So we made a, I'd say, a strategic decision that all the price increases we did were all baked into the product price.
So we did not do surcharges that tied to some index or something like that. So I feel good about the approach that we took. And obviously, our goal if a recession hit some commodity costs come down would be to then get a gap, maintain a gap going forward where obviously, we're maintaining more price than the decrease on the commodity. And we're, by the way, we've been working on these scenarios for the last month our teams like where do we feel and how much can we hold in each of our end markets, but our goal is going to clearly be to hold a gap so that we can help our EBITDA margin percent, which is, as Lori just mentioned, obviously, hit the other way with the price cost thing, but where we can benefit from it.
So I won't get into each end market, but I think we have the opportunity to do what I just said, to what extent we'll see as it plays out. But that -- by the way, that's interesting. And this if a recession hits, that's the one thing that is very, very different for companies like ours and many others, where in the past, you didn't have this dynamic. You had a recession, you were cutting your costs or whatever you did.
And this time, you have -- this is probably the single biggest dynamic that improved financial performance that clearly we have and many, many global companies have.
John Walsh -- Credit Suisse -- Analyst
No. That's a very interesting perspective. Thank you. And then the $15 million headwind that you're going to see in W&P in Q3, does that fully reverse out in Q4? And kind of what's the confidence level that, that third party can get beyond their disruption?
Ed Breen -- Chief Executive Officer
So we're already getting past the disruption. We've been bringing lines up this week. This problem hit a week and a half ago. And it's just it's a safety issue, by the way.
We have to methodically go through, look at all the lines, what ended up being just call it stuck in the when it went down. So it's a little bit of a process. But we're bringing some lines up a day ago and later today, we bring a line up again. So we know we're out of the problem here over the next few days.
But we don't make that up. Because for instance, Tyvek is one of the products, big products there. It's a sold-out asset. So we can only make so much and we're sold out.
But by the way, just the give you a sequence from the third to the fourth quarter, you see a little bit of a lift, which is not necessarily the seasonal pattern. But what's happening there is we have the sprint not being down, so we don't have that third quarter to fourth quarter problem. We'll be running full tilt there. We have a new water line that we've been telling you about that's coming up at Edina, which will give us incremental volume on a sold-out business, also our reverse osmosis product line.
And then remember, we have the Kapton line coming up in our electronics business and our Circleville facility, and they all hit the fourth quarter and give us the incremental volume and cap downs also a sold-out asset. So we're not expecting a sequential third to fourth necessary change in demand in the marketplace. They just happen to be the sold-out assets where we start getting some production out of them.
John Walsh -- Credit Suisse -- Analyst
Great. Thanks for taking the questions. I'll pass it on.
Ed Breen -- Chief Executive Officer
Thanks.
Operator
Your next question comes from John McNulty from BMO Capital Markets. Please go ahead.
John McNulty -- BMO Capital Markets -- Analyst
Yeah. Thanks for taking my question. I believe about 20% of your sales come from the EMEA region. Can you give us a little bit of color as to your exposure to Germany and any precautions that you're taking or any levers that you can pull if there are any issues with regard to gas and power as we kind of progress through the rest of the season.
Lori Koch -- Chief Financial Officer
Yeah. Right now, we're not expecting any material impact as they start to ration energy in Germany. There's one plant site in our existing go-forward portfolio that doesn't use it, so we don't see an impact there. It's in the businesses that we retained from M&M.
M&M does have a plant in Germany so that they could be impacted minimally if there were some rationale going on there. But as we see it right now, we don't see a headwind from a utilization perspective. We'll obviously continue to watch the European natural gas prices, which have an impact on primarily W&P and the RemainCo portfolio. They've got a few plant sites in Europe.
So they're up again. I think they were EUR 210 or so as of the last couple of days. So we'll continue to keep an eye on those to see where that moves.
John McNulty -- BMO Capital Markets -- Analyst
Got it. Thanks for the color. OK. And then just in the Tyvek garment business, how far back to normal or reversing kind of that big surge would you say we are? And it sounds like you had some incremental headwinds that aren't just on the mix shift, but also on the line shifting.
I guess can you break that out in terms of how much of a hit that might have been on the margin and how we should be thinking about that going forward through the rest of the year?
Lori Koch -- Chief Financial Officer
Yes. So in the second quarter, garment volumes were down about $40 million. So we were able to make up a little of that with increasing sales in the medical and other end markets. But in total, garments were down $40 million.
We expect that to be hit again in 3Q on a year-over-year basis. And then in the fourth quarter, we start to get out of that year-over-year comp headwind. The piece, too, on the production side, you not so much a demand because you can shift the demand to other end markets from the garments. It's more around the product produced that you net out to a headwind.
And so when we were making garments, we were able to just run garment the entire time. And minimize the changeovers on the lines. Now that we're back to a more normal product mix, we're having to have more changeovers that we had last year, so therefore, translating to lower pounds produced.
John McNulty -- BMO Capital Markets -- Analyst
Got it. OK. Thanks very much for the color.
Operator
Your next question comes from Christopher Parkinson from Mizuho. Please go ahead.
Christopher Parkinson -- Mizuho Securities -- Analyst
Great. Thanks for taking my question. Just pretty much a corollary of the last two and a half questions or so. Can you just give us your updated thoughts on the intermediate to long-term margin outlook for W&P, just given the question about structural price increases, improving reliability across the asset base, product mix, and so on and so forth.
Just any updated color there and your confidence in those numbers would be very helpful. Thank you.
Ed Breen -- Chief Executive Officer
Yeah. I'll give you really both of the bigger businesses here. I think E&I and you've seen us do this ex the price cost, we should be able to run that 32%, 33% EBITDA margin. And this quarter, we weren't far off of that and then a little bit of price cost there.
And I think that's about where that will run and pretty consistently have been there. In the W&P, we really think we can get that over time to kind of more of a 27%, 28% business. Now by the way, we're planning on getting some of that as commodities at some point here, drift down, and we maintain, as I mentioned a minute ago, some incremental pricing above that. But then internally, in our own control is really capacity release at our facilities.
And that would be specifically on Tyvek, our water assets and our Nomex product line would be the big ones for continued capacity release. And in our prepared remarks, Chris, one of the things you see we've been working heavily on working on a lot of digital tools that we're implementing on our facilities that are helping us on the reliability side. These are big heavy assets on the W&P side, so you get a 1% improvement. You get quite a bit of throughput.
So we're really spending our time working kind of our operational excellence playbook. And that's what will really help us on the W&P to keep incrementing that up.
Lori Koch -- Chief Financial Officer
Yeah. I think as we look toward the second half, we don't see any material margin movement in the second half versus the first half, we were around 23%, more like 25%, 26% when you take away the price cost headwinds in the first half. And so as we look to the second half, we would expect that same 23% roughly underlying and then you have 25-ish percent, 26% when you take away the price cost headwind.
Christopher Parkinson -- Mizuho Securities -- Analyst
That's very helpful. And just as a very quick follow-up. To the extent you can, can you just give us a little bit more color on the expectations for Delrin versus your commentary over the past few quarters in terms of price, number of suitors, and so on and so forth. Thank you.
Ed Breen -- Chief Executive Officer
Yeah, Chris. So what we've been doing on Delrin is we've been working on standing it up. It was a division and a division. So it was a little extra up from workforce.
We finished up the data room. We're going to actually really launch the process here in the early fall. We're just waiting to get through the summer. So I can't give you any color commentary on detailed number of people.
But I would think it's more strategics that are going to be interested in this asset. By the way, it's a business that has 30% EBITDA margins. It's doing very well still in this environment. So that's probably the timing of it.
And that's why we said, so if that's the timing by the time you get to the to close the deal. You're probably about the middle of 2023. And that would really be the end of the kind of the divestiture and getting the portfolio where we want it. Now, remember that asset is already in discontinued operations.
Christopher Parkinson -- Mizuho Securities -- Analyst
Yep. So very helpful. Thank you so much.
Ed Breen -- Chief Executive Officer
Thanks.
Operator
Your next question comes from Steve Byrne from Bank of America. Please go ahead. Steve, your line is open.
Steve Byrne -- Bank of America Merrill Lynch -- Analyst
Sorry about that. I wanted to ask you a little bit about your semiconductor business and a couple of potential longer-term drivers, one being whether the product mix is potentially shifting with any of the semiconductor fabs that you support where they are shifting to other products is that possible? Is that a way for those businesses to remain pretty robust? And then the other driver being the new semiconductor fabs under construction, do you have already some awarded business for fabs that are coming online in the intermediate term?
Lori Koch -- Chief Financial Officer
Yeah. I think to your first part of your question, I don't see them changing the product mix that they make on the fabs, but they can kind of shift around the end markets. And so we've seen them move away as there's been some weakness in the consumer electronics space. do more of the data center applications where the demand remains very, very robust, which is favorable to our portfolio, just given the higher advanced technologies associated with those end market data center applications.
And so you can see in our results in the second quarter, we continue to post very strong results. And we're well-positioned as we go forward to take advantage of the increase in the fabs through the construction that's taking place. And so right now, I believe, over the next few years, we'll bring on an incremental about 7% capacity when it comes to wafer starts, and we're very well-positioned. We've got great relationships with the majority of those stats that are putting in capacity.
And so while it's hard to say if you want any new capacity from those new lines coming on, I don't know if they actually have all that in place, but we'll continue to maintain very strong relationships with those large players that are putting in capacity. We've said in the past that we'll be about 200 to 300 basis points ahead of MSI growth. We're posting those results this year. So I don't see any reason why we wouldn't continue to do that.
And I think it's important to note, the semi market and the revenue that's posted is a function of both price and volume and our exposure is to the volume piece. And so price can be volatile in the semi market. That doesn't impact our results. It's really a focus on the wafer starts and the MSI so the millions of square inches of wafers produced.
Steve Byrne -- Bank of America Merrill Lynch -- Analyst
Just curious if you can comment on any update on PFAS litigation settlement discussions.
Ed Breen -- Chief Executive Officer
Yeah. It's ongoing conversation. And as you know, the judge just encouraged that to go on. But I don't have anything new to say we continue to have pretty consistent conversations to try to resolve the issues, and I'm still optimistic.
But nothing new to say.
Steve Byrne -- Bank of America Merrill Lynch -- Analyst
Thank you.
Ed Breen -- Chief Executive Officer
Yep. Thanks.
Operator
Your next question comes from David Begleiter from Deutsche Bank. Please go ahead.
David Begleiter -- Deutsche Bank -- Analyst
Thank you. Good morning. Just on your EV exposure with Rogers, how large will be and what type of growth are you looking forward to going forward?
Lori Koch -- Chief Financial Officer
Yes. So we see the opportunity in EV between our portfolio and Roger's portfolio to be about $250 a car. So a really nice content number. As I had mentioned earlier, today, we have about $400 million of revenue between the two portfolios.
So about $200 million coming in from Rogers and about $200 million in our existing portfolio, which is predominantly made up of adhesives. And then we have a no-mix paper application for the e-motor piece. So a very nice opportunity, as I had mentioned for the two companies to come together to continue to drive opportunities in the space. It's a really high growth rate as we've mentioned before, too.
So EV applications are overall growing in the mid-teens. ADAS applications even higher than that. We've got a nice data portfolio today with the incoming Laird acquisition and lots of opportunities for growth. .
David Begleiter -- Deutsche Bank -- Analyst
Great. And just on tieback between now when line eight comes online, is there anything you can do to bring out more -- get more capacity or further improve the mix in this business to keep on growing earnings until the new capacity is on stream?
Lori Koch -- Chief Financial Officer
Yes. That's a key opportunity for us is to continue to get capacity to release also sold-out assets. And so during a pandemic, recall that we brought Line 1 back up so we were able to bring on a little bit of incremental capacity. Line one is the oldest line in the portfolio, so it doesn't have as much production as the newer lines, but it was incremental capacity for us.
So we'll continue to try to get more pounds off of all the lines between both Spruance and Luxembourg as we await the new Tyvek asset, which we expect sometime around the end of 2023.
David Begleiter -- Deutsche Bank -- Analyst
Thank you very much.
Operator
Your next question comes from Vincent Andrews from Morgan Stanley. Please go ahead.
Vincent Andrews -- Morgan Stanley -- Analyst
Thank you. Good morning, everyone. Ed, well articulated that your preference is for share buybacks with the proceeds, but you still mentioned bolt-on. So if you could just give us an update on what's out there and then maybe give us an update on -- I think in the past, you've sort of sized bolt-ons.
So maybe you just want to redefine what a bolt-on could look like on a go-forward basis?
Ed Breen -- Chief Executive Officer
Yeah. Thanks for the question, Vincent. So any bolt-on that we would do, first of all, would be on one of the five pillars that we talk about. And we've been looking at things that are -- let me say, a bolt-on would be more like Laird, not as big as Rogers.
That $1 billion, $2 billion type range, and it would be something that would bring additional technology to play in one of those pillars that was back to the electronics example, just give us more tools in the toolkit to resolve issues for our customers because we're so strong in application engineering, and we're really seeing the benefit of that with layer tied together with the DuPont electronics portfolio. I know we're going to see it with the Rogers one. So it would be something like that in one of those pillars that we would look at.
Vincent Andrews -- Morgan Stanley -- Analyst
OK. And then just may be less of an issue for the refined DuPont portfolio now. But in the past, when we've been in these tricky macro outlooks, we'd get into 4Q and customers could destock more than they typically do seasonally just sort of to manage uncertainty going into year-end. Are you picking up any with of that in your sort of level to C-level conversations or anything that we should be thinking about?
Ed Breen -- Chief Executive Officer
No. We're not, and trust me, we're watching it closely. But no, we're not seeing that.
Vincent Andrews -- Morgan Stanley -- Analyst
OK. Thanks very much, Ed.
Operator
Your next question comes from Alex Yefremov from KeyBanc Capital Markets. Please go ahead.
Alex Yefremov -- KeyBanc Capital Markets -- Analyst
Thanks and good morning, everyone. In your E&I segment overall and in semis in particular, is your outlook for third quarter kind of better or worse or about in line with normal seasonality?
Lori Koch -- Chief Financial Officer
I would say it's in line with normal seasonality. So with the one exception of, we will start to return to posting growth within the interconnect solutions business on a year-over-year basis. just given that last year was a little odd with respect to the smartphone shipments of what they normally do this year, it's more on a normal pattern. So you saw the headwind in the first half as we posted volume declines, we expect to have volume increases in the second half with the interconnect solutions not a year-over-year basis, but sequentially, no, no material change to our usual pattern.
With the one exception, as Ed had mentioned, at the Kapton line coming on, which will provide some incremental revenue in the back half of the year.
Alex Yefremov -- KeyBanc Capital Markets -- Analyst
Makes sense. Thanks, Lori. To follow up on W&P, your margin comments that margins would be similar in the back half compared to the first half. Is this also a function of the outage that you see? Because I seem to remember you were expecting higher margins in the back half.
Is this still an expectation maybe just delayed into fourth quarter or first quarter of '23?
Lori Koch -- Chief Financial Officer
Yeah. I mean I think maybe coming into the year, we had expected some margin improvement as we went into the back half, but the last quarter and this quarter, we've seen those more flatten out. It's a function of, one, the incremental price headwinds that we've seen. So a lot of it is that.
So recall back when we originally gave guidance for the full year, we thought overall raw materials, logistics, and energy would only be $350 million. That number has now went to $700 million as we have mentioned, and the majority of that increase is in W&P. So that creates as reported margin headwind for us.
Alex Yefremov -- KeyBanc Capital Markets -- Analyst
Thanks, Lori.
Operator
Your next question comes from Josh Spector from UBS. Please go ahead.
Josh Spector -- UBS -- Analyst
Hi. Thanks for taking my question. I guess within safety solutions, can you comment on how the business, excluding Tyvek, is running. I guess is there anything materially different there we should be thinking about from a volume perspective that might be better or worse relative to industrial production or any other metrics we should be looking out for? Thanks.
Lori Koch -- Chief Financial Officer
Yes. No, those are generally performing. Well, we had a little bit of a shortfall in the second quarter with access to raw materials within our Nomex. So it really wasn't a structural demand issue or an operational issue is we couldn't get access to some of the key inputs to make the Nomex product.
But nothing to work through on the Aramid side as far as asset utilization like we're seeing on the tieback side with the increased changeovers as we ride through the garment change.
Josh Spector -- UBS -- Analyst
I guess just on the demand side as well, anything changing through the quarter? Or are you seeing any weakening with customers may be pulling back on spending? Or is demand still relatively steady?
Lori Koch -- Chief Financial Officer
No. Demand is still steady in the market yes.
Josh Spector -- UBS -- Analyst
OK. Thank you.
Operator
Your next question comes from Mike Sison from Wells Fargo. Please go ahead.
Mike Sison -- Wells Fargo Securities -- Analyst
Hey, good morning. Nice quarter. In terms of Rogers, can you remind us what type of sales growth you expect in 2022? It sounds like it's coming on plan and looks pretty good. And then if there is a shortfall versus the $270 million in EBITDA, it sounds like as you head into '23, the bulk of the shortfall will be somewhat within their control to close the gap?
Ed Breen -- Chief Executive Officer
Yes. The items they're having operationally all are in their control, I would say, except for the silicon supply which obviously we're having the same issues here, so we understand it. But yes, others are going to control, so they can work through those. As you said, it hopefully tee up well for of 2023.
The modeling by the way, for them was for growth in the high single digits in 2022. And they hit that, obviously, in the first quarter. And I can't say anything about the second quarter, I'm not allowed to, but we would expect them to perform high single digits this year on top line. So that's nice and to Lori's point a few minutes ago, they're really seeing nice opportunities as we are on the EV side.
So feeling good about that work through the operational issues.
Mike Sison -- Wells Fargo Securities -- Analyst
Got it. And as a quick follow-up, at the midpoint for your 2022 guidance would imply that the fourth quarter could be up sequentially versus the third quarter. That's seasonally difficult, I guess, when you look back historically so any thoughts on why it could be better fourth quarter versus third, if you were to hit the midpoint?
Lori Koch -- Chief Financial Officer
Yes. So the math you're getting to is about a $30 million sequential increase from 3Q at approximately $810 million and then you back into about $840 million. So it's really coming from three primary drivers. One is you don't have the headwind from the outage at Spruance.
We have sized that at $15 million. So you're able to get that volume back in the fourth quarter. And then the other two key drivers are the capacity additions that we have from the water asset that we spoke about earlier and then Kapton getting production off that cap online. So no underlying change in market of those three items.
Mike Sison -- Wells Fargo Securities -- Analyst
OK. Thank you.
Operator
Your next question comes from PJ Juvekar from Citi. Please go ahead.
PJ Juvekar -- Citi -- Analyst
Yes. Good morning. What do -- thank you. What do you see in terms of semiconductor shortages? And how quickly can automotive production come back? Do you think it's a snap back next year? Or is it more of an extended recovery in '23 and '24?
Lori Koch -- Chief Financial Officer
Yes. I mean I think the expectations right now are for 86 million cars produced next year, that's off of 80 million this year, so still well below the high 90s where we used to be. So there's still some opportunity. We see continued strength and growth heading into 2024.
Obviously, it will all depend on is the semiconductor chip shortage resolving itself. But even beyond that, I mean, the third quarter is expected to be up 22% and 7% sequentially. So it feels like things are getting a little bit better there. as we resolve some of the supply chain issues.
Ed Breen -- Chief Executive Officer
PJ, I had also mentioned, back to points Lori was talking about earlier too, we very much care about production on the EV side of things. The new portfolio -- new DuPont portfolio is very much weighted toward that and not the ICE engine. We are more ICE engine-related, I'll say, because of the M&M portfolio, which, by the way, M&M will also sell nice in the EVs. But this new portfolio was very EV-driven.
So the growth rate of that becomes way more important. Obviously, we like the overall growth rate of autos to go up, but it's even very weighted toward that piece.
PJ Juvekar -- Citi -- Analyst
Great. And quickly, one other question on China. You talked about slowdown in smartphones, but what about the property market there, which has been under pressure. And I know the government is trying to revive it.
What are you seeing there? And what's your exposure to the property market in China? Thank you.
Lori Koch -- Chief Financial Officer
Yeah. We actually saw sequential improvement in China, 2Q over 1Q, and that was on top of that extended lockdown. So we were pleased with the results there. To your specific question on the construction market, we don't really have construction in China.
So it wouldn't impact our overall business. The majority of our construction is in the U.S. and in Japan within Asia.
PJ Juvekar -- Citi -- Analyst
Thank you.
Operator
Your next question comes from our last caller for today, Frank Mitsch from Fermium Research.
Frank Mitsch -- Fermium Research -- Analyst
Hey. Good morning and thanks for squeezing me in. Just a follow-up on China, actually. You did 6% organic growth in Asia.
Obviously, the data on T&I that just came out. was somewhat concerning. What are you actually seeing right now in the third quarter as you progress in that part of the world?
Lori Koch -- Chief Financial Officer
Yeah. We expect to see improvement in China again into the third quarter. And so while we still year over year, probably see the flat, we see sequential improvement as you go from 2Q to 3Q.
Frank Mitsch -- Fermium Research -- Analyst
Great. And then overall, you expect volumes to be up 3Q versus 2Q. Is most of that is Kapton the big driver there? Or are there other businesses that you're seeing volumes materially pick up sequentially in 3Q?
Lori Koch -- Chief Financial Officer
No. I mean Kapton is a piece of it. There's smartphone seasonality as well. So usually, we see very high smartphone sales as we head into the Christmas season within the E&I segment and overall electronics, in general, as they prepare for the holidays.
Operator
I will turn the call back over to Chris Mecray for closing remarks.
Chris Mecray -- Vice President, Investor Relations
OK. Thank you, everyone, for joining the call today. For your reference, a copy of this transcript will be posted on DuPont's website. This concludes our call.
Thank you.
Operator
[Operator signoff]
Duration: 0 minutes
Call participants:
Chris Mecray -- Vice President, Investor Relations
Ed Breen -- Chief Executive Officer
Lori Koch -- Chief Financial Officer
Jeff Sprague -- Vertical Research Partners -- Analyst
Scott Davis -- Melius Research -- Analyst
Steve Tusa -- J.P. Morgan -- Analyst
John Walsh -- Credit Suisse -- Analyst
John McNulty -- BMO Capital Markets -- Analyst
Christopher Parkinson -- Mizuho Securities -- Analyst
Steve Byrne -- Bank of America Merrill Lynch -- Analyst
David Begleiter -- Deutsche Bank -- Analyst
Vincent Andrews -- Morgan Stanley -- Analyst
Alex Yefremov -- KeyBanc Capital Markets -- Analyst
Josh Spector -- UBS -- Analyst
Mike Sison -- Wells Fargo Securities -- Analyst
PJ Juvekar -- Citi -- Analyst
Frank Mitsch -- Fermium Research -- Analyst
More DD analysis
All earnings call transcripts
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.
The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. (NYSE: DD) Q2 2022 Earnings Call Aug 02, 2022, 8:00 a.m. More broadly, our focus on execution continues to drive results as we increase our use of digital tools and other plant site investments to drive additional productivity and capacity release. In addition, I will highlight our continued focus on growth execution on the following slide.
|
Operator [Operator signoff] Duration: 0 minutes Call participants: Chris Mecray -- Vice President, Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst John Walsh -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst Christopher Parkinson -- Mizuho Securities -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst David Begleiter -- Deutsche Bank -- Analyst Vincent Andrews -- Morgan Stanley -- Analyst Alex Yefremov -- KeyBanc Capital Markets -- Analyst Josh Spector -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst PJ Juvekar -- Citi -- Analyst Frank Mitsch -- Fermium Research -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont de Nemours, Inc. (NYSE: DD) Q2 2022 Earnings Call Aug 02, 2022, 8:00 a.m. More broadly, our focus on execution continues to drive results as we increase our use of digital tools and other plant site investments to drive additional productivity and capacity release.
|
Operator [Operator signoff] Duration: 0 minutes Call participants: Chris Mecray -- Vice President, Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst John Walsh -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst Christopher Parkinson -- Mizuho Securities -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst David Begleiter -- Deutsche Bank -- Analyst Vincent Andrews -- Morgan Stanley -- Analyst Alex Yefremov -- KeyBanc Capital Markets -- Analyst Josh Spector -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst PJ Juvekar -- Citi -- Analyst Frank Mitsch -- Fermium Research -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont de Nemours, Inc. (NYSE: DD) Q2 2022 Earnings Call Aug 02, 2022, 8:00 a.m. More broadly, our focus on execution continues to drive results as we increase our use of digital tools and other plant site investments to drive additional productivity and capacity release.
|
Operator [Operator signoff] Duration: 0 minutes Call participants: Chris Mecray -- Vice President, Investor Relations Ed Breen -- Chief Executive Officer Lori Koch -- Chief Financial Officer Jeff Sprague -- Vertical Research Partners -- Analyst Scott Davis -- Melius Research -- Analyst Steve Tusa -- J.P. Morgan -- Analyst John Walsh -- Credit Suisse -- Analyst John McNulty -- BMO Capital Markets -- Analyst Christopher Parkinson -- Mizuho Securities -- Analyst Steve Byrne -- Bank of America Merrill Lynch -- Analyst David Begleiter -- Deutsche Bank -- Analyst Vincent Andrews -- Morgan Stanley -- Analyst Alex Yefremov -- KeyBanc Capital Markets -- Analyst Josh Spector -- UBS -- Analyst Mike Sison -- Wells Fargo Securities -- Analyst PJ Juvekar -- Citi -- Analyst Frank Mitsch -- Fermium Research -- Analyst More DD analysis All earnings call transcripts This article is a transcript of this conference call produced for The Motley Fool. DuPont de Nemours, Inc. (NYSE: DD) Q2 2022 Earnings Call Aug 02, 2022, 8:00 a.m. More broadly, our focus on execution continues to drive results as we increase our use of digital tools and other plant site investments to drive additional productivity and capacity release.
|
738ae03e-a9fa-4682-bf0b-3ef346715302
|
715982.0
|
2022-08-02 00:00:00 UTC
|
Wall Street falls on rising U.S.-China tensions, Caterpillar shares weigh
|
DD
|
https://www.nasdaq.com/articles/wall-street-falls-on-rising-u.s.-china-tensions-caterpillar-shares-weigh
|
nan
|
nan
|
By Aniruddha Ghosh and Devik Jain
Aug 2 (Reuters) - Wall Street's major indexes fell on Tuesday on concerns over rising U.S.-China tensions ahead of the arrival of U.S. House of Representatives Speaker Nancy Pelosi in Taiwan, with losses in industrial bellwether Caterpillar adding to the slide.
Shares of chipmakers with a large exposure to China fell, while Caterpillar CAT.N slid 3.6% as slowing construction activity in the world's second largest economy and a halt in Russia operations added to its supply-chain woes.
"Chip stocks are really exposed to Asia. Some of them have 70% of their sales, especially chip equipment companies, in that region so it's a big deal for them," said Jack DeGan, chief investment officer at Harbor Advisory.
The latest geopolitical uncertainty comes at a time when financial markets are struggling to grapple with the fallout of the Ukraine war, an energy crisis in Europe, soaring inflation and tightening of financial conditions.
"Any kind of geopolitical concern can cause traders who gained quite a bit last week to take a little bit (profit) off the table."
The CBOE volatility index .VIX, also known as Wall Street's fear gauge, rose to 24.31 points, its highest level in nearly a week and the Philadelphia SE semiconductor index .SOX fell 1%.
At 10:16 a.m. ET, the Dow Jones Industrial Average .DJI was down 301.47 points, or 0.92%, at 32,496.93, the S&P 500 .SPX was down 25.27 points, or 0.61%, at 4,093.36, and the Nasdaq Composite .IXIC was down 56.02 points, or 0.45%, at 12,312.95.
Among individual stocks, DuPont de Nemours DD.N fell 1.4% after the industrial materials maker cut full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.6% on downbeat 2022 profit forecast.
Uber Technologies Inc UBER.N jumped 14.1% after the ride-hailing firm reported positive quarterly cash flow for the first time ever and forecast upbeat third-quarter operating profit.
Pinterest Inc PINS.N surged 13.3% as the activist investor Elliott Investment Management become the largest shareholder of the digital pin-board firm.
Meanwhile, data showed U.S. job openings fell more than expected in June, suggesting that labor demand was starting to cool, which could ease the pressure on the Federal Reserve to aggressively raising interest rates.
The U.S. central bank has raised rates by 2.25 percentage points this year and has vowed to be data-driven in its approach toward future hikes.
Declining issues outnumbered advancers for a 1.90-to-1 ratio on the NYSE and for a 1.11-to-1 ratio on the Nasdaq.
The S&P index recorded one new 52-week highs and 30 new lows, while the Nasdaq recorded 21 new highs and 41 new lows.
(Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva and Arun Koyyur)
((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - Wall Street's major indexes fell on Tuesday on concerns over rising U.S.-China tensions ahead of the arrival of U.S. House of Representatives Speaker Nancy Pelosi in Taiwan, with losses in industrial bellwether Caterpillar adding to the slide. Shares of chipmakers with a large exposure to China fell, while Caterpillar CAT.N slid 3.6% as slowing construction activity in the world's second largest economy and a halt in Russia operations added to its supply-chain woes. Among individual stocks, DuPont de Nemours DD.N fell 1.4% after the industrial materials maker cut full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.6% on downbeat 2022 profit forecast.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - Wall Street's major indexes fell on Tuesday on concerns over rising U.S.-China tensions ahead of the arrival of U.S. House of Representatives Speaker Nancy Pelosi in Taiwan, with losses in industrial bellwether Caterpillar adding to the slide. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva and Arun Koyyur) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Shares of chipmakers with a large exposure to China fell, while Caterpillar CAT.N slid 3.6% as slowing construction activity in the world's second largest economy and a halt in Russia operations added to its supply-chain woes.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - Wall Street's major indexes fell on Tuesday on concerns over rising U.S.-China tensions ahead of the arrival of U.S. House of Representatives Speaker Nancy Pelosi in Taiwan, with losses in industrial bellwether Caterpillar adding to the slide. Among individual stocks, DuPont de Nemours DD.N fell 1.4% after the industrial materials maker cut full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.6% on downbeat 2022 profit forecast. Shares of chipmakers with a large exposure to China fell, while Caterpillar CAT.N slid 3.6% as slowing construction activity in the world's second largest economy and a halt in Russia operations added to its supply-chain woes.
|
By Aniruddha Ghosh and Devik Jain Aug 2 (Reuters) - Wall Street's major indexes fell on Tuesday on concerns over rising U.S.-China tensions ahead of the arrival of U.S. House of Representatives Speaker Nancy Pelosi in Taiwan, with losses in industrial bellwether Caterpillar adding to the slide. Shares of chipmakers with a large exposure to China fell, while Caterpillar CAT.N slid 3.6% as slowing construction activity in the world's second largest economy and a halt in Russia operations added to its supply-chain woes. Among individual stocks, DuPont de Nemours DD.N fell 1.4% after the industrial materials maker cut full-year outlook, while shares of credit-rating company S&P Global Inc SPGI.N dipped 2.6% on downbeat 2022 profit forecast.
|
5f81ed4e-42e3-4220-ad6b-43cb61073cba
|
715983.0
|
2022-08-02 00:00:00 UTC
|
DuPont's (DD) Earnings and Revenues Trounce Estimates in Q2
|
DD
|
https://www.nasdaq.com/articles/duponts-dd-earnings-and-revenues-trounce-estimates-in-q2
|
nan
|
nan
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 71 cents per share for second-quarter 2022, down from 73 cents per share in the year-ago quarter.
Barring one-time items, earnings came in at 88 cents per share for the reported quarter, topping the Zacks Consensus Estimate of 74 cents.
DuPont raked in net sales of $3,322 million, up 7% from the year-ago quarter. It also surpassed the Zacks Consensus Estimate of $3,254.7 million. The company saw a 9% rise in organic sales in the quarter, supported by 1% higher volumes and 8% pricing gains. Pricing actions fully offset raw materials, logistics and energy cost inflation.
Volume gains were aided by strong demand in semiconductor, general industrial, water and construction end-markets, offset by reduced volumes from protective garments within the Safety Solutions business. The company saw strong underlying demand in its major end-markets during the quarter.
DuPont de Nemours, Inc. Price, Consensus and EPS Surprise
DuPont de Nemours, Inc. price-consensus-eps-surprise-chart | DuPont de Nemours, Inc. Quote
Segment Highlights
The company’s Electronics & Industrial segment recorded net sales of $1,527 million in the reported quarter, up 16% on a year-over-year comparison basis. Organic sales rose 8% on higher volumes and prices. Semiconductor Technologies organic sales rose on strong demand. Industrial Solutions also registered higher sales while organic sales declined in Interconnect Solutions on lower volumes.
Net sales in the Water & Protection unit were $1,497 million, up 6% year over year. Organic sales rose 9% on 12% pricing gains. Volumes fell 3% in the quarter.
Financials
DuPont had cash and cash equivalents of $1,439 million at the end of the quarter, down around 64% year over year. Long-term debt was $10,625 million, roughly flat year over year.
The company also generated operating cash flow of $86 million during the quarter. It returned $665 million to shareholders through share repurchases and dividends during the quarter.
Outlook
The company sees net sales for 2022 to be between $13 billion and $13.4 billion. It also narrowed its adjusted earnings per share (EPS) guidance for 2022 to the band of $3.27-$3.43 from its earlier view of $3.20-$3.50.
DuPont expects net sales of between $3.17 billion and $3.37 billion for the third quarter of 2022. Adjusted EPS is forecast to be around 81 cents for the quarter.
The company envisions net sales and operating EBITDA for the third quarter to be modestly weaker than the second quarter as higher sequential volumes are expected to be offset by foreign currency headwinds and the absence of the Biomaterials net sales contribution.
DuPont also sees an unfavorable impact in the third quarter on operating EBITDA of roughly $15 million from unplanned downtime at its Spruance site in Virginia. It expects third-quarter net sales to be up 2% at the mid-point of the guidance range on a year-over-year basis, or up high single-digits on an organic basis.
Price Performance
DuPont’s shares are down 19.1% over a year compared with an 8.6% decline recorded by the industry.
Image Source: Zacks Investment Research
Zacks Rank & Other Key Picks
DuPont currently carries a Zacks Rank #5 (Strong Sell).
Better-ranked stocks worth considering in the basic materials space include Cabot Corporation CBT, ATI Inc. ATI and Albemarle Corporation ALB.
Cabot, currently carrying a Zacks Rank #1 (Strong Buy), has an expected earnings growth rate of 22.5% for the current fiscal year. The Zacks Consensus Estimate for CBT's earnings for the current fiscal has been revised 0.8% upward in the past 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.
Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 37% over a year.
ATI, currently carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 1,069.2% for the current year. The Zacks Consensus Estimate for ATI's current-year earnings has been revised 12.5% upward in the past 60 days.
ATI’s earnings beat the Zacks Consensus Estimate in the last four quarters. It has a trailing four-quarter earnings surprise of roughly 128.9%, on average. ATI shares are up around 27% in a year.
Albemarle has a projected earnings growth rate of 247% for the current year. The Zacks Consensus Estimate for ALB’s current-year earnings has been revised 7.8% upward in the past 60 days.
Albemarle’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 20%. ALB has gained roughly 16% in a year. The company flaunts a Zacks Rank #2.
Zacks' Top Picks to Cash in on Electric Vehicles
Big money has already been made in the Electric Vehicle (EV) industry. But, the EV revolution has not hit full throttle yet. There is a lot of money to be made as the next push for future technologies ramps up. Zacks’ Special Report reveals 5 picks investors
See 5 EV Stocks With Extreme Upside Potential >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ATI Inc. (ATI): Free Stock Analysis Report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Albemarle Corporation (ALB): Free Stock Analysis Report
Cabot Corporation (CBT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 71 cents per share for second-quarter 2022, down from 73 cents per share in the year-ago quarter. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont also sees an unfavorable impact in the third quarter on operating EBITDA of roughly $15 million from unplanned downtime at its Spruance site in Virginia.
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 71 cents per share for second-quarter 2022, down from 73 cents per share in the year-ago quarter. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours, Inc. Price, Consensus and EPS Surprise DuPont de Nemours, Inc. price-consensus-eps-surprise-chart | DuPont de Nemours, Inc. Quote Segment Highlights The company’s Electronics & Industrial segment recorded net sales of $1,527 million in the reported quarter, up 16% on a year-over-year comparison basis.
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 71 cents per share for second-quarter 2022, down from 73 cents per share in the year-ago quarter. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report Barring one-time items, earnings came in at 88 cents per share for the reported quarter, topping the Zacks Consensus Estimate of 74 cents.
|
DuPont de Nemours, Inc. DD logged earnings (on a reported basis) from continuing operations of 71 cents per share for second-quarter 2022, down from 73 cents per share in the year-ago quarter. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report The company saw a 9% rise in organic sales in the quarter, supported by 1% higher volumes and 8% pricing gains.
|
c101cf61-0ecf-4eaf-8506-b8f7e8f5e803
|
715984.0
|
2022-08-02 00:00:00 UTC
|
US STOCKS-Futures fall as U.S.-China tensions grow
|
DD
|
https://www.nasdaq.com/articles/us-stocks-futures-fall-as-u.s.-china-tensions-grow
|
nan
|
nan
|
By Aniruddha Ghosh
Aug 2 (Reuters) - U.S. stock index futures fell on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China.
The latest geopolitical uncertainty comes at a time when financial markets are already dealing with the fallout from a war in Ukraine, energy crisis in Europe, soaring inflation and tightening of financial conditions.
Shares of chipmakers, which have a large exposure to China, fell in premarket trading. Qualcomm QCOM.O, Intel Corp INTC.O, Advanced Micro Devices AMD.O, Micron Technology Inc MU.O and Nvidia Corp NVDA.O were down between 1.3% and 2%.
The CBOE volatility index .VIX, also known as Wall Street's fear gauge, rose to 24.50 points, its highest level in a week.
At 6:58 a.m. ET, Dow e-minis 1YMcv1 were down 218 points, or 0.67%, S&P 500 e-minis EScv1 were down 32.5 points, or 0.79%, and Nasdaq 100 e-minis NQcv1 were down 124.5 points, or 0.96%.
Markets have kicked off August on a lackluster note amid heightened fears of a global recession, after data showed factory activity weakened across the United States, Europe and Asia.
Against the backdrop of a difficult macro-economic environment, investors have become increasingly jittery about the health of corporate America.
DuPont de Nemours DD.N fell 2.7% after the industrial materials maker lowered its full-year adjusted earnings and net sales outlook.
Caterpillar Inc CAT.N slid 6.9% after its quarterly sales missed market expectations due to supply-chain issues and the suspension of its Russia operations.
Pinterest Inc PINS.N jumped 19.4% as the activist investor Elliott Investment Management become the largest shareholder of the digital pin-board firm.
(Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva)
((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh Aug 2 (Reuters) - U.S. stock index futures fell on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2.7% after the industrial materials maker lowered its full-year adjusted earnings and net sales outlook. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh Aug 2 (Reuters) - U.S. stock index futures fell on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2.7% after the industrial materials maker lowered its full-year adjusted earnings and net sales outlook. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh Aug 2 (Reuters) - U.S. stock index futures fell on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2.7% after the industrial materials maker lowered its full-year adjusted earnings and net sales outlook. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Aniruddha Ghosh Aug 2 (Reuters) - U.S. stock index futures fell on Tuesday on concerns that a planned visit by U.S. House of Representatives Speaker Nancy Pelosi to Taiwan could worsen tensions between the United States and China. DuPont de Nemours DD.N fell 2.7% after the industrial materials maker lowered its full-year adjusted earnings and net sales outlook. (Reporting by Aniruddha Ghosh and Devik Jain in Bengaluru; Editing by Anil D'Silva) ((Aniruddha.Ghosh@thomsonreuters.com; 91 83 83 81 2416;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
f5f3a926-a281-4771-b44c-51a958b82c2d
|
715985.0
|
2022-08-02 00:00:00 UTC
|
DuPont quarterly profit beat estimates on strong electronics demand
|
DD
|
https://www.nasdaq.com/articles/dupont-quarterly-profit-beat-estimates-on-strong-electronics-demand
|
nan
|
nan
|
Adds details on outlook, shares estimates
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a second-quarter profit that beat Wall Street estimates on Tuesday, bolstered by strong demand for electronics and construction materials.
DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies.
The company, once part of the erstwhile chemical giant DowDuPont, lowered its full-year adjusted earnings to $3.27 and $3.43 per share from its previous guidance of $3.2 to $3.5.
It also toned down annual net sales forecast to between $13 billion and $13.4 billion, from up to $13.7 billion outlined earlier.
Dupont said net sales and operating core earnings in the current quarter would be slightly weaker than second quarter, due to currency headwinds and the absence of the Biomaterials sales contribution.
Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the second quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier.
"Underlying demand during the quarter in our key end-markets remained strong", Chief Executive Officer Ed Breen said in a statement.
To offset the inflationary pressures, Dupont hiked prices of its products by 8% during the quarter.
The company's quarterly adjusted profit of 88 cents per share, came above market estimates of 75 cents per share, according to Refinitiv IBES data.
Total sales jumped 7% to $3.32 billion, beating estimates of $3.25 billion.
Shares were up 1.81% at $61.29 in premarket trading.
(Reporting by Rithika Krishna in Bengaluru; Editing by Rashmi Aich)
((Rithika.Krishna@thomsonreuters.com; Twitter: https://twitter.com/rithika_krishna;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds details on outlook, shares estimates Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a second-quarter profit that beat Wall Street estimates on Tuesday, bolstered by strong demand for electronics and construction materials. The company, once part of the erstwhile chemical giant DowDuPont, lowered its full-year adjusted earnings to $3.27 and $3.43 per share from its previous guidance of $3.2 to $3.5. "Underlying demand during the quarter in our key end-markets remained strong", Chief Executive Officer Ed Breen said in a statement.
|
Adds details on outlook, shares estimates Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a second-quarter profit that beat Wall Street estimates on Tuesday, bolstered by strong demand for electronics and construction materials. The company's quarterly adjusted profit of 88 cents per share, came above market estimates of 75 cents per share, according to Refinitiv IBES data. Total sales jumped 7% to $3.32 billion, beating estimates of $3.25 billion.
|
Adds details on outlook, shares estimates Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a second-quarter profit that beat Wall Street estimates on Tuesday, bolstered by strong demand for electronics and construction materials. Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the second quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier. The company's quarterly adjusted profit of 88 cents per share, came above market estimates of 75 cents per share, according to Refinitiv IBES data.
|
Adds details on outlook, shares estimates Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a second-quarter profit that beat Wall Street estimates on Tuesday, bolstered by strong demand for electronics and construction materials. DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies. The company's quarterly adjusted profit of 88 cents per share, came above market estimates of 75 cents per share, according to Refinitiv IBES data.
|
9b0c3a8b-f651-44d1-9b02-2eb650947dff
|
715986.0
|
2022-08-02 00:00:00 UTC
|
EI DuPont De Nemours & Co. Reveals Increase In Q2 Bottom Line
|
DD
|
https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-reveals-increase-in-q2-bottom-line
|
nan
|
nan
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year
The company's bottom line totaled $787 million, or $1.55 per share. This compares with $478 million, or $0.90 per share, in last year's second quarter.
Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period.
The company's revenue for the quarter rose 7.1% to $3.32 billion from $3.10 billion last year.
EI DuPont De Nemours & Co. earnings at a glance (GAAP) :
-Earnings (Q2): $787 Mln. vs. $478 Mln. last year. -EPS (Q2): $1.55 vs. $0.90 last year. -Revenue (Q2): $3.32 Bln vs. $3.10 Bln last year.
-Guidance: Full year EPS guidance: $3.27 -$3.43 Full year revenue guidance: $13,000 -$13,400 Mln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period. -Guidance: Full year EPS guidance: $3.27 -$3.43 Full year revenue guidance: $13,000 -$13,400 Mln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period. EI DuPont De Nemours & Co. earnings at a glance (GAAP) : -Earnings (Q2): $787 Mln.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period. -Guidance: Full year EPS guidance: $3.27 -$3.43 Full year revenue guidance: $13,000 -$13,400 Mln The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period. vs. $478 Mln.
|
8c537db9-58f2-46c5-9963-a234e2f67781
|
715987.0
|
2022-08-02 00:00:00 UTC
|
DuPont quarterly profit jumps 63% on strong electronics demand
|
DD
|
https://www.nasdaq.com/articles/dupont-quarterly-profit-jumps-63-on-strong-electronics-demand
|
nan
|
nan
|
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 63% surge in second-quarter profit on Tuesday, bolstered by strong demand for electronics and construction materials.
DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies.
Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier.
"Underlying demand during the quarter in our key end-markets remained strong", Chief Executive Officer Ed Breen said in a statement.
The company, once part of the erstwhile chemical giant DowDuPont, lowered its full-year adjusted earnings to be between $3.27 and $3.43 per share, compared with its previous guidance of $3.2 to $3.5, citing impact from foreign currency headwinds and divestiture of its biomaterials unit.
It also toned down annual net sales forecast to between $13 billion and $13.4 billion, from $13.3 billion and $13.7 billion outlined earlier.
To offset the inflationary pressures, Dupont hiked prices of its products by 8% during the quarter.
The company's net income was $795 million, or $1.55 per share, in the three months ended June 30, compared with $487 million, or 90 cents per share, a year earlier.
Total sales jumped 7% to $3.32 billion.
(Reporting by Rithika Krishna in Bengaluru; Editing by Rashmi Aich)
((Rithika.Krishna@thomsonreuters.com; Twitter: https://twitter.com/rithika_krishna;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 63% surge in second-quarter profit on Tuesday, bolstered by strong demand for electronics and construction materials. DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies. "Underlying demand during the quarter in our key end-markets remained strong", Chief Executive Officer Ed Breen said in a statement.
|
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 63% surge in second-quarter profit on Tuesday, bolstered by strong demand for electronics and construction materials. Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier. It also toned down annual net sales forecast to between $13 billion and $13.4 billion, from $13.3 billion and $13.7 billion outlined earlier.
|
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 63% surge in second-quarter profit on Tuesday, bolstered by strong demand for electronics and construction materials. DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies. Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier.
|
Aug 2 (Reuters) - Industrial materials maker DuPont de Nemours DD.N reported a 63% surge in second-quarter profit on Tuesday, bolstered by strong demand for electronics and construction materials. DuPont, which makes electronic materials used in chip packaging and mobile devices, said it benefited from a firm demand for high-end semiconductor technologies boosted by growth in 5G communications and data centers, amid an ongoing transition to more advanced node technologies. Sales from electronics and industrial unit, one of the company's highest revenue generating segments, rose 16% to $1.53 billion in the quarter, while the water and protection segment, which provides treatment and purification technologies, brought in $1.5 billion, up 6% from a year earlier.
|
a080c5bb-b510-4416-a608-c9ea9113d76c
|
715988.0
|
2022-08-02 00:00:00 UTC
|
EI DuPont De Nemours & Co. Q2 22 Earnings Conference Call At 8:00 AM ET
|
DD
|
https://www.nasdaq.com/articles/ei-dupont-de-nemours-co.-q2-22-earnings-conference-call-at-8%3A00-am-et
|
nan
|
nan
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on August 2, 2022, to discuss Q2 22 earnings results.
To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx
To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on August 2, 2022, to discuss Q2 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on August 2, 2022, to discuss Q2 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on August 2, 2022, to discuss Q2 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) will host a conference call at 8:00 AM ET on August 2, 2022, to discuss Q2 22 earnings results. To access the live webcast, log on to https://www.investors.dupont.com/investors/dupont-investors/events-and-presentations/default.aspx To Participate in the call, dial (888) 440-4172 (US) or +1(646) 960-0673 (Inernational) and Conference ID is 5994046. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
099a71cc-d593-4e64-9b86-b360358c639f
|
715989.0
|
2022-08-02 00:00:00 UTC
|
DuPont Reveals Increase In Q2 Bottom Line; Narrows FY22 Guidance - Update
|
DD
|
https://www.nasdaq.com/articles/dupont-reveals-increase-in-q2-bottom-line-narrows-fy22-guidance-update
|
nan
|
nan
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year
The company's bottom line totaled $787 million, or $1.55 per share. This compares with $478 million, or $0.90 per share, in last year's second quarter.
Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period.
The company's revenue for the quarter rose 7.1% to $3.32 billion from $3.10 billion last year.
Outlook
DuPont narrowed its full-year earnings guidance.
The company now expects earnings for the year of $3.27-$3.43, compared to $3.20-$3.50 provided earlier, citing foreign currency headwinds and absence of contribution from Biomaterials business, which was sold in May.
On average, 13 analysts polled by Thomson Reuters expect earnings of $4.30 per share for the year. Analysts' estimates typically exclude special items.
Net sales for the year are now expected to be $13 billion to $13.40 billion, while analysts expect $16.5 billion for the year.
For the third quarter, the company expects adjusted earnings per share of around $0.81 and net sales between $3.17 billion and $3.37 billion. Analysts expect earnings of $1.1 per share on sales of $4.17 billion.
Lori Koch, chief financial officer, said the company is also expecting third-quarter net sales and operating EBITDA to be slightly weaker than second quarter 2022 .
EI DuPont De Nemours & Co. earnings at a glance (GAAP) :
-Earnings (Q2): $787 Mln. vs. $478 Mln. last year. -EPS (Q2): $1.55 vs. $0.90 last year. -Revenue (Q2): $3.32 Bln vs. $3.10 Bln last year.
-Guidance: Full year EPS guidance: $3.27 -$3.43 Full year revenue guidance: $13,000 -$13,400 Mln
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. The company now expects earnings for the year of $3.27-$3.43, compared to $3.20-$3.50 provided earlier, citing foreign currency headwinds and absence of contribution from Biomaterials business, which was sold in May. Lori Koch, chief financial officer, said the company is also expecting third-quarter net sales and operating EBITDA to be slightly weaker than second quarter 2022 .
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Excluding items, EI DuPont De Nemours & Co. reported adjusted earnings of $446 million or $0.88 per share for the period. For the third quarter, the company expects adjusted earnings per share of around $0.81 and net sales between $3.17 billion and $3.37 billion.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. Net sales for the year are now expected to be $13 billion to $13.40 billion, while analysts expect $16.5 billion for the year. For the third quarter, the company expects adjusted earnings per share of around $0.81 and net sales between $3.17 billion and $3.37 billion.
|
(RTTNews) - EI DuPont De Nemours & Co. (DD) released a profit for its second quarter that increased from the same period last year The company's bottom line totaled $787 million, or $1.55 per share. This compares with $478 million, or $0.90 per share, in last year's second quarter. For the third quarter, the company expects adjusted earnings per share of around $0.81 and net sales between $3.17 billion and $3.37 billion.
|
169748b2-f5ee-461c-84dd-682851a6472a
|
715990.0
|
2022-07-28 00:00:00 UTC
|
Eastman Chemical (EMN) Surpasses Q2 Earnings and Revenue Estimates
|
DD
|
https://www.nasdaq.com/articles/eastman-chemical-emn-surpasses-q2-earnings-and-revenue-estimates
|
nan
|
nan
|
Eastman Chemical (EMN) came out with quarterly earnings of $2.83 per share, beating the Zacks Consensus Estimate of $2.69 per share. This compares to earnings of $2.46 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 5.20%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $2.07 per share when it actually produced earnings of $2.06, delivering a surprise of -0.48%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Eastman Chemical, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $2.78 billion for the quarter ended June 2022, surpassing the Zacks Consensus Estimate by 1.14%. This compares to year-ago revenues of $2.65 billion. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Eastman Chemical shares have lost about 21.4% since the beginning of the year versus the S&P 500's decline of -15.6%.
What's Next for Eastman Chemical?
While Eastman Chemical has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Eastman Chemical: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $2.65 on $2.74 billion in revenues for the coming quarter and $9.75 on $10.82 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the bottom 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, DuPont de Nemours (DD), has yet to report results for the quarter ended June 2022. The results are expected to be released on August 2.
This specialty chemicals maker is expected to post quarterly earnings of $0.74 per share in its upcoming report, which represents a year-over-year change of -30.2%. The consensus EPS estimate for the quarter has been revised 1.9% lower over the last 30 days to the current level.
DuPont de Nemours' revenues are expected to be $3.25 billion, down 21.3% from the year-ago quarter.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eastman Chemical Company (EMN): Free Stock Analysis Report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Another stock from the same industry, DuPont de Nemours (DD), has yet to report results for the quarter ended June 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Another stock from the same industry, DuPont de Nemours (DD), has yet to report results for the quarter ended June 2022.
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Another stock from the same industry, DuPont de Nemours (DD), has yet to report results for the quarter ended June 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Another stock from the same industry, DuPont de Nemours (DD), has yet to report results for the quarter ended June 2022. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
e4147a6e-1df9-40cc-809a-46dad90f7e8e
|
715991.0
|
2022-07-28 00:00:00 UTC
|
DuPont (DD) Warms Up to Q2 Earnings: What's in the Cards?
|
DD
|
https://www.nasdaq.com/articles/dupont-dd-warms-up-to-q2-earnings%3A-whats-in-the-cards
|
nan
|
nan
|
DuPont de Nemours, Inc. DD is scheduled to come up with second-quarter 2022 results, before the opening bell on Aug 2. The company is likely to have benefited from strong end-market demand and its pricing and productivity actions. However, its results are likely to reflect the impacts of raw material cost inflation and supply-chain challenges.
The company surpassed the Zacks Consensus Estimate in each of the trailing four quarters. In this timeframe, it delivered an earnings surprise of around 11.2%, on average. It posted an earnings surprise of 22.4% in the last reported quarter.
DuPont’s shares have lost 20% over a year compared with 11.6% decline recorded by the industry it belongs to.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What do the Estimates Say?
The Zacks Consensus Estimate for revenues for the second quarter for DuPont is currently pinned at $3,265.2 million, suggesting an expected year-over-year decline of 21%.
Some Factors to Watch For
The company is expected to have benefited from sustained strong global demand in semiconductors in the second quarter. Strong demand in electronics, industrial technologies and construction end-markets is likely to have supported its volumes.
DuPont is also likely to have benefited from its cost and productivity actions in the quarter to be reported. Its structural cost actions are likely to have contributed to its bottom line in the quarter.
The company is likely to have gained from its pricing actions. It continues to implement strategic price increases to offset the cost inflation. These actions are likely to have supported its results in the June quarter.
However, the company is likely to have faced challenges from higher raw material and logistics costs in the second quarter. Supply constraints for major raw materials are expected to have continued in the June quarter. Higher energy costs are also expected to have impacted its results.
DuPont is also likely to have faced headwinds from global supply-chain challenges, exacerbated by the impact of the Russia-Ukraine conflict and new pandemic-related shutdowns in China. This might have impacted volumes and margins in the second quarter.
DuPont de Nemours, Inc. Price and EPS Surprise
DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote
Zacks Model
Our proven model does not conclusively predict an earnings beat for DuPont this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for DuPont is -0.65%. The Zacks Consensus Estimate for earnings for the second quarter is currently pegged at 74 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: DuPont currently carries a Zacks Rank #4 (Sell).
Stocks That Warrant a Look
Here are some companies in the basic materials space you may want to consider as our model shows these have the right combination of elements to post an earnings beat this quarter:
Albemarle Corporation ALB, scheduled to release earnings on Aug 3, has an Earnings ESP of +11.87% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Albemarle's second-quarter earnings has been revised 11.8% upward over the past 60 days. The consensus estimate for ALB’s earnings for the quarter is currently pegged at $2.94.
Cabot Corporation CBT, slated to release earnings on Aug 8, has an Earnings ESP of +0.16% and sports a Zacks Rank #1.
The consensus estimate for Cabot’s fiscal third-quarter earnings has been revised 1% upward in the past 60 days. The Zacks Consensus Estimate for CBT’s earnings for the quarter is pegged at $1.53.
Air Products and Chemicals, Inc. APD, slated to release earnings on Aug 4, has an Earnings ESP of +0.29% and carries a Zacks Rank #3.
The Zacks Consensus Estimate for Air Products’ fiscal third-quarter earnings has been stable over the past 60 days. The consensus estimate for APD’s earnings for the quarter stands at $2.61.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Air Products and Chemicals, Inc. (APD): Free Stock Analysis Report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Albemarle Corporation (ALB): Free Stock Analysis Report
Cabot Corporation (CBT): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours, Inc. DD is scheduled to come up with second-quarter 2022 results, before the opening bell on Aug 2. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report The Zacks Consensus Estimate for revenues for the second quarter for DuPont is currently pinned at $3,265.2 million, suggesting an expected year-over-year decline of 21%.
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours, Inc. DD is scheduled to come up with second-quarter 2022 results, before the opening bell on Aug 2. DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
DuPont de Nemours, Inc. DD is scheduled to come up with second-quarter 2022 results, before the opening bell on Aug 2. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report DuPont de Nemours, Inc. Price and EPS Surprise DuPont de Nemours, Inc. price-eps-surprise | DuPont de Nemours, Inc. Quote Zacks Model Our proven model does not conclusively predict an earnings beat for DuPont this season.
|
DuPont de Nemours, Inc. DD is scheduled to come up with second-quarter 2022 results, before the opening bell on Aug 2. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report It posted an earnings surprise of 22.4% in the last reported quarter.
|
c9d84ee9-877b-4d42-96a7-1be730f43dae
|
715992.0
|
2022-07-26 00:00:00 UTC
|
Ex-Dividend Reminder: Jacobs Engineering Group, CSW Industrials and DuPont
|
DD
|
https://www.nasdaq.com/articles/ex-dividend-reminder%3A-jacobs-engineering-group-csw-industrials-and-dupont
|
nan
|
nan
|
Looking at the universe of stocks we cover at Dividend Channel, on 7/28/22, Jacobs Engineering Group, Inc. (Symbol: J), CSW Industrials Inc (Symbol: CSWI), and DuPont (Symbol: DD) will all trade ex-dividend for their respective upcoming dividends. Jacobs Engineering Group, Inc. will pay its quarterly dividend of $0.23 on 8/26/22, CSW Industrials Inc will pay its quarterly dividend of $0.17 on 8/12/22, and DuPont will pay its quarterly dividend of $0.33 on 9/15/22. As a percentage of J's recent stock price of $130.14, this dividend works out to approximately 0.18%, so look for shares of Jacobs Engineering Group, Inc. to trade 0.18% lower — all else being equal — when J shares open for trading on 7/28/22. Similarly, investors should look for CSWI to open 0.15% lower in price and for DD to open 0.57% lower, all else being equal.
Below are dividend history charts for J, CSWI, and DD, showing historical dividends prior to the most recent ones declared.
Jacobs Engineering Group, Inc. (Symbol: J):
CSW Industrials Inc (Symbol: CSWI):
DuPont (Symbol: DD):
In general, dividends are not always predictable, following the ups and downs of company profits over time. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. This can help in judging whether the most recent dividends from these companies are likely to continue. If they do continue, the current estimated yields on annualized basis would be 0.71% for Jacobs Engineering Group, Inc., 0.60% for CSW Industrials Inc, and 2.30% for DuPont.
In Tuesday trading, Jacobs Engineering Group, Inc. shares are currently trading flat, CSW Industrials Inc shares are up about 0.1%, and DuPont shares are off about 1% on the day.
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Looking at the universe of stocks we cover at Dividend Channel, on 7/28/22, Jacobs Engineering Group, Inc. (Symbol: J), CSW Industrials Inc (Symbol: CSWI), and DuPont (Symbol: DD) will all trade ex-dividend for their respective upcoming dividends. Similarly, investors should look for CSWI to open 0.15% lower in price and for DD to open 0.57% lower, all else being equal. Below are dividend history charts for J, CSWI, and DD, showing historical dividends prior to the most recent ones declared.
|
Looking at the universe of stocks we cover at Dividend Channel, on 7/28/22, Jacobs Engineering Group, Inc. (Symbol: J), CSW Industrials Inc (Symbol: CSWI), and DuPont (Symbol: DD) will all trade ex-dividend for their respective upcoming dividends. Jacobs Engineering Group, Inc. (Symbol: J): CSW Industrials Inc (Symbol: CSWI): DuPont (Symbol: DD): In general, dividends are not always predictable, following the ups and downs of company profits over time. Similarly, investors should look for CSWI to open 0.15% lower in price and for DD to open 0.57% lower, all else being equal.
|
Looking at the universe of stocks we cover at Dividend Channel, on 7/28/22, Jacobs Engineering Group, Inc. (Symbol: J), CSW Industrials Inc (Symbol: CSWI), and DuPont (Symbol: DD) will all trade ex-dividend for their respective upcoming dividends. Jacobs Engineering Group, Inc. (Symbol: J): CSW Industrials Inc (Symbol: CSWI): DuPont (Symbol: DD): In general, dividends are not always predictable, following the ups and downs of company profits over time. Similarly, investors should look for CSWI to open 0.15% lower in price and for DD to open 0.57% lower, all else being equal.
|
Looking at the universe of stocks we cover at Dividend Channel, on 7/28/22, Jacobs Engineering Group, Inc. (Symbol: J), CSW Industrials Inc (Symbol: CSWI), and DuPont (Symbol: DD) will all trade ex-dividend for their respective upcoming dividends. Similarly, investors should look for CSWI to open 0.15% lower in price and for DD to open 0.57% lower, all else being equal. Below are dividend history charts for J, CSWI, and DD, showing historical dividends prior to the most recent ones declared.
|
de863721-7b65-4051-a283-5166d2930fdb
|
715993.0
|
2022-07-26 00:00:00 UTC
|
Analysts Estimate DuPont de Nemours (DD) to Report a Decline in Earnings: What to Look Out for
|
DD
|
https://www.nasdaq.com/articles/analysts-estimate-dupont-de-nemours-dd-to-report-a-decline-in-earnings%3A-what-to-look-out
|
nan
|
nan
|
Wall Street expects a year-over-year decline in earnings on lower revenues when DuPont de Nemours (DD) reports results for the quarter ended June 2022. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on August 2, 2022, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on theearnings call it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus Estimate
This specialty chemicals maker is expected to post quarterly earnings of $0.74 per share in its upcoming report, which represents a year-over-year change of -30.2%.
Revenues are expected to be $3.27 billion, down 21% from the year-ago quarter.
Estimate Revisions Trend
The consensus EPS estimate for the quarter has been revised 1.72% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Earnings Whisper
Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for DuPont de Nemours?
For DuPont de Nemours, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.65%.
On the other hand, the stock currently carries a Zacks Rank of #5.
So, this combination makes it difficult to conclusively predict that DuPont de Nemours will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?
Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that DuPont de Nemours would post earnings of $0.67 per share when it actually produced earnings of $0.82, delivering a surprise of +22.39%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom Line
An earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
DuPont de Nemours doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry Player
Another stock from the Zacks Chemical - Diversified industry, Eastman Chemical (EMN), is soon expected to post earnings of $2.69 per share for the quarter ended June 2022. This estimate indicates a year-over-year change of +9.4%. Revenues for the quarter are expected to be $2.75 billion, up 3.7% from the year-ago quarter.
The consensus EPS estimate for Eastman Chemical has been revised 0.5% lower over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of 0.16%.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Eastman Chemical will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
This Little-Known Semiconductor Stock Could Lead to Big Gains for Your Portfolio
The significance of semiconductors can't be overstated. Your smartphone couldn't function without it. Your personal computer would crash in minutes. Digital cameras, washing machines, refrigerators, ovens. You wouldn't be able to use any of them without semiconductors.
Disruptions in the supply chain have given semiconductors tremendous pricing power. That's why they present such a tremendous opportunity for investors.
And today, in a new free report, Zacks' leading stock strategist is revealing the one semiconductor stock that stands to gain the most. It's yours free and with no obligation.
>>Give me access to my free special report.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
Eastman Chemical Company (EMN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Wall Street expects a year-over-year decline in earnings on lower revenues when DuPont de Nemours (DD) reports results for the quarter ended June 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
Wall Street expects a year-over-year decline in earnings on lower revenues when DuPont de Nemours (DD) reports results for the quarter ended June 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
Wall Street expects a year-over-year decline in earnings on lower revenues when DuPont de Nemours (DD) reports results for the quarter ended June 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
Wall Street expects a year-over-year decline in earnings on lower revenues when DuPont de Nemours (DD) reports results for the quarter ended June 2022. That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
|
73af87c1-4a27-49ff-b445-f97ad0c5d0f7
|
715994.0
|
2022-07-25 00:00:00 UTC
|
DuPont de Nemours (DD) Outpaces Stock Market Gains: What You Should Know
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-dd-outpaces-stock-market-gains%3A-what-you-should-know-4
|
nan
|
nan
|
In the latest trading session, DuPont de Nemours (DD) closed at $58.03, marking a +1.34% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.13%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.04%.
Prior to today's trading, shares of the specialty chemicals maker had lost 2.2% over the past month. This has was narrower than the Basic Materials sector's loss of 9.11% and lagged the S&P 500's gain of 5.55% in that time.
Wall Street will be looking for positivity from DuPont de Nemours as it approaches its next earnings report date. This is expected to be August 2, 2022. The company is expected to report EPS of $0.74, down 30.19% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $3.27 billion, down 21.04% from the prior-year quarter.
DD's full-year Zacks Consensus Estimates are calling for earnings of $3.34 per share and revenue of $13.46 billion. These results would represent year-over-year changes of -22.33% and -19.16%, respectively.
Investors might also notice recent changes to analyst estimates for DuPont de Nemours. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 1.39% lower. DuPont de Nemours is holding a Zacks Rank of #5 (Strong Sell) right now.
Investors should also note DuPont de Nemours's current valuation metrics, including its Forward P/E ratio of 17.12. This represents a premium compared to its industry's average Forward P/E of 9.51.
Investors should also note that DD has a PEG ratio of 1.85 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. DD's industry had an average PEG ratio of 1.22 as of yesterday's close.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 203, which puts it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2021. Previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the latest trading session, DuPont de Nemours (DD) closed at $58.03, marking a +1.34% move from the previous day. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.04%. DD's full-year Zacks Consensus Estimates are calling for earnings of $3.34 per share and revenue of $13.46 billion.
|
In the latest trading session, DuPont de Nemours (DD) closed at $58.03, marking a +1.34% move from the previous day. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.04%.
|
DuPont de Nemours, Inc. (DD): Free Stock Analysis Report In the latest trading session, DuPont de Nemours (DD) closed at $58.03, marking a +1.34% move from the previous day. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.04%.
|
In the latest trading session, DuPont de Nemours (DD) closed at $58.03, marking a +1.34% move from the previous day. DuPont de Nemours, Inc. (DD): Free Stock Analysis Report At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.04%.
|
0d100896-55cd-4695-be2e-a895592dcb59
|
715995.0
|
2022-07-22 00:00:00 UTC
|
What To Expect From Corning's Q2?
|
DD
|
https://www.nasdaq.com/articles/what-to-expect-from-cornings-q2
|
nan
|
nan
|
Corning (NYSE: GLW) is scheduled to report its Q2 2022 results on Wednesday, July 27. We expect the company to post revenue and earnings in line with the street expectations. The company should benefit from 5G expansion and cloud computing. However, the Covid induced lockdowns in China may hamper the overall growth. Also, the ongoing semiconductor chip shortage likely weighed on the company’s automotive business. The company undertook pricing actions earlier this year, which should aid the margin expansion in the near term. Although we expect Corning to report an in-line Q2, we find that GLW stock is undervalued at its current levels, as discussed below. Our interactive dashboard analysis of Corning Earnings Preview has additional details.
(1) Revenues expected to be in line with the consensus estimates
Trefis estimates Corning’s Q2 2022 revenues to be around $3.8 billion, aligning with the consensus estimate.
Corning will likely see a pickup in demand for optical fiber as carriers continue to expand their 5G coverage.
The company will likely benefit from higher price realization for its display glass.
However, looking at environmental technologies, the sales may decline due to the impact of the semiconductor chip shortage on the automotive industry.
Looking back at Q1 2022, Corning’s revenues grew 15% y-o-y to $3.7 billion, led by a 28% growth in optical communications and an 11% rise in display technologies.
Our dashboard on Corning’s Revenues offers more details on the company’s segments.
2) EPS likely to align with the consensus estimates
Corning’s Q2 2022 earnings per share (EPS) is expected to be $0.58 per Trefis analysis, broadly aligning with the consensus estimate of $0.57.
Corning’s adjusted net income of $465 million in Q1 2022 reflected a 16% rise from its $402 million figure in the prior-year quarter. This can be attributed to higher revenues and a 40 bps improvement in net margins.
We expect the margins to improve in Q2 as well, led by pricing actions taken by the company.
For the full-year 2022, we expect the adjusted EPS to be higher at $2.36, compared to $2.07 in 2021.
(3) GLE stock looks undervalued
We estimate Corning’s Valuation to be around $45 per share, which is over 35% above the current market price of $33.
At its current levels, Corning stock is trading at a forward P/E multiple of just 14x based on our EPS estimate of $2.36 for 2022, compared to the last three-year average of 18x, implying that GLW stock has some more room for growth.
Furthermore, if the company reports upbeat Q2 results and provides an outlook better than the street estimates, the P/E multiple will likely be revised upward, resulting in higher levels for GLW stock.
Note: P/E Multiples are based on Share Price at the end of the year and reported (or expected) Earnings for the full year
While GLW stock looks like it has some more room for growth, it is helpful to see how Corning’s Peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.
Furthermore, the Covid-19 crisis has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for 3M vs. AGCO.
With inflation rising and the Fed raising interest rates, among other factors, GLW stock has fallen 12% this year. Can it drop more? See how low Corning stock can go by comparing its decline in previous market crashes. Here is a performance summary of all stocks in previous market crashes.
What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.
Returns Jul 2022
MTD [1] 2022
YTD [1] 2017-22
Total [2]
GLW Return 4% -12% 35%
S&P 500 Return 1% -20% 71%
Trefis Multi-Strategy Portfolio 3% -21% 214%
[1] Month-to-date and year-to-date as of 7/19/2022
[2] Cumulative total returns since the end of 2016
Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Although we expect Corning to report an in-line Q2, we find that GLW stock is undervalued at its current levels, as discussed below. Looking back at Q1 2022, Corning’s revenues grew 15% y-o-y to $3.7 billion, led by a 28% growth in optical communications and an 11% rise in display technologies.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q2 2022 revenues to be around $3.8 billion, aligning with the consensus estimate. 2) EPS likely to align with the consensus estimates Corning’s Q2 2022 earnings per share (EPS) is expected to be $0.58 per Trefis analysis, broadly aligning with the consensus estimate of $0.57.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. (1) Revenues expected to be in line with the consensus estimates Trefis estimates Corning’s Q2 2022 revenues to be around $3.8 billion, aligning with the consensus estimate. Note: P/E Multiples are based on Share Price at the end of the year and reported (or expected) Earnings for the full year While GLW stock looks like it has some more room for growth, it is helpful to see how Corning’s Peers fare on metrics that matter.
|
Our interactive dashboard analysis of Corning Earnings Preview has additional details. Although we expect Corning to report an in-line Q2, we find that GLW stock is undervalued at its current levels, as discussed below. (3) GLE stock looks undervalued We estimate Corning’s Valuation to be around $45 per share, which is over 35% above the current market price of $33.
|
2115a42a-97e9-4c65-b0d5-9079702a9a43
|
715996.0
|
2022-07-13 00:00:00 UTC
|
DuPont de Nemours Inc Shares Near 52-Week Low - Market Mover
|
DD
|
https://www.nasdaq.com/articles/dupont-de-nemours-inc-shares-near-52-week-low-market-mover
|
nan
|
nan
|
DuPont de Nemours Inc (DD) shares closed today at 1.8% above its 52 week low of $52.57, giving the company a market cap of $27B. The stock is currently down 31.5% year-to-date, down 29.4% over the past 12 months, and down 55.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.2%.
Trading Activity
Trading volume this week was 39.8% lower than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date lags the peer average by 123.3%
The company's stock price performance over the past 12 months lags the peer average by 238.7%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 63.9% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
DuPont de Nemours Inc (DD) shares closed today at 1.8% above its 52 week low of $52.57, giving the company a market cap of $27B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 123.3% The company's stock price performance over the past 12 months lags the peer average by 238.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 63.9% higher than the average peer.
|
DuPont de Nemours Inc (DD) shares closed today at 1.8% above its 52 week low of $52.57, giving the company a market cap of $27B. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
|
DuPont de Nemours Inc (DD) shares closed today at 1.8% above its 52 week low of $52.57, giving the company a market cap of $27B. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 123.3% The company's stock price performance over the past 12 months lags the peer average by 238.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 63.9% higher than the average peer. This story was produced by the Kwhen Automated News Generator.
|
DuPont de Nemours Inc (DD) shares closed today at 1.8% above its 52 week low of $52.57, giving the company a market cap of $27B. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.2%. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
|
e879a2cd-b0cd-428a-bc92-18ef417e646d
|
715997.0
|
2022-07-13 00:00:00 UTC
|
Is Warren Buffett Stock Celanese a Buy?
|
DD
|
https://www.nasdaq.com/articles/is-warren-buffett-stock-celanese-a-buy
|
nan
|
nan
|
Warren Buffett has been on a buying spree this year amid the market meltdown. During the first quarter of 2022, Buffett's Berkshire Hathaway added 16 new stocks to its portfolio. One of these new stocks is Celanese (NYSE: CE), a global chemicals producer. At the end of the first quarter, Berkshire had a more than 7% stake in the business.
Buffett is a fan of companies that generate plenty of free cash flow and have defensible positions in their industries, and Celanese fits the bill here. While it's not exactly a household name, this chemist's work is found all over the place. However, that hasn't spared it from a 34% decline so far in 2022, far worse than the S&P 500's 19% drop. Is this Buffett stock a buy now?
A chemical portfolio for everyone
Celanese has a huge portfolio of polymers and plastics, emulsions, cellulose, and other chemical products. These base products show up all over the place in paints and construction materials, clothes, medical devices, pharmaceuticals, electronics components, even food. Some top featured use cases on Celanese's website include 5G mobile network base stations and electric vehicles.
Though it has a hand in the production of some of today's top-trending tech trends, this is not a growth company. Chemicals that Celanese specializes in have already proliferated throughout the global manufacturing supply chain. Rather, this company is all about managing the bottom line. As is the case with many industrial materials producers, Celanese is an active acquirer and frequently enters new manufacturing joint ventures with other businesses.
Most recently, Celanese entered an agreement to acquire the Mobility and Materials (M&M) segment from its peer DuPont for $11 billion in cash. DuPont's M&M unit generated sales of $3.5 billion in 2021. Celanese will add the product line to its own automotive and industrial plastics segment.
Basically, this is not a sexy high-growth stock, but that's what can be expected from a Buffett stock. So why Celanese now? Maybe it was designed to be a bet on the inflation of basic materials prices -- although inflation and an uptick in Celanese's revenue this year haven't saved Celanese's stock from the market turmoil. More likely, though, Buffett and his company's interest in Celanese had to do with the price tag.
A cheap stock you need to buy now?
Celanese's stock can currently be purchased at a cheaper value than what Berkshire initially paid for it back in Q1. At recent prices, shares trade for a meager 8.5 times trailing 12-month free cash flow and less than 7 times current-year expected earnings. Even for a company with minimal amount of growth expectations, this is a compelling value.
Granted, the market seems to be discounting risk from the DuPont M&M acquisition. Celanese will need to take out new debt to finance the purchase, and it wasn't exactly a cheap price tag (DuPont M&M generated only about $800 million in operational EBITDA last year, so the $11 billion price puts a bit of a premium on the business). Nevertheless, Celanese is highly profitable and shouldn't have too much trouble digesting the big purchase. Celanese generated free cash flow of over $1.4 billion in the last 12-month stretch for a healthy free cash flow margin of 15.6%. The company had $614 million in cash and short-term investments and $3.99 billion in debt at the end of Q1, not an unreasonable amount for a capital-intensive manufacturing operation.
Besides trading on the cheap, Celanese is also a dividend stock -- it pays an annualized yield of roughly 2.4% a year. The company has been aggressively raising this payout over the last decade, with annual dividends paid up nearly 1,000% since 2012.
So is Celanese a buy? Maybe. Here are a few things that might sway you.
Celanese is a top chemicals company that should generate stable revenue and profits over time.
The company pays a dividend, making it ideal for investors seeking income.
Shares could be a long-term value after the steep tumble this year.
Granted, if you already own shares of Berkshire Hathaway, you might not need to add Celanese to your portfolio. After all, there are lots of great dividend stocks out there, so I see no need to over-allocate to this one in particular. And if you're a growth-oriented investor, pass on Celanese. There are better stocks to ride secular growth trends like 5G mobile and self-driving cars.
10 stocks we like better than Celanese
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Celanese wasn't one of them! That's right -- they think these 10 stocks are even better buys.
See the 10 stocks
*Stock Advisor returns as of June 2, 2022
Nicholas Rossolillo and his clients have positions in Berkshire Hathaway (B shares). The Motley Fool has positions in and recommends Berkshire Hathaway (B shares). The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
During the first quarter of 2022, Buffett's Berkshire Hathaway added 16 new stocks to its portfolio. Celanese will add the product line to its own automotive and industrial plastics segment. Granted, if you already own shares of Berkshire Hathaway, you might not need to add Celanese to your portfolio.
|
During the first quarter of 2022, Buffett's Berkshire Hathaway added 16 new stocks to its portfolio. Celanese will add the product line to its own automotive and industrial plastics segment. Granted, if you already own shares of Berkshire Hathaway, you might not need to add Celanese to your portfolio.
|
During the first quarter of 2022, Buffett's Berkshire Hathaway added 16 new stocks to its portfolio. Celanese will add the product line to its own automotive and industrial plastics segment. Granted, if you already own shares of Berkshire Hathaway, you might not need to add Celanese to your portfolio.
|
During the first quarter of 2022, Buffett's Berkshire Hathaway added 16 new stocks to its portfolio. Celanese will add the product line to its own automotive and industrial plastics segment. Granted, if you already own shares of Berkshire Hathaway, you might not need to add Celanese to your portfolio.
|
72c3bf7d-537a-432f-908a-894746a1830a
|
715998.0
|
2022-07-11 00:00:00 UTC
|
7 Overlooked Blue-Chip Stocks to Add to Your Buy List
|
DD
|
https://www.nasdaq.com/articles/7-overlooked-blue-chip-stocks-to-add-to-your-buy-list
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
While arguably most financial advisors will recommend their clients to bulk up their portfolios with proven large-capitalization ideas, you can leverage the present market dynamics in a nuanced manner with overlooked blue-chip stocks to buy. Rather than go with the flavors of the week, you may enjoy higher-probability successes by dipping a bit beneath the radar.
Why might this strategy be appropriate under the present context? For one thing, when everyone bets on the same horse, the payout for each individual tends to diminish. However, some of the biggest gains in the broader capital markets typically stem from ideas that people weren’t paying attention to. Therefore, the subsequent rush of excitement as the public catches on could buoy overlooked blue-chip stocks to buy.
7 Best Clean Air and Water Stocks to Buy Now
Another factor to consider is the balanced nature of large-cap firms. Yes, it’s admittedly far more exciting to wager on groundbreaking technology firms. However, in a downturn, these ideas could drop further or even implode altogether. On the flipside, by electing overlooked blue-chip stocks to buy, you’re engaging quality companies: It’s just that the rest of the market hasn’t recognized it yet.
Ticker Company Recent Price
CAT Caterpillar $176.73
GM General Motors $31.75
DD DuPont $54.88
IBM IBM $140.81
CI Cigna $279.20
ABBV AbbVie $153.81
BTI British American Tobacco $40.23
Caterpillar (CAT)
With a market cap of $95 billion, Caterpillar (NYSE:CAT) might not immediately strike you as one of the overlooked blue-chip stocks to buy. Indeed, throughout the runup to the 2016 presidential election, the industrial equipment manufacturer represented one of the key talking points.
Nevertheless, with the mainstream media focusing recently on brewing global recession fears, it’s understandable why many investors would now regard CAT as one of the overlooked blue-chip stocks. If a downturn hits us, the international community probably wouldn’t be too keen on building stuff.
But then, here’s the other side of the coin (literally). Rising inflation and the associated loss of purchasing power means that astute investors are looking for wealth-preserving assets. Historically, precious metals have been reliable safe havens and this narrative could rise once again. Should this happen, Caterpillar could easily go along for the ride as the company is a stalwart in the mining equipment sector.
General Motors (GM)
It’s tough being in the automotive industry right now. Yes, if global growth slows down due to inflation and other headwinds, consumer demand could fade, resulting in the easing of the semiconductor crisis. Theoretically, that would be a positive for General Motors (NYSE:GM). But then, the aforementioned loss of demand would impose a Pyrrhic victory.
As well, GM has plenty of competition. Electric vehicles have been exploding in popularity over the years and the military conflict in eastern Europe has only exacerbated this trend. Therefore, the fundamental realities of the auto sector suggest GM is overlooked.
But in my view, it’s one of the overlooked blue-chip stocks to buy. Sure, GM has tanked 48% on a year-to-date basis, let’s just keep it real. At the same time, it might be a substantially discounted opportunity because the company is rolling out exciting products for the green crowd and the gearheads.
7 Best Cheap Stocks Under $10 to Buy in July
The upcoming GMC Hummer EV should bring a macho cool factor to SUV ownership while the eighth-generation Corvette has been absolutely killing the sports car segment.
DuPont (DD)
When the topic of overlooked blue-chip stocks to buy came up, DuPont (NYSE:DD) was among the companies that came immediately to mind. Like other applied science and industrial chemicals firms, DuPont is vital to the economy. It’s just that few people talk about these companies. They physically undergird much-discussed innovations, but they’re not the innovation itself.
However, the boring nature of DuPont might make it an ideal candidate for a market comeback. To be fair, the comeback may take time, but it should be worth it. For instance, DuPont is actively researching flexible printed circuits, which “can be bent, folded and configured in nearly any shape or thickness imaginable.” Such circuits would have enormously positive implications for electric vehicles as well as 5G and the Internet of Things.
Further, DuPont produces materials that are practical right now, such as Kevlar. This synthetic lightweight fiber offers myriad applications, including automotive, aerospace and military/defense.
IBM (IBM)
One of the forefathers of the big technology market, IBM (NYSE:IBM) long dominated the sector thanks to its unparalleled computer technologies. But as computing gradually transitioned from on-premise platforms to the cloud, “Big Blue” started to lose its edge to other popular tech firms. Over the years, IBM stock languished in frustrating sideways consolidation patterns.
However, this appears to be changing. For instance, IBM is up nearly 4% YTD; whereas, the technology-centric Nasdaq index is down 24% during the same period. In fairness, in the trailing five years, shares have declined by 4% — not exactly riveting stuff. But as the popular big tech giants are struggling, it’s very encouraging that IBM is rising.
7 Cryptos to Sell to Escape the Crypto Contagion
Fundamentally, this contrast can continue operating in Big Blue’s favor. The company is making investments in myriad sectors, including artificial intelligence, cybersecurity and even the blockchain. As well, it’s gaining ground in the cloud space with its Red Hat acquisition.
Cigna (CI)
An American multinational firm specializing in managed healthcare and insurance, Cigna (NYSE:CI) is somewhat like a bail bondsman. It’s better to know one and not need it than need it and not know one. As such, Cigna is one of the overlooked blue-chip stocks but as you might imagine from the title of this article, it should belong on your buy list.
Frankly, the catalyst for Cigna’s bullish case is cynical. Healthcare and insurance products are always relevant. However, they can be more so during a market downturn. Should a recession really be on the horizon, you can expect consumers to cut down on their spending. However, core services like health insurance will be the last to get cut because they basically help prevent utter financial devastation.
Not surprisingly, CI has been a strong performer this year, gaining around 20% since the beginning of January. With the benchmark S&P 500 down almost 19% during the same period, CI looks mighty attractive.
AbbVie (ABBV)
Regarding the biotechnology and pharmaceutical space, the coronavirus pandemic imposed a bifurcated all-or-nothing dynamic. If you were directly working on a Covid-19 vaccine, your stock went up. Right now, Covid has become far less of a concern. However, the monkeypox outbreak may have some investors thinking about highly specialized biotech firms.
Yet again, AbbVie (NYSE:ABBV) finds itself on the outskirts of the hottest trends of its underlying industry. But on the positive front, that just makes ABBV one of the overlooked blue-chip stocks to buy. While the company offers many exciting products in its pipeline, I’m particularly interested in Botox, the neurotoxin that basically acts as the pharmaceutical fountain of youth.
7 Moonshot Investments Upending a $10 Trillion Industry
Indeed, some patients are getting Botox at a young age as a preventative measure against the signs of aging. Either way, with Covid-19 fears declining, more socialization opportunities will sprout. That makes ABBV a smart but somewhat cynical idea for overlooked blue-chip stocks to buy.
British American Tobacco (BTI)
British American Tobacco (NYSE:BTI) is one of the overlooked blue-chip stocks and many would argue for good reason. Thanks to multiple public service announcements, anti-tobacco advocacy groups have succeeded in helping to reduce smoking rates. Further, these trends are noticed worldwide. With the practice falling out of favor, you’d think that BTI would also be plunging.
Yet the stock has performed fairly well among non-hydrocarbon-related securities, gaining around 6% YTD. On a longer-term basis, shares have been rising since 2019. It begs the question, what the heck is going on here?
Certain scientific data suggests that “the propensity to become a smoker increases significantly during an economic downturn.” Considering the global inflation problem along with the possibility of upcoming job losses, the situation doesn’t look particularly bright. This might drive more demand for tobacco products.
And while cigarette smoking may have lost its luster, vaping has risen dramatically. So, BTI is relevant though you’re going to have to come to terms with the underlying controversy.
On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
The post 7 Overlooked Blue-Chip Stocks to Add to Your Buy List appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Ticker Company Recent Price CAT Caterpillar $176.73 GM General Motors $31.75 DD DuPont $54.88 DuPont (DD) When the topic of overlooked blue-chip stocks to buy came up, DuPont (NYSE:DD) was among the companies that came immediately to mind. The post 7 Overlooked Blue-Chip Stocks to Add to Your Buy List appeared first on InvestorPlace.
|
Ticker Company Recent Price CAT Caterpillar $176.73 GM General Motors $31.75 DD DuPont $54.88 DuPont (DD) When the topic of overlooked blue-chip stocks to buy came up, DuPont (NYSE:DD) was among the companies that came immediately to mind. The post 7 Overlooked Blue-Chip Stocks to Add to Your Buy List appeared first on InvestorPlace.
|
DuPont (DD) When the topic of overlooked blue-chip stocks to buy came up, DuPont (NYSE:DD) was among the companies that came immediately to mind. Ticker Company Recent Price CAT Caterpillar $176.73 GM General Motors $31.75 DD DuPont $54.88 The post 7 Overlooked Blue-Chip Stocks to Add to Your Buy List appeared first on InvestorPlace.
|
DuPont (DD) When the topic of overlooked blue-chip stocks to buy came up, DuPont (NYSE:DD) was among the companies that came immediately to mind. Ticker Company Recent Price CAT Caterpillar $176.73 GM General Motors $31.75 DD DuPont $54.88 The post 7 Overlooked Blue-Chip Stocks to Add to Your Buy List appeared first on InvestorPlace.
|
6668e72f-f976-489b-b9e3-b5ab7348a65b
|
715999.0
|
2022-07-01 00:00:00 UTC
|
Daily Dividend Report: PNC,DD,LNN,WSO,MU
|
DD
|
https://www.nasdaq.com/articles/daily-dividend-report%3A-pncddlnnwsomu
|
nan
|
nan
|
The board of directors of The PNC Financial Services Group declared a quarterly cash dividend on the common stock of $1.50 per share. The dividend will be payable Aug. 5, 2022, to shareholders of record at the close of business July 13, 2022.
DuPont today announced that its Board of Directors has declared a third quarter dividend of thirty-three cents per share on the outstanding Common Stock payable on September 15, 2022, to holders of record of said stock at the close of business on July 29, 2022.
Lindsay, a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.34 per share, payable August 31, 2022, to shareholders of record at the close of business on August 17, 2022. This quarterly cash dividend rate represents a 3.0% increase in the previous quarterly indicated rate of $0.33 per share. The new annual indicated rate is $1.36 per share, up from the previous annual indicated rate of $1.32 per share.
As of June 25, 2022, Lindsay had approximately 11.0 million shares outstanding, which are traded on the New York Stock Exchange under the symbol LNN.
Watsco's Board of Directors has declared a regular quarterly cash dividend of $2.20 on each outstanding share of its Common and Class B common stock payable on July 29, 2022 to shareholders of record at the close of business on July 15, 2022. Watsco has paid dividends to shareholders for 48 consecutive years.
On June 30, 2022, the Micron Technology Board of Directors declared a quarterly dividend of $0.115 per share, payable in cash on July 26, 2022, to shareholders of record as of the close of business on July 11, 2022.
VIDEO: Daily Dividend Report: PNC,DD,LNN,WSO,MU
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
VIDEO: Daily Dividend Report: PNC,DD,LNN,WSO,MU The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The board of directors of The PNC Financial Services Group declared a quarterly cash dividend on the common stock of $1.50 per share. Lindsay, a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.34 per share, payable August 31, 2022, to shareholders of record at the close of business on August 17, 2022.
|
VIDEO: Daily Dividend Report: PNC,DD,LNN,WSO,MU The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Lindsay, a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.34 per share, payable August 31, 2022, to shareholders of record at the close of business on August 17, 2022. Watsco's Board of Directors has declared a regular quarterly cash dividend of $2.20 on each outstanding share of its Common and Class B common stock payable on July 29, 2022 to shareholders of record at the close of business on July 15, 2022.
|
VIDEO: Daily Dividend Report: PNC,DD,LNN,WSO,MU The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. DuPont today announced that its Board of Directors has declared a third quarter dividend of thirty-three cents per share on the outstanding Common Stock payable on September 15, 2022, to holders of record of said stock at the close of business on July 29, 2022. Watsco's Board of Directors has declared a regular quarterly cash dividend of $2.20 on each outstanding share of its Common and Class B common stock payable on July 29, 2022 to shareholders of record at the close of business on July 15, 2022.
|
VIDEO: Daily Dividend Report: PNC,DD,LNN,WSO,MU The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. DuPont today announced that its Board of Directors has declared a third quarter dividend of thirty-three cents per share on the outstanding Common Stock payable on September 15, 2022, to holders of record of said stock at the close of business on July 29, 2022. Watsco's Board of Directors has declared a regular quarterly cash dividend of $2.20 on each outstanding share of its Common and Class B common stock payable on July 29, 2022 to shareholders of record at the close of business on July 15, 2022.
|
769614e6-5e99-4a8b-85f8-b8bd3df4b955
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.